No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3nyxA, 1.0000, 0.00, 1.000, 287, 285, NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE- THIOPHENE INHIBITOR
2, 4bbeC, 0.9220, 2.05, 0.509, 288, 281, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
3, 4bbeB, 0.9218, 2.05, 0.509, 288, 281, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
4, 5cf5B, 0.9211, 1.93, 0.464, 294, 280, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 7-[(DIMETHYL-13-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.026] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
5, 4zimB, 0.9210, 2.06, 0.480, 294, 281, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR
6, 5l3aA, 0.9207, 2.18, 0.491, 290, 283, FRAGMENT-BASED DISCOVERY OF 6-ARYLINDAZOLE JAK INHIBITORS
7, 5f1zA, 0.9203, 1.56, 0.974, 281, 274, STRUCTURE OF TYK2 WITH INHIBITOR 16: 3-AZANYL-5-[(2~{S})-3- METHYLBUTAN-2-YL]-7-[1-METHYL-5-(2-OXIDANYLPROPAN-2-YL)PYRAZOL-3-YL]- 1~{H}-PYRAZOLO[43-C]PYRIDIN-4-ONE
8, 4bbfA, 0.9196, 2.19, 0.507, 288, 282, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
9, 4e4mD, 0.9195, 1.98, 0.482, 296, 280, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
10, 4e4mB, 0.9194, 1.99, 0.482, 296, 280, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
11, 4bbfD, 0.9194, 2.19, 0.507, 288, 282, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
12, 4bbeD, 0.9193, 2.11, 0.509, 288, 281, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
13, 5tq5A, 0.9189, 2.31, 0.484, 291, 283, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
14, 5cf4B, 0.9184, 2.10, 0.480, 291, 281, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
15, 4bbeA, 0.9181, 2.13, 0.505, 288, 281, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
16, 5tq8A, 0.9178, 2.30, 0.491, 291, 283, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
17, 4e4mE, 0.9175, 2.08, 0.484, 296, 281, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
18, 4e4mA, 0.9175, 2.08, 0.484, 296, 281, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
19, 4gihA, 0.9172, 2.12, 0.943, 288, 281, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}BENZAMIDE
20, 3q32A, 0.9172, 1.99, 0.468, 291, 280, STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
21, 4gmyA, 0.9170, 2.21, 0.489, 298, 282, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH 26-DICHLORO-N-{2- [(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
22, 4gj2A, 0.9170, 2.12, 0.943, 288, 281, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-N-[2-({[(1R2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
23, 4gvjA, 0.9169, 2.47, 0.968, 290, 285, TYK2 (JH1) IN COMPLEX WITH ADENOSINE DI-PHOSPHATE
24, 4bbfC, 0.9168, 2.26, 0.500, 288, 282, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
25, 4gj3A, 0.9167, 2.13, 0.943, 288, 281, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-4-CYANO-N-[2-({[(1R2R)-2- FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
26, 4d0xA, 0.9167, 1.97, 0.486, 291, 280, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
27, 3e63A, 0.9167, 2.05, 0.484, 290, 281, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
28, 3e62A, 0.9164, 2.05, 0.484, 291, 281, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
29, 4d0wA, 0.9163, 2.06, 0.488, 289, 281, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
30, 4bbfB, 0.9162, 2.26, 0.504, 288, 282, AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
31, 4gfmA, 0.9161, 2.06, 0.484, 289, 281, JAK2 KINASE (JH1 DOMAIN) WITH 26-DICHLORO-N-(2-OXO-25- DIHYDROPYRIDIN-4-YL)BENZAMIDE
32, 3iokA, 0.9161, 1.86, 0.489, 285, 278, 2-AMINOPYRAZOLO[15-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
33, 3e64A, 0.9161, 2.07, 0.484, 291, 281, FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
34, 3krrA, 0.9160, 2.05, 0.484, 291, 281, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR
35, 3pjcA, 0.9157, 2.07, 0.487, 286, 279, CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY
36, 4py1A, 0.9156, 2.32, 0.965, 289, 283, CRYSTAL STRUCTURE OF TYK2 IN COMPLEX WITH COMPOUND 15 6-((25- DIMETHOXYPHENYL)THIO)-3-(1-METHYL-1H-PYRAZOL-4-YL)-[124]TRIAZOLO[4 3-B]PYRIDAZINE
37, 3nz0A, 0.9156, 1.85, 0.957, 285, 276, NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6
38, 4aqcB, 0.9155, 2.16, 0.480, 295, 281, TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2
39, 4giiA, 0.9154, 2.15, 0.943, 289, 281, TYK2 (JH1) IN COMPLEX WITH 26-DICHLORO-4-CYANO-N-{2- [(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
40, 4jiaA, 0.9150, 2.12, 0.480, 298, 281, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 9
41, 4e6qA, 0.9147, 2.03, 0.461, 296, 280, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12
42, 5wevA, 0.9143, 2.01, 0.484, 293, 279, IDENTIFICATION OF AN IMIDAZOPYRIDINE SCAFFOLD TO GENERATE POTENT AND SELECTIVE TYK2 INHIBITORS THAT DEMONSTRATE ACTIVITY IN AN IN VIVO PSORIASIS MODEL
43, 3q32B, 0.9143, 2.16, 0.480, 294, 281, STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
44, 4ythA, 0.9142, 2.02, 0.470, 287, 279, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASES
45, 4ivaA, 0.9142, 2.04, 0.471, 290, 280, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-[(8AS)- 2-[(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(8AH)- YL]CYCLOHEXANECARBONITRILE
46, 5cf6A, 0.9140, 1.97, 0.478, 285, 278, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-[(2S)-23-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-35810- TETRAAZATRICYCLO [7.3.0.026]DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
47, 4aqcA, 0.9137, 2.06, 0.486, 289, 280, TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2
48, 4zimA, 0.9131, 1.96, 0.489, 285, 278, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1- CARBOXAMIDE INHIBITOR
49, 3tjcB, 0.9131, 1.96, 0.486, 287, 278, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8
50, 5cf6B, 0.9126, 1.85, 0.469, 290, 277, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-[(2S)-23-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-35810- TETRAAZATRICYCLO [7.3.0.026]DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
51, 3kckA, 0.9125, 2.04, 0.487, 285, 279, A NOVEL CHEMOTYPE OF KINASE INHIBITORS
52, 5aepA, 0.9124, 1.98, 0.487, 287, 279, NOVEL PYRROLE CARBOXAMIDE INHIBITORS OF JAK2 AS POTENTIAL TREATMENT OF MYELOPROLIFERATIVE DISORDERS
53, 5cf5A, 0.9122, 1.86, 0.477, 287, 277, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 7-[(DIMETHYL-13-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.026] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
54, 4e1zA, 0.9122, 2.15, 0.868, 288, 280, STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR
55, 4ytfA, 0.9120, 1.84, 0.473, 283, 277, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASES
56, 4e6qB, 0.9120, 2.07, 0.461, 296, 280, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12
57, 3io7A, 0.9120, 1.86, 0.491, 282, 277, 2-AMINOPYRAZOLO[15-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
58, 2b7aB, 0.9119, 1.86, 0.469, 287, 277, THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
59, 5cf8B, 0.9118, 1.94, 0.487, 288, 277, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
60, 4ytcA, 0.9115, 1.98, 0.471, 284, 278, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE
61, 3tjdB, 0.9109, 2.00, 0.486, 287, 278, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19
62, 4ytiA, 0.9102, 1.90, 0.473, 284, 277, DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE
63, 4hgeB, 0.9102, 2.02, 0.486, 288, 278, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8
64, 3jy9A, 0.9101, 1.81, 0.475, 282, 276, JANUS KINASE 2 INHIBITORS
65, 5usyB, 0.9097, 2.21, 0.498, 287, 279, JAK2 JH1 IN COMPLEX WITH JNJ-7706621
66, 4ji9B, 0.9094, 2.05, 0.486, 288, 278, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209
67, 5tq3B, 0.9093, 2.23, 0.504, 285, 278, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
68, 5f20A, 0.9091, 1.51, 0.981, 274, 270, STRUCTURE OF TYK2 WITH INHIBITOR 4: 3-AZANYL-5-(2-METHYLPHENYL)-7-(1- METHYLPYRAZOL-3-YL)-1~{H}-PYRAZOLO[43-C]PYRIDIN-4-ONE
69, 6gl9B, 0.9087, 2.24, 0.472, 291, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 10 (FM475) 
70, 5usyA, 0.9087, 2.27, 0.496, 287, 280, JAK2 JH1 IN COMPLEX WITH JNJ-7706621
71, 3lxpA, 0.9084, 2.08, 0.938, 285, 276, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
72, 4p7eB, 0.9083, 1.89, 0.475, 285, 276, TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634
73, 6gl9A, 0.9082, 2.22, 0.472, 292, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 10 (FM475) 
74, 3fupB, 0.9082, 2.03, 0.486, 287, 278, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
75, 4f08A, 0.9079, 2.10, 0.484, 288, 279, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
76, 5lwnA, 0.9078, 2.25, 0.475, 290, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 5 (FM409)
77, 4f08B, 0.9076, 2.12, 0.484, 288, 279, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
78, 5lwmA, 0.9075, 2.26, 0.475, 290, 282, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 4 (FM381)
79, 3lxnA, 0.9075, 2.18, 0.946, 287, 279, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
80, 2w1iB, 0.9073, 1.85, 0.491, 284, 275, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
81, 5walA, 0.9072, 2.34, 0.964, 286, 281, IDENTIFICATION OF AN IMIDAZOPYRIDINE SCAFFOLD TO GENERATE POTENT AND SELECTIVE TYK2 INHIBITORS THAT DEMONSTRATE ACTIVITY IN AN IN VIVO PSORIASIS MODEL
82, 4f09A, 0.9071, 2.19, 0.477, 288, 279, DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
83, 2w1iA, 0.9068, 1.87, 0.491, 284, 275, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
84, 5cf8A, 0.9066, 1.94, 0.493, 285, 276, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
85, 4gl9C, 0.9066, 1.88, 0.491, 282, 275, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
86, 4gfoA, 0.9064, 1.29, 0.989, 272, 267, TYK2 KINASE (JH1 DOMAIN) WITH 26-DICHLORO-N-(2-OXO-25- DIHYDROPYRIDIN-4-YL)BENZAMIDE
87, 4ji9A, 0.9062, 1.83, 0.476, 284, 275, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209
88, 4e6dB, 0.9060, 1.92, 0.467, 286, 276, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7
89, 4e6dA, 0.9058, 1.89, 0.475, 286, 276, JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7
90, 5cf4A, 0.9053, 1.86, 0.473, 283, 275, CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH NN-DICYCLOPROPYL- 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-35810- TETRAAZATRICYCLO[7.3.0.06] DODECA-1(9)2(6)4711-PENTAENE-11- CARBOXAMIDE
91, 4e20A, 0.9053, 2.01, 0.891, 282, 276, STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE INHIBITOR
92, 3rvgA, 0.9049, 1.97, 0.489, 285, 276, CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[43-B]INDOL-4- CARBOXAMIDE INHIBITOR
93, 6drwA, 0.9048, 2.16, 0.489, 289, 278, JAK2 JH1 IN COMPLEX WITH JNJ-7706621 (CRYSTAL FORM 2) 
94, 4gl9D, 0.9046, 2.00, 0.489, 282, 276, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
95, 4gl9A, 0.9046, 1.91, 0.491, 282, 275, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
96, 4hgeA, 0.9044, 1.89, 0.491, 284, 275, JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8
97, 2b7aA, 0.9037, 1.88, 0.473, 284, 275, THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
98, 6bbvA, 0.9031, 2.30, 0.468, 289, 280, CRYSTAL STRUCTURE OF JAK2 IN COMPLEX WITH COMPOUND 25
99, 3tjcA, 0.9029, 2.00, 0.489, 284, 276, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8
100, 3eyhA, 0.9028, 2.21, 0.574, 285, 277, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
101, 3lpbB, 0.9027, 1.91, 0.485, 284, 274, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 28-DIARYL- QUINOXALINE INHIBITOR
102, 5tq3A, 0.9020, 2.13, 0.502, 282, 275, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
103, 6glaA, 0.9018, 2.19, 0.470, 288, 279, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 11 (FM481) 
104, 3fupA, 0.9015, 1.94, 0.473, 284, 275, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
105, 1yvjA, 0.9013, 2.40, 0.475, 288, 280, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
106, 3tjdA, 0.9005, 2.04, 0.489, 284, 276, CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19
107, 6glbB, 0.9004, 2.21, 0.470, 288, 279, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 20 (FM484) 
108, 5tq4A, 0.9004, 2.44, 0.495, 290, 281, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
109, 6glbA, 0.9001, 2.19, 0.466, 288, 279, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 20 (FM484) 
110, 4hvgA, 0.8985, 1.95, 0.482, 281, 274, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-2-HYDROXY-12-DIMETHYL-PROPYL)- AMIDE
111, 6glaB, 0.8984, 2.10, 0.469, 286, 277, CRYSTAL STRUCTURE OF JAK3 IN COMPLEX WITH COMPOUND 11 (FM481) 
112, 4rioA, 0.8978, 2.27, 0.484, 285, 277, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE CARBOXAMIDE INHIBITOR
113, 4p7eA, 0.8977, 2.01, 0.500, 281, 274, TRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE JAK1 INHIBITORS: FROM HIT IDENTIFICATION TO GLPG0634
114, 4gl9B, 0.8968, 2.01, 0.493, 280, 274, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
115, 3lpbA, 0.8967, 1.77, 0.487, 278, 271, CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 28-DIARYL- QUINOXALINE INHIBITOR
116, 2xa4A, 0.8967, 1.86, 0.494, 276, 271, INHIBITORS OF JAK2 KINASE DOMAIN
117, 4oliA, 0.8965, 1.76, 0.963, 539, 270, THE PSEUDOKINASE/KINASE PROTEIN FROM JAK-FAMILY MEMBER TYK2
118, 4d1sA, 0.8959, 2.10, 0.496, 280, 274, PYRROLE-3-CARBOXAMIDES AS POTENT AND SELECTIVE JAK2 INHIBITORS
119, 3eygA, 0.8954, 2.04, 0.579, 280, 273, CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
120, 4hvhA, 0.8951, 1.88, 0.485, 278, 272, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((R)-2-HYDROXY-12-DIMETHYL-PROPYL
121, 2xa4B, 0.8923, 1.70, 0.504, 275, 268, INHIBITORS OF JAK2 KINASE DOMAIN
122, 4qt1A, 0.8920, 1.89, 0.487, 277, 271, JAK3 KINASE DOMAIN IN COMPLEX WITH 1-[(3S)-1-ISOBUTYLSULFONYL-3- PIPERIDYL]-3-(5H-PYRROLO[23-B]PYRAZIN-2-YL)UREA
123, 3zepC, 0.8920, 2.02, 0.493, 276, 272, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
124, 5khwA, 0.8916, 2.06, 0.596, 276, 272, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP
125, 4i6qA, 0.8910, 1.90, 0.483, 277, 271, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-PHENOXY-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1-CYCLOPROPYL-ETHYL)-AMIDE
126, 5hx8A, 0.8906, 2.07, 0.573, 291, 274, JAK1 COMPLEX WITH 4-[(4-AMINOCYCLOHEXYL)AMINO]-3-(1H-BENZIMIDAZOL-2- YL)-1H-PYRIDIN-2-ONE
127, 4k77A, 0.8905, 2.08, 0.573, 282, 274, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6
128, 3lxlA, 0.8900, 2.11, 0.491, 281, 273, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
129, 5e1eA, 0.8899, 1.98, 0.574, 279, 272, HUMAN JAK1 KINASE IN COMPLEX WITH COMPOUND 30 AT 2.30 ANGSTROMS RESOLUTION
130, 4c61B, 0.8899, 1.69, 0.509, 274, 267, INHIBITORS OF JAK2 KINASE DOMAIN
131, 3zmmB, 0.8897, 1.70, 0.509, 274, 267, INHIBITORS OF JAK2 KINASE DOMAIN
132, 4z16B, 0.8895, 2.13, 0.502, 276, 271, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
133, 3zmmA, 0.8891, 1.79, 0.500, 273, 268, INHIBITORS OF JAK2 KINASE DOMAIN
134, 4c62A, 0.8890, 1.80, 0.500, 273, 268, INHIBITORS OF JAK2 KINASE DOMAIN
135, 4hvdA, 0.8889, 1.88, 0.485, 276, 270, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((S)-122-TRIMETHYL-PROPYL)-AMIDE
136, 5tozA, 0.8888, 2.07, 0.485, 278, 272, JAK3 WITH COVALENT INHIBITOR PF-06651600
137, 4k77B, 0.8883, 2.05, 0.571, 280, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6
138, 4e4nB, 0.8880, 2.07, 0.568, 280, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49
139, 4c61A, 0.8878, 1.62, 0.481, 272, 266, INHIBITORS OF JAK2 KINASE DOMAIN
140, 4fk6B, 0.8877, 2.22, 0.535, 284, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72
141, 5e1eB, 0.8875, 2.07, 0.571, 280, 273, HUMAN JAK1 KINASE IN COMPLEX WITH COMPOUND 30 AT 2.30 ANGSTROMS RESOLUTION
142, 5wo4A, 0.8874, 2.14, 0.573, 292, 274, JAK1 COMPLEXED WITH COMPOUND 28
143, 4fk6A, 0.8874, 2.29, 0.542, 285, 275, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72
144, 4c62B, 0.8874, 1.57, 0.506, 271, 265, INHIBITORS OF JAK2 KINASE DOMAIN
145, 4ivdB, 0.8869, 2.09, 0.575, 280, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34
146, 4ivbB, 0.8865, 2.00, 0.562, 280, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE
147, 3zepA, 0.8855, 1.96, 0.500, 274, 268, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
148, 4qpsC, 0.8853, 1.99, 0.496, 276, 270, CRYSTAL STRUCTURE OF JAK3 COMPLEXED TO N-[3-(6-PHENYLAMINO-PYRAZIN-2- YL)-3H-BENZOIMIDAZOL-5-YL]-ACRYLAMIDE
149, 4e5wA, 0.8853, 2.02, 0.562, 292, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26
150, 5khwB, 0.8852, 2.14, 0.592, 276, 272, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH ADP
151, 4e4nA, 0.8851, 2.07, 0.570, 291, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49
152, 5hx8B, 0.8850, 2.12, 0.575, 279, 273, JAK1 COMPLEX WITH 4-[(4-AMINOCYCLOHEXYL)AMINO]-3-(1H-BENZIMIDAZOL-2- YL)-1H-PYRIDIN-2-ONE
153, 4ei4B, 0.8848, 2.12, 0.553, 280, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20
154, 6c7yA, 0.8846, 2.04, 0.574, 273, 270, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS1 IN COMPLEX WITH JAK1 KINASE DOMAIN 
155, 6bbuA, 0.8845, 2.19, 0.555, 279, 274, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH COMPOUND 25
156, 4hviA, 0.8845, 1.81, 0.489, 274, 268, JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[23- B]PYRAZINE-7-CARBOXYLIC ACID ((R)-1-METHYL-2-OXO-2-PIPERIDIN-1-YL- ETHYL)-AMIDE
157, 4ivcB, 0.8843, 2.13, 0.553, 280, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXYL)ACETONITRILE
158, 5ttvA, 0.8840, 2.22, 0.489, 280, 272, JAK3 WITH COVALENT INHIBITOR 6
159, 4ivbA, 0.8840, 2.07, 0.574, 291, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXANECARBONITRILE
160, 4k6zA, 0.8838, 2.04, 0.574, 279, 272, THE JAK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 37
161, 5wo4B, 0.8836, 2.06, 0.562, 280, 272, JAK1 COMPLEXED WITH COMPOUND 28
162, 4ehzA, 0.8832, 2.32, 0.549, 290, 275, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
163, 5khxA, 0.8830, 2.11, 0.533, 276, 272, CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH PF-4950736
164, 4i5cB, 0.8830, 2.09, 0.574, 291, 272, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
165, 4i5cA, 0.8830, 2.10, 0.577, 279, 272, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
166, 3zc6B, 0.8830, 2.05, 0.481, 276, 270, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
167, 3zc6A, 0.8829, 2.28, 0.485, 277, 272, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
168, 4qpsA, 0.8828, 1.64, 0.494, 270, 265, CRYSTAL STRUCTURE OF JAK3 COMPLEXED TO N-[3-(6-PHENYLAMINO-PYRAZIN-2- YL)-3H-BENZOIMIDAZOL-5-YL]-ACRYLAMIDE
169, 4ehzB, 0.8828, 2.14, 0.557, 280, 273, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
170, 5ttuA, 0.8826, 1.71, 0.496, 271, 266, JAK3 WITH COVALENT INHIBITOR 7
171, 4ivdA, 0.8825, 2.05, 0.576, 290, 271, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34
172, 3lxkA, 0.8825, 2.12, 0.487, 279, 271, STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
173, 4ivcA, 0.8819, 2.12, 0.574, 291, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2- [(1R)-1-HYDROXYETHYL]IMIDAZO[45-D]PYRROLO[23-B]PYRIDIN-1(6H)- YL}CYCLOHEXYL)ACETONITRILE
174, 5ttsA, 0.8810, 1.91, 0.493, 274, 268, JAK3 WITH COVALENT INHIBITOR 4
175, 4e4lD, 0.8806, 2.25, 0.553, 281, 273, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
176, 4e4lE, 0.8803, 2.15, 0.559, 280, 272, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
177, 5tq7A, 0.8800, 1.93, 0.491, 275, 267, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
178, 5w86D, 0.8793, 2.15, 0.500, 272, 268, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
179, 3zepD, 0.8791, 1.93, 0.500, 272, 266, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
180, 4ehzC, 0.8790, 2.14, 0.555, 278, 272, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
181, 4ehzD, 0.8789, 2.22, 0.557, 280, 273, THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
182, 4e5wB, 0.8786, 2.03, 0.567, 278, 270, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26
183, 4ei4A, 0.8784, 2.05, 0.578, 289, 270, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20
184, 2jiuA, 0.8784, 1.96, 0.347, 303, 268, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
185, 5tq6A, 0.8774, 1.81, 0.474, 274, 266, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
186, 4e4lB, 0.8773, 2.12, 0.557, 279, 271, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
187, 3ikaA, 0.8766, 1.97, 0.341, 310, 267, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002
188, 4z16A, 0.8750, 1.99, 0.491, 271, 265, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
189, 4z16D, 0.8745, 2.13, 0.500, 271, 266, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
190, 4z16C, 0.8743, 2.12, 0.500, 271, 266, CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN COVALENTLY BOUND TO N-(3- (((5-CHLORO-2-((2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO) PYRIMIDIN-4-YL)AMINO)METHYL)PHENYL)ACRYLAMIDE
191, 5tq6B, 0.8740, 1.81, 0.475, 271, 265, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
192, 5w86C, 0.8739, 2.43, 0.494, 273, 269, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
193, 3zc6C, 0.8738, 2.25, 0.489, 275, 270, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
194, 4e4lA, 0.8736, 2.03, 0.565, 277, 269, JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
195, 4v0gB, 0.8732, 2.32, 0.489, 272, 268, JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR
196, 5xgnA, 0.8721, 2.05, 0.345, 302, 267, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/C797S IN COMPLEX WITH GO6976
197, 4riyD, 0.8719, 2.14, 0.343, 297, 268, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
198, 3zepB, 0.8716, 1.71, 0.498, 268, 263, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
199, 5w86A, 0.8715, 1.99, 0.500, 269, 264, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
200, 4g5pA, 0.8715, 2.08, 0.341, 299, 267, CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
201, 5tq7B, 0.8712, 1.77, 0.494, 269, 263, DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN
202, 4riwD, 0.8707, 2.14, 0.343, 297, 268, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
203, 5vo6A, 0.8704, 1.95, 0.491, 271, 265, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE INHIBITOR
204, 4wd5A, 0.8701, 2.15, 0.347, 307, 268, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH QL-X138
205, 5ugaA, 0.8695, 2.11, 0.343, 283, 268, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH 4-(4-{[2-{[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9- (PROPAN-2-YL)-9H-PURIN-6-YL]AMINO}PHENYL)-1-METHYLPIPERAZIN-1-IUM
206, 5hg7A, 0.8694, 1.94, 0.343, 280, 265, EGFR (L858R T790M V948R) IN COMPLEX WITH 1-{(3R4R)-3-[5-CHLORO-2- (1-METHYL-1H-PYRAZOL-4-YLAMINO)-7H-PYRROLO[23-D]PYRIMIDIN-4- YLOXYMETHYL]-4-METHOXY-PYRROLIDIN-1-YL}PROPENONE (PF-06459988)
207, 5hg5A, 0.8693, 2.11, 0.347, 302, 268, EGFR (L858R T790M V948R) IN COMPLEX WITH N-{3-[(2-{[4-(4- METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-7H-PYRROLO[23-D]PYRIMIDIN-4-YL) OXY]PHENYL}PROP-2-ENAMIDE
208, 5u8lA, 0.8682, 2.01, 0.333, 289, 267, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH A SULFONYL FLUORIDE PROBE XO44
209, 4rixD, 0.8676, 2.21, 0.345, 297, 267, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
210, 5ugcA, 0.8673, 1.90, 0.345, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(3- METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO]-9-METHYL-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
211, 5jebA, 0.8673, 2.07, 0.342, 299, 266, CRYSTAL STRUCTURE OF EGFR TYROSINE KINASE DOMAIN WITH NOVEL INHIBITOR OF ACTIVE STATE OF HER2
212, 5hg8A, 0.8670, 2.15, 0.347, 300, 268, EGFR (L858R T790M V948R) IN COMPLEX WITH N-[3-({2-[(1-METHYL-1H- PYRAZOL-4-YL)AMINO]-7H-PYRROLO[23-D]PYRIMIDIN-4-YL}OXY)PHENYL]PROP- 2-ENAMIDE
213, 5ug8A, 0.8668, 1.91, 0.345, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(1- METHYL-1H-PYRAZOL-4-YL)AMINO]-9-(PROPAN-2-YL)-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
214, 5ug9A, 0.8664, 1.92, 0.345, 280, 264, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH A COVALENT INHIBITOR N-[(3R4R)-4-FLUORO-1-{6-[(3- METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO]-9-(PROPAN-2-YL)-9H-PURIN-2- YL}PYRROLIDIN-3-YL]PROPANAMIDE
215, 2jitA, 0.8663, 2.05, 0.316, 299, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
216, 5hg9A, 0.8657, 1.95, 0.345, 280, 264, EGFR (L858R T790M V948R) IN COMPLEX WITH 1-[(3R4R)-3-[({2-[(1- METHYL-1H-PYRAZOL-4-YL)AMINO]-7H-PYRROLO[23-D]PYRIMIDIN-4-YL}OXY) METHYL]-4-(TRIFLUOROMETHYL)PYRROLIDIN-1-YL]PROP-2-EN-1-ONE
217, 4lrmE, 0.8651, 2.12, 0.345, 290, 267, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
218, 4lrmC, 0.8646, 2.13, 0.345, 293, 267, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
219, 4li5A, 0.8645, 2.26, 0.345, 306, 267, EGFR-K IN COMPLEX WITH N-[3-[[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2- YL]AMINO]-4-METHOXY-PHENYL] PROP-2-ENAMIDE
220, 5w86B, 0.8641, 2.17, 0.494, 267, 263, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
221, 4lrmD, 0.8641, 2.16, 0.345, 289, 267, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
222, 4lrmB, 0.8635, 2.22, 0.341, 293, 267, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
223, 4lrmA, 0.8634, 2.14, 0.345, 307, 267, EGFR D770_N771INSNPG IN COMPLEX WITH PD168393
224, 4v0gA, 0.8604, 2.13, 0.504, 267, 262, JAK3 IN COMPLEX WITH A COVALENT EGFR INHIBITOR
225, 4jq8A, 0.8593, 2.25, 0.342, 303, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4B
226, 4riyB, 0.8584, 2.16, 0.348, 293, 264, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
227, 3zc6D, 0.8583, 2.03, 0.496, 267, 262, CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH AN INDAZOLE SUBSTITUTED PYRROLOPYRAZINE INHIBITOR
228, 5wfjA, 0.8581, 1.87, 0.492, 265, 260, THE JAK3 KINASE DOMAIN IN COMPLEX WITH A COVALENT INHIBITOR
229, 5ugbA, 0.8577, 2.27, 0.346, 307, 266, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN IN COMPLEX WITH 4-(4-{[2- {[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9-(PROPAN-2-YL)-9H-PURIN-6- YL]AMINO}PHENYL)-1-METHYLPIPERAZIN-1-IUM
230, 4ewhA, 0.8576, 2.33, 0.383, 274, 266, CO-CRYSTAL STRUCTURE OF ACK1 WITH INHIBITOR
231, 4jr3A, 0.8571, 2.31, 0.342, 303, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 3G
232, 4jq7A, 0.8570, 2.31, 0.342, 303, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 2A
233, 3pp0A, 0.8568, 1.99, 0.318, 286, 264, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
234, 2j6mA, 0.8568, 2.33, 0.342, 306, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
235, 5cy3A, 0.8567, 2.28, 0.352, 276, 267, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT AND ORALLY BIOAVAILABLE BENZISOTHIAZOLE INHIBITOR
236, 4jrvA, 0.8566, 2.24, 0.343, 300, 265, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4C
237, 4tksA, 0.8565, 2.21, 0.343, 307, 265, NATIVE-SAD PHASING FOR HUMAN EGFR KINASE DOMAIN.
238, 2itpA, 0.8563, 2.32, 0.346, 305, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
239, 2gs6A, 0.8561, 2.25, 0.347, 311, 265, CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE
240, 1m17A, 0.8555, 2.33, 0.342, 312, 266, EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
241, 4riwB, 0.8553, 2.20, 0.345, 293, 264, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
242, 2itqA, 0.8553, 2.31, 0.346, 300, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
243, 5cavA, 0.8550, 2.35, 0.342, 306, 266, EGFR KINASE DOMAIN WITH COMPOUND 41A
244, 5eg3A, 0.8548, 2.47, 0.352, 301, 267, CRYSTAL STRUCTURE OF THE ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH THE CSH2 DOMAIN OF PHOSPHOLIPASE C GAMMA (PLCGAMMA)
245, 4k33A, 0.8548, 2.47, 0.365, 293, 266, CRYSTAL STRUCTURE OF FGF RECEPTOR 3 (FGFR3) KINASE DOMAIN HARBORING THE K650E MUTATION A GAIN-OF-FUNCTION MUTATION RESPONSIBLE FOR THANATOPHORIC DYSPLASIA TYPE II AND SPERMATOCYTIC SEMINOMA
246, 4rixB, 0.8547, 2.22, 0.346, 293, 263, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
247, 4zogA, 0.8542, 2.13, 0.326, 269, 264, VX-680/MK-0457 BINDS TO HUMAN ABL1 ALSO IN INACTIVE DFG CONFORMATIONS.
248, 3pp0B, 0.8542, 2.19, 0.321, 296, 265, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
249, 4ewhB, 0.8538, 2.34, 0.381, 273, 265, CO-CRYSTAL STRUCTURE OF ACK1 WITH INHIBITOR
250, 1m14A, 0.8535, 2.33, 0.346, 307, 266, TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
251, 2g2hB, 0.8526, 2.08, 0.326, 272, 264, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
252, 3eqpB, 0.8525, 2.30, 0.381, 270, 265, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
253, 2j5eA, 0.8520, 2.32, 0.340, 309, 265, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
254, 2itwA, 0.8518, 2.39, 0.346, 300, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
255, 4i23A, 0.8510, 2.21, 0.335, 304, 263, CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH DACOMITINIB (SOAKED)
256, 3vjnA, 0.8509, 2.18, 0.342, 297, 263, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH AMPPNP.
257, 3bceC, 0.8505, 2.24, 0.356, 286, 264, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
258, 3eqpA, 0.8504, 2.24, 0.384, 268, 263, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
259, 2ivuA, 0.8504, 2.50, 0.374, 288, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474
260, 5xdkA, 0.8503, 2.48, 0.346, 307, 266, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH CO-1686
261, 3r7oA, 0.8503, 2.31, 0.325, 299, 265, STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG
262, 2f4jA, 0.8502, 2.23, 0.330, 287, 264, STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
263, 2qohA, 0.8501, 1.99, 0.330, 271, 261, CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
264, 3gqiA, 0.8498, 2.40, 0.370, 304, 265, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
265, 2ivsA, 0.8497, 2.58, 0.372, 284, 266, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
266, 3bkbA, 0.8496, 2.45, 0.321, 373, 265, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)
267, 2ivtA, 0.8496, 2.51, 0.374, 288, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
268, 4zogB, 0.8495, 2.03, 0.332, 268, 262, VX-680/MK-0457 BINDS TO HUMAN ABL1 ALSO IN INACTIVE DFG CONFORMATIONS.
269, 2x2kA, 0.8495, 2.51, 0.374, 289, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
270, 2qohB, 0.8494, 1.98, 0.330, 281, 261, CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
271, 4gfgA, 0.8491, 2.54, 0.363, 277, 267, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R9021
272, 3eqrA, 0.8491, 2.30, 0.379, 270, 264, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
273, 3bceB, 0.8490, 2.23, 0.357, 286, 263, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
274, 5flfD, 0.8489, 2.56, 0.375, 290, 267, DISEASE LINKED MUTATION IN FGFR
275, 3ugcA, 0.8488, 2.58, 0.494, 274, 265, STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594
276, 5cxhA, 0.8487, 2.52, 0.348, 277, 267, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT ORALLY BIOAVAILABLE THIAZOLE INHIBITOR
277, 3q6wA, 0.8486, 2.36, 0.325, 297, 265, STRUCTURE OF DUALLY-PHOSPHORYLATED MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG WITH SPECIFICITY FOR THE ACTIVATED RECEPTOR
278, 2z60A, 0.8485, 2.02, 0.330, 281, 261, CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A
279, 5flfA, 0.8484, 2.60, 0.375, 296, 267, DISEASE LINKED MUTATION IN FGFR
280, 4id7A, 0.8483, 2.24, 0.388, 268, 263, ACK1 KINASE IN COMPLEX WITH THE INHIBITOR CIS-3-[8-AMINO-1-(4- PHENOXYPHENYL)IMIDAZO[15-A]PYRAZIN-3-YL]CYCLOBUTANOL
281, 3clyA, 0.8483, 2.33, 0.358, 289, 265, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
282, 2gs2A, 0.8477, 2.41, 0.343, 305, 265, CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
283, 4twpB, 0.8474, 2.14, 0.327, 271, 263, THE CRYSTAL STRUCTURE OF HUMAN ABL1 T315I GATEKEEPER MUTANT KINASE DOMAIN IN COMPLEX WITH AXITINIB
284, 3bceA, 0.8474, 2.33, 0.356, 285, 264, CRYSTAL STRUCTURE OF THE ERBB4 KINASE
285, 4wnmA, 0.8472, 2.44, 0.351, 273, 265, SYK CATALYTIC DOMAIN IN COMPLEX WITH A POTENT TRIAZOLOPYRIDINE INHIBITOR
286, 4iwdA, 0.8472, 2.36, 0.326, 299, 264, STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-8033 ANALOG
287, 2x2mA, 0.8471, 2.50, 0.379, 286, 264, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
288, 4ckiA, 0.8470, 2.52, 0.375, 293, 264, CRYSTAL STRUCTURE OF ONCOGENIC RET TYROSINE KINASE M918T BOUND TO ADENOSINE
289, 5y5uA, 0.8469, 2.22, 0.354, 266, 263, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
290, 3eqrB, 0.8468, 2.27, 0.376, 271, 263, CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
291, 5y9tA, 0.8467, 2.46, 0.350, 300, 266, CRYSTAL STRUCTURE OF EGFR T790M MUTANT IN COMPLEX WITH NAQUOTINIB 
292, 5tr6A, 0.8466, 2.37, 0.352, 272, 264, DISCOVERY OF TAK-659 AN ORALLY AVAILABLE INVESTIGATIONAL INHIBITOR OF SPLEEN TYROSINE KINASE (SYK)
293, 4ckjA, 0.8466, 2.50, 0.386, 292, 264, CRYSTAL STRUCTURE OF RET TYROSINE KINASE DOMAIN BOUND TO ADENOSINE
294, 3ug1A, 0.8465, 2.12, 0.342, 296, 260, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN THE APO FORM
295, 1m52A, 0.8465, 2.19, 0.318, 271, 264, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
296, 1m52B, 0.8462, 2.14, 0.312, 272, 263, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
297, 5em8A, 0.8461, 2.33, 0.346, 303, 263, EGFR KINASE DOMAIN WITH PYRIDONE COMPOUND 13: 4-[(2-METHOXYPHENYL) AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2-OXIDANYLIDENE-1~{H}- PYRIDINE-3-CARBOXAMIDE
298, 5j9yA, 0.8460, 2.30, 0.354, 300, 263, EGFR-T790M IN COMPLEX WITH PYRAZOLOPYRIMIDINE INHIBITOR 1B
299, 4wkqA, 0.8460, 2.06, 0.340, 296, 259, 1.85 ANGSTROM STRUCTURE OF EGFR KINASE DOMAIN WITH GEFITINIB
300, 4rx7A, 0.8460, 2.53, 0.353, 272, 266, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT TRIAZINE INHIBITOR
301, 5ui0B, 0.8459, 2.64, 0.360, 304, 267, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING AN E565A/K659M DOUBLE GAIN-OF-FUNCTION MUTATION
302, 3cblA, 0.8459, 2.44, 0.321, 356, 265, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
303, 2xynA, 0.8457, 2.10, 0.322, 264, 261, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
304, 2jiuB, 0.8457, 2.24, 0.307, 309, 264, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
305, 3vjoA, 0.8456, 2.29, 0.335, 298, 263, CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH AMPPNP.
306, 5u6bD, 0.8455, 2.33, 0.284, 291, 264, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
307, 4j96B, 0.8453, 2.64, 0.363, 305, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER.
308, 3w2qA, 0.8453, 2.50, 0.346, 307, 266, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH HKI-272
309, 4r3pA, 0.8451, 2.43, 0.343, 310, 265, CRYSTAL STRUCTURES OF EGFR IN COMPLEX WITH MIG6
310, 5flfB, 0.8450, 2.63, 0.375, 292, 267, DISEASE LINKED MUTATION IN FGFR
311, 4j98B, 0.8450, 2.64, 0.363, 304, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659Q MUTATION.
312, 5u6bB, 0.8448, 2.32, 0.284, 291, 264, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
313, 4i21B, 0.8448, 2.36, 0.337, 302, 267, CRYSTAL STRUCTURE OF L858R + T790M EGFR KINASE DOMAIN IN COMPLEX WITH MIG6 PEPTIDE
314, 4i21A, 0.8447, 2.37, 0.337, 290, 267, CRYSTAL STRUCTURE OF L858R + T790M EGFR KINASE DOMAIN IN COMPLEX WITH MIG6 PEPTIDE
315, 2ivvA, 0.8446, 2.63, 0.385, 282, 265, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1
316, 5tt7A, 0.8445, 2.33, 0.357, 274, 263, DISCOVERY OF TAK-659 AN ORALLY AVAILABLE INVESTIGATIONAL INHIBITOR OF SPLEEN TYROSINE KINASE (SYK)
317, 3kulB, 0.8445, 2.40, 0.302, 271, 265, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
318, 4xg3A, 0.8442, 2.09, 0.358, 262, 260, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
319, 5ui0A, 0.8438, 2.68, 0.360, 301, 267, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING AN E565A/K659M DOUBLE GAIN-OF-FUNCTION MUTATION
320, 2eb2A, 0.8437, 2.22, 0.344, 305, 262, CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S)
321, 2x2lA, 0.8436, 2.53, 0.373, 287, 263, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
322, 5czhA, 0.8435, 2.54, 0.346, 311, 266, EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATE
323, 5cxzA, 0.8434, 2.40, 0.354, 269, 263, SYK CATALYTIC DOMAIN COMPLEXED WITH NAPHTHYRIDINE INHIBITOR
324, 4zjvA, 0.8434, 2.32, 0.331, 282, 266, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH MITOGEN- INDUCIBLE GENE 6 PROTEIN
325, 5hibA, 0.8433, 2.23, 0.352, 314, 261, EGFR KINASE DOMAIN MUTANT TMLR WITH A PYRAZOLOPYRIMIDINE INHIBITOR
326, 1xbcA, 0.8431, 2.37, 0.350, 268, 263, CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN
327, 4wa9B, 0.8430, 2.21, 0.314, 276, 264, THE CRYSTAL STRUCTURE OF HUMAN ABL1 WILD TYPE KINASE DOMAIN IN COMPLEX WITH AXITINIB
328, 2g2hA, 0.8430, 2.34, 0.330, 272, 264, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
329, 4j98A, 0.8429, 2.69, 0.363, 304, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659Q MUTATION.
330, 2jitB, 0.8428, 2.31, 0.307, 312, 264, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
331, 4j96A, 0.8427, 2.70, 0.363, 302, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER.
332, 3w2oA, 0.8426, 2.49, 0.346, 305, 266, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH TAK-285
333, 3kxxA, 0.8426, 2.61, 0.376, 305, 266, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
334, 4pv0A, 0.8423, 2.37, 0.357, 268, 263, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH AN IMIDAZOPYRAZINE INHIBITOR
335, 4twpA, 0.8422, 2.00, 0.328, 266, 259, THE CRYSTAL STRUCTURE OF HUMAN ABL1 T315I GATEKEEPER MUTANT KINASE DOMAIN IN COMPLEX WITH AXITINIB
336, 3vf8A, 0.8422, 2.24, 0.356, 265, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416
337, 4xg6A, 0.8421, 2.41, 0.348, 271, 264, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
338, 6bl8A, 0.8419, 2.44, 0.311, 270, 264, PREDICTING THE CONFORMATIONAL VARIABILITY OF ABL TYROSINE KINASE USING MOLECULAR DYNAMICS SIMULATIONS AND MARKOV STATE MODELS
339, 3kf4B, 0.8419, 2.12, 0.326, 270, 261, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
340, 2hziB, 0.8418, 2.02, 0.323, 264, 260, ABL KINASE DOMAIN IN COMPLEX WITH PD180970
341, 4dfnA, 0.8417, 2.52, 0.366, 269, 265, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH AN ADAMANTYLPYRAZINE INHIBITOR
342, 3kf4A, 0.8415, 2.02, 0.332, 281, 259, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
343, 3kxxB, 0.8414, 2.62, 0.376, 305, 266, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
344, 5cziA, 0.8413, 2.47, 0.343, 310, 265, EGFR L858R MUTANT IN COMPLEX WITH A SHC PEPTIDE SUBSTRATE
345, 2fo0A, 0.8413, 2.25, 0.330, 465, 264, ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
346, 4rssA, 0.8412, 2.45, 0.351, 269, 265, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE SYK WITH AN INHIBITOR
347, 1xbaA, 0.8412, 2.26, 0.356, 266, 261, CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
348, 3ue4A, 0.8411, 2.37, 0.323, 270, 263, STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
349, 3dk3B, 0.8407, 2.06, 0.323, 269, 260, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
350, 1u59A, 0.8407, 2.35, 0.333, 282, 264, CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
351, 3dk7B, 0.8405, 1.99, 0.324, 268, 259, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
352, 3ug2A, 0.8403, 2.20, 0.342, 299, 260, CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH GEFITINIB
353, 3fqhA, 0.8402, 2.19, 0.358, 262, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
354, 2gqgA, 0.8402, 2.36, 0.327, 277, 263, X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
355, 4xg9B, 0.8401, 2.32, 0.359, 265, 262, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
356, 2x2mB, 0.8401, 2.45, 0.375, 279, 261, CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
357, 5lmbA, 0.8400, 2.28, 0.352, 264, 261, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
358, 3srvB, 0.8400, 2.26, 0.356, 263, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR
359, 1oplB, 0.8399, 2.32, 0.331, 365, 263, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
360, 4r3rA, 0.8398, 2.46, 0.340, 309, 265, CRYSTAL STRUCTURES OF EGFR IN COMPLEX WITH MIG6
361, 1opkA, 0.8398, 2.39, 0.330, 449, 264, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
362, 2g2fB, 0.8395, 2.06, 0.317, 264, 259, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
363, 3hmiA, 0.8394, 2.29, 0.322, 268, 264, THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-3-{[4- (AMINOSULFONYL)PHENYL]AMINO}-N-(26-DIFLUOROPHENYL)-1H-124- TRIAZOLE-1-CARBOTHIOAMIDE
364, 3dqwC, 0.8394, 2.32, 0.333, 275, 261, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
365, 3dqwD, 0.8392, 2.32, 0.333, 276, 261, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
366, 3cd3A, 0.8392, 2.25, 0.318, 352, 261, CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
367, 5flfC, 0.8391, 2.54, 0.364, 283, 264, DISEASE LINKED MUTATION IN FGFR
368, 6fekA, 0.8390, 2.54, 0.374, 294, 262, ONCOGENIC POINT MUTATION OF RET RECEPTOR TYROSINE KINASE
369, 3vf9A, 0.8390, 2.31, 0.356, 265, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 027
370, 1qpjA, 0.8390, 2.30, 0.349, 265, 261, CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
371, 1oplA, 0.8390, 2.40, 0.330, 451, 264, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
372, 5c26A, 0.8389, 2.66, 0.358, 272, 265, CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 1
373, 2of4A, 0.8389, 2.39, 0.351, 271, 262, CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
374, 3w2pA, 0.8388, 2.55, 0.342, 308, 266, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 2
375, 4rx8A, 0.8384, 2.41, 0.359, 269, 262, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT TRIAZINE INHIBITOR2
376, 4j99C, 0.8384, 2.67, 0.353, 291, 266, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
377, 4xg3B, 0.8383, 2.53, 0.356, 267, 264, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
378, 2xynC, 0.8383, 2.10, 0.328, 262, 259, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
379, 4xliB, 0.8382, 2.19, 0.327, 264, 260, CRYSTAL STRUCTURE OF ABL2/ARG KINASE IN COMPLEX WITH DASATINIB
380, 4j97A, 0.8382, 2.56, 0.352, 282, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
381, 4j95B, 0.8381, 2.72, 0.363, 282, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
382, 2itxA, 0.8381, 2.40, 0.347, 307, 262, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP- PNP
383, 3srvA, 0.8380, 2.26, 0.362, 262, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR
384, 2gqgB, 0.8380, 2.31, 0.328, 276, 262, X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
385, 1u4dB, 0.8374, 2.09, 0.391, 262, 258, STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
386, 2of2A, 0.8373, 2.41, 0.351, 271, 262, CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
387, 5ugxA, 0.8371, 2.72, 0.350, 297, 266, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A E565A/D650V DOUBLE GAIN-OF-FUNCTION MUTATION
388, 2pvfA, 0.8371, 2.63, 0.360, 285, 264, CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
389, 1pkgA, 0.8370, 2.41, 0.347, 290, 262, STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
390, 2xynB, 0.8369, 2.25, 0.322, 264, 261, HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
391, 4j99B, 0.8367, 2.74, 0.363, 291, 267, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
392, 2v7aA, 0.8367, 2.36, 0.324, 269, 262, CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
393, 2j0lA, 0.8364, 2.44, 0.348, 274, 264, CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP.
394, 5lmaA, 0.8363, 2.55, 0.357, 267, 263, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
395, 3kxzA, 0.8363, 2.28, 0.350, 263, 260, THE COMPLEX CRYSTAL STRUCTURE OF LCK WITH A PROBE MOLECULE W259
396, 5amnA, 0.8362, 2.49, 0.387, 287, 261, THE DISCOVERY OF 2-SUBSTITUTED PHENOL QUINAZOLINES AS POTENT AND SELECTIVE RET KINASE INHIBITORS
397, 4j95C, 0.8362, 2.62, 0.355, 281, 265, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
398, 1qpdA, 0.8362, 2.37, 0.345, 270, 261, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
399, 5c27A, 0.8361, 2.66, 0.347, 272, 265, CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 2
400, 4xg7A, 0.8361, 2.32, 0.356, 266, 261, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
401, 2ofuA, 0.8361, 2.40, 0.349, 272, 261, X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
402, 4j97C, 0.8360, 2.58, 0.357, 283, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
403, 4zjvB, 0.8359, 2.18, 0.345, 273, 261, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH MITOGEN- INDUCIBLE GENE 6 PROTEIN
404, 4dflA, 0.8359, 2.18, 0.355, 263, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A SULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR
405, 4puzB, 0.8358, 2.39, 0.352, 265, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH GS- 9973
406, 4j97B, 0.8357, 2.58, 0.354, 283, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
407, 3bymA, 0.8357, 2.40, 0.349, 271, 261, X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK
408, 2g2fA, 0.8357, 2.53, 0.326, 275, 264, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
409, 3fqeA, 0.8355, 2.40, 0.352, 269, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306
410, 1qpcA, 0.8355, 2.41, 0.349, 270, 261, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
411, 6bl8B, 0.8353, 2.23, 0.315, 268, 260, PREDICTING THE CONFORMATIONAL VARIABILITY OF ABL TYROSINE KINASE USING MOLECULAR DYNAMICS SIMULATIONS AND MARKOV STATE MODELS
412, 4g5jA, 0.8352, 1.87, 0.343, 307, 254, CRYSTAL STRUCTURE OF EGFR KINASE IN COMPLEX WITH BIBW2992
413, 4rx9A, 0.8350, 2.43, 0.364, 268, 261, SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT PYRIMIDINE INHIBITOR
414, 3kmmA, 0.8349, 2.42, 0.349, 270, 261, STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITOR
415, 4j97D, 0.8346, 2.52, 0.355, 285, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
416, 3ac1A, 0.8346, 2.42, 0.349, 270, 261, CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
417, 5uhnA, 0.8343, 2.76, 0.350, 282, 266, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A N549H/E565A DOUBLE GAIN-OF-FUNCTION MUTATION
418, 5y5tA, 0.8342, 2.29, 0.358, 263, 260, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
419, 3kxxD, 0.8342, 2.61, 0.379, 288, 264, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
420, 3kxxC, 0.8341, 2.71, 0.377, 286, 265, STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
421, 5fedA, 0.8340, 2.05, 0.344, 288, 256, EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE INHIBITOR.
422, 4xeyA, 0.8340, 2.17, 0.315, 269, 260, CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL TYROSINE KINASE
423, 4puzA, 0.8337, 2.42, 0.352, 263, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH GS- 9973
424, 3kulA, 0.8337, 2.48, 0.313, 267, 262, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
425, 3dqwA, 0.8337, 2.41, 0.333, 278, 261, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
426, 5tiuA, 0.8335, 2.29, 0.363, 266, 259, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH INHIBITOR
427, 5hezD, 0.8334, 2.53, 0.460, 289, 263, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
428, 1u54B, 0.8334, 2.11, 0.391, 261, 256, CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
429, 5feqA, 0.8333, 2.24, 0.357, 290, 258, EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE
430, 4j99D, 0.8333, 2.65, 0.364, 281, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
431, 3ad6A, 0.8333, 2.44, 0.349, 272, 261, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
432, 3ac5A, 0.8333, 2.42, 0.349, 270, 261, CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
433, 4xliA, 0.8332, 2.33, 0.327, 264, 260, CRYSTAL STRUCTURE OF ABL2/ARG KINASE IN COMPLEX WITH DASATINIB
434, 3ue4B, 0.8332, 2.33, 0.324, 268, 262, STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
435, 3ac2A, 0.8331, 2.44, 0.352, 270, 261, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
436, 3lckA, 0.8329, 2.45, 0.349, 270, 261, THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK) ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
437, 3lcdA, 0.8329, 2.58, 0.340, 290, 262, INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
438, 3acjA, 0.8329, 2.44, 0.352, 270, 261, CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
439, 2zm4A, 0.8329, 2.44, 0.352, 270, 261, CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK ACTIVATED FORM (AUTO- PHOSPHORYLATED ON TYR394)
440, 2zm1A, 0.8329, 2.44, 0.349, 270, 261, CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
441, 2hziA, 0.8329, 2.50, 0.326, 268, 264, ABL KINASE DOMAIN IN COMPLEX WITH PD180970
442, 6d8eA, 0.8328, 2.36, 0.351, 304, 259, DISCOVERY OF A HIGHLY POTENT AND BROADLY EFFECTIVE EGFR AND HER2 EXON 20 INSERTION MUTANT INHIBITOR 
443, 3ikaB, 0.8328, 2.27, 0.299, 310, 261, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002
444, 3dqwB, 0.8328, 2.42, 0.333, 278, 261, C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
445, 3ad4A, 0.8328, 2.45, 0.352, 270, 261, CRYSTAL STRUCTURE OF METHOXY BENZOFURAN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
446, 3ac4A, 0.8328, 2.45, 0.352, 270, 261, CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
447, 2v7aB, 0.8328, 2.33, 0.322, 268, 261, CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
448, 5hezB, 0.8325, 2.59, 0.460, 289, 263, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
449, 3ac3A, 0.8325, 2.45, 0.349, 270, 261, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
450, 5ghvB, 0.8324, 2.41, 0.356, 265, 261, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
451, 3w2sA, 0.8324, 2.11, 0.352, 307, 256, EGFR KINASE DOMAIN WITH COMPOUND4
452, 3ackA, 0.8324, 2.45, 0.349, 270, 261, CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
453, 3byoA, 0.8323, 2.47, 0.349, 270, 261, X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5  4 :56]PYRIMIDO[12-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK
454, 1qpeA, 0.8322, 2.45, 0.349, 270, 261, STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
455, 3ad5A, 0.8321, 2.46, 0.349, 270, 261, CRYSTAL STRUCTURE OF TRIAZOLONE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
456, 2g2iB, 0.8321, 2.18, 0.333, 265, 258, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
457, 5ghvA, 0.8320, 2.42, 0.356, 265, 261, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
458, 2zybA, 0.8319, 2.44, 0.349, 270, 261, CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
459, 2pvyA, 0.8319, 2.51, 0.352, 288, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
460, 2g2iA, 0.8319, 2.23, 0.332, 271, 259, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
461, 4i0tA, 0.8318, 2.27, 0.368, 266, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(5678- TETRAHYDRO-IMIDAZO[15-A]PYRIDIN-1-YL)-5H-PYRROLO[23-B]PYRAZINE-7- CARBOXYLIC ACID TERT-BUTYLAMIDE
462, 2pvyD, 0.8318, 2.52, 0.352, 283, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
463, 2dq7X, 0.8317, 2.07, 0.332, 262, 256, CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
464, 5yu9D, 0.8315, 2.05, 0.361, 300, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
465, 5hezC, 0.8315, 2.59, 0.456, 289, 263, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
466, 3ac8A, 0.8315, 2.45, 0.352, 270, 261, CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK (AUTO-PHOSPHORYLATED ON TYR394)
467, 4fl1A, 0.8314, 2.84, 0.366, 268, 265, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
468, 1y57A, 0.8313, 2.47, 0.337, 452, 261, STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
469, 4hzrA, 0.8312, 2.11, 0.383, 261, 256, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN
470, 4xg4A, 0.8310, 2.39, 0.358, 264, 260, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
471, 2psqA, 0.8308, 2.67, 0.348, 287, 264, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
472, 5x2aB, 0.8307, 2.39, 0.344, 322, 259, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
473, 3fqhB, 0.8307, 2.20, 0.358, 258, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
474, 4hzrB, 0.8306, 2.10, 0.382, 258, 254, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN
475, 3dk7A, 0.8306, 2.16, 0.324, 265, 259, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
476, 5x2aC, 0.8305, 2.01, 0.354, 303, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
477, 5x2fC, 0.8304, 2.00, 0.354, 302, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
478, 3dk3A, 0.8304, 2.23, 0.323, 266, 260, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
479, 1u54A, 0.8304, 2.07, 0.384, 262, 255, CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
480, 1oecA, 0.8304, 2.85, 0.342, 280, 266, FGFR2 KINASE DOMAIN
481, 4fyoA, 0.8303, 2.38, 0.351, 267, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH N-{(S)-1- [7-(34-DIMETHOXY-PHENYLAMINO)-THIAZOLO[54-D]PYRIMIDIN-5-YL]- PYRROLIDIN-3-YL}-TEREPHTHALAMIC ACID
482, 5uwdA, 0.8302, 2.06, 0.327, 271, 254, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN (L858R T790M V948R) IN COMPLEX WITH THE COVALENT INHIBITOR CO-1686
483, 4zseC, 0.8302, 1.89, 0.340, 301, 253, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
484, 4fynA, 0.8302, 2.48, 0.358, 267, 260, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 3-(8-{4- [ETHYL-(2-HYDROXY-ETHYL)-AMINO]-PHENYLAMINO}-IMIDAZO[12-A]PYRAZIN-5- YL)-PHENOL
485, 3b2tA, 0.8301, 2.92, 0.352, 288, 267, STRUCTURE OF PHOSPHOTRANSFERASE
486, 4i0sA, 0.8300, 2.36, 0.351, 267, 259, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(6- CHLORO-1-METHYL-1H-INDAZOL-3-YL)-5H-PYRROLO[23-B]PYRAZINE-7- CARBOXYLIC ACID ISOPROPYLAMIDE
487, 3sxsA, 0.8300, 2.25, 0.315, 264, 260, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEXED WITH PP2
488, 2rfeA, 0.8298, 2.21, 0.346, 286, 257, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
489, 2hz4B, 0.8298, 2.05, 0.328, 261, 256, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
490, 1k2pA, 0.8298, 2.09, 0.324, 258, 256, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE DOMAIN
491, 1gjoA, 0.8297, 2.86, 0.342, 280, 266, THE FGFR2 TYROSINE KINASE DOMAIN
492, 1xbbA, 0.8293, 2.48, 0.358, 268, 260, CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC
493, 4zseA, 0.8292, 2.06, 0.349, 297, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
494, 5uglA, 0.8291, 2.81, 0.353, 285, 266, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 TYROSINE KINASE DOMAIN HARBORING THE D650V ACTIVATING MUTATION
495, 4i0rA, 0.8290, 2.27, 0.362, 264, 257, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(345- TRIMETHOXY-PHENYL)-5H-PYRROLO[23-B]PYRAZINE-7-CARBOXYLIC ACID ISOPROPYLAMIDE
496, 5x2cA, 0.8289, 2.07, 0.357, 304, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(5)
497, 4i20A, 0.8288, 2.56, 0.337, 287, 267, CRYSTAL STRUCTURE OF MONOMERIC (V948R) PRIMARY ONCOGENIC MUTANT L858R EGFR KINASE DOMAIN
498, 3zzeA, 0.8285, 2.47, 0.328, 286, 259, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N - ((3Z)-4-CHLORO-7-METHYL-2-OXO-12-DIHYDRO-3H-INDOL-3- YLIDENE)-2-(4-HYDROXYPHENYL)PROPANOHYDRAZIDE
499, 5x2fD, 0.8282, 2.39, 0.344, 309, 259, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
500, 5hezA, 0.8282, 2.57, 0.458, 287, 262, JAK2 KINASE (JH1 DOMAIN) MUTANT P1057A IN COMPLEX WITH TG101209
501, 4px6A, 0.8282, 2.24, 0.362, 262, 257, SYK CATALYTIC DOMAIN IN COMPLEX WITH A POTENT PYRIDOPYRIMIDINONE INHIBITOR
502, 4hjoA, 0.8282, 2.44, 0.336, 278, 259, CRYSTAL STRUCTURE OF THE INACTIVE EGFR TYROSINE KINASE DOMAIN WITH ERLOTINIB
503, 3rhkA, 0.8282, 2.44, 0.338, 298, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
504, 2hz4A, 0.8279, 2.27, 0.328, 262, 259, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
505, 2psqB, 0.8278, 2.95, 0.357, 286, 266, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
506, 2rf9A, 0.8275, 2.34, 0.344, 280, 262, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
507, 4fz6A, 0.8274, 2.38, 0.364, 266, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH [6-((S)-2- METHYL-PYRROLIDIN-1-YL)-PYRIDIN-2-YL]-(6-PHENYL-IMIDAZO[12- B]PYRIDAZIN-8-YL)-AMINE
508, 4lqmA, 0.8273, 2.38, 0.345, 305, 258, EGFR L858R IN COMPLEX WITH PD168393
509, 4yjoA, 0.8272, 2.68, 0.361, 267, 263, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000222
510, 3fqsA, 0.8271, 2.69, 0.368, 268, 261, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406
511, 1u46B, 0.8271, 1.95, 0.387, 257, 253, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
512, 2gs7A, 0.8270, 2.52, 0.337, 281, 261, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
513, 5gtzA, 0.8269, 2.63, 0.350, 317, 260, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH JTS-1-39
514, 2gs7B, 0.8269, 2.44, 0.323, 288, 260, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
515, 3w2rA, 0.8266, 1.93, 0.316, 297, 253, EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 4
516, 4j99A, 0.8265, 2.67, 0.363, 280, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
517, 2py3B, 0.8265, 2.82, 0.354, 284, 263, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
518, 4xeyB, 0.8262, 2.06, 0.306, 359, 255, CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL TYROSINE KINASE
519, 4fz7A, 0.8262, 2.41, 0.357, 265, 258, CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 6-((1R2S)- 2-AMINO-CYCLOHEXYLAMINO)-4-(6-ETHYL-PYRIDIN-2-YLAMINO)-PYRIDAZINE-3- CARBOXYLIC ACID AMIDE
520, 5cnnB, 0.8261, 2.17, 0.344, 304, 256, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT I682Q
521, 5x2aA, 0.8260, 2.06, 0.354, 297, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
522, 3ri1A, 0.8260, 2.96, 0.367, 285, 267, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
523, 5feeA, 0.8259, 2.09, 0.346, 287, 254, EGFR KINASE DOMAIN T790M MUTANT IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE INHIBITOR.
524, 4wrgA, 0.8258, 2.02, 0.340, 289, 253, 1.9 ANGSTROM STRUCTURE OF EGFR KINASE DOMAIN
525, 5x2kA, 0.8257, 2.58, 0.354, 314, 260, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH WZ4003
526, 2j5fA, 0.8257, 2.40, 0.345, 308, 258, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
527, 5x2cB, 0.8256, 2.18, 0.344, 303, 256, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(5)
528, 3rhkB, 0.8256, 2.49, 0.342, 299, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
529, 3plsA, 0.8255, 2.51, 0.344, 298, 262, RON IN COMPLEX WITH LIGAND AMP-PNP
530, 2pwlA, 0.8255, 2.78, 0.345, 284, 264, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
531, 4aoiA, 0.8254, 2.35, 0.332, 289, 256, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H- PYRROLO(23-B)PYRIDIN-3-YL)METHYL)-(124)TRIAZOLO( 43-B)(124) TRIAZIN-6-YL)BENZONITRILE
532, 4yc8B, 0.8253, 2.20, 0.322, 264, 258, C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE
533, 5x2fB, 0.8251, 2.43, 0.344, 312, 259, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
534, 2pwlB, 0.8251, 2.91, 0.355, 286, 265, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
535, 4r1vA, 0.8248, 2.60, 0.332, 289, 259, IDENTIFICATION AND OPTIMIZATION OF PYRIDAZINONES AS POTENT AND SELECTIVE C-MET KINASE INHIBITORS
536, 3zclA, 0.8247, 2.38, 0.332, 289, 256, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-3-(1-(1H-PYRROLO(23-B)PYRIDIN-3-YL)ETHYL)-N-ISOPROPYL-( 124)TRIAZOLO(43-B)PYRIDAZIN-6-AMINE
537, 4f4pA, 0.8246, 2.22, 0.363, 262, 256, SYK IN COMPLEX WITH LIGAND LASW836
538, 4yc8A, 0.8245, 2.01, 0.319, 259, 254, C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE
539, 3zbxA, 0.8245, 2.36, 0.332, 282, 256, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR 6- ((6-(4-FLUOROPHENYL)-(124)TRIAZOLO(43-B)(124)TRIAZIN- 3-YL)METHYL)QUINOLINE.
540, 2g15A, 0.8245, 2.65, 0.324, 301, 262, STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
541, 3ri1B, 0.8244, 2.99, 0.353, 283, 266, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
542, 5d41B, 0.8241, 2.13, 0.353, 302, 255, EGFR KINASE DOMAIN IN COMPLEX WITH MUTANT SELECTIVE ALLOSTERIC INHIBITOR
543, 4i24B, 0.8240, 2.43, 0.362, 304, 257, STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB
544, 4i1zA, 0.8240, 2.62, 0.341, 287, 267, CRYSTAL STRUCTURE OF THE MONOMERIC (V948R) FORM OF THE GEFITINIB/ERLOTINIB RESISTANT EGFR KINASE DOMAIN L858R+T790M
545, 3dk6A, 0.8240, 2.11, 0.324, 262, 256, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
546, 2wd1A, 0.8240, 2.56, 0.333, 289, 258, HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
547, 2g1tC, 0.8240, 2.23, 0.332, 276, 256, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
548, 4xg8A, 0.8238, 2.16, 0.361, 258, 255, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
549, 3zc5A, 0.8238, 2.49, 0.339, 289, 257, X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-6-(1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-(124)TRIAZOLO(43- B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE.
550, 4ll0A, 0.8237, 1.99, 0.327, 291, 254, EGFR L858R/T790M IN COMPLEX WITH PD168393
551, 4ap7A, 0.8237, 2.42, 0.327, 289, 257, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4- FLUOROPHENYL)-(124)TRIAZOLO(43-B)(124)TRIAZIN-3-YL)METHYL) PHENOL
552, 4xg9A, 0.8236, 2.35, 0.362, 259, 257, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
553, 4j95A, 0.8236, 2.72, 0.359, 279, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
554, 4zseB, 0.8235, 2.36, 0.359, 313, 256, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
555, 3b2tB, 0.8234, 2.76, 0.346, 287, 263, STRUCTURE OF PHOSPHOTRANSFERASE
556, 2r4bA, 0.8234, 2.00, 0.350, 292, 254, ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
557, 3zxzA, 0.8233, 2.48, 0.342, 289, 257, X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET
558, 2rfeB, 0.8233, 2.24, 0.345, 273, 255, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
559, 4zauA, 0.8232, 2.18, 0.350, 283, 254, AZD9291 COMPLEX WITH WILD TYPE EGFR
560, 2hz4C, 0.8232, 2.14, 0.328, 259, 256, ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
561, 5x27A, 0.8231, 2.42, 0.342, 302, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(5)
562, 5gtyH, 0.8231, 2.07, 0.361, 300, 252, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
563, 5x26A, 0.8230, 2.42, 0.342, 302, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(3)
564, 2rfdA, 0.8230, 2.01, 0.333, 288, 252, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
565, 2rfeD, 0.8229, 2.23, 0.354, 278, 254, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
566, 5lmbB, 0.8228, 2.48, 0.360, 261, 258, HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
567, 1u4dA, 0.8228, 2.08, 0.385, 258, 252, STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
568, 5x28A, 0.8227, 2.45, 0.342, 310, 257, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH SKLB(6)
569, 3w32A, 0.8226, 2.51, 0.330, 317, 261, EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 20A
570, 2g1tB, 0.8224, 2.27, 0.332, 273, 256, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
571, 5zwjA, 0.8223, 2.02, 0.351, 267, 251, CRYSTAL STRUCTURE OF EGFR 675-1022 T790M/C797S/V948R IN COMPLEX WITH EAI045 
572, 5yu9C, 0.8223, 2.05, 0.361, 306, 252, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
573, 3u6iA, 0.8223, 1.96, 0.333, 281, 252, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 58A
574, 6g4yB, 0.8220, 2.45, 0.198, 328, 262, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 1A 
575, 2r2pA, 0.8220, 2.83, 0.297, 283, 266, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
576, 4ll0B, 0.8219, 1.91, 0.321, 281, 252, EGFR L858R/T790M IN COMPLEX WITH PD168393
577, 5xgnB, 0.8217, 2.32, 0.306, 308, 258, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/C797S IN COMPLEX WITH GO6976
578, 2itoA, 0.8217, 2.42, 0.342, 303, 257, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH IRESSA
579, 3lctA, 0.8213, 2.77, 0.307, 308, 264, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
580, 3faaE, 0.8213, 2.99, 0.244, 330, 270, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
581, 2q0bB, 0.8212, 2.84, 0.351, 282, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
582, 4xg2A, 0.8211, 2.25, 0.365, 259, 255, CRYSTAL STRUCTURE OF LIGAND-FREE SYK
583, 2wgjA, 0.8209, 2.49, 0.327, 289, 257, X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
584, 2r4bB, 0.8208, 2.09, 0.354, 291, 254, ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
585, 3sxrA, 0.8207, 2.27, 0.319, 260, 257, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
586, 3kcfE, 0.8207, 2.88, 0.230, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
587, 3lcsA, 0.8204, 2.78, 0.303, 304, 264, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
588, 2g1tD, 0.8204, 2.19, 0.325, 277, 255, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
589, 5t8pB, 0.8203, 2.52, 0.202, 328, 263, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO BENZOXEPIN COMPOUND 2
590, 5eobA, 0.8201, 2.64, 0.336, 288, 259, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
591, 2ittA, 0.8201, 2.44, 0.346, 302, 257, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
592, 5x2fA, 0.8200, 2.38, 0.359, 301, 256, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(6)
593, 2pz5B, 0.8200, 2.83, 0.352, 280, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
594, 2py3A, 0.8200, 2.83, 0.355, 282, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
595, 2pzpB, 0.8198, 2.84, 0.352, 282, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
596, 5t68B, 0.8197, 2.61, 0.358, 264, 260, CRYSTAL STRUCTURE OF SYK CATALYTIC DOMAIN IN COMPLEX WITH A FURO[32- D]PYRIMIDINE
597, 5mjbA, 0.8197, 2.70, 0.281, 276, 263, KINASE DOMAIN OF HUMAN EPHB1 G703C MUTANT COVALENTLY BOUND TO A QUINAZOLINE-BASED INHIBITOR
598, 2rgpA, 0.8197, 2.05, 0.347, 284, 251, STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE A POTENT DUAL INHIBITOR
599, 2itzA, 0.8196, 2.40, 0.344, 302, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
600, 2q0bA, 0.8194, 2.85, 0.351, 280, 262, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
601, 2itnA, 0.8194, 2.47, 0.342, 304, 257, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
602, 1xkkA, 0.8194, 2.10, 0.345, 289, 252, EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR- GW572016
603, 4g5pB, 0.8193, 2.18, 0.298, 303, 255, CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
604, 3faaC, 0.8193, 2.99, 0.241, 330, 270, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
605, 1k2pB, 0.8193, 2.11, 0.322, 258, 255, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE DOMAIN
606, 5t68A, 0.8192, 2.62, 0.358, 266, 260, CRYSTAL STRUCTURE OF SYK CATALYTIC DOMAIN IN COMPLEX WITH A FURO[32- D]PYRIMIDINE
607, 5x2aD, 0.8191, 2.22, 0.354, 297, 254, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R IN COMPLEX WITH SKLB(3)
608, 1iasD, 0.8191, 2.92, 0.238, 330, 269, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
609, 5t8qB, 0.8189, 2.54, 0.202, 328, 263, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO ARYL PYRROLE FRAGMENT 17
610, 4wd5B, 0.8189, 2.46, 0.304, 304, 260, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH QL-X138
611, 4g3cB, 0.8189, 2.53, 0.202, 327, 263, CRYSTAL STRUCTURE OF APO MURINE NF-KAPPAB INDUCING KINASE (NIK)
612, 1iasE, 0.8189, 2.91, 0.238, 330, 269, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
613, 4yjtA, 0.8186, 2.85, 0.364, 268, 261, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233
614, 4yjpA, 0.8186, 2.88, 0.374, 263, 262, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223
615, 4fl2A, 0.8186, 2.47, 0.337, 555, 258, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
616, 2wkmA, 0.8186, 2.83, 0.335, 286, 260, X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
617, 5yu9A, 0.8185, 2.00, 0.347, 302, 251, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
618, 5t8oB, 0.8185, 2.41, 0.199, 328, 261, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO IMIDAZOBENZOXEPIN COMPOUND 3
619, 2g1tA, 0.8185, 2.14, 0.327, 271, 254, A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
620, 1k9aA, 0.8185, 2.04, 0.377, 439, 252, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
621, 4trlA, 0.8184, 2.55, 0.313, 268, 259, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
622, 2z8cA, 0.8184, 2.89, 0.316, 297, 263, PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2- YL]AMINO}PHENYL)ACETIC ACID
623, 5yu9B, 0.8183, 2.00, 0.364, 295, 250, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH IBRUTINIB
624, 2pzrB, 0.8183, 2.84, 0.349, 282, 261, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
625, 5gtyD, 0.8182, 1.93, 0.348, 297, 250, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
626, 2ityA, 0.8182, 2.39, 0.352, 300, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA
627, 1u46A, 0.8182, 2.07, 0.392, 255, 250, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
628, 1k9aE, 0.8182, 2.05, 0.377, 440, 252, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
629, 1b6cD, 0.8181, 3.19, 0.234, 326, 273, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
630, 5gtyE, 0.8180, 1.92, 0.348, 297, 250, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
631, 1iasC, 0.8180, 2.93, 0.238, 330, 269, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
632, 1b6cB, 0.8180, 3.21, 0.234, 326, 273, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
633, 4yjuA, 0.8179, 2.65, 0.368, 262, 258, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249
634, 3u6hA, 0.8179, 1.99, 0.335, 280, 251, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 26
635, 5gtyG, 0.8178, 2.01, 0.356, 299, 250, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
636, 5d41A, 0.8178, 1.83, 0.344, 300, 250, EGFR KINASE DOMAIN IN COMPLEX WITH MUTANT SELECTIVE ALLOSTERIC INHIBITOR
637, 3lzbA, 0.8178, 2.09, 0.353, 265, 252, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
638, 2x7oB, 0.8177, 2.94, 0.230, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
639, 2pvyC, 0.8177, 2.51, 0.359, 285, 256, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
640, 2hk5A, 0.8176, 2.50, 0.349, 269, 258, HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247
641, 1b6cF, 0.8176, 3.16, 0.234, 326, 273, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
642, 5gtyA, 0.8175, 2.11, 0.357, 300, 252, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
643, 3belA, 0.8175, 2.03, 0.348, 280, 250, X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR
644, 2x7oE, 0.8175, 2.94, 0.234, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
645, 2pzrA, 0.8175, 2.64, 0.344, 280, 259, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
646, 2itvA, 0.8175, 2.46, 0.346, 303, 257, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
647, 1iasA, 0.8175, 2.94, 0.238, 330, 269, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
648, 3pozA, 0.8174, 2.11, 0.359, 293, 251, EGFR KINASE DOMAIN COMPLEXED WITH TAK-285
649, 3dk6B, 0.8173, 1.94, 0.319, 259, 251, CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
650, 1k9aB, 0.8173, 2.10, 0.377, 441, 252, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
651, 3faaD, 0.8172, 3.05, 0.244, 330, 270, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
652, 2x7oA, 0.8172, 2.95, 0.234, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
653, 3kcfD, 0.8171, 2.95, 0.238, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
654, 2x7oC, 0.8171, 2.94, 0.234, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
655, 5hcyA, 0.8169, 2.24, 0.356, 302, 253, EGFR KINASE DOMAIN MUTANT TMLR WITH 3-CARBOXAMIDE AZAINDOLE COMPOUND 13
656, 2pzpA, 0.8169, 2.68, 0.347, 280, 259, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
657, 2pz5A, 0.8169, 2.69, 0.347, 280, 259, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
658, 3zewA, 0.8168, 2.46, 0.275, 269, 258, CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE
659, 3zfxA, 0.8167, 2.40, 0.293, 267, 256, CRYSTAL STRUCTURE OF EPHB1
660, 3lzbB, 0.8167, 2.09, 0.353, 265, 252, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
661, 5mjbB, 0.8166, 2.86, 0.278, 278, 266, KINASE DOMAIN OF HUMAN EPHB1 G703C MUTANT COVALENTLY BOUND TO A QUINAZOLINE-BASED INHIBITOR
662, 3dkcA, 0.8166, 2.66, 0.313, 312, 262, STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
663, 2x7oD, 0.8165, 2.95, 0.234, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR
664, 2b4sB, 0.8162, 2.81, 0.318, 294, 261, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
665, 1b6cH, 0.8162, 3.23, 0.234, 326, 273, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
666, 4hctA, 0.8160, 2.37, 0.299, 265, 254, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52
667, 3ppzB, 0.8158, 2.09, 0.289, 264, 253, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
668, 3faaA, 0.8158, 2.99, 0.245, 328, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
669, 5zj6A, 0.8157, 2.29, 0.333, 271, 252, CRYSTAL STRUCTURE OF HCK KINASE COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4- PHENOXYPHENYL)-7H-PYRROLO[2;3-D]PYRIMIDIN-4-AMINE 
670, 5gtyB, 0.8157, 2.08, 0.355, 299, 251, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
671, 4yhfB, 0.8157, 2.20, 0.304, 269, 253, BRUTON S TYROSINE KINASE IN COMPLEX WITH A T-BUTYL CYANOACRYLAMIDE INHIBITOR
672, 4idvC, 0.8157, 2.50, 0.210, 335, 262, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
673, 5y5uB, 0.8155, 2.40, 0.361, 257, 255, CRYSTAL STRUCTURES OF SPLEEN TYROSINE KINASE IN COMPLEX WITH A NOVEL INHIBITOR 
674, 5cnnA, 0.8155, 2.05, 0.355, 300, 251, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT I682Q
675, 4uxlA, 0.8155, 2.55, 0.332, 288, 259, STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH PF-06463922
676, 3d7uC, 0.8155, 2.04, 0.375, 257, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
677, 3d7uA, 0.8155, 2.04, 0.375, 257, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
678, 5zj6B, 0.8154, 2.30, 0.333, 270, 252, CRYSTAL STRUCTURE OF HCK KINASE COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4- PHENOXYPHENYL)-7H-PYRROLO[2;3-D]PYRIMIDIN-4-AMINE 
679, 3kcfA, 0.8154, 2.91, 0.231, 328, 268, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
680, 5t8pA, 0.8153, 2.55, 0.198, 327, 262, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO BENZOXEPIN COMPOUND 2
681, 3zfxH, 0.8153, 2.46, 0.293, 266, 256, CRYSTAL STRUCTURE OF EPHB1
682, 4idvB, 0.8151, 2.50, 0.214, 335, 262, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
683, 2pvyB, 0.8151, 2.48, 0.357, 286, 255, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
684, 3a4pA, 0.8150, 2.37, 0.325, 285, 255, HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
685, 3zfxD, 0.8148, 2.36, 0.294, 265, 255, CRYSTAL STRUCTURE OF EPHB1
686, 3l8vA, 0.8148, 2.51, 0.329, 293, 258, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR
687, 3kcfC, 0.8148, 2.97, 0.238, 330, 269, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
688, 2b4sD, 0.8148, 2.81, 0.318, 294, 261, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
689, 4cnhB, 0.8147, 2.32, 0.306, 293, 255, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2- METHOXYPHENYL)ETHOXY)-5-(1-METHYL-1H-123-TRIAZOL-5-YL) PYRIDIN-2-AMINE
690, 4y93A, 0.8146, 2.33, 0.315, 429, 254, CRYSTAL STRUCTURE OF THE PH-TH-KINASE CONSTRUCT OF BRUTON S TYROSINE KINASE (BTK)
691, 4idvD, 0.8146, 2.52, 0.214, 335, 262, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
692, 2ivsB, 0.8146, 2.61, 0.373, 277, 255, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
693, 3gt8A, 0.8145, 2.08, 0.353, 300, 252, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
694, 5p9gA, 0.8143, 2.38, 0.307, 265, 254, STRUCTURE OF BTK WITH RN486
695, 5gtyF, 0.8143, 2.08, 0.363, 297, 251, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
696, 5hcxA, 0.8142, 2.15, 0.359, 298, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH AZABENZIMIDAZOLE COMPOUND 7
697, 3efjA, 0.8142, 2.10, 0.332, 276, 250, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
698, 6g4zB, 0.8141, 2.48, 0.200, 325, 260, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 2F 
699, 3gt8B, 0.8141, 2.09, 0.349, 292, 252, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
700, 4yhfA, 0.8140, 2.41, 0.314, 268, 255, BRUTON S TYROSINE KINASE IN COMPLEX WITH A T-BUTYL CYANOACRYLAMIDE INHIBITOR
701, 4idvA, 0.8140, 2.53, 0.210, 335, 262, CRYSTAL STRUCTURE OF NIK WITH COMPOUND 4-{3-[2-AMINO-5-(2- METHOXYETHOXY)PYRIMIDIN-4-YL]-1H-INDOL-5-YL}-2-METHYLBUT-3-YN-2-OL (13V)
702, 4zseD, 0.8139, 2.26, 0.352, 297, 253, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M/V948R CRYSTAL FORM II
703, 3lzbD, 0.8138, 1.79, 0.355, 261, 248, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
704, 5hicA, 0.8137, 2.24, 0.357, 302, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH A IMIDAZOPYRIDINYL- AMINOPYRIMIDINE INHIBITOR
705, 1rqqA, 0.8137, 2.87, 0.326, 294, 261, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
706, 4g3eB, 0.8136, 2.49, 0.204, 325, 260, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)
707, 3faaB, 0.8134, 2.98, 0.246, 324, 268, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A 2- AMINOIMIDAZOLE INHIBITOR
708, 5eycA, 0.8133, 2.47, 0.345, 288, 255, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NAPHTHYRIDINONE INHIBITOR 5
709, 4yjsA, 0.8133, 2.48, 0.365, 257, 255, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226
710, 4zlzA, 0.8132, 2.44, 0.325, 270, 255, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE IN COMPLEX WITH A SUBSTITUTED CINNOLINE
711, 4z3vA, 0.8132, 2.44, 0.325, 271, 255, FRAGMENT-BASED DISCOVERY OF A SMALL MOLECULE REVERSIBLE INHIBITOR OF BRUTON S TYROSINE KINASE
712, 5e90A, 0.8131, 3.09, 0.221, 303, 271, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249F S280T Y282FS287NA350CL352F) IN COMPLEX WITH 3-AMINO-6- [4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2- CARBOXAMIDE
713, 4xg8C, 0.8131, 2.30, 0.364, 254, 253, CRYSTAL STRUCTURE OF AN INHIBITOR-BOUND SYK
714, 2ituA, 0.8131, 2.45, 0.348, 304, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
715, 5p9fA, 0.8130, 2.25, 0.316, 266, 253, BTK IN COMPLEX WITH GDC-0834
716, 3sxrB, 0.8130, 2.28, 0.318, 258, 255, CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
717, 1rqqB, 0.8130, 2.83, 0.326, 294, 261, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
718, 5vloB, 0.8129, 2.58, 0.211, 293, 261, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
719, 3gt8C, 0.8129, 2.39, 0.350, 296, 254, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
720, 3c0gB, 0.8129, 2.45, 0.225, 320, 258, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P1 FORM
721, 4g3dA, 0.8127, 2.45, 0.208, 324, 259, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
722, 3w33A, 0.8127, 2.08, 0.348, 297, 250, EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 19B
723, 5gmpA, 0.8126, 2.53, 0.357, 305, 255, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH XTF-262
724, 3ppzA, 0.8126, 2.35, 0.298, 264, 255, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
725, 3efjB, 0.8126, 2.10, 0.333, 275, 249, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
726, 3c0hA, 0.8126, 2.45, 0.225, 300, 258, CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX P1 FORM
727, 6b8yA, 0.8125, 3.01, 0.219, 304, 270, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3- FLUOROPYRIDIN-4-YL)-2-[6-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-7H-PYRROLO[2 3-D]PYRIMIDIN-4-AMINE
728, 2jivB, 0.8125, 2.43, 0.359, 272, 256, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
729, 6aywB, 0.8124, 2.59, 0.211, 293, 261, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
730, 4y95B, 0.8124, 2.28, 0.312, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
731, 4xyfA, 0.8124, 2.59, 0.344, 290, 256, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH (S)-5-(8-FLUORO-3-(1-(3-(2- METHOXYETHOXY)QUINOLIN-6-YL)ETHYL)-[124]TRIAZOLO[43-A]PYRIDIN-6- YL)-3-METHYLISOXAZOLE
732, 4u5jB, 0.8124, 2.36, 0.339, 267, 254, C-SRC IN COMPLEX WITH RUXOLITINIB
733, 4i22A, 0.8124, 2.04, 0.357, 297, 249, STRUCTURE OF THE MONOMERIC (V948R)GEFITINIB/ERLOTINIB RESISTANT DOUBLE MUTANT (L858R+T790M) EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH GEFITINIB
734, 3emgA, 0.8124, 2.29, 0.372, 255, 253, DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2- PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
735, 5e8tA, 0.8123, 3.00, 0.222, 302, 270, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D)
736, 4y95C, 0.8123, 2.28, 0.312, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
737, 5hczA, 0.8122, 2.19, 0.359, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH 3-AZETIDINYL AZAINDAZOLE COMPOUND 21
738, 1iasB, 0.8122, 2.89, 0.240, 324, 267, CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
739, 4mkcA, 0.8121, 2.72, 0.292, 303, 260, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE COMPLEXED WITH LDK378
740, 5vfiA, 0.8120, 2.26, 0.316, 271, 253, BRUTON S TYROSINE KINASE (BTK) WITH GDC-0853
741, 5e8zA, 0.8120, 3.09, 0.225, 303, 271, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3- AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3- YL]PYRAZINE-2-CARBOXAMIDE
742, 3c0hB, 0.8120, 2.58, 0.232, 300, 259, CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX P1 FORM
743, 5p9kA, 0.8119, 2.45, 0.318, 271, 255, CRYSTAL STRUCTURE OF BTK WITH CNX 774
744, 3kexA, 0.8119, 2.40, 0.354, 292, 257, CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
745, 3efkA, 0.8119, 2.13, 0.340, 276, 250, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
746, 5p9iA, 0.8118, 2.32, 0.315, 271, 254, BTK1 SOAKED WITH IBRUTINIB-REV
747, 5iuiA, 0.8118, 2.67, 0.300, 303, 260, CRYSTAL STRUCTURE OF ANAPLASTIC LYPHOMA KINASE (ALK) IN COMPLEX WITH 4
748, 3kexB, 0.8118, 2.40, 0.354, 283, 257, CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
749, 4e93A, 0.8117, 2.18, 0.327, 361, 251, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)IN COMPLEX WITH TAE684
750, 3zfxI, 0.8117, 2.33, 0.292, 263, 253, CRYSTAL STRUCTURE OF EPHB1
751, 3l9pA, 0.8117, 2.81, 0.302, 303, 262, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
752, 3bu6A, 0.8117, 2.82, 0.314, 294, 261, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE
753, 3bu3A, 0.8116, 2.74, 0.315, 294, 260, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE
754, 2rfeC, 0.8116, 2.10, 0.353, 262, 249, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
755, 1yi6A, 0.8116, 2.80, 0.342, 274, 260, C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
756, 4y95A, 0.8115, 2.28, 0.312, 266, 253, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
757, 4deiA, 0.8115, 2.47, 0.343, 287, 254, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 24
758, 4ot6A, 0.8114, 2.30, 0.308, 265, 253, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4- METHANESULFONYL-N-(3-{8-[4-(MORPHOLINE-4-CARBONYL)-PHENYLAMINO]- IMIDAZO[12-A]PYRAZIN-6-YL}-PHENYL)-BENZAMIDE
759, 3kcfB, 0.8114, 2.92, 0.236, 324, 267, CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
760, 2rf9B, 0.8114, 2.15, 0.356, 269, 253, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
761, 2j0jA, 0.8114, 2.46, 0.355, 611, 256, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
762, 1yi6B, 0.8114, 2.63, 0.340, 274, 259, C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
763, 5ugxB, 0.8113, 2.67, 0.352, 282, 256, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A E565A/D650V DOUBLE GAIN-OF-FUNCTION MUTATION
764, 4zlyA, 0.8112, 2.45, 0.318, 270, 255, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE BOUND TO A CINNOLINE FRAGMENT
765, 4knbA, 0.8112, 2.35, 0.333, 273, 252, C-MET IN COMPLEX WITH OSI LIGAND
766, 1qcfA, 0.8112, 2.41, 0.331, 449, 254, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELECTIVE TYROSINE KINASE INHIBITOR
767, 5canA, 0.8111, 2.27, 0.357, 301, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 27
768, 3dqxB, 0.8111, 2.50, 0.337, 268, 255, CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
769, 3c0gA, 0.8111, 2.41, 0.222, 309, 257, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P1 FORM
770, 5cnoB, 0.8110, 2.07, 0.356, 302, 250, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT V924R
771, 4hcuA, 0.8110, 2.33, 0.312, 263, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40
772, 3mfsA, 0.8110, 2.46, 0.236, 303, 258, CASK-4M CAM KINASE DOMAIN AMPPNP
773, 5e8uA, 0.8109, 3.07, 0.221, 306, 271, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249FS280T Y282FS287NA350CL352F)
774, 4u5jA, 0.8109, 2.40, 0.339, 267, 254, C-SRC IN COMPLEX WITH RUXOLITINIB
775, 5u6bA, 0.8107, 2.21, 0.302, 270, 252, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
776, 4rwjA, 0.8107, 2.61, 0.375, 307, 259, CRYSTAL STRUCTURE OF FGFR1 (C488A C584S) IN COMPLEX WITH AZD4547 (N- {3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)
777, 3mfuA, 0.8107, 2.72, 0.238, 302, 260, CASK-4M CAM KINASE DOMAIN AMPPNP-MN2+
778, 3c4fB, 0.8106, 2.65, 0.369, 290, 260, FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3- METHOXYBENZYL)-7-AZAINDOLE
779, 3c4fA, 0.8106, 2.66, 0.369, 290, 260, FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3- METHOXYBENZYL)-7-AZAINDOLE
780, 6eixA, 0.8105, 3.36, 0.243, 312, 272, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE Q207E MUTANT OF ACVR1 (ALK2) IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR K02288
781, 5fm3A, 0.8105, 2.95, 0.392, 276, 260, CRYSTAL STRUCTURE OF HYPER-PHOSPHORYLATED RET KINASE DOMAIN WITH (PROXIMAL) JUXTAMEMBRANE SEGMENT
782, 5fm2A, 0.8105, 2.87, 0.394, 273, 259, CRYSTAL STRUCTURE OF HYPER-PHOSPHORYLATED RET KINASE DOMAIN WITH (PROXIMAL) JUXTAMEMBRANE SEGMENT
783, 4asxB, 0.8105, 3.14, 0.226, 307, 270, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C
784, 2vz6A, 0.8105, 2.52, 0.212, 291, 259, STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
785, 3lzbC, 0.8104, 1.81, 0.356, 259, 247, EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[21-B]THIAZOLE INHIBITOR
786, 5cnoA, 0.8103, 2.18, 0.347, 300, 251, CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT V924R
787, 4xmoA, 0.8103, 2.57, 0.345, 289, 255, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH (R)-5-(8-FLUORO-3-(1- FLUORO-1-(3-METHOXYQUINOLIN-6-YL)ETHYL)-[124]TRIAZOLO[43- A]PYRIDIN-6-YL)-3-METHYLISOXAZOLE
788, 5gnkA, 0.8102, 2.48, 0.346, 277, 254, CRYSTAL STRUCTURE OF EGFR 696-988 T790M IN COMPLEX WITH LXX-6-34
789, 5p9jA, 0.8099, 2.43, 0.323, 263, 254, BTK1 COCRYSTALLIZED WITH IBRUTINIB
790, 3bbwA, 0.8099, 2.23, 0.359, 268, 251, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
791, 3bbtB, 0.8099, 2.23, 0.359, 274, 251, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
792, 5p9hA, 0.8098, 2.38, 0.308, 264, 253, BTK1 COCRYSTALLIZED WITH RN983
793, 3c0iA, 0.8098, 2.78, 0.231, 298, 260, CASK CAM-KINASE DOMAIN- 3 -AMP COMPLEX P212121 FORM
794, 3bbwB, 0.8097, 2.23, 0.355, 275, 251, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
795, 4gg7A, 0.8096, 2.63, 0.331, 278, 257, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
796, 6babA, 0.8094, 2.39, 0.218, 290, 257, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
797, 4yjqA, 0.8093, 2.83, 0.360, 264, 258, SYK KINASE DOMAIN IN COMPLEX WITH INHIBITOR GTC000224
798, 3bu5A, 0.8093, 2.79, 0.320, 291, 259, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP
799, 4at3A, 0.8092, 2.45, 0.390, 289, 254, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N
800, 3zfxE, 0.8092, 2.28, 0.294, 262, 252, CRYSTAL STRUCTURE OF EPHB1
801, 5j87B, 0.8091, 2.40, 0.315, 274, 254, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
802, 5e8wA, 0.8090, 3.06, 0.223, 303, 269, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINE
803, 4z55A, 0.8090, 2.71, 0.290, 294, 259, ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE DERIVATIVE OF LDK378
804, 4xi2A, 0.8090, 2.49, 0.314, 421, 255, CRYSTAL STRUCTURE OF AN AUTO-INHIBITED FORM OF BRUTON S TRYROSINE KINASE
805, 4j95D, 0.8090, 2.66, 0.367, 271, 256, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
806, 5u6bC, 0.8089, 2.23, 0.302, 270, 252, STRUCTURE OF THE AXL KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
807, 5bmmA, 0.8089, 2.48, 0.337, 275, 255, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC25B
808, 3l8pA, 0.8089, 2.03, 0.337, 292, 249, CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207
809, 2wotA, 0.8089, 3.04, 0.231, 303, 268, ALK5 IN COMPLEX WITH 4-((56-DIMETHYL-2-(2-PYRIDYL)-3- PYRIDYL)OXY)-N-(345-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE
810, 1fvrB, 0.8089, 2.54, 0.329, 300, 258, TIE2 KINASE DOMAIN
811, 5bpyA, 0.8087, 2.33, 0.317, 263, 252, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
812, 4xlvA, 0.8087, 2.89, 0.330, 307, 261, CRYSTAL STRUCTURE OF THE ACTIVATED INSULIN RECEPTOR TYROSINE KINASE DIMER
813, 4i24A, 0.8087, 2.07, 0.367, 295, 248, STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB
814, 4asxA, 0.8087, 2.94, 0.237, 310, 266, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C
815, 5t3qA, 0.8086, 1.99, 0.327, 278, 248, CRYSTAL STRUCTURE OF THE C-MET KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
816, 4y95D, 0.8086, 2.28, 0.313, 265, 252, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH MUTATIONS IN THE ACTIVATION LOOP
817, 2zvaA, 0.8086, 2.70, 0.350, 261, 257, LYN TYROSINE KINASE DOMAIN-DASATINIB COMPLEX
818, 5xp5A, 0.8085, 2.47, 0.339, 267, 254, C-SRC IN COMPLEX WITH ATP-CHF
819, 1py5A, 0.8085, 3.16, 0.230, 301, 270, CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR
820, 5u9dA, 0.8084, 2.50, 0.318, 271, 255, DISCOVERY OF A POTENT BTK INHIBITOR WITH A NOVEL BINDING MODE USING PARALLEL SELECTIONS WITH A DNA-ENCODED CHEMICAL LIBRARY
821, 5gtyC, 0.8084, 2.04, 0.365, 295, 249, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH LXX-6-26
822, 5calA, 0.8084, 2.25, 0.359, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 24
823, 5fbnC, 0.8083, 2.44, 0.316, 256, 253, BTK KINASE DOMAIN WITH INHIBITOR 1
824, 4yjvA, 0.8083, 2.77, 0.358, 263, 257, THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250
825, 4bcgA, 0.8083, 2.80, 0.201, 312, 264, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
826, 3a4oX, 0.8083, 2.49, 0.362, 259, 254, LYN KINASE DOMAIN
827, 4x2nA, 0.8082, 3.01, 0.223, 303, 269, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
828, 4bcjA, 0.8082, 2.74, 0.202, 309, 263, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
829, 3gt8D, 0.8082, 2.31, 0.349, 295, 252, CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
830, 5casA, 0.8081, 2.32, 0.359, 299, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 41A
831, 4hcvA, 0.8081, 2.40, 0.312, 263, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53
832, 6babD, 0.8080, 2.52, 0.216, 291, 259, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
833, 4y85A, 0.8080, 2.60, 0.185, 307, 260, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
834, 4rx5A, 0.8080, 2.38, 0.304, 265, 253, BRUTON S TYROSINE KINASE (BTK) WITH PYRIDAZINONE COMPOUND 23
835, 4hzsD, 0.8080, 2.51, 0.384, 319, 255, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
836, 4hzsC, 0.8080, 2.51, 0.384, 319, 255, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
837, 4hzsB, 0.8080, 2.51, 0.384, 319, 255, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
838, 4hzsA, 0.8080, 2.51, 0.384, 319, 255, CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN
839, 3vrzB, 0.8080, 2.21, 0.349, 430, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
840, 5xp5B, 0.8079, 2.50, 0.339, 267, 254, C-SRC IN COMPLEX WITH ATP-CHF
841, 5em7A, 0.8079, 2.29, 0.355, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 13: 4-[(2- METHOXYPHENYL)AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2- OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
842, 5em6A, 0.8079, 2.28, 0.359, 301, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 19: 4-[(2- AZANYLPYRIMIDIN-4-YL)AMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]- 2-OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
843, 3vs3B, 0.8079, 2.38, 0.347, 431, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
844, 2jivA, 0.8079, 2.18, 0.353, 270, 252, CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
845, 5e8sA, 0.8078, 2.99, 0.224, 301, 268, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT)
846, 4otrA, 0.8078, 2.25, 0.315, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-CYCLOPROPYL-2- [3-[5-[[5-(4-ETHYLPIPERAZIN-1-YL)-2-PYRIDYL]AMINO]-1-METHYL-6-OXO-3- PYRIDYL]-2-(HYDROXYMETHYL)PHENYL]-8-FLUORO-ISOQUINOLIN-1-ONE
847, 2rfdB, 0.8078, 2.25, 0.344, 286, 253, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
848, 5caqA, 0.8077, 2.38, 0.357, 301, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 33
849, 4rfyA, 0.8077, 2.25, 0.315, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DIMETHYLAMINO)-2-[2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5-(MORPHOLINE-4- CARBONYL)-2-PYRIDYL]AMINO]-6-OXO-3-PYRIDYL]PHENYL]-34- DIHYDROISOQUINOLIN-1-ONE
850, 5bmmB, 0.8076, 2.49, 0.337, 275, 255, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC25B
851, 5t8qA, 0.8075, 2.54, 0.201, 323, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO ARYL PYRROLE FRAGMENT 17
852, 5fbnD, 0.8075, 2.39, 0.313, 255, 252, BTK KINASE DOMAIN WITH INHIBITOR 1
853, 5eydA, 0.8075, 2.54, 0.344, 289, 253, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH AMG 337
854, 4or5A, 0.8074, 2.89, 0.201, 319, 264, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB AND AFF4
855, 2h8hA, 0.8074, 2.44, 0.339, 444, 254, SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
856, 5u6cA, 0.8073, 2.39, 0.332, 272, 253, CRYSTAL STRUCTURE OF THE MER KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
857, 5j87A, 0.8073, 2.33, 0.317, 263, 252, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
858, 4x2kA, 0.8073, 3.04, 0.223, 303, 269, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
859, 4x2jA, 0.8073, 3.04, 0.223, 303, 269, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
860, 6aywA, 0.8071, 2.72, 0.218, 293, 262, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
861, 5p9mA, 0.8071, 2.46, 0.312, 271, 253, BTK1 BINDS COVALENTLY TO HY-15771 ONO-4059
862, 3mfrA, 0.8071, 2.69, 0.228, 302, 259, CASK-4M CAM KINASE DOMAIN NATIVE
863, 1fgiA, 0.8071, 2.63, 0.375, 283, 259, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
864, 4g3dB, 0.8070, 2.61, 0.208, 318, 259, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
865, 4cd0A, 0.8070, 2.75, 0.306, 295, 258, STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPANE-12-DIOL
866, 3my1A, 0.8070, 2.83, 0.201, 314, 264, STRUCTURE OF CDK9/CYCLINT1 IN COMPLEX WITH DRB
867, 3genA, 0.8069, 2.34, 0.321, 264, 252, THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
868, 4x2gA, 0.8068, 3.13, 0.233, 303, 270, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
869, 4o27B, 0.8068, 2.84, 0.269, 281, 260, CRYSTAL STRUCTURE OF MST3-MO25 COMPLEX WITH WIF MOTIF
870, 4an9A, 0.8068, 2.75, 0.197, 281, 259, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
871, 3mdyC, 0.8068, 2.88, 0.243, 320, 263, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN- 193189
872, 5capA, 0.8067, 2.33, 0.361, 303, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 30
873, 4uwcA, 0.8067, 2.60, 0.380, 300, 258, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P3
874, 4otqA, 0.8067, 2.23, 0.323, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 1-[5-[3-(7-TERT- BUTYL-4-OXO-QUINAZOLIN-3-YL)-2-METHYL-PHENYL]-1-METHYL-2-OXO-3- PYRIDYL]-3-METHYL-UREA
875, 3socA, 0.8067, 3.13, 0.224, 307, 268, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN
876, 6f3fA, 0.8066, 2.37, 0.324, 448, 253, AUTOINHIBITED SRC KINASE BOUND TO ADP
877, 4dehA, 0.8066, 2.43, 0.345, 286, 252, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 3
878, 2vz6B, 0.8066, 2.76, 0.222, 294, 261, STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
879, 2ckeA, 0.8066, 2.91, 0.221, 301, 263, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
880, 4rwkA, 0.8065, 2.77, 0.378, 308, 259, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) IN COMPLEX WITH N-{3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H- PYRAZOL-5-YL}-4-[(3R5S)-35-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)
881, 2srcA, 0.8065, 2.37, 0.328, 449, 253, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC IN COMPLEX WITH AMP-PNP
882, 5c8mA, 0.8064, 2.37, 0.357, 302, 252, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 17
883, 4y85B, 0.8064, 2.60, 0.185, 306, 260, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
884, 3vs4A, 0.8064, 2.34, 0.348, 429, 250, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
885, 3mdyA, 0.8064, 2.77, 0.249, 320, 261, CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN- 193189
886, 2yabB, 0.8064, 2.91, 0.221, 299, 262, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP
887, 4x2fA, 0.8063, 3.13, 0.233, 303, 270, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
888, 4an2A, 0.8063, 2.51, 0.191, 282, 256, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
889, 5usqA, 0.8062, 3.01, 0.221, 299, 267, ALK-5 KINASE INHIBITOR COMPLEX
890, 3f66A, 0.8062, 2.46, 0.343, 288, 254, HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
891, 3dqxA, 0.8062, 2.52, 0.339, 267, 254, CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
892, 4mneB, 0.8061, 2.68, 0.257, 270, 261, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
893, 4bciA, 0.8061, 2.65, 0.203, 308, 261, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
894, 3lmgB, 0.8061, 2.53, 0.355, 268, 256, CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
895, 2yaaB, 0.8061, 2.90, 0.221, 299, 262, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP
896, 2hz0A, 0.8061, 2.63, 0.323, 265, 257, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
897, 5friA, 0.8060, 3.13, 0.223, 301, 269, ALK5 IN COMPLEX WITHA AN N-(4-ANILINO-2-PYRIDYL)ACETAMIDE INHIBITOR.
898, 4k11A, 0.8060, 2.36, 0.328, 447, 253, THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G
899, 5j87D, 0.8059, 2.38, 0.310, 263, 252, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
900, 5h0eA, 0.8059, 2.49, 0.333, 446, 252, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANAMIDE
901, 5h0bA, 0.8059, 2.38, 0.335, 446, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOIC ACID
902, 4otwA, 0.8059, 2.50, 0.348, 272, 256, HER3 PSEUDOKINASE DOMAIN BOUND TO BOSUTINIB
903, 3vs6B, 0.8059, 2.26, 0.349, 434, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
904, 3ocsA, 0.8059, 2.33, 0.306, 264, 252, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746
905, 5vgoA, 0.8058, 2.41, 0.304, 265, 253, BRUTON S TYROSINE KINASE (BTK) WITH COMPOUND G-744
906, 4zsaA, 0.8058, 2.73, 0.369, 289, 260, CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN IN COMPLEX WITH 7N
907, 3vs6A, 0.8058, 2.27, 0.349, 434, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
908, 2c0tA, 0.8058, 2.14, 0.340, 427, 247, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
909, 5c8nA, 0.8057, 2.33, 0.359, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 23
910, 4rj7A, 0.8057, 2.20, 0.357, 295, 249, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 1
911, 4rfmA, 0.8057, 2.01, 0.312, 249, 247, ITK KINASE DOMAIN IN COMPLEX WITH COMPOUND 1 N-{1-[(11-DIOXO-1-THIAN- 2-YL)(PHENYL)METHYL]-1H- PYRAZOL-4-YL}-55-DIFLUORO-5A-METHYL-1H4H 4AH5H5AH6H-CYCLOPROPA[F]INDAZOLE-3-CARBOXAMIDE
912, 3vrzA, 0.8057, 2.23, 0.351, 429, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
913, 5mjaB, 0.8056, 2.91, 0.285, 274, 263, KINASE DOMAIN OF HUMAN EPHB1 BOUND TO A QUINAZOLINE-BASED INHIBITOR
914, 5kupA, 0.8056, 2.41, 0.304, 265, 253, BRUTON S TYROSINE KINASE (BTK) WITH PYRIDAZINONE COMPOUND 9
915, 4x0mA, 0.8056, 3.13, 0.233, 303, 270, SELECTION OF FRAGMENTS FOR KINASE INHIBITOR DESIGN: DECORATION IS KEY
916, 4r5sA, 0.8056, 2.58, 0.352, 299, 256, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH FIIN-3
917, 3vs1A, 0.8056, 2.25, 0.351, 424, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
918, 2ckeB, 0.8056, 2.88, 0.221, 300, 262, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
919, 4or5F, 0.8055, 2.91, 0.197, 324, 264, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB AND AFF4
920, 4anbA, 0.8055, 2.54, 0.191, 282, 256, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
921, 4an3A, 0.8055, 2.69, 0.198, 280, 258, CRYSTAL STRUCTURES OF HUMAN MEK1 WITH CARBOXAMIDE-BASED ALLOSTERIC INHIBITOR XL518 (GDC-0973) OR RELATED ANALOGS.
922, 2c0tB, 0.8055, 2.24, 0.351, 429, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
923, 6g4yA, 0.8054, 2.47, 0.202, 322, 257, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 1A 
924, 5h0hA, 0.8054, 2.37, 0.335, 446, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-NN4-TRIMETHYLPENTANAMIDE
925, 4m0yA, 0.8054, 2.52, 0.311, 263, 254, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 1 [4- (CARBAMOYLAMINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE]
926, 2ckeC, 0.8054, 2.88, 0.225, 300, 262, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
927, 3vryA, 0.8053, 2.25, 0.349, 428, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
928, 6g4zA, 0.8052, 2.47, 0.202, 322, 257, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK) IN COMPLEX WITH COMPOUND 2F 
929, 5h09A, 0.8052, 2.37, 0.335, 446, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-ETHYL2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOATE
930, 3lmgA, 0.8051, 2.50, 0.357, 268, 255, CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
931, 5j9zA, 0.8050, 2.32, 0.359, 291, 251, EGFR-T790M IN COMPLEX WITH PYRAZOLOPYRIMIDINE INHIBITOR 1A
932, 4b4lA, 0.8050, 2.80, 0.215, 299, 261, CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT
933, 2xuuA, 0.8050, 2.79, 0.211, 301, 261, CRYSTAL STRUCTURE OF A DAP-KINASE 1 MUTANT
934, 2c0iA, 0.8050, 2.15, 0.340, 433, 247, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
935, 1gagA, 0.8050, 2.98, 0.330, 300, 261, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
936, 1fvrA, 0.8050, 2.54, 0.331, 299, 257, TIE2 KINASE DOMAIN
937, 4degA, 0.8049, 2.38, 0.351, 286, 251, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDAZINE INHIBITOR 2
938, 3socB, 0.8049, 2.90, 0.230, 309, 265, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN
939, 2j0kA, 0.8049, 2.25, 0.363, 598, 251, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
940, 5t8oA, 0.8048, 2.53, 0.201, 324, 259, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO IMIDAZOBENZOXEPIN COMPOUND 3
941, 5h0gA, 0.8048, 2.41, 0.335, 446, 251, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-N4-DIMETHYLPENTANAMIDE
942, 5cauA, 0.8048, 2.32, 0.360, 297, 250, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 41B
943, 4rj8A, 0.8048, 2.30, 0.360, 298, 250, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 8
944, 4rg0A, 0.8048, 2.25, 0.323, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[8-FLUORO-2- [2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5-(4-METHYLPIPERAZIN-1-YL)-2- PYRIDYL]AMINO]-6-OXO-3-PYRIDYL]PHENYL]-1-OXO-34-DIHYDROISOQUINOLIN- 6-YL]-2-METHYL-PROPANENITRILE
945, 4fl3A, 0.8048, 2.49, 0.358, 538, 254, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
946, 3q4tB, 0.8048, 2.80, 0.236, 308, 263, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN
947, 2xvdA, 0.8048, 2.52, 0.275, 270, 255, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
948, 2hckA, 0.8048, 2.28, 0.340, 437, 250, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
949, 4yjrA, 0.8047, 2.87, 0.358, 263, 257, SYK KINASE DOMAIN IN COMPLEX WITH INHIBITOR GTC000225
950, 4y85C, 0.8047, 2.64, 0.185, 303, 260, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(5-(1H-INDOL- 3-YL)-1H-PYRROLO[23-B]PYRIDIN-3-YL)-134-OXADIAZOL-2-AMINE
951, 4c02A, 0.8047, 3.17, 0.251, 313, 267, CRYSTAL STRUCTURE OF HUMAN ACVR1 (ALK2) IN COMPLEX WITH FKBP12.6 AND DORSOMORPHIN
952, 3vs0A, 0.8047, 2.25, 0.351, 428, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
953, 2biyA, 0.8047, 3.01, 0.228, 287, 263, STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
954, 3mftA, 0.8046, 2.58, 0.221, 302, 258, CASK-4M CAM KINASE DOMAIN MN2+
955, 2yaaA, 0.8046, 2.91, 0.221, 300, 262, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP
956, 1kswA, 0.8046, 2.39, 0.328, 449, 253, STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
957, 2a2aA, 0.8045, 2.94, 0.224, 304, 263, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
958, 4tt7A, 0.8044, 2.69, 0.297, 291, 256, CRYSTAL STRUCTURE OF HUMAN ALK WITH A COVALENT MODIFICATION
959, 3zosB, 0.8044, 2.82, 0.357, 303, 258, STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB
960, 4rj4A, 0.8043, 2.37, 0.355, 299, 251, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 6
961, 4ec8A, 0.8043, 2.83, 0.194, 325, 263, STRUCTURE OF FULL LENGTH CDK9 IN COMPLEX WITH CYCLINT AND DRB
962, 3vs0B, 0.8043, 2.23, 0.351, 433, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
963, 3pxkB, 0.8043, 2.24, 0.361, 258, 249, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[23- D]THIAZOLE
964, 3ky2A, 0.8043, 2.70, 0.360, 307, 258, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
965, 2c0iB, 0.8043, 2.26, 0.351, 433, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
966, 5c8kA, 0.8042, 2.37, 0.359, 300, 251, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 1
967, 4ot5A, 0.8042, 2.30, 0.315, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4-TERT-BUTYL-N- (3-{8-[4-(4-METHYL-PIPERAZINE-1-CARBONYL)-PHENYLAMINO]-IMIDAZO[12- A]PYRAZIN-6-YL}-PHENYL)-BENZAMIDE
968, 4bchA, 0.8042, 2.78, 0.202, 308, 262, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
969, 3vs4B, 0.8042, 2.27, 0.349, 434, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
970, 2c0oB, 0.8042, 2.24, 0.351, 433, 248, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
971, 5xp7B, 0.8041, 2.37, 0.343, 267, 251, C-SRC IN COMPLEX WITH ATP-CHCL
972, 5bq0A, 0.8041, 2.40, 0.324, 265, 253, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
973, 4rwiA, 0.8041, 2.92, 0.373, 305, 260, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) APO
974, 2wouA, 0.8040, 3.06, 0.225, 299, 267, ALK5 IN COMPLEX WITH 4-((4-((26-DIMETHYL-3-PYRIDYL)OXY)-2- PYRIDYL)AMINO)BENZENESULFONAMIDE
975, 1rw8A, 0.8040, 3.19, 0.230, 301, 270, CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR
976, 4m13A, 0.8039, 2.46, 0.311, 264, 254, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4- (CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE]
977, 4fobA, 0.8039, 2.79, 0.301, 295, 259, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 1
978, 3kfaA, 0.8039, 2.40, 0.340, 284, 253, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
979, 4nwmB, 0.8038, 2.38, 0.311, 261, 251, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4- (MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE
980, 3kfaB, 0.8038, 2.40, 0.340, 284, 253, STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
981, 5ftoA, 0.8037, 2.75, 0.305, 298, 259, CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH ENTRECTINIB
982, 4rfzA, 0.8037, 2.32, 0.315, 263, 251, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DIMETHYLAMINO)-8-FLUORO-2-[2-(HYDROXYMETHYL)-3-[1-METHYL-5-[[5- (MORPHOLINE-4-CARBONYL)-2-PYRIDYL]AMINO]-6-OXO-3- PYRIDYL]PHENYL]ISOQUINOLIN-1-ONE
983, 1pkgB, 0.8037, 2.37, 0.348, 277, 250, STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
984, 1ir3A, 0.8037, 2.97, 0.330, 300, 261, PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
985, 4imyA, 0.8036, 2.95, 0.205, 314, 264, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
986, 3lvpC, 0.8036, 2.80, 0.318, 293, 261, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
987, 2c0oA, 0.8036, 2.17, 0.340, 433, 247, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
988, 1z9xB, 0.8035, 2.95, 0.224, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
989, 1z9xA, 0.8035, 2.95, 0.224, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
990, 4gu6A, 0.8034, 2.79, 0.354, 271, 257, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO- 2-PHENYL-1H-PYRROLO[23-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}- N-METHYL-METHANESULFONAMIDE
991, 3vs1B, 0.8034, 2.25, 0.351, 433, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
992, 3efkB, 0.8034, 2.07, 0.341, 272, 246, STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
993, 3bprA, 0.8034, 2.00, 0.329, 261, 246, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
994, 2eb3A, 0.8034, 2.38, 0.347, 294, 251, CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP
995, 1ad5A, 0.8034, 2.41, 0.347, 437, 251, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
996, 4gg5A, 0.8033, 2.64, 0.340, 274, 253, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
997, 2ckeD, 0.8033, 2.96, 0.221, 300, 263, HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
998, 4rj6A, 0.8032, 2.33, 0.356, 297, 250, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 4
999, 4m0zA, 0.8031, 2.48, 0.311, 264, 254, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 5 {4- (CARBAMOYLAMINO)-1-(7-METHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE}
1000, 4bcfA, 0.8031, 2.74, 0.203, 307, 261, STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
1001, 5wr7A, 0.8030, 2.67, 0.373, 301, 255, CRYSTAL STRUCTURE OF TRK-A COMPLEXED WITH A SELECTIVE INHIBITOR CH7057288
1002, 3vs2A, 0.8030, 2.19, 0.340, 430, 247, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
1003, 3vryB, 0.8030, 2.28, 0.349, 434, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
1004, 5e8xA, 0.8029, 2.98, 0.229, 304, 266, TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204DI211VY249FS280T Y282FS287NA350CL352F) IN COMPLEX WITH STAUROSPORINE
1005, 3q4tA, 0.8029, 3.14, 0.225, 305, 267, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN
1006, 5aabA, 0.8028, 2.62, 0.294, 293, 255, STRUCTURE OF C1156YL1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1007, 4d55A, 0.8028, 2.43, 0.360, 260, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1008, 2hckB, 0.8028, 2.31, 0.340, 437, 250, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
1009, 5uhnB, 0.8027, 2.65, 0.354, 269, 254, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 2 HARBORING A N549H/E565A DOUBLE GAIN-OF-FUNCTION MUTATION
1010, 4u8zA, 0.8027, 2.88, 0.258, 289, 260, CRYSTAL STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF- 06447475)
1011, 3b2wA, 0.8027, 2.52, 0.352, 261, 253, CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK
1012, 2yabA, 0.8027, 2.90, 0.218, 299, 262, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP
1013, 2bdfB, 0.8027, 2.50, 0.344, 265, 253, SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
1014, 3wzeA, 0.8025, 2.81, 0.344, 298, 256, KDR IN COMPLEX WITH LIGAND SORAFENIB
1015, 3g6hA, 0.8025, 2.46, 0.341, 266, 252, SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
1016, 5wnoA, 0.8024, 2.43, 0.311, 302, 254, CRYSTAL STRUCTURE OF C. ELEGANS LET-23 KINASE DOMAIN COMPLEXED WITH AMP-PNP
1017, 3js2A, 0.8024, 2.78, 0.369, 295, 260, CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
1018, 2x9fA, 0.8024, 2.44, 0.277, 265, 253, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1019, 4w8dA, 0.8023, 2.99, 0.257, 289, 261, CRYSTAL STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF- 06454589).
1020, 4m15A, 0.8023, 2.45, 0.312, 263, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3- CARBOXAMIDE] AND ADP
1021, 4m12A, 0.8023, 2.50, 0.311, 264, 254, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 7 [4- (CARBAMOYLAMINO)-1-(7-ETHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- CARBOXAMIDE]
1022, 5ig1A, 0.8022, 2.92, 0.262, 300, 263, CRYSTAL STRUCTURE OF S. ROSETTA CAMKII KINASE DOMAIN
1023, 4ueuA, 0.8022, 2.43, 0.371, 256, 251, TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL
1024, 2a2aC, 0.8022, 2.86, 0.214, 303, 262, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1025, 1ad5B, 0.8022, 2.43, 0.347, 437, 251, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1026, 5dg5B, 0.8021, 2.82, 0.335, 297, 257, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP- 4157
1027, 5ng0B, 0.8020, 2.73, 0.243, 282, 259, STRUCTURE OF RIP2K(L294F) WITH BOUND AMPPCP
1028, 5zv2A, 0.8019, 2.61, 0.366, 284, 257, FGFR-1 IN COMPLEX WITH LIGAND LENVATINIB 
1029, 5aaaA, 0.8019, 2.75, 0.304, 294, 257, STRUCTURE OF L1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1030, 3vs3A, 0.8019, 2.34, 0.349, 434, 249, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
1031, 3vs2B, 0.8019, 2.26, 0.355, 433, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
1032, 3g2fA, 0.8019, 2.94, 0.256, 302, 262, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION
1033, 3f6xD, 0.8019, 2.49, 0.345, 267, 252, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1034, 3bbtD, 0.8019, 2.08, 0.363, 259, 248, CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
1035, 2a2aB, 0.8019, 2.84, 0.211, 303, 261, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1036, 6d20A, 0.8018, 2.72, 0.376, 296, 255, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 5-(4-FLUOROPHENYL)THIENO[2;3-D]PYRIMIDIN-4(3H)-ONE AND 5-{[2;4- DICHLORO-5-(PYRIDIN-2-YL)BENZENE-1-CARBONYL]AMINO}-N-(2-HYDROXY-2- METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-3-CARBOXAMIDE INHIBITORS 
1037, 5mjaA, 0.8018, 2.73, 0.287, 271, 258, KINASE DOMAIN OF HUMAN EPHB1 BOUND TO A QUINAZOLINE-BASED INHIBITOR
1038, 4bkjB, 0.8017, 2.72, 0.352, 297, 256, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB
1039, 3uo5A, 0.8017, 2.76, 0.233, 267, 258, AURORA A IN COMPLEX WITH YL1-038-31
1040, 3u4wA, 0.8017, 2.55, 0.339, 275, 254, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC4B
1041, 5vloA, 0.8016, 2.59, 0.216, 290, 259, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1042, 3uodA, 0.8016, 2.79, 0.233, 266, 258, AURORA A IN COMPLEX WITH RPM1693
1043, 4uwyA, 0.8015, 2.59, 0.361, 296, 255, FGFR1 APO STRUCTURE
1044, 3up2A, 0.8015, 2.86, 0.236, 266, 259, AURORA A IN COMPLEX WITH RPM1686
1045, 1ql6A, 0.8015, 2.59, 0.222, 281, 257, THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES
1046, 3vs5A, 0.8014, 2.28, 0.351, 429, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1047, 3vntA, 0.8014, 2.82, 0.348, 301, 256, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1 3]THIAZOLO[54-B]PYRIDINE DERIVATIVE
1048, 3tn8A, 0.8014, 2.70, 0.204, 304, 260, CDK9/CYCLIN T IN COMPLEX WITH CAN508
1049, 3en4B, 0.8014, 2.43, 0.343, 266, 251, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121 A MULTITARGETED KINASE INHIBITOR
1050, 4fodA, 0.8013, 2.71, 0.292, 308, 257, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 36
1051, 4focA, 0.8013, 2.63, 0.294, 296, 255, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 2
1052, 3vs5B, 0.8013, 2.26, 0.351, 427, 248, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
1053, 3v8sD, 0.8013, 3.16, 0.211, 397, 266, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1054, 5jrsA, 0.8012, 2.21, 0.310, 258, 248, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -34-DIHYDROQUINAZOLIN-3-YL) PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE
1055, 4qmoA, 0.8012, 3.00, 0.257, 288, 261, MST3 IN COMPLEX WITH IMIDAZOLO-OXINDOLE PKR INHIBITOR C16
1056, 4idtB, 0.8012, 2.51, 0.199, 335, 256, CRYSTAL STRUCTURE OF NIK WITH 11-BROMO-5678-TETRAHYDROPYRIMIDO[4  5 :34]CYCLOHEPTA[12-B]INDOL-2-AMINE (T28)
1057, 4deaA, 0.8012, 2.77, 0.236, 266, 258, AURORA A IN COMPLEX WITH YL1-038-18
1058, 4ag8A, 0.8012, 2.81, 0.348, 296, 256, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H- INDAZOL-6- YLSULFANYL)-BENZAMIDE)
1059, 2xirA, 0.8012, 2.80, 0.348, 296, 256, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH PF-00337210 (N2-DIMETHYL-6-(7-(2-MORPHOLINOETHOXY) QUINOLIN-4-YLOXY)BENZOFURAN-3-CARBOXAMIDE)
1060, 3zosA, 0.8011, 2.87, 0.353, 301, 258, STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB
1061, 3miaA, 0.8011, 2.94, 0.202, 324, 263, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH ATP-BOUND HUMAN P-TEFB
1062, 2a2aD, 0.8011, 2.88, 0.214, 303, 262, HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
1063, 4cljA, 0.8010, 2.80, 0.306, 295, 258, STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
1064, 3mi9A, 0.8010, 2.94, 0.202, 328, 263, CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB
1065, 3ik3A, 0.8010, 2.46, 0.340, 280, 253, AP24534 A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE
1066, 3dkfA, 0.8010, 2.44, 0.341, 294, 252, STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
1067, 5caoA, 0.8009, 2.25, 0.357, 300, 249, EGFR KINASE DOMAIN MUTANT TMLR WITH COMPOUND 29
1068, 5aa9A, 0.8009, 2.78, 0.304, 295, 257, STRUCTURE OF L1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
1069, 4qrcA, 0.8009, 2.97, 0.369, 297, 260, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 4 IN COMPLEX WITH PONATINIB
1070, 2qu5A, 0.8009, 2.81, 0.329, 292, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
1071, 4qmpA, 0.8008, 3.00, 0.257, 289, 261, MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III 5-AMINO-3-{[4- (AMINOSULFONYL)PHENYL]AMINO}-N-(26-DIFLUOROPHENYL)-1H-124- TRIAZOLE-1-CARBOTHIOAMIDE
1072, 4ogrI, 0.8008, 3.13, 0.195, 318, 267, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
1073, 3ornA, 0.8008, 2.89, 0.197, 280, 259, MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH CH4987655 AND MGAMP-PNP
1074, 2ozoA, 0.8008, 2.56, 0.335, 545, 254, AUTOINHIBITED INTACT HUMAN ZAP-70
1075, 4wnkA, 0.8007, 3.01, 0.244, 499, 262, CRYSTAL STRUCTURE OF BOVINE G PROTEIN COUPLED-RECEPTOR KINASE 5 IN COMPLEX WITH CCG215022
1076, 4tl0A, 0.8007, 2.89, 0.222, 300, 261, CRYSTAL STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 WITH A CRUCIAL PHOSPHOMIMICKING MUTATION
1077, 3pp1A, 0.8007, 2.96, 0.196, 291, 260, CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGATP
1078, 3e8nA, 0.8007, 3.08, 0.194, 291, 263, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) COMPLEXED WITH A POTENT INHIBITOR RDEA119 AND MGATP
1079, 1fpuB, 0.8007, 2.40, 0.341, 270, 252, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1080, 5j7hA, 0.8006, 2.39, 0.298, 291, 252, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) BOUND BY BRIGATINIB
1081, 5fg8A, 0.8005, 2.76, 0.216, 269, 259, DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP
1082, 4mxcA, 0.8005, 2.72, 0.336, 290, 256, CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
1083, 1k3aA, 0.8005, 2.77, 0.309, 288, 259, STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1084, 5am7A, 0.8004, 2.67, 0.366, 294, 257, FGFR1 MUTANT WITH AN INHIBITOR
1085, 5htiA, 0.8003, 2.81, 0.339, 290, 257, CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH LXM108
1086, 5am6A, 0.8003, 2.67, 0.362, 295, 257, NATIVE FGFR1 WITH AN INHIBITOR
1087, 4knbC, 0.8003, 2.25, 0.332, 271, 247, C-MET IN COMPLEX WITH OSI LIGAND
1088, 3tv7B, 0.8003, 3.15, 0.207, 397, 266, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1089, 1t46A, 0.8003, 2.67, 0.341, 297, 255, STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1090, 6dkiA, 0.8002, 2.59, 0.379, 279, 253, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 19. 
1091, 5i9vA, 0.8002, 2.67, 0.320, 279, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH AGS
1092, 5hznG, 0.8002, 2.77, 0.307, 296, 257, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1093, 4u0iA, 0.8002, 2.76, 0.341, 297, 255, CRYSTAL STRUCTURE OF KIT IN COMPLEX WITH PONATINIB
1094, 4qmmA, 0.8002, 3.01, 0.257, 288, 261, MST3 IN COMPLEX WITH AT-9283 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]- 1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
1095, 2f2uB, 0.8002, 3.07, 0.188, 383, 266, CRYSTAL STRUCTURE OF THE RHO-KINASE KINASE DOMAIN
1096, 1opjA, 0.8002, 2.48, 0.340, 287, 253, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1097, 5nkeA, 0.8001, 3.20, 0.309, 292, 265, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3A
1098, 5h9bA, 0.8001, 2.76, 0.216, 269, 259, DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/AMPPN
1099, 5d7vB, 0.8001, 2.62, 0.312, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1100, 2bdjA, 0.8001, 2.33, 0.345, 254, 249, SRC KINASE IN COMPLEX WITH INHIBITOR AP23464
1101, 6c0tA, 0.8000, 2.87, 0.247, 334, 259, CRYSTAL STRUCTURE OF CGMP-DEPENDENT PROTEIN KINASE IALPHA (PKG IALPHA) CATALYTIC DOMAIN BOUND WITH N46 
1102, 5ig1B, 0.8000, 2.98, 0.262, 304, 263, CRYSTAL STRUCTURE OF S. ROSETTA CAMKII KINASE DOMAIN
1103, 4bkjA, 0.8000, 2.68, 0.357, 295, 255, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB
1104, 2xikA, 0.8000, 2.96, 0.259, 288, 259, STRUCTURE OF HUMAN YSK1 (YEAST SPS1-STE20-RELATED KINASE 1)
1105, 3bhhB, 0.7999, 2.47, 0.206, 289, 257, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
1106, 2x4fB, 0.7999, 2.60, 0.236, 288, 259, THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156.
1107, 4v05B, 0.7998, 2.58, 0.371, 286, 256, FGFR1 IN COMPLEX WITH AZD4547.
1108, 4otfA, 0.7998, 2.32, 0.308, 262, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON S TYROSINE KINASE WITH GDC0834
1109, 3vs7A, 0.7998, 2.24, 0.352, 432, 247, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
1110, 2ya9A, 0.7998, 2.90, 0.222, 299, 261, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2
1111, 4rzvB, 0.7997, 2.65, 0.256, 271, 258, CRYSTAL STRUCTURE OF THE BRAF (R509H) KINASE DOMAIN MONOMER BOUND TO VEMURAFENIB
1112, 3t9tA, 0.7997, 2.33, 0.303, 263, 251, CRYSTAL STRUCTURE OF BTK MUTANT (F435TK596R) COMPLEXED WITH IMIDAZO[15-A]QUINOXALINE
1113, 2oiqB, 0.7997, 2.45, 0.343, 265, 251, CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
1114, 2j0mB, 0.7997, 2.32, 0.368, 257, 250, CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE.
1115, 5t18A, 0.7996, 2.42, 0.307, 261, 251, CRYSTAL STRUCTURE OF BRUTON AGAMMABULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-986142 AKA (2S)-6-FLUORO-5-[3-(8-FLUORO-1-METHYL-24-DIOXO- 1234-TETRAHYDROQUINAZOLIN-3-YL)-2-METHYLPHENYL]-2-(2- HYDROXYPROPAN-2-YL)-2349-TETRAHYDRO-1H-CARBAZOLE-8-CARBOXAMIDE
1116, 5k9iB, 0.7996, 2.19, 0.335, 262, 248, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH A COVALENT LYSINE PROBE
1117, 4nwmA, 0.7996, 2.43, 0.311, 261, 251, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4- (MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE
1118, 4k2rA, 0.7996, 2.41, 0.349, 551, 252, STRUCTURAL BASIS FOR ACTIVATION OF ZAP-70 BY PHOSPHORYLATION OF THE SH2-KINASE LINKER
1119, 4cmoA, 0.7996, 2.81, 0.304, 295, 257, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 2-((1R)-1-((3-AMINO-6-(2- METHOXYPYRIDIN- -YL)PYRAZIN-2-YL)OXY)ETHYL)-4-FLUORO-N-METHYLBENZAMIDE
1120, 2w4kA, 0.7996, 2.95, 0.225, 301, 262, X-RAY STRUCTURE OF A DAP-KINASE 2-302
1121, 2etkB, 0.7996, 3.05, 0.201, 398, 264, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
1122, 2a27A, 0.7996, 2.90, 0.218, 304, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1123, 4asdA, 0.7995, 2.84, 0.348, 305, 256, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006)
1124, 3geqB, 0.7995, 2.32, 0.349, 273, 249, STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
1125, 2rfnB, 0.7995, 2.11, 0.327, 269, 245, X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
1126, 2j0kB, 0.7995, 2.46, 0.369, 612, 252, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
1127, 2a27B, 0.7995, 2.89, 0.218, 303, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1128, 1mqbB, 0.7995, 2.47, 0.316, 265, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
1129, 4pniA, 0.7994, 3.21, 0.244, 492, 266, BOVINE G PROTEIN-COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH GSK2163632A
1130, 4nw6A, 0.7994, 2.97, 0.198, 302, 262, RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 27
1131, 4m14A, 0.7994, 2.49, 0.312, 263, 253, CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3- CARBOXAMIDE]
1132, 3c50A, 0.7994, 3.08, 0.243, 499, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 2.6A
1133, 5xdlA, 0.7993, 2.46, 0.348, 292, 250, CRYSTAL STRUCTURE OF EGFR 696-1022 L858R IN COMPLEX WITH CO-1686
1134, 5k0xA, 0.7993, 1.94, 0.327, 258, 245, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2541
1135, 5hznC, 0.7993, 2.88, 0.310, 296, 258, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1136, 4ccuA, 0.7993, 2.57, 0.300, 292, 253, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPAN-2-OL
1137, 5osdA, 0.7992, 2.74, 0.233, 266, 257, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1138, 5h2uB, 0.7992, 2.64, 0.316, 263, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1139, 4cmuA, 0.7992, 2.80, 0.304, 294, 257, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR (10R)-7-AMINO-12-FLUORO-1310 16-TETRAMETHYL-1617-DIHYDRO-1H-84-(METHENO)PYRAZOLO(43- H)(2511)BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE
1140, 3twjA, 0.7992, 3.10, 0.212, 396, 264, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1447
1141, 3e5aA, 0.7992, 2.74, 0.237, 264, 257, CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH VX-680 AND TPX2
1142, 2zv8A, 0.7992, 2.65, 0.360, 257, 253, LYN TYROSINE KINASE DOMAIN-AMP-PNP COMPLEX
1143, 4o0vA, 0.7991, 3.08, 0.211, 290, 261, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1144, 4cliA, 0.7991, 2.82, 0.304, 294, 257, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-21016-TRIMETHYL-15 -OXO-10151617-TETRAHYDRO-2H-84-(METHENO)PYRAZOLO(43-H) (2511)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE).
1145, 3f6xA, 0.7991, 2.13, 0.344, 264, 247, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1146, 3c51A, 0.7991, 3.00, 0.243, 487, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 3.55A
1147, 4u7zA, 0.7990, 3.19, 0.193, 291, 264, MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK1) BOUND TO G805
1148, 4d4vA, 0.7990, 2.22, 0.363, 256, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1149, 3tv7D, 0.7990, 3.18, 0.207, 397, 266, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1150, 3q4uD, 0.7990, 3.18, 0.249, 299, 265, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1151, 3eqhA, 0.7990, 2.81, 0.197, 314, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH U0126 ADP AND MG2P
1152, 4wboC, 0.7989, 3.06, 0.247, 481, 263, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1153, 4nw5A, 0.7989, 2.98, 0.198, 302, 262, RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 8
1154, 3vs7B, 0.7989, 2.13, 0.354, 426, 246, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
1155, 3v8sB, 0.7989, 3.09, 0.204, 397, 265, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1156, 3oy3B, 0.7989, 2.50, 0.340, 284, 253, CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG- OUT INHIBITOR AP24589
1157, 3f6xB, 0.7989, 2.35, 0.332, 267, 250, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1158, 2a27H, 0.7989, 2.90, 0.218, 304, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1159, 5hznF, 0.7988, 2.69, 0.309, 296, 256, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1160, 5hznB, 0.7988, 2.69, 0.309, 296, 256, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1161, 5hznA, 0.7988, 2.70, 0.305, 296, 256, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1162, 5dg5A, 0.7988, 2.90, 0.335, 297, 257, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP- 4157
1163, 4ludB, 0.7988, 2.19, 0.354, 409, 246, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
1164, 3mblA, 0.7988, 2.99, 0.196, 290, 260, CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGADP
1165, 3lq5A, 0.7988, 2.74, 0.200, 307, 260, STRUCTURE OF CDK9/CYCLINT IN COMPLEX WITH S-CR8
1166, 2etrB, 0.7988, 3.12, 0.208, 398, 265, CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
1167, 2a27G, 0.7988, 2.90, 0.218, 303, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1168, 5ew8A, 0.7987, 2.97, 0.369, 291, 260, FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693
1169, 5d7vC, 0.7987, 2.63, 0.316, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1170, 4mxzA, 0.7987, 2.50, 0.355, 266, 251, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1171, 4mxyA, 0.7987, 2.50, 0.355, 266, 251, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1172, 2rfnA, 0.7987, 2.12, 0.327, 268, 245, X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
1173, 6d1zA, 0.7986, 2.69, 0.378, 290, 254, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 5-(4-FLUOROPHENYL)THIENO[2;3-D]PYRIMIDIN-4(3H)-ONE INHIBITOR 
1174, 5os5A, 0.7986, 2.75, 0.233, 267, 257, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1175, 4qmvA, 0.7986, 2.96, 0.258, 288, 260, MST3 IN COMPLEX WITH PF-03814735 N-{2-[(1S4R)-6-{[4- (CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}-1234- TETRAHYDRO-14-EPIMINONAPHTHALEN-9-YL]-2-OXOETHYL}ACETAMIDE
1176, 4aseA, 0.7986, 2.84, 0.348, 305, 256, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)
1177, 3tacA, 0.7986, 2.77, 0.231, 324, 260, CRYSTAL STRUCTURE OF THE LIPRIN-ALPHA/CASK COMPLEX
1178, 3ik3B, 0.7986, 2.50, 0.340, 286, 253, AP24534 A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE
1179, 4ogrE, 0.7985, 2.97, 0.194, 310, 263, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
1180, 3gvuA, 0.7985, 2.35, 0.339, 271, 251, THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC
1181, 3eqfA, 0.7985, 2.85, 0.198, 314, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH K252A AND MG2P
1182, 3eqcA, 0.7985, 2.94, 0.196, 312, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH COMPOUND 1 ATP-GS AND MG2P
1183, 3c4zA, 0.7985, 3.16, 0.239, 493, 264, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 1.84A
1184, 2a27C, 0.7985, 3.03, 0.224, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1185, 5xy1A, 0.7984, 2.38, 0.365, 253, 249, CRYSTAL STRUCTURE OF LYN KINASE DOMAIN IN COMPLEX WITH N-(1H-INDAZOL- 6-YL)-8-(PIPERIDIN-4-YLOXY)-6-PROPYLQUINAZOLIN-2-AMINE
1186, 5t0pA, 0.7984, 2.33, 0.345, 264, 249, C-SRC KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
1187, 3oy3A, 0.7984, 2.50, 0.340, 284, 253, CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG- OUT INHIBITOR AP24589
1188, 5kktB, 0.7983, 3.15, 0.211, 394, 265, ROCK 1 BOUND TO AZAINDOLE THIOZOLE PIPERAZINE INHIBITOR
1189, 4o0xA, 0.7983, 3.02, 0.204, 290, 260, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1190, 4l9iB, 0.7983, 3.05, 0.251, 493, 263, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH PAROXETINE
1191, 4idtA, 0.7983, 2.54, 0.199, 334, 256, CRYSTAL STRUCTURE OF NIK WITH 11-BROMO-5678-TETRAHYDROPYRIMIDO[4  5 :34]CYCLOHEPTA[12-B]INDOL-2-AMINE (T28)
1192, 4d58B, 0.7983, 2.74, 0.373, 261, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1193, 3oomA, 0.7983, 3.23, 0.241, 297, 266, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[12-B]PYRIDAZINE INHIBITOR K00507
1194, 3f6xC, 0.7983, 2.30, 0.347, 265, 248, C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1195, 2ya9B, 0.7983, 2.91, 0.222, 299, 261, CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2
1196, 2qluA, 0.7983, 2.81, 0.239, 297, 259, CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN
1197, 2a27D, 0.7983, 2.91, 0.218, 304, 261, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1198, 1k9aF, 0.7983, 2.14, 0.379, 436, 248, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
1199, 5y25A, 0.7982, 2.30, 0.357, 292, 249, EGFR KINASE DOMAIN MUTANT (T790M/L858R) WITH COVALENT LIGAND NS-062 
1200, 4jajA, 0.7982, 2.87, 0.229, 265, 258, CRYSTAL STRUCTURE OF AURORA KINASE A IN COMPLEX WITH BENZO[C][1 8]NAPHTHYRIDIN-6(5H)-ONE
1201, 3vo3A, 0.7982, 2.85, 0.348, 303, 256, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1 2-B]PYRIDAZINE DERIVATIVE
1202, 3k5vA, 0.7982, 2.45, 0.341, 286, 252, STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
1203, 2zm3B, 0.7982, 2.86, 0.308, 296, 260, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1204, 5nk5A, 0.7981, 3.13, 0.312, 287, 263, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1M
1205, 4wboD, 0.7981, 3.11, 0.246, 491, 264, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1206, 4deeA, 0.7981, 2.75, 0.226, 271, 257, AURORA A IN COMPLEX WITH ADP
1207, 3vvhC, 0.7981, 2.95, 0.192, 283, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
1208, 3bhhA, 0.7981, 2.49, 0.206, 289, 257, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
1209, 1s9jA, 0.7981, 2.96, 0.200, 289, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
1210, 5kz0A, 0.7980, 2.60, 0.307, 293, 254, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-[(1R)- 1-{[2-AMINO-5-(13-DIMETHYL-1H-PYRAZOL-4-YL)PYRIDIN-3-YL]OXY}ETHYL]- 4-FLUORO-NN-DIMETHYLBENZAMIDE
1211, 4qqjA, 0.7980, 2.68, 0.371, 282, 256, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE DOMAIN HARBORING THE V550L GATE-KEEPER MUTATION
1212, 4j8nC, 0.7980, 2.82, 0.236, 266, 258, AURORA A KINASE APO
1213, 4a4oA, 0.7980, 2.92, 0.277, 290, 260, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2- (2-AMINO-PYRIMIDIN-4-YL)-1567-TETRAHYDRO-PYRROLOPYRIDIN- 4-ONE INHIBITOR
1214, 2vn9B, 0.7980, 2.77, 0.222, 301, 261, CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1 CAMKD
1215, 2a27E, 0.7980, 3.03, 0.224, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1216, 5nkhA, 0.7979, 3.13, 0.307, 295, 264, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3E
1217, 5e8yA, 0.7979, 2.96, 0.217, 298, 263, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH STAUROSPORINE
1218, 4uv0A, 0.7979, 3.00, 0.221, 300, 262, STRUCTURE OF A SEMISYNTHETIC PHOSPHORYLATED DAPK
1219, 4a4lA, 0.7979, 2.92, 0.277, 290, 260, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO-PYRIMIDIN-4-YL)-1H-PYRROLE INHIBITOR
1220, 3vhkA, 0.7979, 2.80, 0.345, 297, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BACK POCKET BINDER
1221, 3kb7A, 0.7979, 2.93, 0.281, 289, 260, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
1222, 3eqgA, 0.7979, 2.93, 0.196, 314, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH PD ADP AND MG2P
1223, 2zm3D, 0.7979, 2.79, 0.313, 293, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1224, 4kabB, 0.7978, 2.51, 0.357, 258, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-METHYL-14- DIHYDRO-PYRAZOLO[45-C]PYRAZOLE
1225, 3thbA, 0.7978, 2.92, 0.285, 287, 260, STRUCTURE OF PLK1 KINASE DOMAIN IN COMPLEX WITH A BENZOLACTAM-DERIVED INHIBITOR
1226, 3orxC, 0.7977, 2.81, 0.216, 283, 259, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1227, 3orxA, 0.7977, 2.81, 0.216, 283, 259, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1228, 3eqbA, 0.7977, 2.96, 0.200, 289, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
1229, 2zm3A, 0.7977, 2.87, 0.312, 300, 260, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1230, 2vn9A, 0.7977, 2.78, 0.222, 301, 261, CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1 CAMKD
1231, 5u6yI, 0.7976, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1232, 5u6yF, 0.7976, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1233, 5u6yD, 0.7976, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1234, 5u6yB, 0.7976, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1235, 5u6yA, 0.7976, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1236, 5oxgC, 0.7976, 3.27, 0.244, 301, 266, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1237, 5o49A, 0.7976, 2.86, 0.355, 289, 259, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
1238, 5hznE, 0.7976, 2.88, 0.306, 296, 258, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1239, 5a9uA, 0.7976, 2.60, 0.296, 292, 253, STRUCTURE OF C1156Y MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12-FLUORO-210 16-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H-84-(METHENO) PYRAZOLO(43-H)(2511)BENZOXADIAZACYCLOTETRADECINE-3- CARBONITRILE).
1240, 4debA, 0.7976, 2.80, 0.233, 264, 258, AURORA A IN COMPLEX WITH RK2-17-01
1241, 4anqA, 0.7976, 2.72, 0.294, 293, 255, STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1242, 3vvhB, 0.7976, 3.09, 0.195, 290, 261, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
1243, 2a27F, 0.7976, 3.04, 0.224, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
1244, 1fpuA, 0.7976, 2.40, 0.335, 275, 251, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1245, 4j8nB, 0.7975, 2.82, 0.236, 266, 258, AURORA A KINASE APO
1246, 3zlxA, 0.7975, 2.84, 0.194, 312, 258, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 18
1247, 3js2B, 0.7975, 2.98, 0.369, 291, 260, CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
1248, 1opjB, 0.7975, 2.53, 0.340, 288, 253, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1249, 5u6yL, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1250, 5u6yK, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1251, 5u6yJ, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1252, 5u6yH, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1253, 5u6yG, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1254, 5u6yE, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1255, 5u6yC, 0.7974, 2.70, 0.226, 459, 257, PSEUDO-ATOMIC MODEL OF THE CAMKIIA HOLOENZYME.
1256, 4mxzB, 0.7974, 2.45, 0.356, 264, 250, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1257, 4mxyB, 0.7974, 2.45, 0.356, 264, 250, SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1258, 4l9iA, 0.7974, 3.11, 0.247, 504, 263, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH PAROXETINE
1259, 4arkA, 0.7974, 3.07, 0.188, 291, 261, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH  A SMALL MOLECULE INHIBITOR AND ADP
1260, 3tzmA, 0.7974, 2.98, 0.223, 295, 264, TGF-BETA RECEPTOR TYPE 1 IN COMPLEX WITH SB431542
1261, 3fzrA, 0.7974, 2.42, 0.351, 261, 251, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
1262, 5uglB, 0.7973, 2.74, 0.358, 271, 254, CRYSTAL STRUCTURE OF FGF RECEPTOR 2 TYROSINE KINASE DOMAIN HARBORING THE D650V ACTIVATING MUTATION
1263, 4qqtA, 0.7973, 2.69, 0.367, 283, 256, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 TYROSINE KINASE DOMAIN
1264, 3qc9D, 0.7973, 3.10, 0.243, 486, 263, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1265, 3qc9B, 0.7973, 3.10, 0.243, 481, 263, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1266, 3my0M, 0.7973, 3.46, 0.229, 298, 271, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1267, 3g2fB, 0.7973, 2.73, 0.261, 300, 257, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE II (BMPR2) AT 2.35 A RESOLUTION
1268, 1phkA, 0.7973, 2.61, 0.223, 277, 256, TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE SUBSTRATE-ANALOGUE AND PRODUCT
1269, 5kksB, 0.7972, 3.16, 0.208, 395, 265, ROCK 1 BOUND TO AZAINDOLE THIOZOLE INHIBITOR
1270, 5e92A, 0.7972, 3.08, 0.239, 298, 264, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH AMPPNP
1271, 4j8nA, 0.7972, 2.83, 0.236, 266, 258, AURORA A KINASE APO
1272, 4aojC, 0.7972, 2.44, 0.381, 261, 252, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
1273, 3qc9C, 0.7972, 3.10, 0.243, 482, 263, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1274, 4imyE, 0.7971, 2.88, 0.199, 313, 261, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
1275, 3uo4A, 0.7971, 2.77, 0.233, 266, 258, AURORA A IN COMPLEX WITH RPM1680
1276, 3qc9A, 0.7971, 3.10, 0.243, 486, 263, CRYSTAL STRUCTURE OF CROSS-LINKED BOVINE GRK1 T8C/N480C DOUBLE MUTANT COMPLEXED WITH ADP AND MG
1277, 3my0L, 0.7971, 3.42, 0.234, 296, 269, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1278, 3c4xB, 0.7971, 3.07, 0.247, 475, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.9A
1279, 5p9lA, 0.7970, 2.37, 0.319, 252, 248, BTK1 IN COMPLEX WITH CC 292
1280, 5iu2B, 0.7970, 2.65, 0.171, 313, 258, DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS
1281, 5hznH, 0.7970, 2.87, 0.306, 303, 258, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1282, 4otdA, 0.7970, 2.91, 0.266, 334, 259, CRYSTAL STRUCTURE OF PRK1 CATALYTIC DOMAIN
1283, 4mxoA, 0.7970, 2.54, 0.347, 266, 251, HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB
1284, 3c4wB, 0.7970, 3.06, 0.247, 518, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.7A
1285, 5l1zA, 0.7969, 2.99, 0.194, 310, 263, TAR COMPLEX WITH HIV-1 TAT-AFF4-P-TEFB
1286, 5hznD, 0.7969, 2.87, 0.306, 304, 258, STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE
1287, 4l7sB, 0.7969, 2.26, 0.320, 250, 247, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBENZOTHIAZOLE INHIBITOR
1288, 4k8aB, 0.7969, 2.59, 0.364, 258, 253, FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE INHIBITORS
1289, 3zlsA, 0.7969, 2.78, 0.194, 315, 258, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 6
1290, 3zbfA, 0.7969, 2.58, 0.336, 281, 253, STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH CRIZOTINIB
1291, 3tt0A, 0.7969, 2.88, 0.359, 305, 259, CO-STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN WITH 3-(26-DICHLORO-35-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1- YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA (BGJ398)
1292, 5u7qB, 0.7968, 3.09, 0.193, 385, 264, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1293, 5kvtA, 0.7968, 2.77, 0.379, 287, 256, THE STRUCTURE OF TRKA KINASE DOMAIN BOUND TO THE INHIBITOR ENTRECTINIB
1294, 5ackA, 0.7968, 2.94, 0.232, 286, 259, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND 7 BOUND TO THE PIF-POCKET
1295, 5aa8A, 0.7968, 2.61, 0.296, 292, 253, STRUCTURE OF C1156YL1198F MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PF-06463922 ((10R)-7-AMINO-12- FLUORO-21016-TRIMETHYL-15-OXO-10151617-TETRAHYDRO-2H- 84-(METHENO)PYRAZOLO(43-H)(2511) BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE).
1296, 4xbuA, 0.7968, 2.93, 0.212, 292, 259, IN VITRO CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INKA PEPTIDE
1297, 4mxxA, 0.7968, 2.50, 0.347, 266, 251, HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
1298, 4bb4A, 0.7968, 2.56, 0.281, 265, 253, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1299, 4aojA, 0.7968, 2.42, 0.375, 260, 251, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
1300, 3zlyA, 0.7968, 2.95, 0.193, 310, 259, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 8
1301, 3my0N, 0.7968, 3.43, 0.230, 300, 270, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1302, 3c50B, 0.7968, 3.06, 0.243, 496, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 2.6A
1303, 2bdwB, 0.7968, 2.58, 0.244, 309, 258, CRYSTAL STRUCTURE OF THE AUTO-INHIBITED KINASE DOMAIN OF CALCIUM/CALMODULIN ACTIVATED KINASE II
1304, 1r0pA, 0.7968, 2.67, 0.344, 301, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
1305, 4yo4A, 0.7967, 2.84, 0.225, 280, 258, CRYSTAL STRUCTURE OF DAPK1 CATALYTIC DOMAIN IN COMPLEX WITH THE HINGE BINDING FRAGMENT PHTHALAZINE
1306, 4xx9A, 0.7967, 2.94, 0.232, 288, 259, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RF4
1307, 4ogrA, 0.7967, 3.01, 0.194, 314, 263, CRYSTAL STRUCTURE OF P-TEFB COMPLEX WITH AFF4 AND TAT
1308, 3wigA, 0.7967, 2.85, 0.191, 278, 257, HUMAN MEK1 KINASE IN COMPLEX WITH CH5126766 AND MGAMP-PNP
1309, 3up7A, 0.7967, 2.84, 0.233, 264, 258, AURORA A IN COMPLEX WITH YL1-038-09
1310, 3rcdC, 0.7967, 2.20, 0.344, 281, 247, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1311, 2zm3C, 0.7967, 2.77, 0.309, 296, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
1312, 2y7jB, 0.7967, 2.74, 0.221, 281, 258, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1313, 5edqA, 0.7966, 2.45, 0.355, 298, 251, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 15: ~{N}-(7- CHLORANYL-1~{H}-INDAZOL-3-YL)-77-DIMETHYL-2-(1~{H}-PYRAZOL-4-YL)- 5~{H}-FURO[34-D]PYRIMIDIN-4-AMINE
1314, 4ansA, 0.7966, 2.73, 0.298, 293, 255, STRUCTURE OF L1196MG1269A DOUBLE MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1315, 3rcdA, 0.7966, 2.20, 0.344, 281, 247, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1316, 3bprC, 0.7966, 2.01, 0.332, 259, 244, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
1317, 1vjyA, 0.7966, 3.06, 0.226, 299, 265, CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF- BETA TYPE I RECEPTOR
1318, 1t45A, 0.7966, 2.88, 0.335, 331, 257, STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C- KIT TYROSINE KINASE
1319, 5o4aA, 0.7965, 3.00, 0.369, 290, 260, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
1320, 5d7vD, 0.7965, 2.65, 0.316, 264, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1321, 4wboA, 0.7965, 3.10, 0.239, 497, 264, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1322, 3et7A, 0.7965, 2.43, 0.343, 261, 251, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
1323, 3cs9A, 0.7965, 2.30, 0.341, 264, 249, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
1324, 2jkmA, 0.7965, 2.49, 0.361, 260, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1325, 5k0kA, 0.7964, 2.11, 0.332, 260, 247, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2434
1326, 5h2uD, 0.7964, 2.66, 0.316, 263, 253, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1327, 5a46B, 0.7964, 2.89, 0.380, 297, 258, FGFR1 IN COMPLEX WITH DOVITINIB
1328, 4mneG, 0.7964, 2.20, 0.260, 259, 250, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
1329, 4lmnA, 0.7964, 3.01, 0.196, 292, 260, CRYSTAL STRUCTURE OF MEK1 KINASE BOUND TO GDC0973
1330, 4agcA, 0.7964, 2.89, 0.348, 304, 256, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-( 3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)- BENZAMIDE)
1331, 3orxD, 0.7964, 2.78, 0.217, 282, 258, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1332, 3bprD, 0.7964, 2.03, 0.332, 259, 244, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
1333, 5ta6A, 0.7963, 2.94, 0.277, 294, 260, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A NOVEL 56- DIHYDROIMIDAZOLO[15-F]PTERIDINE INHIBITOR.
1334, 5iu2A, 0.7963, 2.60, 0.171, 312, 257, DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT SELECTIVE AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS
1335, 4uwbA, 0.7963, 2.86, 0.376, 299, 258, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P5
1336, 4l7sA, 0.7963, 2.26, 0.320, 250, 247, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBENZOTHIAZOLE INHIBITOR
1337, 4d4sB, 0.7963, 2.72, 0.378, 260, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1338, 3rhxA, 0.7963, 2.98, 0.369, 289, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
1339, 5h2uC, 0.7962, 2.57, 0.317, 264, 252, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1340, 5e91A, 0.7962, 3.05, 0.236, 297, 263, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4- (MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE
1341, 4wboB, 0.7962, 3.16, 0.246, 495, 264, BOVINE G PROTEIN COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH AMLEXANOX
1342, 4v05A, 0.7962, 2.65, 0.379, 287, 256, FGFR1 IN COMPLEX WITH AZD4547.
1343, 4j52A, 0.7962, 2.95, 0.277, 293, 260, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A PYRIMIDODIAZEPINONE INHIBITOR
1344, 4d4yA, 0.7962, 2.22, 0.360, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1345, 4ccbA, 0.7962, 2.60, 0.298, 287, 252, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 3-((R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(5-METHYL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE
1346, 3eqiA, 0.7962, 2.85, 0.198, 315, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ADP AND MG2P
1347, 2hiwA, 0.7962, 2.41, 0.335, 274, 251, CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
1348, 5u7rC, 0.7961, 3.18, 0.192, 387, 265, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1349, 4d5kA, 0.7961, 2.22, 0.360, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1350, 3geqA, 0.7961, 2.31, 0.351, 272, 248, STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
1351, 2zv9A, 0.7961, 2.59, 0.357, 256, 252, LYN TYROSINE KINASE DOMAIN-PP2 COMPLEX
1352, 2bdfA, 0.7961, 2.51, 0.347, 261, 251, SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
1353, 5edpA, 0.7960, 2.46, 0.355, 295, 251, EGFR KINASE (T790M/L858R) APO
1354, 4uwcB, 0.7960, 2.91, 0.359, 301, 259, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P3
1355, 4ub7A, 0.7960, 2.68, 0.195, 334, 257, HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26) SHOWING AN EXTREME DISTORTION OF THE ATP-BINDING LOOP COMBINED WITH A PI-HALOGEN BOND
1356, 3c4xA, 0.7960, 3.05, 0.243, 496, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.9A
1357, 3c4wA, 0.7960, 3.07, 0.247, 494, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ATP AND MAGNESIUM CHLORIDE AT 2.7A
1358, 2yacA, 0.7960, 2.96, 0.277, 290, 260, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH NMS-P937
1359, 5j87C, 0.7959, 2.50, 0.331, 261, 251, DISCOVERY OF N-(3-(5-((3-ACRYLAMIDO-4-(MORPHOLINE-4-CARBONYL)PHENYL) AMINO)-1-METHYL-6-OXO-16-DIHYDROPYRIDIN-3-YL)-2-METHYLPHENYL)-4- (TERT-BUTYL)BENZAMIDE (CHMFL-BTK-01) AS A HIGHLY SELECTIVE IRREVERSIBLE BTK KINASE INHIBITOR
1360, 5dr2A, 0.7959, 2.78, 0.234, 264, 256, AURORA A KINASE IN COMPLEX WITH AA30 AND ATP IN SPACE GROUP P6122
1361, 4yveB, 0.7959, 3.18, 0.211, 393, 265, ROCK 1 BOUND TO METHOXYPHENYL THIAZOLE INHIBITOR
1362, 4qmqA, 0.7959, 3.05, 0.257, 289, 261, MST3 IN COMPLEX WITH CP-673451
1363, 3zlwA, 0.7959, 2.87, 0.194, 312, 258, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 3
1364, 3dv3A, 0.7959, 2.97, 0.201, 288, 259, MEK1 WITH PF-04622664 BOUND
1365, 2etmB, 0.7959, 2.46, 0.359, 263, 251, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [23-D] PYRIMIDINE DERIVATIVE
1366, 5lxmA, 0.7958, 2.75, 0.227, 266, 255, CRYSTAL STRUCTURE OF AURORA-A BOUND TO A HYDROCARBON-STAPLED PROTEOMIMETIC OF TPX2
1367, 5h2uA, 0.7958, 2.56, 0.321, 265, 252, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN COMPLEXED WITH DASATINIB
1368, 5aacA, 0.7958, 2.62, 0.296, 292, 253, STRUCTURE OF C1156Y MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1369, 4yvcB, 0.7958, 3.18, 0.211, 392, 265, ROCK 1 BOUND TO THIAZOLE INHIBITOR
1370, 4fnyA, 0.7958, 2.12, 0.301, 273, 246, CRYSTAL STRUCTURE OF THE R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
1371, 3gu8A, 0.7958, 2.66, 0.219, 278, 256, CRYSTAL STRUCTURE OF DAPKL93G WITH N6-CYCLOPENTYLADENOSINE
1372, 3dgkA, 0.7958, 2.76, 0.226, 278, 257, CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
1373, 5vndB, 0.7957, 2.86, 0.364, 295, 258, CRYSTAL STRUCTURE OF FGFR1-Y563C (FGFR4 SURROGATE) COVALENTLY BOUND TO H3B-6527
1374, 4uy9A, 0.7957, 2.65, 0.312, 313, 256, STRUCTURE OF MLK1 KINASE DOMAIN WITH LEUCINE ZIPPER 1
1375, 4rqvA, 0.7957, 2.94, 0.232, 288, 259, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RS2
1376, 1wvxA, 0.7957, 2.79, 0.218, 275, 257, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1377, 5bx0A, 0.7956, 2.84, 0.190, 315, 258, AN AUTOMATED MICROSCALE THERMOPHORESIS SCREENING APPROACH FOR FRAGMENT-BASED LEAD DISCOVERY
1378, 4o0sA, 0.7956, 2.76, 0.234, 265, 256, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
1379, 4fzfB, 0.7956, 2.71, 0.246, 279, 256, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX WITH DKI
1380, 3lvpB, 0.7956, 2.89, 0.312, 295, 260, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1381, 2esmB, 0.7956, 3.16, 0.208, 398, 265, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
1382, 5dt3A, 0.7955, 2.77, 0.231, 263, 255, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P6122
1383, 4rqkA, 0.7955, 2.95, 0.236, 285, 259, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND THE PIF-POCKET LIGAND RS1
1384, 4imyC, 0.7955, 2.78, 0.197, 310, 259, THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
1385, 3vheA, 0.7955, 2.90, 0.344, 303, 256, CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH A NOVEL PYRROLOPYRIMIDINE INHIBITOR.
1386, 3k5vB, 0.7955, 2.38, 0.340, 283, 250, STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
1387, 5vedA, 0.7954, 2.94, 0.205, 289, 259, PAK4 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1388, 5ta8A, 0.7954, 3.00, 0.285, 294, 260, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A NOVEL 56- DIHYDROIMIDAZOLO[15-F]PTERIDINE INHIBITOR
1389, 4rj5A, 0.7954, 2.34, 0.351, 296, 248, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 5
1390, 4d5hA, 0.7954, 2.24, 0.360, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1391, 3eqdA, 0.7954, 2.87, 0.198, 315, 258, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ATP-GS AND MG2P
1392, 2hyyC, 0.7954, 2.42, 0.340, 262, 250, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1393, 2etmA, 0.7954, 2.67, 0.354, 262, 254, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [23-D] PYRIMIDINE DERIVATIVE
1394, 1iepB, 0.7954, 2.43, 0.343, 274, 251, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1395, 5kksA, 0.7953, 3.24, 0.208, 395, 265, ROCK 1 BOUND TO AZAINDOLE THIOZOLE INHIBITOR
1396, 4kioC, 0.7953, 2.35, 0.319, 251, 248, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
1397, 4j53A, 0.7953, 2.94, 0.277, 293, 260, CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH TAK-960
1398, 3mtfB, 0.7953, 3.28, 0.233, 298, 266, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2- AMINOPYRIDINE INHIBITOR
1399, 2owbA, 0.7953, 2.95, 0.281, 294, 260, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
1400, 6dkgA, 0.7952, 2.55, 0.381, 276, 252, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 13B. 
1401, 4wo5A, 0.7952, 2.63, 0.257, 266, 257, CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER
1402, 4u81A, 0.7952, 3.02, 0.200, 289, 260, MEK1 KINASE BOUND TO SMALL MOLECULE INHIBITOR G659
1403, 3vvhA, 0.7952, 3.02, 0.193, 287, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
1404, 3v04A, 0.7952, 3.01, 0.200, 289, 260, DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
1405, 2yakA, 0.7952, 2.82, 0.217, 277, 258, STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OSV)
1406, 4txcA, 0.7951, 2.82, 0.221, 276, 258, CRYSTAL STRUCTURE OF DAPK1 KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1407, 3nynA, 0.7951, 2.90, 0.232, 553, 259, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH SANGIVAMYCIN
1408, 3nrmA, 0.7951, 2.81, 0.233, 263, 257, IMIDAZO[12-A]PYRAZINE-BASED AURORA KINASE INHIBITORS
1409, 5wngA, 0.7950, 3.04, 0.201, 395, 264, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1410, 4ypdA, 0.7950, 2.78, 0.226, 281, 257, CRYSTAL STRUCTURE OF DAPK1 CATALYTIC DOMAIN IN COMPLEX WITH THE HINGE BINDING FRAGMENT 4-METHYLPYRIDAZINE
1411, 4njdA, 0.7950, 2.99, 0.208, 290, 259, STRUCTURE OF P21-ACTIVATED KINASE 4 WITH A NOVEL INHIBITOR KY-04031
1412, 2rfsA, 0.7950, 2.39, 0.352, 264, 247, X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
1413, 5d7vA, 0.7949, 2.56, 0.317, 268, 252, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN
1414, 4j8nD, 0.7949, 2.82, 0.237, 265, 257, AURORA A KINASE APO
1415, 3gu5A, 0.7949, 2.87, 0.225, 280, 258, CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP-MG2+
1416, 2p55A, 0.7949, 3.03, 0.200, 289, 260, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
1417, 5bmlB, 0.7948, 3.20, 0.211, 395, 265, ROCK 1 BOUND TO A PYRIDINE THIAZOLE INHIBITOR
1418, 5av0A, 0.7948, 2.88, 0.229, 275, 258, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH 73 4 - TRIHYDROXYISOFLAVONE.
1419, 4ks8A, 0.7948, 3.00, 0.208, 286, 259, PAK6 KINASE DOMAIN IN COMPLEX WITH SUNITINIB
1420, 4ec9A, 0.7948, 2.72, 0.194, 306, 258, CRYSTAL STRUCTURE OF FULL-LENGTH CDK9 IN COMPLEX WITH CYCLIN T
1421, 4d4yB, 0.7948, 2.73, 0.378, 260, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1422, 3nynB, 0.7948, 2.87, 0.236, 553, 259, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH SANGIVAMYCIN
1423, 3cthA, 0.7948, 2.88, 0.322, 295, 258, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
1424, 3blrA, 0.7948, 2.75, 0.201, 300, 259, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL
1425, 2vx0A, 0.7948, 3.01, 0.278, 273, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1426, 4d5hB, 0.7947, 2.74, 0.378, 260, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1427, 4d58A, 0.7947, 2.25, 0.360, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1428, 2v7oA, 0.7947, 2.93, 0.202, 305, 263, CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA
1429, 5lvlA, 0.7946, 2.96, 0.236, 285, 259, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND PS653 BOUND TO THE ATP-BINDING SITE
1430, 3d9vB, 0.7946, 3.18, 0.208, 398, 265, CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI- METHYLATED VARIANT OF FASUDIL
1431, 3brbB, 0.7946, 2.35, 0.324, 271, 250, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH ADP
1432, 2xb7A, 0.7946, 2.35, 0.301, 286, 249, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP- TAE684
1433, 2e2bA, 0.7946, 2.34, 0.337, 270, 249, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
1434, 5lvoA, 0.7945, 2.95, 0.239, 285, 259, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PSE10 BOUND TO THE PIF-POCKET
1435, 4yzbA, 0.7945, 2.83, 0.239, 466, 259, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1521
1436, 3v8sC, 0.7945, 3.08, 0.197, 395, 264, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1437, 3v8sA, 0.7945, 3.07, 0.197, 395, 264, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
1438, 3tnhA, 0.7945, 2.63, 0.202, 288, 257, CDK9/CYCLIN T IN COMPLEX WITH CAN508
1439, 3gubA, 0.7945, 2.78, 0.230, 278, 257, CRYSTAL STRUCTURE OF DAPKL93G COMPLEXED WITH N6-(2- PHENYLETHYL)ADENOSINE
1440, 3gu7A, 0.7945, 2.89, 0.229, 280, 258, CRYSTAL STRUCTURE OF DAPKQ23V-ADP-MG2+
1441, 2rkuA, 0.7945, 2.97, 0.277, 294, 260, STRUCTURE OF PLK1 IN COMPLEX WITH BI2536
1442, 5xp7A, 0.7944, 2.51, 0.344, 265, 250, C-SRC IN COMPLEX WITH ATP-CHCL
1443, 4ymjA, 0.7944, 2.69, 0.415, 270, 253, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1444, 4jdiA, 0.7944, 2.85, 0.198, 289, 258, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
1445, 2hyyB, 0.7944, 2.39, 0.340, 265, 250, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1446, 2auhA, 0.7944, 2.97, 0.324, 297, 259, CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE
1447, 5ng2B, 0.7943, 2.58, 0.248, 278, 254, STRUCTURE OF RIP2K(D146N) WITH BOUND STAUROSPORINE
1448, 5i9uA, 0.7943, 2.72, 0.318, 281, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
1449, 5av1A, 0.7943, 2.88, 0.229, 275, 258, CRYSTAL STRUCTURE OF DAPK1 IN THE PRESENCE OF BROMIDE IONS.
1450, 4o2pB, 0.7943, 2.41, 0.337, 265, 249, KINASE DOMAIN OF CSRC IN COMPLEX WITH A SUBSTITUTED PYRAZOLOPYRIMIDINE
1451, 4l6qA, 0.7943, 3.12, 0.197, 388, 264, ROCK2 IN COMPLEX WITH BENZOXABOROLE
1452, 4dedA, 0.7943, 2.87, 0.236, 265, 258, AURORA A IN COMPLEX WITH YL1-038-21
1453, 3my0A, 0.7943, 3.43, 0.230, 296, 269, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1454, 3bprB, 0.7943, 2.02, 0.333, 256, 243, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
1455, 1jklA, 0.7943, 2.89, 0.229, 280, 258, 1.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE
1456, 1iepA, 0.7943, 2.39, 0.340, 274, 250, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1457, 5t0pB, 0.7942, 2.41, 0.345, 263, 249, C-SRC KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
1458, 5oy6D, 0.7942, 3.01, 0.249, 292, 261, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1459, 5orpA, 0.7942, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1460, 5dh3B, 0.7942, 2.85, 0.230, 283, 257, CRYSTAL STRUCTURE OF MST2 IN COMPLEX WITH XMU-MP-1
1461, 4o0yA, 0.7942, 2.90, 0.198, 290, 258, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1462, 3gu6A, 0.7942, 2.79, 0.230, 280, 257, CRYSTAL STRUCTURE OF DAPKQ23V-ADP
1463, 2zv7A, 0.7942, 2.68, 0.360, 257, 253, LYN TYROSINE KINASE DOMAIN APO FORM
1464, 2xp2A, 0.7942, 2.59, 0.303, 285, 251, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
1465, 5hu3A, 0.7941, 2.70, 0.227, 266, 256, DROSOPHILA CAMKII-D136N IN COMPLEX WITH A PHOSPHORYLATED FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP
1466, 5dn3A, 0.7941, 2.93, 0.233, 264, 258, AURORA A IN COMPLEX WITH ATP AND AA35.
1467, 4mxoB, 0.7941, 2.51, 0.348, 264, 250, HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB
1468, 4l6qB, 0.7941, 3.21, 0.192, 388, 265, ROCK2 IN COMPLEX WITH BENZOXABOROLE
1469, 3utoB, 0.7941, 2.85, 0.180, 566, 261, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
1470, 3nyoA, 0.7941, 3.00, 0.235, 553, 260, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH AMP
1471, 3mj2A, 0.7941, 2.31, 0.306, 259, 248, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-509744
1472, 3f5gA, 0.7941, 2.89, 0.229, 279, 258, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
1473, 5xvfA, 0.7940, 2.84, 0.198, 289, 258, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH062
1474, 5wneA, 0.7940, 3.16, 0.208, 384, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1475, 5av3A, 0.7940, 2.89, 0.229, 275, 258, CRYSTAL STRUCTURE OF DAPK1-KAEMPFEROL COMPLEX IN THE PRESENCE OF IODIDE IONS.
1476, 4o0tA, 0.7940, 3.32, 0.226, 292, 265, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
1477, 3v01A, 0.7940, 2.97, 0.197, 289, 259, DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
1478, 3q4uA, 0.7940, 3.26, 0.242, 298, 265, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1479, 3gu4A, 0.7940, 2.70, 0.223, 280, 256, CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP
1480, 3fc2A, 0.7940, 2.97, 0.277, 293, 260, PLK1 IN COMPLEX WITH BI6727
1481, 3cd8A, 0.7940, 2.39, 0.352, 278, 247, X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
1482, 1wmkB, 0.7940, 3.01, 0.218, 314, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1483, 6d1yA, 0.7939, 2.68, 0.379, 300, 253, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH 2;4-DICHLORO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)BENZAMIDE INHIBITOR 
1484, 5u7rA, 0.7939, 3.14, 0.197, 387, 264, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1485, 5osfA, 0.7939, 2.69, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1486, 5oseA, 0.7939, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1487, 5os1A, 0.7939, 2.73, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1488, 5orzA, 0.7939, 2.68, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1489, 4zsaB, 0.7939, 2.63, 0.376, 282, 255, CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN IN COMPLEX WITH 7N
1490, 4u80A, 0.7939, 2.94, 0.201, 286, 259, MEK 1 KINASE BOUND TO G799
1491, 3zfxF, 0.7939, 2.01, 0.295, 254, 244, CRYSTAL STRUCTURE OF EPHB1
1492, 2yfxA, 0.7939, 2.77, 0.306, 292, 255, STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
1493, 2w4jA, 0.7939, 2.79, 0.226, 276, 257, X-RAY STRUCTURE OF A DAP-KINASE 2-277
1494, 1wmkD, 0.7939, 3.01, 0.218, 314, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1495, 5zv2B, 0.7938, 2.68, 0.365, 282, 255, FGFR-1 IN COMPLEX WITH LIGAND LENVATINIB 
1496, 5ornA, 0.7938, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1497, 1wmkG, 0.7938, 3.02, 0.218, 313, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1498, 1wmkE, 0.7938, 3.02, 0.218, 313, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1499, 1wmkC, 0.7938, 3.02, 0.218, 303, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1500, 5grnA, 0.7937, 2.99, 0.336, 285, 256, CRYSTAL STRUCTURE OF PDGFRA IN COMPLEX WITH WQ-C-159
1501, 4otgA, 0.7937, 2.95, 0.266, 322, 259, CRYSTAL STRUCTURE OF PRK1 CATALYTIC DOMAIN IN COMPLEX WITH LESTAURTINIB
1502, 4jboA, 0.7937, 2.81, 0.233, 266, 257, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
1503, 4dc2A, 0.7937, 2.86, 0.190, 328, 258, STRUCTURE OF PKC IN COMPLEX WITH A SUBSTRATE PEPTIDE FROM PAR-3
1504, 4c7tA, 0.7937, 2.70, 0.358, 259, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-135-TRIAZINE INHIBITOR
1505, 4aw2A, 0.7937, 3.20, 0.183, 398, 263, CRYSTAL STRUCTURE OF CDC42 BINDING PROTEIN KINASE ALPHA (MRCK ALPHA)
1506, 3zfxB, 0.7937, 2.13, 0.290, 254, 245, CRYSTAL STRUCTURE OF EPHB1
1507, 1wmkH, 0.7937, 3.02, 0.218, 304, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1508, 1wmkF, 0.7937, 3.02, 0.218, 303, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1509, 4l67A, 0.7936, 2.90, 0.198, 289, 258, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PAK4
1510, 4gu9B, 0.7936, 2.60, 0.357, 255, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO- PHENYL)-(1H-PYRAZOLO[34-D]PYRIMIDIN-4-YL)-AMINE
1511, 3p08A, 0.7936, 2.44, 0.305, 252, 249, CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
1512, 3eh9A, 0.7936, 2.72, 0.223, 278, 256, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
1513, 1wmkA, 0.7936, 3.02, 0.218, 303, 262, HUMAN DEATH-ASSOCIATED KINASE DRP-1 MUTANT S308D D40
1514, 1jksA, 0.7936, 2.90, 0.229, 280, 258, 1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1515, 5xvaA, 0.7935, 3.01, 0.205, 292, 259, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH216
1516, 5orxA, 0.7935, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1517, 5orwA, 0.7935, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1518, 5oroA, 0.7935, 2.69, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1519, 5i0bA, 0.7935, 3.07, 0.204, 288, 260, STRUCTURE OF PAK4
1520, 5ftqA, 0.7935, 2.74, 0.306, 293, 255, CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH CMPD 17
1521, 5auwA, 0.7935, 2.85, 0.226, 274, 257, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH QUERCETIN.
1522, 4wotC, 0.7935, 3.04, 0.186, 392, 263, ROCK2 IN COMPLEX WITH 1426382-07-1
1523, 3ehaA, 0.7935, 2.89, 0.229, 279, 258, CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
1524, 1fgiB, 0.7935, 2.67, 0.380, 272, 255, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
1525, 5wnhA, 0.7934, 3.15, 0.208, 394, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1526, 5oxgA, 0.7934, 3.12, 0.240, 293, 262, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1527, 5oryA, 0.7934, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1528, 5orvA, 0.7934, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1529, 5orrA, 0.7934, 2.73, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1530, 5kktA, 0.7934, 3.10, 0.198, 389, 263, ROCK 1 BOUND TO AZAINDOLE THIOZOLE PIPERAZINE INHIBITOR
1531, 5jfxA, 0.7934, 2.38, 0.373, 277, 249, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-06273340
1532, 5ew3A, 0.7934, 2.64, 0.335, 274, 251, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN IN COMPLEX WITH AAL993
1533, 3tv6B, 0.7934, 2.73, 0.285, 276, 256, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A METHOXYPYRAZOLOPYRIDINYL BENZAMIDE INHIBITOR
1534, 3hmmA, 0.7934, 2.97, 0.229, 293, 262, STRUCTURE OF ALK5 + GW855857
1535, 5xvgA, 0.7933, 2.92, 0.205, 292, 258, CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH226
1536, 5os3A, 0.7933, 2.70, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1537, 5os0A, 0.7933, 2.74, 0.235, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1538, 5auvA, 0.7933, 2.90, 0.229, 275, 258, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH APIGENIN.
1539, 4bggA, 0.7933, 3.24, 0.242, 296, 264, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1540, 3q4uC, 0.7933, 3.06, 0.244, 296, 262, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1541, 3ndmB, 0.7933, 3.20, 0.208, 396, 265, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
1542, 3iw4A, 0.7933, 2.86, 0.238, 330, 260, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
1543, 3dfcB, 0.7933, 2.80, 0.230, 280, 257, CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
1544, 2i1mA, 0.7933, 2.96, 0.336, 311, 256, CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
1545, 6babB, 0.7932, 2.45, 0.221, 285, 253, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1546, 5edrA, 0.7932, 2.46, 0.356, 299, 250, EGFR KINASE (T790M/L858R) WITH INHIBITOR COMPOUND 27: ~{N}-(1~{H}- INDAZOL-3-YL)-77-DIMETHYL-2-(2-METHYLPYRAZOL-3-YL)-5~{H}-FURO[34- D]PYRIMIDIN-4-AMINE
1547, 4uakA, 0.7932, 3.25, 0.208, 404, 264, MRCK BETA IN COMPLEX WITH ADP
1548, 4hvsA, 0.7932, 2.85, 0.345, 326, 255, CRYSTAL STRUCTURE OF KIT KINASE DOMAIN WITH A SMALL MOLECULE INHIBITOR PLX647
1549, 4ctcA, 0.7932, 2.53, 0.303, 288, 251, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 7-AMINO-3-CYCLOPROPYL-12-FLUORO- 11016-TRIMETHYL-1617-DIHYDRO-1H-84-(METHENO)PYRAZOLO(4 3-H)(2511)BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE
1550, 4b6lA, 0.7932, 3.09, 0.245, 281, 261, DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN
1551, 2etkA, 0.7932, 3.16, 0.208, 400, 264, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
1552, 5vndA, 0.7931, 2.89, 0.377, 302, 257, CRYSTAL STRUCTURE OF FGFR1-Y563C (FGFR4 SURROGATE) COVALENTLY BOUND TO H3B-6527
1553, 5os4A, 0.7931, 2.71, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1554, 4d4sA, 0.7931, 2.26, 0.360, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1555, 3uqgA, 0.7931, 2.47, 0.345, 263, 249, C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW1243
1556, 2y0aA, 0.7931, 2.95, 0.215, 300, 261, STRUCTURE OF DAPK1 CONSTRUCT RESIDUES 1-304
1557, 6fd3A, 0.7930, 2.88, 0.202, 296, 258, THIOPHOSPHORYLATED PAK3 KINASE DOMAIN
1558, 5wnfD, 0.7930, 3.19, 0.204, 396, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1559, 5os6A, 0.7930, 2.70, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1560, 5auyA, 0.7930, 2.81, 0.230, 275, 257, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH MORIN.
1561, 4yveA, 0.7930, 3.24, 0.211, 390, 265, ROCK 1 BOUND TO METHOXYPHENYL THIAZOLE INHIBITOR
1562, 4ckrA, 0.7930, 2.79, 0.353, 295, 255, CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH DDR1-IN-1
1563, 4bggB, 0.7930, 3.23, 0.242, 293, 264, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
1564, 3ndmD, 0.7930, 3.20, 0.208, 396, 265, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
1565, 2x0gA, 0.7930, 3.07, 0.218, 318, 262, X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
1566, 2oiqA, 0.7930, 2.38, 0.343, 265, 248, CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
1567, 5wnfA, 0.7929, 3.16, 0.208, 395, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1568, 5dnrA, 0.7929, 2.92, 0.233, 264, 257, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P41212
1569, 4ymjB, 0.7929, 2.66, 0.413, 275, 252, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1570, 4ctbA, 0.7929, 2.72, 0.303, 292, 254, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR (5R)-8-AMINO-3-FLUORO-519-DIMETHYL-20-OXO-5181920- TETRAHYDRO-711-(AZENO)PYRIDO(2 1 :23)IMIDAZO(45-H)(2511) BENZOXADIAZACYCLOTETRADECINE-14-CARBONITRILE
1571, 3zfxG, 0.7929, 2.05, 0.291, 253, 244, CRYSTAL STRUCTURE OF EPHB1
1572, 5wnjA, 0.7928, 2.24, 0.261, 264, 249, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN KINASE 4 (RIPK4) D143N IN COMPLEX WITH LESTAURTINIB 
1573, 5wngD, 0.7928, 3.17, 0.208, 396, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1574, 5k9iA, 0.7928, 2.10, 0.343, 258, 245, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH A COVALENT LYSINE PROBE
1575, 5vefA, 0.7927, 2.80, 0.195, 289, 257, PAK4 KINASE DOMAIN IN COMPLEX WITH FASUDIL
1576, 5upkB, 0.7927, 2.95, 0.197, 288, 259, CDC42 BINDS PAK4 VIA AN EXTENDED GTPASE-EFFECTOR INTERFACE - 3 PEPTIDE: PAK4CAT PAK4-N45 CDC42
1577, 5tehB, 0.7927, 2.21, 0.341, 262, 246, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-156
1578, 5am7B, 0.7927, 2.68, 0.369, 287, 255, FGFR1 MUTANT WITH AN INHIBITOR
1579, 4wotB, 0.7927, 3.14, 0.189, 394, 264, ROCK2 IN COMPLEX WITH 1426382-07-1
1580, 4fiiA, 0.7927, 2.78, 0.195, 291, 257, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
1581, 3nczA, 0.7927, 3.14, 0.205, 399, 264, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
1582, 5orsA, 0.7926, 2.70, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1583, 5hvuA, 0.7926, 3.20, 0.211, 394, 265, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH A PYRIDINE THIAZOLE PIPERIDINE INHIBITOR
1584, 4fr4F, 0.7926, 3.20, 0.232, 346, 263, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1585, 3oxzA, 0.7926, 2.10, 0.343, 268, 245, CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24534
1586, 1jkkA, 0.7926, 2.81, 0.230, 277, 257, 2.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG.
1587, 6gipA, 0.7925, 3.15, 0.247, 296, 263, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH A QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 2; 5-DIMETHYL CORE. 
1588, 5av4A, 0.7925, 2.87, 0.230, 274, 257, CRYSTAL STRUCTURE OF DAPK1-GENISTEIN COMPLEX IN THE PRESENCE OF BROMIDE IONS.
1589, 4utdA, 0.7925, 2.78, 0.235, 266, 255, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP IN AN ACTIVE CONFORMATION
1590, 3orxB, 0.7925, 2.74, 0.219, 280, 256, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
1591, 3brbA, 0.7925, 2.25, 0.328, 260, 247, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE- PROTEIN KINASE MER IN COMPLEX WITH ADP
1592, 2y7jD, 0.7925, 2.79, 0.217, 281, 258, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1593, 2y7jC, 0.7925, 2.78, 0.221, 284, 258, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1594, 2vx1A, 0.7925, 3.03, 0.290, 274, 259, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1595, 2ou7A, 0.7925, 3.00, 0.288, 292, 260, STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
1596, 2hyyA, 0.7925, 2.38, 0.341, 263, 249, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1597, 5jfwA, 0.7924, 2.39, 0.369, 277, 249, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-05247452
1598, 5av2A, 0.7924, 2.82, 0.230, 275, 257, CRYSTAL STRUCTURE OF DAPK1-KAEMPFEROL COMPLEX IN THE PRESENCE OF BROMIDE IONS.
1599, 4ybkA, 0.7924, 2.46, 0.344, 266, 250, C-HELIX-OUT DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
1600, 4riwA, 0.7924, 2.55, 0.354, 269, 254, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
1601, 4d5kB, 0.7924, 2.49, 0.379, 256, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1602, 5ew8B, 0.7923, 2.95, 0.372, 290, 258, FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693
1603, 5auxA, 0.7923, 2.82, 0.230, 275, 257, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH KAEMPFEROL.
1604, 2vwyA, 0.7923, 2.85, 0.276, 274, 257, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1605, 1ig1A, 0.7923, 2.81, 0.230, 280, 257, 1.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN.
1606, 6gi6A, 0.7922, 3.32, 0.241, 298, 266, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH A QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 5-METHYL CORE. 
1607, 5jfsA, 0.7922, 2.50, 0.384, 277, 250, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-00593174
1608, 4pp7B, 0.7922, 3.03, 0.260, 274, 258, HIGHLY POTENT AND SELECTIVE 3-N-METHYLQUINAZOLINE-4(3H)-ONE BASED INHIBITORS OF B-RAFV600E KINASE
1609, 4fijA, 0.7922, 2.81, 0.195, 291, 257, CATALYTIC DOMAIN OF HUMAN PAK4
1610, 3tv7C, 0.7922, 3.18, 0.204, 394, 265, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1611, 3rwqA, 0.7922, 2.93, 0.221, 283, 258, DISCOVERY OF A NOVEL POTENT AND SELECTIVE INHIBITOR OF 3- PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
1612, 3nyoB, 0.7922, 2.89, 0.228, 553, 259, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 6 IN COMPLEX WITH AMP
1613, 2q0nA, 0.7922, 2.84, 0.194, 293, 258, STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE
1614, 5ng2A, 0.7921, 2.51, 0.250, 274, 252, STRUCTURE OF RIP2K(D146N) WITH BOUND STAUROSPORINE
1615, 5m4iA, 0.7921, 2.75, 0.195, 331, 257, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO-FLAVONOL (FLC21) CRYSTALLIZED UNDER HIGH-SALT CONDITIONS
1616, 4riyA, 0.7921, 2.63, 0.357, 269, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
1617, 4fihA, 0.7921, 2.81, 0.195, 291, 257, CATALYTIC DOMAIN OF HUMAN PAK4 WITH QKFTGLPRQW PEPTIDE
1618, 3tkuB, 0.7921, 3.17, 0.198, 395, 263, MRCK BETA IN COMPLEX WITH FASUDIL
1619, 6fnkA, 0.7920, 2.82, 0.288, 274, 257, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1620, 5wnhD, 0.7920, 3.20, 0.208, 397, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1621, 5hzeA, 0.7920, 2.83, 0.187, 305, 256, MEK1 ADOPTS DFG-OUT CONFORMATION WHEN BOUND TO AN ANALOG OF E6201.
1622, 5hq0A, 0.7920, 2.83, 0.202, 292, 257, TERNARY COMPLEX OF HUMAN PROTEINS CDK1 CYCLIN B AND CKS2 BOUND TO AN INHIBITOR
1623, 4y72A, 0.7920, 2.83, 0.202, 292, 257, HUMAN CDK1/CYCLINB1/CKS2 WITH INHIBITOR
1624, 4w8eA, 0.7920, 3.08, 0.258, 290, 260, STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF-06645342)
1625, 4pp9B, 0.7920, 2.13, 0.311, 247, 244, ITK KINASE DOMAIN WITH COMPOUND 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4- YL]-2H-INDAZOLE-3-CARBOXAMIDE)
1626, 4pf4A, 0.7920, 2.80, 0.226, 278, 257, 1.1A X-RAY STRUCTURE OF THE APO CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE 1 AA 1-277
1627, 2phkA, 0.7920, 2.65, 0.219, 277, 256, THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION
1628, 2j0iA, 0.7920, 3.03, 0.219, 289, 260, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
1629, 2ijmA, 0.7920, 2.43, 0.360, 260, 250, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
1630, 5u7rB, 0.7919, 3.15, 0.193, 387, 264, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1631, 5fboA, 0.7919, 2.28, 0.321, 255, 249, BTK-INHIBITOR CO-STRUCTURE
1632, 5b7vA, 0.7919, 2.59, 0.360, 282, 253, HUMAN FGFR1 KINASE IN COMPLEX WITH CH5183284
1633, 4mhaA, 0.7919, 2.07, 0.327, 256, 245, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1817
1634, 4jdhA, 0.7919, 2.88, 0.194, 289, 258, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
1635, 4bn1A, 0.7919, 2.77, 0.235, 261, 255, CRYSTAL STRUCTURE OF V174M MUTANT OF AURORA-A KINASE
1636, 3twjC, 0.7919, 3.10, 0.197, 396, 264, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1447
1637, 3tv4B, 0.7919, 2.89, 0.280, 276, 257, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN BROMOPYRIDINE BENZAMIDE INHIBITOR
1638, 2jkkA, 0.7919, 2.59, 0.361, 258, 252, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1639, 2etrA, 0.7919, 3.25, 0.211, 400, 265, CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
1640, 4mneC, 0.7918, 2.33, 0.259, 260, 251, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
1641, 4a06A, 0.7918, 2.93, 0.233, 282, 257, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS114 BOUND TO THE PIF-POCKET
1642, 3tv7A, 0.7918, 3.19, 0.204, 394, 265, HUMAN RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1342
1643, 3tkuA, 0.7918, 3.08, 0.192, 395, 261, MRCK BETA IN COMPLEX WITH FASUDIL
1644, 3q4uB, 0.7918, 3.26, 0.243, 300, 263, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN- 193189
1645, 2hiwB, 0.7918, 2.38, 0.340, 274, 250, CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
1646, 5ng3A, 0.7917, 2.52, 0.249, 283, 253, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
1647, 3zm4A, 0.7917, 2.85, 0.195, 309, 256, CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 1
1648, 3q9xB, 0.7917, 2.90, 0.190, 330, 258, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5
1649, 3my0C, 0.7917, 3.47, 0.230, 299, 269, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1650, 3hrfA, 0.7917, 2.97, 0.233, 284, 258, CRYSTAL STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN ALLOSTERIC ACTIVATOR BOUND TO THE PIF-POCKET
1651, 3g6gB, 0.7917, 2.37, 0.332, 263, 247, EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
1652, 3el8A, 0.7917, 2.49, 0.345, 263, 249, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
1653, 1ol5A, 0.7917, 2.90, 0.230, 263, 256, STRUCTURE OF AURORA-A 122-403 PHOSPHORYLATED ON THR287 THR288 AND BOUND TO TPX2 1-43
1654, 6cz4A, 0.7916, 2.59, 0.328, 257, 250, STRUCTURE OF THE PTK6 KINASE DOMAIN BOUND TO A TYPE II INHIBITOR 2- {[(3R;4S)-3-FLUORO-1-{[4-(TRIFLUOROMETHOXY)PHENYL]ACETYL}PIPERIDIN-4- YL]OXY}-5-(1-METHYL-1H-IMIDAZOL-4-YL)PYRIDINE-3-CARBOXAMIDE 
1655, 5imxA, 0.7916, 2.06, 0.307, 266, 244, ANAPLASTIC LYMPHOMA KINASE (ALK) CATALYTIC DOMAIN COMPLEXED WITH NOVEL INHIBITOR 3-SULFONYLPYRAZOL-4-AMINO PYRIMIDINE
1656, 5auuA, 0.7916, 2.89, 0.230, 274, 257, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH LUTEOLIN.
1657, 4fbxA, 0.7916, 2.80, 0.191, 333, 257, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A BISUBSTRATE INHIBITOR
1658, 3qfvA, 0.7916, 3.18, 0.198, 395, 263, MRCK BETA IN COMPLEX WITH TPCA-1
1659, 3my0B, 0.7916, 3.50, 0.230, 295, 269, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1660, 3h3cA, 0.7916, 2.43, 0.344, 263, 250, CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE- SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG
1661, 3d9vA, 0.7916, 3.34, 0.207, 400, 266, CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI- METHYLATED VARIANT OF FASUDIL
1662, 1agwA, 0.7916, 2.63, 0.366, 278, 254, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1663, 6gt1A, 0.7915, 2.48, 0.250, 267, 252, NEK7 BOUND TO PURINE INHIBITOR 
1664, 6babC, 0.7915, 2.38, 0.215, 284, 251, THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR
1665, 4wa9A, 0.7915, 1.69, 0.331, 246, 239, THE CRYSTAL STRUCTURE OF HUMAN ABL1 WILD TYPE KINASE DOMAIN IN COMPLEX WITH AXITINIB
1666, 4rixA, 0.7915, 2.64, 0.361, 269, 255, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
1667, 4fr4D, 0.7915, 3.21, 0.232, 346, 263, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1668, 4brxA, 0.7915, 2.66, 0.360, 259, 253, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-135-TRIAZINE INHIBITOR
1669, 3utoA, 0.7915, 2.90, 0.180, 559, 261, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
1670, 3beaA, 0.7915, 3.01, 0.328, 310, 256, CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
1671, 5wneD, 0.7914, 3.21, 0.204, 396, 265, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1672, 5oxgB, 0.7914, 3.12, 0.240, 296, 262, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1673, 5bmsA, 0.7914, 3.05, 0.204, 290, 260, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 4 IN COMPLEX WITH AN INHIBITOR COMPOUND 29
1674, 3my0U, 0.7914, 3.44, 0.231, 285, 268, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1675, 3f82A, 0.7914, 2.19, 0.343, 278, 245, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N- (4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4- ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-12-DIHYDROPYRIDINE-3- CARBOXAMIDE
1676, 1lufA, 0.7914, 2.59, 0.300, 275, 250, CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION
1677, 6fnhB, 0.7913, 3.11, 0.318, 271, 261, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1678, 5u7qC, 0.7913, 3.18, 0.193, 390, 264, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1679, 3slsB, 0.7913, 2.73, 0.196, 294, 255, CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
1680, 3lvpD, 0.7913, 2.42, 0.315, 282, 251, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1681, 5jfvA, 0.7912, 2.41, 0.369, 277, 249, CRYSTAL STRUCTURE OF TRKA IN COMPLEX WITH PF-05206283
1682, 4jdjA, 0.7912, 2.94, 0.190, 288, 258, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
1683, 4f64A, 0.7912, 2.64, 0.366, 278, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 6
1684, 3u51A, 0.7912, 2.06, 0.342, 256, 243, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1
1685, 3qfvB, 0.7912, 3.27, 0.197, 396, 264, MRCK BETA IN COMPLEX WITH TPCA-1
1686, 3my0D, 0.7912, 3.45, 0.231, 298, 268, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1687, 1kobA, 0.7912, 2.89, 0.211, 352, 261, TWITCHIN KINASE FRAGMENT (APLYSIA) AUTOREGULATED PROTEIN KINASE DOMAIN
1688, 6ginB, 0.7911, 3.28, 0.242, 296, 265, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH AN QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 4-MORPHOLINOPHENYL SOLVENT ACCESSIBLE GROUP. 
1689, 5owhA, 0.7911, 2.78, 0.195, 334, 257, HIGH SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3-AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
1690, 4eheB, 0.7911, 2.77, 0.281, 276, 256, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOTHIENOPYRIMIDINE-BASED INHIBITOR
1691, 4e26A, 0.7911, 2.83, 0.267, 270, 258, BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
1692, 3skcB, 0.7911, 2.78, 0.270, 276, 256, HUMAN B-RAF KINASE IN COMPLEX WITH AN AMIDE LINKED PYRAZOLOPYRIDINE INHIBITOR
1693, 2h9vA, 0.7911, 3.21, 0.186, 383, 264, STRUCTURAL BASIS FOR INDUCED-FIT BINDING OF RHO-KINASE TO THE INHIBITOR Y27632
1694, 1koaA, 0.7911, 2.87, 0.177, 447, 260, TWITCHIN KINASE FRAGMENT (C.ELEGANS) AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS
1695, 5hu9A, 0.7910, 2.65, 0.341, 266, 252, CRYSTAL STRUCTURE OF ABL1 IN COMPLEX WITH CHMFL-074
1696, 5fd2A, 0.7910, 2.68, 0.283, 264, 254, B-RAF WILD-TYPE KINASE DOMAIN IN COMPLEX WITH A PURINYLPYRIDINYLAMINO- BASED INHIBITOR
1697, 4fr4A, 0.7910, 3.13, 0.233, 350, 262, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1698, 4appA, 0.7910, 3.10, 0.212, 291, 260, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4- CARBONYL)-66-DIMETHYL-1456-TETRAHYDROPYRROLO(34-C) PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE
1699, 3t8oA, 0.7910, 3.15, 0.231, 493, 264, RHODOPSIN KINASE (GRK1) L166K MUTANT AT 2.5A RESOLUTION
1700, 3qa0B, 0.7910, 2.82, 0.187, 330, 257, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5
1701, 3i5nA, 0.7910, 2.50, 0.351, 280, 248, CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13
1702, 2vd5A, 0.7910, 3.13, 0.188, 390, 261, STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
1703, 2v55C, 0.7910, 3.17, 0.208, 396, 265, MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
1704, 1ol7A, 0.7910, 2.69, 0.229, 261, 253, STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287 THR288
1705, 1fgkA, 0.7910, 2.70, 0.361, 278, 255, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
1706, 4fzdB, 0.7909, 2.72, 0.247, 275, 255, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX WITH WSF MOTIF
1707, 2jkqA, 0.7909, 2.54, 0.363, 258, 251, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
1708, 5lvnA, 0.7908, 2.93, 0.237, 283, 257, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ADENOSINE BOUND TO THE ATP- BINDING SITE
1709, 4fzaB, 0.7908, 2.83, 0.237, 281, 257, CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX
1710, 2y4iC, 0.7908, 2.86, 0.198, 313, 257, KSR2-MEK1 HETERODIMER
1711, 2esmA, 0.7908, 3.21, 0.208, 400, 264, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
1712, 5iuhA, 0.7907, 2.31, 0.308, 285, 247, CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE (ALK) IN COMPLEX WITH 5D
1713, 5bmlA, 0.7907, 3.18, 0.217, 393, 263, ROCK 1 BOUND TO A PYRIDINE THIAZOLE INHIBITOR
1714, 5auzA, 0.7907, 2.90, 0.230, 274, 257, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH GENISTEIN.
1715, 4fnwA, 0.7907, 2.65, 0.302, 304, 252, CRYSTAL STRUCTURE OF THE APO F1174L ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
1716, 4cegA, 0.7907, 2.74, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA A 122-403 C290A C393A BOUND TO ADP
1717, 2hyyD, 0.7907, 2.43, 0.341, 264, 249, HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571 GLIVEC)
1718, 1s9iA, 0.7907, 3.01, 0.201, 303, 259, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
1719, 5u7qA, 0.7906, 3.19, 0.193, 388, 264, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1720, 5iugA, 0.7906, 2.37, 0.310, 285, 248, CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) IN COMPLEX WITH 5A
1721, 4rwkB, 0.7906, 2.76, 0.379, 282, 256, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) IN COMPLEX WITH N-{3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H- PYRAZOL-5-YL}-4-[(3R5S)-35-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)
1722, 4f63A, 0.7906, 2.72, 0.361, 278, 255, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 1
1723, 4aw0A, 0.7906, 2.93, 0.237, 283, 257, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS182 BOUND TO THE PIF-POCKET
1724, 2fgiA, 0.7906, 2.57, 0.368, 274, 253, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
1725, 4rrvA, 0.7905, 2.94, 0.237, 283, 257, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND PIFTIDE
1726, 4anlA, 0.7905, 2.81, 0.294, 292, 255, STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE
1727, 1mq4A, 0.7905, 2.81, 0.231, 261, 255, CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE
1728, 5uzjB, 0.7904, 3.10, 0.206, 386, 262, CRYSTAL STRUCTURE OF ROCK1 BOUND TO AN AMINOPYRIDINE INHIBITOR
1729, 4d4vB, 0.7904, 2.49, 0.381, 255, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN
1730, 3u9cB, 0.7904, 2.91, 0.194, 331, 258, STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN
1731, 3q6uA, 0.7904, 2.63, 0.339, 287, 251, STRUCTURE OF THE APO MET RECEPTOR KINASE IN THE DUALLY-PHOSPHORYLATED ACTIVATED STATE
1732, 2vwzA, 0.7904, 2.86, 0.284, 274, 257, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1733, 2v55A, 0.7904, 3.19, 0.211, 393, 265, MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
1734, 2ijmB, 0.7904, 2.40, 0.361, 261, 249, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
1735, 5a46A, 0.7903, 2.93, 0.381, 289, 257, FGFR1 IN COMPLEX WITH DOVITINIB
1736, 4yzbB, 0.7903, 2.79, 0.241, 464, 257, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1521
1737, 3rcdB, 0.7903, 2.28, 0.329, 271, 246, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1738, 3nczD, 0.7903, 3.16, 0.205, 397, 264, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
1739, 2ogvA, 0.7903, 2.98, 0.336, 317, 256, CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
1740, 5ortA, 0.7902, 2.73, 0.227, 264, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1741, 5ar5A, 0.7902, 2.36, 0.247, 284, 251, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BENZIMIDAZOLE
1742, 5ar2B, 0.7902, 2.34, 0.247, 285, 251, RIP2 KINASE CATALYTIC DOMAIN (1 - 310)
1743, 4rixC, 0.7902, 2.52, 0.360, 275, 253, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-Q790R MUTATION
1744, 4agdA, 0.7902, 2.97, 0.348, 303, 256, CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2- DIETHYLAMINOETHYL)-5-((Z)-(5-FLUORO-2-OXO-1H-INDOL-3- YLIDENE)METHYL)-24-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE)
1745, 3dkgA, 0.7902, 2.33, 0.328, 281, 247, STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
1746, 3ccnA, 0.7902, 2.37, 0.351, 275, 245, X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
1747, 2vwxA, 0.7902, 2.96, 0.279, 274, 258, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
1748, 4mcvB, 0.7901, 2.34, 0.343, 265, 248, STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE
1749, 4f0iB, 0.7901, 2.81, 0.366, 294, 254, CRYSTAL STRUCTURE OF APO TRKA
1750, 4cmtA, 0.7901, 2.57, 0.300, 284, 250, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2-(2H-123-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(3-(METHYLSULFONYL)PHENYL)PYRIDIN-2-AMINE
1751, 4at5A, 0.7901, 2.84, 0.374, 294, 254, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580
1752, 3rcdD, 0.7901, 2.29, 0.329, 271, 246, HER2 KINASE DOMAIN COMPLEXED WITH TAK-285
1753, 2xzsA, 0.7901, 3.05, 0.222, 301, 261, DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
1754, 2x4fA, 0.7901, 2.61, 0.230, 289, 256, THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156.
1755, 2w1cA, 0.7900, 2.77, 0.240, 261, 254, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
1756, 5uzjA, 0.7899, 3.22, 0.208, 387, 264, CRYSTAL STRUCTURE OF ROCK1 BOUND TO AN AMINOPYRIDINE INHIBITOR
1757, 4mbjB, 0.7899, 2.76, 0.285, 276, 256, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINE-BASED INHIBITOR
1758, 4ct1A, 0.7899, 3.02, 0.240, 283, 258, HUMAN PDK1-PKCZETA KINASE CHIMERA IN COMPLEX WITH ALLOSTERIC COMPOUND PS315 BOUND TO THE PIF-POCKET
1759, 4wotD, 0.7898, 3.09, 0.187, 389, 262, ROCK2 IN COMPLEX WITH 1426382-07-1
1760, 4jdkA, 0.7898, 3.01, 0.201, 288, 259, CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
1761, 3my0G, 0.7898, 3.35, 0.233, 294, 266, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1762, 3h9rA, 0.7898, 2.98, 0.256, 312, 258, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
1763, 3d5uA, 0.7898, 2.90, 0.247, 288, 259, CRYSTAL STRUCTURE OF A WILDTYPE POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN.
1764, 2f2uA, 0.7898, 3.22, 0.181, 386, 265, CRYSTAL STRUCTURE OF THE RHO-KINASE KINASE DOMAIN
1765, 1h1wA, 0.7898, 2.96, 0.225, 284, 258, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN
1766, 6ginA, 0.7897, 3.38, 0.237, 296, 266, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH AN QUINAZOLINONE BASED ALK2 INHIBITOR WITH A 4-MORPHOLINOPHENYL SOLVENT ACCESSIBLE GROUP. 
1767, 6fnmA, 0.7897, 2.79, 0.277, 270, 256, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH DASATINIB 
1768, 5oteA, 0.7897, 3.25, 0.208, 407, 264, MRCK BETA IN COMPLEX WITH BDP-00008900
1769, 3ha6A, 0.7897, 2.94, 0.230, 263, 256, CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
1770, 3aoxA, 0.7897, 2.70, 0.300, 298, 253, X-RAY CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CH5424802
1771, 4riyC, 0.7896, 2.54, 0.356, 275, 253, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER CONTAINING THE CANCER-ASSOCIATED HER3-E909G MUTATION
1772, 4mcvA, 0.7896, 2.30, 0.343, 267, 248, STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE
1773, 4e4xB, 0.7896, 2.75, 0.271, 274, 255, CRYSTAL STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH A DIHYDROPYRIDO[23-D]PYRIMIDINONE-BASED INHIBITOR
1774, 3my0E, 0.7896, 3.38, 0.233, 294, 266, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1775, 3f5uA, 0.7896, 2.81, 0.230, 279, 256, CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
1776, 1kobB, 0.7896, 2.87, 0.215, 352, 260, TWITCHIN KINASE FRAGMENT (APLYSIA) AUTOREGULATED PROTEIN KINASE DOMAIN
1777, 5ia2A, 0.7895, 2.68, 0.324, 287, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 66
1778, 5em5A, 0.7895, 2.41, 0.355, 298, 248, EGFR KINASE DOMAIN MUTANT TMLR WITH PYRIDONE COMPOUND 2: 4-[2-(4- CHLOROPHENYL)ETHYLAMINO]-~{N}-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-2- OXIDANYLIDENE-1~{H}-PYRIDINE-3-CARBOXAMIDE
1779, 4qmsA, 0.7895, 3.17, 0.264, 283, 261, MST3 IN COMPLEX WITH DASATINIB
1780, 3rpsB, 0.7895, 2.82, 0.195, 334, 257, STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4567-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL
1781, 2v5qA, 0.7895, 3.01, 0.282, 285, 259, CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
1782, 5oy6B, 0.7894, 2.97, 0.246, 292, 260, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1783, 5dzcA, 0.7894, 2.98, 0.223, 816, 260, CRYSTAL STRUCTURE OF PVX_084705 IN COMPLEX WITH AMP-PNP
1784, 4wotA, 0.7894, 2.98, 0.188, 389, 260, ROCK2 IN COMPLEX WITH 1426382-07-1
1785, 4uwbB, 0.7894, 2.97, 0.374, 299, 257, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P5
1786, 4md7H, 0.7894, 2.93, 0.190, 330, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1787, 3fxxA, 0.7894, 3.00, 0.309, 288, 259, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW
1788, 2v5qB, 0.7894, 3.00, 0.273, 285, 260, CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
1789, 2uztA, 0.7894, 2.82, 0.251, 336, 255, PKA STRUCTURES OF AKT INDAZOLE-PYRIDINE INHIBITORS
1790, 1uvrA, 0.7894, 3.07, 0.228, 284, 259, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8
1791, 5wnlA, 0.7893, 2.25, 0.263, 262, 247, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO STAUROSPORINE 
1792, 5oxgD, 0.7893, 3.16, 0.240, 293, 262, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH LDN- 212854
1793, 4riwC, 0.7893, 2.54, 0.360, 275, 253, CRYSTAL STRUCTURE OF AN EGFR/HER3 KINASE DOMAIN HETERODIMER
1794, 3krjA, 0.7893, 2.93, 0.332, 304, 253, CFMS TYROSINE KINASE IN COMPLEX WITH 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID (2-CYCLOHEX-1-ENYL-4-PIPERIDIN-4-YL-PHENYL)-AMIDE
1795, 2y7jA, 0.7893, 2.83, 0.221, 284, 258, STRUCTURE OF HUMAN PHOSPHORYLASE KINASE GAMMA 2
1796, 5hlwA, 0.7892, 2.70, 0.332, 284, 250, CRYSTAL STRUCTURE OF C-MET MUTANT Y1230H IN COMPLEX WITH COMPOUND 14
1797, 5autA, 0.7892, 2.82, 0.230, 274, 256, CRYSTAL STRUCTURE OF DAPK1 IN COMPLEX WITH ANS.
1798, 4y83B, 0.7891, 2.71, 0.191, 302, 256, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
1799, 4r7hA, 0.7891, 2.90, 0.340, 308, 253, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR PLX3397
1800, 3v5lD, 0.7891, 2.16, 0.316, 246, 244, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
1801, 3svvA, 0.7891, 2.31, 0.329, 261, 246, CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE- PYRAZOLOPYRIMIDINE 9
1802, 3g5dB, 0.7891, 1.99, 0.342, 257, 243, KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB
1803, 3fy2A, 0.7891, 2.97, 0.310, 285, 258, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW
1804, 3f3tB, 0.7891, 2.05, 0.337, 259, 243, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III)
1805, 5d12A, 0.7890, 2.18, 0.347, 260, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40
1806, 4yvcA, 0.7890, 3.19, 0.209, 388, 263, ROCK 1 BOUND TO THIAZOLE INHIBITOR
1807, 4fr4C, 0.7890, 3.15, 0.233, 344, 262, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1808, 3q9zB, 0.7890, 2.75, 0.187, 332, 256, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5
1809, 2yhvA, 0.7890, 2.81, 0.303, 291, 254, STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE
1810, 5wnkA, 0.7889, 2.16, 0.259, 263, 247, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO TG100-115 
1811, 5uafA, 0.7889, 2.35, 0.348, 291, 244, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
1812, 5uadA, 0.7889, 2.35, 0.348, 291, 244, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
1813, 4rt7A, 0.7889, 2.83, 0.332, 274, 253, CRYSTAL STRUCTURE OF FLT3 WITH A SMALL MOLECULE INHIBITOR
1814, 4md7G, 0.7889, 2.94, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1815, 4g3cA, 0.7889, 2.46, 0.206, 315, 252, CRYSTAL STRUCTURE OF APO MURINE NF-KAPPAB INDUCING KINASE (NIK)
1816, 3u9cA, 0.7889, 2.94, 0.190, 331, 258, STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE ATP-COMPETITIVE INHIBITOR RESORUFIN
1817, 3pxkA, 0.7889, 2.26, 0.362, 256, 246, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[23- D]THIAZOLE
1818, 3my0R, 0.7889, 3.36, 0.233, 294, 266, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1819, 3cquA, 0.7889, 2.77, 0.246, 318, 256, CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
1820, 2hy81, 0.7889, 3.14, 0.202, 293, 262, PAK1 COMPLEX WITH ST2001
1821, 1zwsD, 0.7889, 3.00, 0.204, 278, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1822, 5g1xA, 0.7888, 2.87, 0.231, 262, 255, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH N-MYC
1823, 4yneA, 0.7888, 2.29, 0.387, 281, 248, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
1824, 4rwlA, 0.7888, 2.67, 0.366, 282, 254, CRYSTAL STRUCTURE OF FGFR1 (C488A C584C) IN COMPLEX WITH 6-(7-((1- AMINOCYCLOPROPYL) METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1- NAPHTHAMIDE (E3810)
1825, 3v8tB, 0.7888, 1.97, 0.318, 244, 242, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477
1826, 3fwqA, 0.7888, 2.80, 0.191, 334, 257, INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
1827, 3ckxA, 0.7888, 2.84, 0.263, 276, 255, CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3 STK24) IN COMPLEX WITH STAUROSPORINE
1828, 6gt1B, 0.7887, 2.65, 0.249, 269, 253, NEK7 BOUND TO PURINE INHIBITOR 
1829, 3u6jA, 0.7887, 3.07, 0.344, 308, 256, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
1830, 3slsA, 0.7887, 2.59, 0.198, 292, 253, CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
1831, 3qlfB, 0.7887, 2.16, 0.340, 258, 244, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5
1832, 3os3A, 0.7887, 2.74, 0.197, 272, 254, MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH CH4858061 AND MGATP
1833, 3my0H, 0.7887, 3.44, 0.232, 294, 267, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1834, 3lq8A, 0.7887, 2.57, 0.341, 278, 249, STRUCTURE OF THE KINASE DOMAIN OF C-MET BOUND TO XL880 (GSK1363089)
1835, 3f66B, 0.7887, 2.39, 0.350, 269, 246, HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
1836, 3en5B, 0.7887, 2.22, 0.347, 261, 245, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP494 A MULTITARGETED KINASE INHIBITOR
1837, 2vd5B, 0.7887, 3.22, 0.188, 380, 261, STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
1838, 5li1A, 0.7886, 3.01, 0.197, 331, 259, STRUCTURE OF A PAR3-INHIBITORY PEPTIDE BOUND TO PKCIOTA CORE KINASE DOMAIN
1839, 5i4nA, 0.7886, 2.72, 0.264, 275, 254, CRYSTAL STRUCTURE OF THE E596A V617F MUTANT JAK2 PSEUDOKINASE DOMAIN BOUND TO MG-ATP
1840, 4qmyA, 0.7886, 3.23, 0.264, 287, 261, MST3 IN COMPLEX WITH STAUROSPORINE
1841, 4md9F, 0.7886, 2.80, 0.191, 327, 256, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1842, 4md7F, 0.7886, 2.94, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1843, 4dn5B, 0.7886, 2.51, 0.202, 330, 252, CRYSTAL STRUCTURE OF NF-KB-INDUCING KINASE (NIK)
1844, 3qhrC, 0.7886, 2.64, 0.204, 297, 255, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1845, 3juhB, 0.7886, 2.95, 0.198, 334, 258, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
1846, 3iw4C, 0.7886, 2.91, 0.242, 332, 260, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
1847, 5kmnA, 0.7885, 2.86, 0.378, 296, 254, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-[[2- (TRIFLUOROMETHYL)PHENYL]METHYL]UREA
1848, 4xcuA, 0.7885, 2.93, 0.358, 288, 257, CRYSTAL STRUCTURE OF FGFR4 WITH AN IRREVERSIBLE INHIBITOR
1849, 4wsqA, 0.7885, 2.92, 0.208, 317, 255, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1850, 4uxqA, 0.7885, 2.77, 0.362, 286, 254, FGFR4 IN COMPLEX WITH PONATINIB
1851, 2hznA, 0.7885, 2.39, 0.335, 272, 248, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210
1852, 2gcdB, 0.7885, 2.99, 0.270, 308, 259, TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
1853, 2cdzA, 0.7885, 2.78, 0.200, 289, 255, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A
1854, 3vw8A, 0.7884, 2.61, 0.348, 303, 250, CRYSTAL STRUCTURE OF HUMAN C-MET KINASE DOMAIN WITH ITS INHIBITOR
1855, 3rcjA, 0.7884, 3.12, 0.236, 281, 259, RAPID PREPARATION OF TRIAZOLYL SUBSTITUTED NH-HETEROCYCLIC KINASE INHIBITORS VIA ONE-POT SONOGASHIRA COUPLING TMS-DEPROTECTION CUAAC SEQUENCE
1856, 3qhrA, 0.7884, 2.64, 0.204, 297, 255, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1857, 2jdrA, 0.7884, 2.90, 0.241, 316, 257, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A- 443654
1858, 1snxB, 0.7884, 2.03, 0.314, 245, 242, CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1859, 1s9iB, 0.7884, 2.85, 0.200, 291, 255, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
1860, 6dkbA, 0.7883, 2.62, 0.377, 272, 252, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 10B. 
1861, 5o49B, 0.7883, 2.74, 0.358, 286, 254, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
1862, 5e8vA, 0.7883, 3.03, 0.218, 296, 261, TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431AR433AE485AK488AR493A R495A)
1863, 4qmtA, 0.7883, 3.18, 0.258, 284, 260, MST3 IN COMPLEX WITH HESPERADIN
1864, 4pp7A, 0.7883, 2.81, 0.270, 267, 256, HIGHLY POTENT AND SELECTIVE 3-N-METHYLQUINAZOLINE-4(3H)-ONE BASED INHIBITORS OF B-RAFV600E KINASE
1865, 5owlB, 0.7882, 2.85, 0.191, 332, 257, LOW SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3- AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
1866, 4yhjB, 0.7882, 3.22, 0.221, 490, 263, STRUCTURE AND FUNCTION OF THE HYPERTENSION VARIANT A486V OF G PROTEIN- COUPLED RECEPTOR KINASE 4 (GRK4)
1867, 4ks7A, 0.7882, 3.09, 0.212, 286, 260, PAK6 KINASE DOMAIN IN COMPLEX WITH PF-3758309
1868, 3u51B, 0.7882, 2.06, 0.343, 255, 242, SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1
1869, 3qhwC, 0.7882, 2.64, 0.204, 297, 255, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1870, 3ms9B, 0.7882, 2.40, 0.339, 272, 248, ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
1871, 1zwsB, 0.7882, 2.94, 0.208, 278, 259, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1872, 1snxA, 0.7882, 2.04, 0.314, 245, 242, CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1873, 5orlA, 0.7881, 2.68, 0.220, 264, 254, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
1874, 5ezrA, 0.7881, 2.98, 0.223, 803, 260, CRYSTAL STRUCTURE OF PVX_084705 BOUND TO COMPOUND
1875, 4wunA, 0.7881, 2.44, 0.386, 282, 249, STRUCTURE OF FGFR1 IN COMPLEX WITH AZD4547 (N-{3-[2-(35- DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) AT 1.65 ANGSTROM
1876, 4mneE, 0.7881, 3.16, 0.196, 286, 260, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
1877, 3my0S, 0.7881, 3.45, 0.232, 294, 267, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1878, 3my0F, 0.7881, 3.44, 0.232, 294, 267, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1879, 3g0fB, 0.7881, 3.01, 0.341, 293, 255, KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
1880, 3el8B, 0.7881, 2.13, 0.350, 259, 243, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
1881, 4uy9B, 0.7880, 2.84, 0.320, 315, 256, STRUCTURE OF MLK1 KINASE DOMAIN WITH LEUCINE ZIPPER 1
1882, 4md7E, 0.7880, 2.95, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
1883, 4g3fA, 0.7880, 2.53, 0.194, 312, 253, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 2-(AMINOTHIAZOLY)PHENOL (CMP2)
1884, 4g3eA, 0.7880, 2.38, 0.208, 314, 250, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) BOUND TO A 6-ALKYNYLINDOLINE (CMP1)
1885, 4fr4E, 0.7880, 3.16, 0.233, 342, 262, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1886, 4ct2A, 0.7880, 2.75, 0.244, 277, 254, HUMAN PDK1-PKCZETA KINASE CHIMERA
1887, 4aw1A, 0.7880, 2.89, 0.243, 283, 255, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS210 BOUND TO THE PIF-POCKET
1888, 2bujA, 0.7880, 3.06, 0.204, 291, 260, CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
1889, 5j5sA, 0.7879, 2.00, 0.329, 258, 243, SRC KINASE IN COMPLEX WITH A SULFONAMIDE INHIBITOR
1890, 4w7pB, 0.7879, 3.26, 0.205, 387, 264, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
1891, 4dggA, 0.7879, 2.24, 0.339, 261, 245, C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176
1892, 3rpsA, 0.7879, 2.84, 0.191, 334, 257, STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4567-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL
1893, 3my0O, 0.7879, 3.43, 0.232, 297, 267, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1894, 3cc6A, 0.7879, 2.91, 0.323, 269, 257, CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
1895, 3a8xA, 0.7879, 3.08, 0.202, 334, 262, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
1896, 5otfA, 0.7878, 3.23, 0.189, 411, 264, MRCK BETA IN COMPLEX WITH BDP-00009066
1897, 5nkgA, 0.7878, 2.85, 0.320, 292, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3D
1898, 5ng0A, 0.7878, 2.51, 0.247, 274, 251, STRUCTURE OF RIP2K(L294F) WITH BOUND AMPPCP
1899, 4ludA, 0.7878, 2.14, 0.361, 421, 241, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
1900, 3qhwA, 0.7878, 2.74, 0.211, 297, 256, STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
1901, 2yjrA, 0.7878, 2.32, 0.304, 278, 247, STRUCTURE OF F1174L MUTANT ANAPLASTIC LYMPHOMA KINASE
1902, 5f9eA, 0.7877, 2.98, 0.267, 334, 258, STRUCTURE OF PROTEIN KINASE C THETA WITH COMPOUND 10: 22-DIMETHYL-7- (2-OXIDANYLIDENE-3~{H}-IMIDAZO[45-B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)- 3~{H}-QUINAZOLIN-4-ONE
1903, 4qmzA, 0.7877, 3.17, 0.258, 286, 260, MST3 IN COMPLEX WITH SUNITINIB
1904, 4qmxA, 0.7877, 3.24, 0.264, 287, 261, MST3 IN COMPLEX WITH SARACATINIB
1905, 4qmuA, 0.7877, 3.24, 0.264, 286, 261, MST3 IN COMPLEX WITH JNJ-7706621 4-({5-AMINO-1-[(26-DIFLUOROPHENYL) CARBONYL]-1H-124-TRIAZOL-3-YL}AMINO)BENZENESULFONAMIDE
1906, 4nkaB, 0.7877, 2.87, 0.366, 287, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2
1907, 5uplA, 0.7876, 3.00, 0.197, 290, 259, CDC42 BINDS PAK4 VIA AN EXTENDED GTPASE-EFFECTOR INTEFACE - 2 PEPTIDE: PAK4FL CDC42 - UNREFINED
1908, 4w7pC, 0.7876, 3.16, 0.194, 383, 263, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
1909, 4pp9A, 0.7876, 2.15, 0.313, 246, 243, ITK KINASE DOMAIN WITH COMPOUND 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4- YL]-2H-INDAZOLE-3-CARBOXAMIDE)
1910, 4o2pA, 0.7876, 2.48, 0.351, 265, 248, KINASE DOMAIN OF CSRC IN COMPLEX WITH A SUBSTITUTED PYRAZOLOPYRIMIDINE
1911, 4md9M, 0.7876, 2.85, 0.191, 331, 257, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1912, 3p08B, 0.7876, 2.52, 0.306, 258, 248, CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
1913, 3my0Q, 0.7876, 3.43, 0.233, 294, 266, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
1914, 3lvpA, 0.7876, 2.76, 0.310, 289, 255, CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
1915, 2ptkA, 0.7876, 2.08, 0.339, 425, 242, CHICKEN SRC TYROSINE KINASE
1916, 2eufB, 0.7876, 2.81, 0.198, 282, 257, X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THE INHIBITOR PD0332991
1917, 5wnmA, 0.7875, 2.19, 0.263, 263, 247, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN 4 (RIPK4) D143N BOUND TO TOZASERTIB (VX-680) 
1918, 5oniB, 0.7875, 2.78, 0.187, 334, 256, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
1919, 4g3gA, 0.7875, 2.54, 0.190, 312, 253, CRYSTAL STRUCTURE OF MURINE NF-KAPPAB INDUCING KINASE (NIK) V408L BOUND TO A 2-(AMINOTHIAZOLYL)PHENOL (CMP3)
1920, 4fr4B, 0.7875, 3.17, 0.233, 350, 262, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE 32A (YANK1)
1921, 4dn5A, 0.7875, 2.53, 0.206, 331, 252, CRYSTAL STRUCTURE OF NF-KB-INDUCING KINASE (NIK)
1922, 3ce3A, 0.7875, 3.07, 0.331, 293, 257, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR
1923, 1jktA, 0.7875, 2.93, 0.225, 276, 258, TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1924, 6fnhA, 0.7874, 2.99, 0.318, 277, 258, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
1925, 5vilC, 0.7874, 3.04, 0.217, 271, 258, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
1926, 5veeA, 0.7874, 3.17, 0.211, 289, 261, PAK4 KINASE DOMAIN IN COMPLEX WITH FRAX486
1927, 5oy6A, 0.7874, 3.05, 0.247, 291, 259, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1928, 5b7vB, 0.7874, 2.76, 0.366, 277, 254, HUMAN FGFR1 KINASE IN COMPLEX WITH CH5183284
1929, 4qnaA, 0.7874, 3.26, 0.264, 284, 261, MST3 IN COMPLEX WITH 2-(46-DIAMINO-135-TRIAZIN-2-YL)PHENOL
1930, 3byuA, 0.7874, 2.47, 0.356, 256, 247, CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23
1931, 2wxvA, 0.7874, 2.98, 0.208, 302, 259, STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(43-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
1932, 2i0yA, 0.7874, 3.02, 0.333, 289, 255, CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
1933, 5u7qD, 0.7873, 3.10, 0.195, 383, 261, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1934, 4fieB, 0.7873, 3.00, 0.193, 300, 259, FULL-LENGTH HUMAN PAK4
1935, 3u87B, 0.7873, 2.86, 0.191, 329, 257, STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA  IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE
1936, 3dbeA, 0.7873, 2.94, 0.253, 284, 257, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 557
1937, 2i0vA, 0.7873, 3.02, 0.329, 303, 255, C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
1938, 2acxA, 0.7873, 3.20, 0.236, 495, 263, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
1939, 1rejA, 0.7873, 2.80, 0.244, 333, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 1
1940, 5wnhC, 0.7872, 3.07, 0.207, 388, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
1941, 5vioD, 0.7872, 3.04, 0.221, 271, 258, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1942, 5omyA, 0.7872, 2.86, 0.191, 332, 257, HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
1943, 4fieA, 0.7872, 3.00, 0.193, 300, 259, FULL-LENGTH HUMAN PAK4
1944, 3zh8C, 0.7872, 3.13, 0.196, 312, 260, A NOVEL SMALL MOLECULE APKC INHIBITOR
1945, 3qtiA, 0.7872, 2.58, 0.348, 292, 250, C-MET KINASE IN COMPLEX WITH NVP-BVU972
1946, 3mtfA, 0.7872, 3.39, 0.238, 296, 265, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2- AMINOPYRIDINE INHIBITOR
1947, 3db6A, 0.7872, 2.97, 0.255, 287, 259, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 902
1948, 2uzvA, 0.7872, 2.96, 0.258, 336, 256, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
1949, 6d22A, 0.7871, 2.86, 0.373, 299, 255, CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR 
1950, 5vioC, 0.7871, 2.94, 0.226, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
1951, 4qmlA, 0.7871, 3.12, 0.270, 280, 259, MST3 IN COMPLEX WITH AMP-PNP
1952, 4pmmA, 0.7871, 2.75, 0.378, 285, 251, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR N-(3-CYCLOPROPYL- 1-PHENYL-1H-PYRAZOL-5-YL)-2-{4-[3-METHOXY-4-(4-METHYL-1H-IMIDAZOL-1- YL)PHENYL]-1H-123-TRIAZOL-1-YL}ACETAMIDE
1953, 4gk4A, 0.7871, 2.84, 0.302, 275, 255, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 90
1954, 4fvrA, 0.7871, 2.72, 0.264, 274, 254, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN MUTANT V617F (MG- ATP-BOUND FORM)
1955, 3fwqB, 0.7871, 2.84, 0.195, 334, 257, INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
1956, 1zwsG, 0.7871, 3.15, 0.211, 278, 261, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1957, 5u7rD, 0.7870, 3.06, 0.200, 382, 260, IDENTIFICATION OF A NEW CLASS OF POTENT CDC7 INHIBITORS DESIGNED BY PUTATIVE PHARMACOPHORE MODEL: SYNTHESIS AND BIOLOGICAL EVALUATION OF 23-DIHYDROTHIENO[32-D]PYRIMIDIN-4(1H)-ONES
1958, 5lvmA, 0.7870, 3.00, 0.237, 283, 257, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ADENINE BOUND TO THE ATP- BINDING SITE
1959, 5bpyB, 0.7870, 2.24, 0.320, 247, 244, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-824171 AKA 6-[(3R)-3-(4-TERT-BU TYLBENZAMIDO) PIPERIDIN-1-YL]-2-{[4-(MORPHOLINE-4-CARBONYL) PHENYL]AMINO}PYRIDINE- 3-CARBOXAMIDE
1960, 4rzvA, 0.7870, 2.41, 0.275, 261, 251, CRYSTAL STRUCTURE OF THE BRAF (R509H) KINASE DOMAIN MONOMER BOUND TO VEMURAFENIB
1961, 4mf1B, 0.7870, 2.07, 0.311, 246, 244, ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S2S)- 2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-13- BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE
1962, 3zh8A, 0.7870, 3.14, 0.196, 318, 260, A NOVEL SMALL MOLECULE APKC INHIBITOR
1963, 3q5iA, 0.7870, 2.76, 0.259, 470, 255, CRYSTAL STRUCTURE OF PBANKA_031420
1964, 3oxtA, 0.7870, 2.93, 0.251, 335, 255, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
1965, 3g0fA, 0.7870, 2.98, 0.341, 291, 255, KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
1966, 5vjaB, 0.7869, 2.65, 0.212, 266, 255, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
1967, 5ts8A, 0.7869, 2.91, 0.175, 332, 257, Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 56-DIBROMOBENZOTRIAZOLE
1968, 5ng3D, 0.7869, 2.53, 0.246, 278, 252, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
1969, 4qmnA, 0.7869, 3.28, 0.264, 283, 261, MST3 IN COMPLEX WITH BOSUTINIB
1970, 4md9K, 0.7869, 2.93, 0.195, 328, 257, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1971, 3uqgB, 0.7869, 1.94, 0.344, 257, 241, C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW1243
1972, 3soaA, 0.7869, 2.89, 0.215, 436, 260, FULL-LENGTH HUMAN CAMKII
1973, 3g0eA, 0.7869, 2.93, 0.336, 332, 256, KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB
1974, 1wvwA, 0.7869, 2.87, 0.222, 275, 257, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1975, 1u5rB, 0.7869, 2.98, 0.260, 308, 258, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1976, 5nkfA, 0.7868, 2.91, 0.320, 291, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 3B
1977, 5cqwB, 0.7868, 2.80, 0.184, 331, 256, TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
1978, 4nksB, 0.7868, 2.78, 0.370, 271, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3
1979, 4md8F, 0.7868, 2.95, 0.190, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1980, 4mbjA, 0.7868, 2.79, 0.286, 269, 255, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINE-BASED INHIBITOR
1981, 4h1jA, 0.7868, 2.61, 0.356, 263, 253, CRYSTAL STRUCTURE OF PYK2 WITH THE PYRAZOLE 13A
1982, 3v8wB, 0.7868, 1.87, 0.317, 242, 240, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469
1983, 3tv6A, 0.7868, 2.67, 0.264, 268, 254, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A METHOXYPYRAZOLOPYRIDINYL BENZAMIDE INHIBITOR
1984, 2zjwA, 0.7868, 2.71, 0.180, 332, 255, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
1985, 1zwsC, 0.7868, 2.95, 0.212, 278, 259, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1986, 1uu7A, 0.7868, 2.97, 0.222, 280, 257, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2
1987, 4ysjB, 0.7867, 2.72, 0.248, 462, 254, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA IN COMPLEX WITH ADP
1988, 4rwlB, 0.7867, 2.91, 0.369, 285, 255, CRYSTAL STRUCTURE OF FGFR1 (C488A C584C) IN COMPLEX WITH 6-(7-((1- AMINOCYCLOPROPYL) METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1- NAPHTHAMIDE (E3810)
1989, 4md9G, 0.7867, 2.83, 0.191, 329, 256, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
1990, 1zwsF, 0.7867, 3.02, 0.204, 278, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1991, 4md8H, 0.7866, 2.95, 0.194, 331, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1992, 4md8G, 0.7866, 2.95, 0.194, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
1993, 4ib5B, 0.7866, 3.06, 0.199, 329, 261, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
1994, 3d5wA, 0.7866, 3.04, 0.247, 284, 259, CRYSTAL STRUCTURE OF A PHOSPHORYLATED POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH ADP.
1995, 1zwsH, 0.7866, 3.06, 0.212, 278, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1996, 1o6lA, 0.7866, 2.94, 0.230, 316, 257, CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
1997, 5oy6C, 0.7865, 3.22, 0.245, 291, 261, CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH CYCLICAL INHIBITOR OD36.
1998, 5h8eA, 0.7865, 2.80, 0.187, 331, 256, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H
1999, 4gk3A, 0.7865, 2.81, 0.307, 275, 254, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 87
2000, 3qlgB, 0.7865, 2.19, 0.340, 260, 244, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH DASATINIB
2001, 3lijA, 0.7865, 2.66, 0.255, 465, 255, CRYSTAL STRUCTURE OF FULL LENGTH CPCDPK3 (CGD5_820) IN COMPLEX WITH CA2+ AND AMPPNP
2002, 2f7zE, 0.7865, 2.94, 0.254, 336, 256, PROTEIN KINASE A BOUND TO (R)-1-(1H-INDOL-3-YLMETHYL)-2-(2- PYRIDIN-4-YL-[17]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
2003, 5wngC, 0.7864, 3.01, 0.204, 387, 260, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2004, 5kmlA, 0.7864, 2.90, 0.378, 296, 254, TRKA JM-KINASE WITH 1-(5-METHYL-3-PHENYL-12-OXAZOL-4-YL)-3-[[2- (TRIFLUOROMETHYL)PHENYL]METHYL]UREA
2005, 5am6B, 0.7864, 2.86, 0.383, 280, 253, NATIVE FGFR1 WITH AN INHIBITOR
2006, 4tnbA, 0.7864, 3.14, 0.248, 529, 262, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 5 IN COMPLEX WITH SANGIVAMYCIN
2007, 4eojC, 0.7864, 2.86, 0.213, 282, 258, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP
2008, 5o4aB, 0.7863, 2.77, 0.358, 291, 254, HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR
2009, 3juhA, 0.7863, 2.96, 0.198, 334, 258, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
2010, 2ojfE, 0.7863, 2.97, 0.258, 336, 256, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
2011, 1yrpA, 0.7863, 2.79, 0.211, 275, 256, CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
2012, 5x02A, 0.7862, 2.94, 0.339, 305, 254, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR FF- 10101
2013, 5wnfC, 0.7862, 3.09, 0.215, 386, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2014, 4ypsA, 0.7862, 2.39, 0.360, 280, 247, (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS
2015, 4ib5A, 0.7862, 2.92, 0.193, 331, 259, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
2016, 4eokC, 0.7862, 2.80, 0.206, 299, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
2017, 3a7jA, 0.7862, 3.22, 0.281, 286, 260, HUMAN MST3 KINASE IN COMPLEX WITH MNADP
2018, 3a7iA, 0.7862, 3.18, 0.273, 286, 260, HUMAN MST3 KINASE IN COMPLEX WITH ADENINE
2019, 2x4zA, 0.7862, 3.17, 0.188, 290, 260, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH PF-03758309
2020, 1yrpB, 0.7862, 2.79, 0.211, 275, 256, CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
2021, 6dkwA, 0.7861, 2.44, 0.382, 284, 249, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 3. 
2022, 4xbrA, 0.7861, 3.00, 0.205, 315, 259, IN CELLULO CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INKA
2023, 3g5dA, 0.7861, 1.94, 0.336, 256, 241, KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB
2024, 3d14A, 0.7861, 2.62, 0.226, 262, 252, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240->ARG MET302- >LEU) IN COMPLEX WITH 1-{5-[2-(THIENO[32-D]PYRIMIDIN-4-YLAMINO)- ETHYL]- THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
2025, 2f7xE, 0.7861, 2.95, 0.254, 336, 256, PROTEIN KINASE A BOUND TO (S)-2-(1H-INDOL-3-YL)-1-[5-((E)-2- PYRIDIN-4-YL-VINYL)-PYRIDIN-3-YLOXYMETHYL]-ETHYLAMINE
2026, 1re8A, 0.7861, 2.81, 0.244, 337, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 2
2027, 5k5xA, 0.7860, 3.05, 0.341, 345, 255, CRYSTAL STRUCTURE OF HUMAN PDGFRA
2028, 5dh3A, 0.7860, 2.73, 0.232, 287, 254, CRYSTAL STRUCTURE OF MST2 IN COMPLEX WITH XMU-MP-1
2029, 3zh8B, 0.7860, 3.16, 0.192, 317, 260, A NOVEL SMALL MOLECULE APKC INHIBITOR
2030, 5vjaC, 0.7859, 2.86, 0.211, 265, 256, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
2031, 5vjaA, 0.7859, 2.80, 0.207, 266, 256, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
2032, 5objA, 0.7859, 2.69, 0.234, 260, 252, AURORA A KINASE IN COMPLEX WITH 2-(3-FLUOROPHENYL)QUINOLINE-4- CARBOXYLIC ACID AND ATP
2033, 5kkrC, 0.7859, 2.90, 0.199, 309, 256, KSR2:MEK1 COMPLEX BOUND TO THE SMALL MOLECULE APS-2-79
2034, 5f0aA, 0.7859, 3.07, 0.223, 811, 260, CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND 1-TERT-BUTYL-3-(3- CHLOROPHENOXY)-1H-PYRAZOLO[34-D]PYRIMIDIN-4-AMINE INHIBITOR
2035, 5cqwA, 0.7859, 2.90, 0.183, 331, 257, TETRAGONAL COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
2036, 3fzpA, 0.7859, 2.45, 0.361, 259, 249, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
2037, 3d94A, 0.7859, 2.68, 0.317, 288, 252, CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP
2038, 3d7tB, 0.7859, 2.65, 0.323, 265, 251, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
2039, 1o6kA, 0.7859, 2.94, 0.230, 317, 257, STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP
2040, 5xs2A, 0.7858, 3.27, 0.208, 366, 265, CDK8-CYCC IN COMPLEX WITH COMPOUND 17:3-CHLORO-4-(4-PYRIDYL)-1H- PYRROLE-2-CARBOXAMIDE
2041, 4v01B, 0.7858, 2.63, 0.359, 275, 251, FGFR1 IN COMPLEX WITH PONATINIB (CO-CRYSTALLISATION).
2042, 4md9E, 0.7858, 2.84, 0.187, 329, 256, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
2043, 4md8E, 0.7858, 2.97, 0.194, 332, 258, CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E)
2044, 4fnxA, 0.7858, 2.57, 0.296, 292, 250, CRYSTAL STRUCTURE OF THE APO R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
2045, 2helA, 0.7858, 2.63, 0.307, 256, 251, CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A)
2046, 2f7eE, 0.7858, 2.86, 0.247, 336, 255, PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5-ISOQUINOLIN-6- YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE
2047, 1snuA, 0.7858, 2.25, 0.313, 245, 243, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2048, 4e4xA, 0.7857, 2.82, 0.286, 267, 255, CRYSTAL STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH A DIHYDROPYRIDO[23-D]PYRIMIDINONE-BASED INHIBITOR
2049, 4yhjA, 0.7856, 3.16, 0.221, 501, 262, STRUCTURE AND FUNCTION OF THE HYPERTENSION VARIANT A486V OF G PROTEIN- COUPLED RECEPTOR KINASE 4 (GRK4)
2050, 4r1yA, 0.7856, 2.32, 0.350, 265, 243, IDENTIFICATION AND OPTIMIZATION OF PYRIDAZINONES AS POTENT AND SELECTIVE C-MET KINASE INHIBITOR
2051, 4hw7A, 0.7856, 2.91, 0.341, 289, 252, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR PLX647-OME
2052, 4eomC, 0.7856, 2.89, 0.209, 275, 258, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
2053, 4dceB, 0.7856, 2.29, 0.297, 284, 246, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR
2054, 3iw4B, 0.7856, 2.88, 0.244, 325, 258, CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
2055, 3amaA, 0.7856, 2.93, 0.255, 342, 255, PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR JNJ- 7706621
2056, 2oh0E, 0.7856, 2.96, 0.258, 336, 256, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
2057, 5u6cB, 0.7855, 1.92, 0.317, 257, 240, CRYSTAL STRUCTURE OF THE MER KINASE DOMAIN IN COMPLEX WITH A MACROCYCLIC INHIBITOR
2058, 4yuqA, 0.7855, 2.76, 0.239, 462, 255, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1354
2059, 4uj2A, 0.7855, 2.84, 0.248, 335, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2060, 3rhxB, 0.7855, 2.97, 0.375, 275, 256, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
2061, 5xgmA, 0.7854, 2.53, 0.351, 288, 248, CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH GO6976
2062, 5wneC, 0.7854, 3.11, 0.211, 384, 261, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
2063, 4gt5A, 0.7854, 2.78, 0.375, 290, 253, CRYSTAL STRUCTURE OF THE INACTIVE TRKA KINASE DOMAIN
2064, 4f64B, 0.7854, 2.81, 0.370, 272, 254, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 6
2065, 3u87A, 0.7854, 2.90, 0.183, 329, 257, STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA  IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE
2066, 3nczC, 0.7854, 3.05, 0.204, 389, 260, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
2067, 2x6dA, 0.7854, 2.87, 0.241, 255, 253, AURORA-A BOUND TO AN INHIBITOR
2068, 2wtkB, 0.7854, 2.79, 0.187, 311, 257, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
2069, 5owlA, 0.7853, 3.12, 0.199, 331, 261, LOW SALT STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA IN COMPLEX WITH 3- AMINOPROPYL-4;5;6;7-TETRABROMOBENZIMIDAZOL 
2070, 5jsmA, 0.7853, 2.47, 0.275, 265, 251, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
2071, 4mxxB, 0.7853, 2.28, 0.335, 260, 245, HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
2072, 4mneF, 0.7853, 2.32, 0.257, 258, 249, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
2073, 4mf1A, 0.7853, 1.93, 0.311, 243, 241, ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S2S)- 2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-13- BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE
2074, 4a07A, 0.7853, 2.97, 0.238, 282, 256, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS171 BOUND TO THE PIF-POCKET
2075, 3v8wA, 0.7853, 2.02, 0.315, 243, 241, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469
2076, 3lcoA, 0.7853, 2.93, 0.341, 293, 252, INHIBITOR BOUND TO A DFG-OUT STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
2077, 3h30B, 0.7853, 2.90, 0.191, 333, 257, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 56-DICHLORO-1-BETA-D- RIBOFURANOSYLBENZIMIDAZOLE
2078, 3d4qB, 0.7853, 2.38, 0.264, 264, 250, PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
2079, 2gnjA, 0.7853, 2.82, 0.248, 335, 254, PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
2080, 1ds5D, 0.7853, 3.05, 0.181, 328, 260, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2081, 4md9P, 0.7852, 2.91, 0.187, 328, 257, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
2082, 4k8aA, 0.7852, 2.36, 0.360, 251, 247, FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE INHIBITORS
2083, 4h58A, 0.7852, 2.37, 0.264, 263, 250, BRAF IN COMPLEX WITH COMPOUND 3
2084, 4eoqC, 0.7852, 2.90, 0.209, 275, 258, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH ATP
2085, 3my0I, 0.7852, 3.43, 0.233, 293, 266, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2086, 3hngA, 0.7852, 2.87, 0.333, 288, 252, CRYSTAL STRUCTURE OF VEGFR1 IN COMPLEX WITH N-(4-CHLOROPHENYL)-2- ((PYRIDIN-4-YLMETHYL)AMINO)BENZAMIDE
2087, 3d0eB, 0.7852, 2.90, 0.230, 322, 256, CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
2088, 3a7fA, 0.7852, 2.99, 0.263, 283, 255, HUMAN MST3 KINASE
2089, 2wpaA, 0.7852, 3.00, 0.208, 302, 259, OPTIMISATION OF 66-DIMETHYL PYRROLO 34-C PYRAZOLES: IDENTIFICATION OF PHA-793887 A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2090, 4ubaB, 0.7851, 2.90, 0.191, 333, 257, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26)
2091, 4f63B, 0.7851, 2.88, 0.365, 271, 255, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 1
2092, 4eolC, 0.7851, 2.79, 0.206, 299, 257, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2093, 2gnlA, 0.7851, 2.93, 0.259, 338, 255, PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H- 1152P
2094, 1xo2B, 0.7851, 2.87, 0.206, 289, 257, CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR FISETIN
2095, 1jktB, 0.7851, 2.96, 0.225, 276, 258, TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
2096, 6eqiC, 0.7850, 3.03, 0.190, 392, 263, STRUCTURE OF PINK1 BOUND TO UBIQUITIN
2097, 3w8lB, 0.7850, 2.94, 0.195, 326, 257, CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE
2098, 3d0eA, 0.7850, 2.90, 0.230, 322, 256, CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
2099, 2uw4A, 0.7850, 2.81, 0.244, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL- 1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2100, 1smhA, 0.7850, 2.90, 0.243, 348, 255, PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N- TERMINAL HELIX
2101, 1sm2A, 0.7850, 2.10, 0.310, 245, 242, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2102, 1q62A, 0.7850, 2.85, 0.244, 336, 254, PKA DOUBLE MUTANT MODEL OF PKB
2103, 1agwB, 0.7850, 2.87, 0.365, 272, 255, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
2104, 5j5sB, 0.7849, 2.04, 0.335, 258, 242, SRC KINASE IN COMPLEX WITH A SULFONAMIDE INHIBITOR
2105, 4fifA, 0.7849, 3.04, 0.197, 293, 259, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
2106, 3dy7A, 0.7849, 2.79, 0.198, 260, 253, X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
2107, 3d4qA, 0.7849, 2.38, 0.264, 264, 250, PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
2108, 2qocA, 0.7849, 2.97, 0.311, 283, 257, HUMAN EPHA3 KINASE DOMAIN PHOSPHORYLATED AMP-PNP BOUND STRUCTURE
2109, 1u5qB, 0.7849, 2.97, 0.260, 308, 258, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2110, 5os2A, 0.7848, 2.70, 0.226, 261, 252, CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH AN ALLOSTERICALLY BINDING FRAGMENT
2111, 4z83E, 0.7848, 2.95, 0.255, 335, 255, PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 47A
2112, 4r7iA, 0.7848, 2.92, 0.341, 290, 252, CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR GLEEVEC
2113, 4nusA, 0.7848, 3.41, 0.189, 301, 264, RSK2 N-TERMINAL KINASE IN COMPLEX WITH LJH685
2114, 3kxmA, 0.7848, 3.04, 0.188, 326, 260, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR K74
2115, 6c9dA, 0.7847, 2.97, 0.272, 425, 257, CRYSTAL STRUCTURE OF KA1-AUTOINHIBITED MARK1 KINASE 
2116, 5n23A, 0.7847, 2.87, 0.248, 333, 254, PROTEIN KINASE A MUTANTS AS SURROGATE MODEL FOR AURORA B WITH AT9283 INHIBITOR
2117, 5kmoA, 0.7847, 2.64, 0.384, 291, 250, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-(2- PYRIDYL)UREA
2118, 5kmjA, 0.7847, 2.77, 0.378, 300, 251, TRKA JM-KINASE WITH {N}-(2-PYRIDYLMETHYL)-2-[2-(2-THIENYL)INDOL-1- YL]ACETAMIDE
2119, 4yhtB, 0.7847, 2.38, 0.272, 258, 250, BRAF COMPLEXED WITH AN INHIBITOR
2120, 4ujbA, 0.7847, 2.83, 0.248, 344, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2121, 3uqfA, 0.7847, 2.43, 0.350, 260, 246, C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89
2122, 3qa0A, 0.7847, 2.92, 0.183, 330, 257, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5
2123, 3pooA, 0.7847, 2.93, 0.255, 331, 255, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2124, 3oogA, 0.7847, 2.84, 0.248, 333, 254, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT
2125, 2oxdA, 0.7847, 3.13, 0.184, 325, 261, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE K17 K22 AND K32 INHIBITORS
2126, 1zwsA, 0.7847, 3.10, 0.215, 278, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2127, 5h8bA, 0.7846, 2.92, 0.183, 331, 257, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2
2128, 4tyjA, 0.7846, 2.69, 0.368, 278, 250, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
2129, 3ppjB, 0.7846, 2.54, 0.254, 264, 252, HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR
2130, 5kwhA, 0.7845, 2.83, 0.184, 331, 256, CRYSTAL STRUCTURE OF CK2
2131, 4dgmA, 0.7845, 3.14, 0.188, 326, 261, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR APIGENIN
2132, 3psdB, 0.7845, 2.45, 0.259, 264, 251, NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE
2133, 3kxgA, 0.7845, 3.12, 0.180, 326, 261, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 34567-PENTABROMO-1H-INDAZOLE (K64)
2134, 3f5pT, 0.7845, 2.95, 0.309, 295, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2135, 2x39A, 0.7845, 2.96, 0.241, 316, 257, STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(23-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB
2136, 2uzuE, 0.7845, 2.98, 0.258, 336, 256, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2137, 1bkxA, 0.7845, 2.86, 0.239, 337, 255, A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL FLEXIBILITY
2138, 4ujaA, 0.7844, 2.86, 0.252, 336, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2139, 4tndA, 0.7844, 3.16, 0.244, 529, 262, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 5 IN COMPLEX WITH AMP-PNP
2140, 4o0rA, 0.7844, 3.15, 0.222, 293, 261, BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
2141, 4md9L, 0.7844, 3.04, 0.194, 328, 258, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
2142, 4hptE, 0.7844, 2.84, 0.240, 335, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING COMPLETE PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE
2143, 2e2bB, 0.7844, 2.31, 0.343, 262, 245, CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2144, 1q61A, 0.7844, 2.90, 0.251, 335, 255, PKA TRIPLE MUTANT MODEL OF PKB
2145, 5vilD, 0.7843, 2.94, 0.223, 271, 256, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
2146, 5uyjA, 0.7843, 3.05, 0.210, 281, 257, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B
2147, 5mrdA, 0.7843, 3.05, 0.233, 283, 257, HUMAN PDK1-PKCIOTA KINASE CHIMERA IN COMPLEX WITH ALLOSTERIC COMPOUND PS267 BOUND TO THE PIF-POCKET
2148, 4zs0A, 0.7843, 2.73, 0.243, 257, 251, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO SB-6-OH
2149, 4yznA, 0.7843, 2.76, 0.272, 269, 254, HUMANIZED ROCO4 BOUND TO COMPOUND 19
2150, 4w7pD, 0.7843, 3.10, 0.206, 387, 262, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2151, 4w7pA, 0.7843, 3.17, 0.198, 388, 263, CRYSTAL STRUCTURE OF ROCK 1 BOUND TO YB-15-QD37
2152, 4fifB, 0.7843, 3.12, 0.204, 292, 260, CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE
2153, 4ekkB, 0.7843, 2.98, 0.237, 318, 257, AKT1 WITH AMP-PNP
2154, 4ekkA, 0.7843, 2.97, 0.245, 318, 257, AKT1 WITH AMP-PNP
2155, 4bggD, 0.7843, 3.10, 0.251, 286, 259, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
2156, 3tcpA, 0.7843, 2.10, 0.329, 256, 243, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC569
2157, 3psbB, 0.7843, 2.45, 0.259, 264, 251, FURO[23-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B- RAF INHIBITORS
2158, 2uw3A, 0.7843, 2.87, 0.244, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4- PHENYL-1H-PYRAZOLE
2159, 2p2iA, 0.7843, 2.67, 0.337, 289, 249, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
2160, 2dwbA, 0.7843, 2.64, 0.219, 259, 251, AURORA-A KINASE COMPLEXED WITH AMPPNP
2161, 5t1hA, 0.7842, 3.04, 0.190, 331, 258, CRYSTAL STRUCTURE OF CK2
2162, 5m0cA, 0.7842, 2.93, 0.251, 336, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE FASUDIL-FRAGMENT ISOQUINOLINE-5-SULFONAMIDE 
2163, 4uj1A, 0.7842, 2.94, 0.259, 335, 255, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2164, 3e88B, 0.7842, 2.99, 0.230, 319, 257, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2165, 3e88A, 0.7842, 2.99, 0.230, 319, 257, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2166, 2yjsA, 0.7842, 2.50, 0.298, 286, 248, STRUCTURE OF C1156Y MUTANT ANAPLASTIC LYMPHOMA KINASE
2167, 2uw7A, 0.7842, 2.85, 0.248, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2168, 2uvxA, 0.7842, 2.91, 0.251, 335, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE
2169, 2pvnA, 0.7842, 3.11, 0.184, 327, 261, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2170, 2c4gA, 0.7842, 3.04, 0.208, 301, 259, STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2171, 5da3A, 0.7841, 2.58, 0.329, 263, 249, CRYSTAL STRUCTURE OF PTK6 KINASE DOMAIN WITH INHIBITOR
2172, 4ysjA, 0.7841, 2.58, 0.251, 459, 251, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA IN COMPLEX WITH ADP
2173, 4w9wA, 0.7841, 2.73, 0.206, 306, 252, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH SMALL MOLECULE AZD-7762
2174, 4mneA, 0.7841, 3.18, 0.197, 286, 259, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
2175, 4dgnA, 0.7841, 3.13, 0.180, 325, 261, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR LUTEOLIN
2176, 3b8rA, 0.7841, 2.59, 0.335, 289, 248, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
2177, 2wihA, 0.7841, 3.01, 0.208, 302, 259, STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2178, 2uw9A, 0.7841, 2.96, 0.241, 316, 257, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2179, 1vywA, 0.7841, 3.04, 0.208, 302, 259, STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
2180, 1jbpE, 0.7841, 2.81, 0.244, 339, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE ADP AND DETERGENT
2181, 4rwiB, 0.7840, 2.81, 0.370, 280, 254, CRYSTAL STRUCTURE OF V561M FGFR1 GATEKEEPER MUTATION (C488A C584S V561M) APO
2182, 4pmpA, 0.7840, 2.67, 0.382, 280, 249, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR 1-CYCLOPROPYL-1- [3-(13-THIAZOL-2-YL)BENZYL]-3-[4-(TRIFLUOROMETHOXY)PHENYL]UREA
2183, 4lfiB, 0.7840, 3.13, 0.203, 371, 261, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
2184, 4ij9A, 0.7840, 2.87, 0.248, 335, 254, BOVINE PKA C-ALPHA IN COMPLEX WITH 2-[[5-(4-PYRIDYL)-1H-124-TRIAZOL- 3-YL]SULFANYL]-1-(2-THIOPHENYL)ETHANONE
2185, 4dceA, 0.7840, 2.46, 0.298, 288, 248, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR
2186, 3pvbA, 0.7840, 2.91, 0.247, 341, 255, CRYSTAL STRUCTURE OF (73-244)RIA:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
2187, 3ppkB, 0.7840, 2.48, 0.259, 264, 251, HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
2188, 3my0V, 0.7840, 3.25, 0.241, 282, 261, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2189, 3my0T, 0.7840, 3.42, 0.234, 292, 265, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2190, 3fhiA, 0.7840, 2.91, 0.251, 336, 255, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE CATALYTIC AND REGULATORY (RI{ALPHA}) SUBUNITS OF PKA
2191, 2uvyA, 0.7840, 2.93, 0.255, 333, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H- PURIN-6-YL)-BENZYL)-AMINE
2192, 1tkiB, 0.7840, 2.74, 0.184, 321, 256, AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
2193, 1tkiA, 0.7840, 2.74, 0.184, 321, 256, AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
2194, 1jluE, 0.7840, 2.84, 0.244, 337, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT
2195, 5a4cB, 0.7839, 2.88, 0.365, 286, 255, FGFR1 LIGAND COMPLEX
2196, 4z84A, 0.7839, 2.86, 0.248, 335, 254, PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 34A
2197, 4ra5A, 0.7839, 3.06, 0.267, 332, 258, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH LIGAND COMPOUND 11A (6- [(13-DIMETHYL-AZETIDIN-3-YL)-METHYL-AMINO]-4(R)-METHYL-7-PHENYL-2 10-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
2198, 4lfiA, 0.7839, 3.13, 0.203, 370, 261, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
2199, 4jnwA, 0.7839, 2.84, 0.183, 320, 257, BACTERIALLY EXPRESSED TITIN KINASE
2200, 4dggB, 0.7839, 2.22, 0.354, 259, 243, C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176
2201, 4cfnC, 0.7839, 2.82, 0.198, 296, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2202, 3l9lA, 0.7839, 2.97, 0.262, 338, 256, CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36
2203, 3b8qA, 0.7839, 2.80, 0.332, 292, 250, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
2204, 3ambA, 0.7839, 2.95, 0.255, 340, 255, PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR VX- 680
2205, 2pvlA, 0.7839, 3.15, 0.188, 327, 261, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2206, 2gfcA, 0.7839, 2.83, 0.244, 335, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2207, 2bkzA, 0.7839, 3.02, 0.208, 302, 259, STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2208, 1xh9A, 0.7839, 2.86, 0.252, 336, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2209, 1xh8A, 0.7839, 2.81, 0.252, 337, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2210, 1xh5A, 0.7839, 3.05, 0.258, 335, 256, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2211, 5wniA, 0.7838, 2.20, 0.252, 263, 246, CRYSTAL STRUCTURE OF MURINE RECEPTOR-INTERACTING PROTEIN KINASE 4 (RIPK4) D143N IN COMPLEX WITH ATP 
2212, 4yxrA, 0.7838, 2.86, 0.252, 334, 254, CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH INHIBITOR.
2213, 4jnwB, 0.7838, 2.83, 0.183, 321, 257, BACTERIALLY EXPRESSED TITIN KINASE
2214, 4fvqA, 0.7838, 2.80, 0.264, 274, 254, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (MG-ATP-BOUND FORM)
2215, 2uw6A, 0.7838, 2.97, 0.251, 334, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (S)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2216, 2pvmA, 0.7838, 3.16, 0.188, 327, 261, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2217, 2erzE, 0.7838, 2.85, 0.244, 334, 254, CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL
2218, 1rdqE, 0.7838, 2.92, 0.243, 340, 255, HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
2219, 6ehuA, 0.7837, 2.85, 0.188, 327, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 32
2220, 5m56B, 0.7837, 3.09, 0.207, 328, 261, MONOCLINIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
2221, 4q9zA, 0.7837, 2.98, 0.268, 331, 257, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH COMPOUND35 ((1R)-9- (AZETIDIN-3-YLAMINO)-18-DIMETHYL-35-DIHYDRO[124]TRIAZINO[34- C][14]BENZOXAZIN-2(1H)-ONE)
2222, 4axaA, 0.7837, 2.86, 0.248, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1S)-2-AMINO-1-( 4-CHLOROPHENYL)-1-(4-(1H-PYRAZOL-4-YL)PHENYL)ETHAN-1-OL
2223, 3ovvA, 0.7837, 2.96, 0.259, 335, 255, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2224, 3ngaB, 0.7837, 2.92, 0.183, 331, 257, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
2225, 3gxlA, 0.7837, 3.03, 0.223, 285, 260, ALK-5 KINASE COMPLEX WITH GW857175
2226, 3aglB, 0.7837, 2.96, 0.259, 335, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
2227, 1q24A, 0.7837, 2.93, 0.247, 335, 255, PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP
2228, 5lcqA, 0.7836, 2.79, 0.248, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH LONG-CHAIN FASUDIL-DERIVATIVE (LIGAND 05)
2229, 5bx6A, 0.7836, 2.85, 0.252, 343, 254, PKA IN COMPLEX WITH A HALOGENATED PHTHALAZINONE FRAGMENT COMPOUND.
2230, 4wb6B, 0.7836, 2.91, 0.247, 340, 255, CRYSTAL STRUCTURE OF A L205R MUTANT OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2231, 4uj9A, 0.7836, 2.86, 0.252, 339, 254, PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR
2232, 4figB, 0.7836, 3.03, 0.205, 292, 259, CATALYTIC DOMAIN OF HUMAN PAK4
2233, 3zo3A, 0.7836, 2.92, 0.259, 337, 255, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2234, 3omvA, 0.7836, 2.44, 0.267, 264, 251, CRYSTAL STRUCTURE OF C-RAF (RAF-1)
2235, 3l9mA, 0.7836, 2.97, 0.254, 338, 256, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 18
2236, 2qc6A, 0.7836, 2.94, 0.179, 326, 257, PROTEIN KINASE CK2 IN COMPLEX WITH DBC
2237, 2gnhA, 0.7836, 2.91, 0.255, 338, 255, PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P
2238, 1okyA, 0.7836, 2.94, 0.227, 281, 256, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
2239, 4nk9B, 0.7835, 2.76, 0.356, 282, 253, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1
2240, 4ie9A, 0.7835, 2.95, 0.259, 335, 255, BOVINE PKA C-ALPHA IN COMPLEX WITH 3-PYRIDYLMETHYL-5-METHYL-1H- PYRAZOLE-3-CARBOXYLATE
2241, 4eklA, 0.7835, 2.95, 0.254, 329, 256, AKT1 WITH GDC0068
2242, 3bhhD, 0.7835, 2.62, 0.217, 286, 254, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
2243, 2gcdA, 0.7835, 3.09, 0.270, 308, 259, TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
2244, 1vebA, 0.7835, 2.84, 0.248, 338, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5
2245, 1ds5C, 0.7835, 3.09, 0.181, 328, 260, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2246, 5vilA, 0.7834, 2.94, 0.227, 271, 256, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
2247, 5m75A, 0.7834, 2.88, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A (S)-METHYL SUBSTITUED FASUDIL-DERIVATIVE 
2248, 4nk9A, 0.7834, 2.67, 0.361, 281, 252, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1
2249, 4lueA, 0.7834, 2.25, 0.360, 422, 242, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
2250, 4gv1A, 0.7834, 3.05, 0.253, 329, 257, PKB ALPHA IN COMPLEX WITH AZD5363
2251, 3vqhA, 0.7834, 2.87, 0.252, 344, 254, BROMINE SAD PARTIALLY RESOLVES MULTIPLE BINDING MODES FOR PKA INHIBITOR H-89
2252, 3tniA, 0.7834, 2.66, 0.193, 297, 254, STRUCTURE OF CDK9/CYCLIN T F241L
2253, 3qkmA, 0.7834, 2.97, 0.254, 329, 256, SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS
2254, 3mv5A, 0.7834, 3.02, 0.249, 315, 257, CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
2255, 3l9mB, 0.7834, 2.87, 0.255, 336, 255, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 18
2256, 3dtwA, 0.7834, 2.59, 0.327, 288, 248, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
2257, 2uzwE, 0.7834, 3.00, 0.254, 336, 256, PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2258, 2acxB, 0.7834, 3.03, 0.227, 492, 260, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
2259, 1zogA, 0.7834, 3.13, 0.184, 325, 261, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES
2260, 1zoeA, 0.7834, 2.95, 0.179, 325, 257, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS
2261, 1rekA, 0.7834, 2.95, 0.243, 336, 255, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 8
2262, 4eevA, 0.7833, 2.85, 0.336, 283, 253, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH LY2801653
2263, 3tudA, 0.7833, 2.56, 0.341, 256, 249, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-(8-METHYL-7- OXO-2-(PHENYLAMINO)-78-DIHYDROPYRIDO[23-D]PYRIMIDIN-6-YL)PHENYL)-3- (TRIFLUOROMETHYL)BENZAMIDE
2264, 3owpA, 0.7833, 2.97, 0.251, 334, 255, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2265, 3e8dB, 0.7833, 2.95, 0.254, 317, 256, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2266, 3bz3A, 0.7833, 2.60, 0.364, 259, 250, CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR
2267, 1zohA, 0.7833, 3.18, 0.188, 326, 261, CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS
2268, 1fgkB, 0.7833, 3.04, 0.375, 272, 256, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
2269, 1f0qA, 0.7833, 3.08, 0.181, 329, 260, CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN
2270, 5ya5A, 0.7832, 2.49, 0.343, 273, 245, CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NOVEL INHIBITOR 
2271, 5nk6A, 0.7832, 2.81, 0.328, 284, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2D
2272, 5n3oA, 0.7832, 2.99, 0.255, 335, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-(13-OXAZOL-5-YL)ANILINE
2273, 5m0bA, 0.7832, 2.80, 0.248, 350, 254, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A SHORT-CHAINED N-(2-AMINOETHYL)ISOQUINOLINE-5-SULFONAMIDE) FASUDIL-DERIVATIVE (LIGAND 03) 
2274, 5bx7A, 0.7832, 2.86, 0.244, 343, 254, PKA IN COMPLEX WITH A BENZOTHIOPHENE FRAGMENT COMPOUND.
2275, 3qklA, 0.7832, 2.93, 0.246, 317, 256, SPIROCHROMANE AKT INHIBITORS
2276, 3qamE, 0.7832, 2.92, 0.239, 348, 255, CRYSTAL STRUCTURE OF GLU208ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
2277, 3fjqE, 0.7832, 2.92, 0.243, 334, 255, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA IN COMPLEX WITH PEPTIDE INHIBITOR PKI ALPHA (6-25)
2278, 3eknA, 0.7832, 3.03, 0.310, 297, 258, INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
2279, 3e8dA, 0.7832, 2.92, 0.246, 315, 256, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2280, 3dneA, 0.7832, 2.97, 0.255, 336, 255, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2281, 2uw5A, 0.7832, 2.90, 0.244, 333, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (R)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2282, 1wvyA, 0.7832, 3.03, 0.229, 273, 258, CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
2283, 1sveA, 0.7832, 2.85, 0.252, 341, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1
2284, 4wihA, 0.7831, 2.84, 0.244, 350, 254, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS
2285, 4qmwA, 0.7831, 3.24, 0.269, 286, 260, MST3 IN COMPLEX WITH PP-121 1-CYCLOPENTYL-3-(1H-PYRROLO[23- B]PYRIDIN-5-YL)-1H-PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
2286, 4figA, 0.7831, 3.05, 0.205, 292, 259, CATALYTIC DOMAIN OF HUMAN PAK4
2287, 3zo4A, 0.7831, 2.87, 0.252, 335, 254, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2288, 3qrjB, 0.7831, 2.56, 0.345, 265, 249, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
2289, 3l9lB, 0.7831, 2.88, 0.259, 337, 255, CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36
2290, 2jedA, 0.7831, 3.03, 0.264, 324, 258, THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2291, 2jdtA, 0.7831, 2.98, 0.255, 334, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2292, 2gniA, 0.7831, 2.83, 0.252, 338, 254, PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR FASUDIL (HA1077)
2293, 1ydrE, 0.7831, 2.85, 0.248, 334, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5- ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE
2294, 1ds5A, 0.7831, 3.06, 0.185, 328, 260, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2295, 1bx6A, 0.7831, 2.83, 0.235, 337, 255, CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
2296, 1apmE, 0.7831, 2.85, 0.240, 338, 254, 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT
2297, 5vioA, 0.7830, 3.02, 0.218, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
2298, 5j5xA, 0.7830, 2.97, 0.263, 340, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1416
2299, 3v5lB, 0.7830, 1.88, 0.318, 241, 239, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
2300, 3kxnA, 0.7830, 3.17, 0.184, 327, 261, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR TETRAIODOBENZIMIDAZOLE (K88)
2301, 2pvjA, 0.7830, 3.08, 0.188, 326, 260, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2302, 2oxxA, 0.7830, 3.15, 0.184, 325, 261, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
2303, 2gnfA, 0.7830, 2.92, 0.255, 339, 255, PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y- 27632
2304, 1svgA, 0.7830, 2.86, 0.252, 338, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4
2305, 5nqcA, 0.7829, 3.03, 0.190, 331, 258, CK2ALPHA IN COMPLEX WITH NMR154
2306, 5ng3B, 0.7829, 2.43, 0.253, 275, 249, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
2307, 5ia5A, 0.7829, 2.93, 0.325, 273, 255, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH GOLVATINIB (E7050)
2308, 4xw5A, 0.7829, 2.88, 0.244, 334, 254, X-RAY STRUCTURE OF PKAC WITH ATP CP20 CALCIUM IONS
2309, 4rlkA, 0.7829, 3.14, 0.180, 327, 261, CRYSTAL STRUCTURE OF Z. MAYS CK2ALPHA IN COMPLEX WITH THE ATP- COMPETITIVE INHIBITOR 4-[(E)-(FLUOREN-9-YLIDENEHYDRAZINYLIDENE)- METHYL] BENZOATE
2310, 4itjB, 0.7829, 2.48, 0.288, 276, 250, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4
2311, 4g2fA, 0.7829, 2.81, 0.304, 275, 253, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 7
2312, 4dymA, 0.7829, 3.33, 0.240, 293, 262, CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[12-B]PYRIDAZINE INHIBITOR K00135
2313, 4dh5A, 0.7829, 2.94, 0.251, 333, 255, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ ADP PHOSPHATE AND IP20
2314, 3v5qB, 0.7829, 2.53, 0.407, 265, 248, DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS
2315, 3cjgA, 0.7829, 2.65, 0.336, 280, 250, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 345-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
2316, 2jdvA, 0.7829, 2.92, 0.255, 334, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654
2317, 1svhA, 0.7829, 2.86, 0.252, 335, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8
2318, 6gmdA, 0.7828, 2.71, 0.189, 325, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3 
2319, 5n3lA, 0.7828, 3.00, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1 2-DIOL
2320, 4x6qC, 0.7828, 2.91, 0.255, 334, 255, AN ISOFORM-SPECIFIC MYRISTYLATION SWITCH TARGETS RIIB PKA HOLOENZYMES TO MEMBRANES
2321, 4wb6A, 0.7828, 2.92, 0.255, 336, 255, CRYSTAL STRUCTURE OF A L205R MUTANT OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2322, 4v04B, 0.7828, 2.90, 0.368, 287, 253, FGFR1 IN COMPLEX WITH PONATINIB.
2323, 4kabA, 0.7828, 2.37, 0.358, 255, 246, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-METHYL-14- DIHYDRO-PYRAZOLO[45-C]PYRAZOLE
2324, 4dgoA, 0.7828, 3.13, 0.184, 325, 261, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH TYRPHOSTIN AG99
2325, 3tnqB, 0.7828, 2.88, 0.248, 331, 254, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
2326, 3qgyB, 0.7828, 2.18, 0.310, 245, 242, CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
2327, 3q53A, 0.7828, 3.25, 0.210, 291, 262, STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN IN COMPLEX WITH ATP
2328, 3nx8A, 0.7828, 2.84, 0.256, 333, 254, HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL
2329, 3e8eA, 0.7828, 3.08, 0.258, 341, 256, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2330, 2pvkA, 0.7828, 3.08, 0.185, 327, 260, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2331, 2c4gC, 0.7828, 2.96, 0.213, 300, 258, STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2332, 1fvvA, 0.7828, 2.81, 0.212, 298, 255, THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
2333, 6ccyA, 0.7827, 3.09, 0.252, 325, 258, CRYSTAL STRUCTURE OF AKT1 IN COMPLEX WITH A SELECTIVE INHIBITOR 
2334, 5m0lA, 0.7827, 2.93, 0.251, 338, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE METHYLATED FASUDIL-DERIVED FRAGMENT N-METHYLISOQUINOLINE-5- SULFONAMIDE (LIGAND 02) 
2335, 5i9yA, 0.7827, 3.01, 0.324, 287, 256, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH DASATINIB
2336, 4yuqB, 0.7827, 2.59, 0.242, 462, 252, CDPK1 FROM EIMERIA TENELLA IN COMPLEX WITH INHIBITOR UW1354
2337, 4wbbB, 0.7827, 2.96, 0.251, 334, 255, SINGLE TURNOVER AUTOPHOSPHORYLATION CYCLE OF THE PKA RIIB HOLOENZYME
2338, 4mwhA, 0.7827, 3.12, 0.199, 371, 261, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP
2339, 4md9H, 0.7827, 3.00, 0.201, 328, 259, CRYSTAL STRUCTURE OF SYMMETRIC CK2 HOLOENZYME WITH MUTATED ALPHA SUBUNIT (F121E TRUNCATED AT AA 336)
2340, 4gu9A, 0.7827, 2.44, 0.360, 252, 247, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO- PHENYL)-(1H-PYRAZOLO[34-D]PYRIMIDIN-4-YL)-AMINE
2341, 4bggC, 0.7827, 3.14, 0.252, 279, 258, CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
2342, 3h30A, 0.7827, 3.02, 0.190, 333, 258, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 56-DICHLORO-1-BETA-D- RIBOFURANOSYLBENZIMIDAZOLE
2343, 3gopA, 0.7827, 1.95, 0.312, 300, 240, CRYSTAL STRUCTURE OF THE EGF RECEPTOR JUXTAMEMBRANE AND KINASE DOMAINS
2344, 2uvzA, 0.7827, 2.95, 0.255, 334, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-( 9H-PURIN-6-YL)-PHENYL)-METHYLAMINE
2345, 1ydsE, 0.7827, 2.86, 0.248, 334, 254, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5- ISOQUINOLINESULFONAMIDE
2346, 5os7B, 0.7826, 2.71, 0.189, 325, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 4
2347, 5hvuB, 0.7826, 3.22, 0.215, 394, 261, RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH A PYRIDINE THIAZOLE PIPERIDINE INHIBITOR
2348, 5a4cA, 0.7826, 2.71, 0.377, 294, 252, FGFR1 LIGAND COMPLEX
2349, 4q9zB, 0.7826, 3.03, 0.267, 308, 258, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH COMPOUND35 ((1R)-9- (AZETIDIN-3-YLAMINO)-18-DIMETHYL-35-DIHYDRO[124]TRIAZINO[34- C][14]BENZOXAZIN-2(1H)-ONE)
2350, 4fi1A, 0.7826, 3.12, 0.199, 371, 261, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH ATP
2351, 4cfuA, 0.7826, 2.88, 0.218, 299, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2352, 3zo2A, 0.7826, 2.97, 0.263, 340, 255, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2353, 3l9nA, 0.7826, 2.86, 0.255, 332, 255, CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A L173M Q181K) WITH COMPOUND 27
2354, 3idbA, 0.7826, 2.97, 0.247, 341, 255, CRYSTAL STRUCTURE OF (108-268)RIIB:C HOLOENZYME OF CAMP- DEPENDENT PROTEIN KINASE
2355, 3gqlA, 0.7826, 2.92, 0.369, 287, 255, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
2356, 2gu8A, 0.7826, 2.88, 0.244, 335, 254, DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2357, 6c9dB, 0.7825, 3.01, 0.280, 422, 257, CRYSTAL STRUCTURE OF KA1-AUTOINHIBITED MARK1 KINASE 
2358, 5ooiB, 0.7825, 3.09, 0.204, 325, 260, STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2359, 5nwzA, 0.7825, 2.51, 0.373, 271, 249, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
2360, 5n1dA, 0.7825, 2.91, 0.263, 348, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-METHYL-1-(5-PYRIDIN-3-YLOXYFURAN-2-YL) METHANAMINE
2361, 4zk5A, 0.7825, 2.72, 0.236, 286, 254, MAP4K4 IN COMPLEX WITH INHIBITOR GNE-495
2362, 4yxsA, 0.7825, 2.87, 0.252, 335, 254, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2363, 4xw6A, 0.7825, 2.95, 0.247, 334, 255, X-RAY STRUCTURE OF PKAC WITH ADP FREE PHOSPHATE ION CP20 MAGNESIUM IONS
2364, 4nkaA, 0.7825, 2.58, 0.360, 279, 250, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2
2365, 3v5lC, 0.7825, 2.18, 0.314, 244, 242, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
2366, 3tnpF, 0.7825, 2.92, 0.255, 334, 255, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
2367, 3tnpC, 0.7825, 2.92, 0.255, 334, 255, STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
2368, 3blqA, 0.7825, 2.81, 0.192, 295, 255, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP
2369, 2qcsA, 0.7825, 2.96, 0.255, 335, 255, A COMPLEX STRUCTURE BETWEEN THE CATALYTIC AND REGULATORY SUBUNIT OF PROTEIN KINASE A THAT REPRESENTS THE INHIBITED STATE
2370, 1xhaA, 0.7825, 2.83, 0.244, 348, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2371, 1q8tA, 0.7825, 2.86, 0.252, 338, 254, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632
2372, 5wilA, 0.7824, 2.79, 0.261, 274, 253, JAK2 PSEUDOKINASE IN COMPLEX WITH AZD7762 
2373, 5nk2A, 0.7824, 2.82, 0.328, 290, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2B
2374, 5n1vA, 0.7824, 2.95, 0.183, 331, 257, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH PYRAZOLO-PYRIMIDINE MACROCYCLIC LIGAND
2375, 4v01A, 0.7824, 2.48, 0.367, 273, 248, FGFR1 IN COMPLEX WITH PONATINIB (CO-CRYSTALLISATION).
2376, 4ubaA, 0.7824, 3.15, 0.199, 333, 261, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH 4 - CARBOXY-68-BROMO-FLAVONOL (FLC26)
2377, 4rwjB, 0.7824, 2.82, 0.374, 282, 254, CRYSTAL STRUCTURE OF FGFR1 (C488A C584S) IN COMPLEX WITH AZD4547 (N- {3-[2-(35-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)
2378, 4ebvA, 0.7824, 2.76, 0.364, 262, 250, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
2379, 3qalE, 0.7824, 2.93, 0.243, 339, 255, CRYSTAL STRUCTURE OF ARG280ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE
2380, 3pwdA, 0.7824, 3.15, 0.184, 327, 261, CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH NBC (Z1)
2381, 3f5pK, 0.7824, 3.00, 0.309, 293, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2382, 3e8cA, 0.7824, 2.99, 0.263, 341, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2383, 3e87A, 0.7824, 3.02, 0.230, 321, 257, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2384, 2vnwA, 0.7824, 2.89, 0.244, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)METHANAMINE
2385, 2uw0A, 0.7824, 2.90, 0.248, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  6-(4-(4-(4- CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE
2386, 2cchC, 0.7824, 2.84, 0.208, 296, 255, THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA- LINKED ATP ANALOGUE
2387, 1m2rA, 0.7824, 3.17, 0.184, 327, 261, CRYSTAL STRUCTURE OF 58-DI-AMINO-14-DI-HYDROXY- ANTHRAQUINONE/CK2 KINASE COMPLEX
2388, 5m6vA, 0.7823, 2.89, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A DOUBLE METHYLATED FASUDIL-DERIVATIVE 
2389, 5j95A, 0.7823, 2.55, 0.224, 284, 250, MAP4K4 IN COMPLEX WITH INHIBITOR
2390, 5izfA, 0.7823, 2.96, 0.259, 336, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1408
2391, 4tyiA, 0.7823, 2.84, 0.383, 277, 253, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4
2392, 3eflA, 0.7823, 2.54, 0.336, 286, 247, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
2393, 3e8eB, 0.7823, 2.99, 0.255, 337, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2394, 3e8cC, 0.7823, 2.99, 0.263, 341, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2395, 3e87B, 0.7823, 3.02, 0.230, 321, 257, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2396, 2vo0A, 0.7823, 2.97, 0.255, 340, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE
2397, 2pvhA, 0.7823, 3.06, 0.188, 327, 260, STRUCTURE-BASED DESIGN OF PYRAZOLO[15-A][135]TRIAZINE DERIVATIVES AS POTENT INHIBITORS OF PROTEIN KINASE CK2
2398, 2c1aA, 0.7823, 2.98, 0.259, 335, 255, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE
2399, 1xh7A, 0.7823, 2.90, 0.252, 337, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2400, 5winA, 0.7822, 2.84, 0.264, 274, 254, JAK2 PSEUDOKINASE IN COMPLEX WITH JNJ7706621 
2401, 5di1A, 0.7822, 2.65, 0.219, 285, 251, MAP4K4 IN COMPLEX WITH AN INHIBITOR
2402, 4x6rA, 0.7822, 2.96, 0.255, 347, 255, AN ISOFORM-SPECIFIC MYRISTYLATION SWITCH TARGETS RIIB PKA HOLOENZYMES TO MEMBRANES
2403, 4iadA, 0.7822, 2.96, 0.247, 334, 255, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2404, 4eonA, 0.7822, 2.74, 0.204, 299, 255, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2405, 4c37A, 0.7822, 2.97, 0.247, 335, 255, PKA-S6K1 CHIMERA WITH COMPOUND 21A (CCT196539) BOUND
2406, 3q9xA, 0.7822, 3.14, 0.199, 330, 261, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5
2407, 3pyyB, 0.7822, 2.11, 0.342, 257, 243, DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE SMALL-MOLECULE C- ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
2408, 3omvB, 0.7822, 2.54, 0.262, 264, 252, CRYSTAL STRUCTURE OF C-RAF (RAF-1)
2409, 3b8qB, 0.7822, 2.70, 0.333, 271, 249, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
2410, 2vo6A, 0.7822, 2.91, 0.244, 335, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4- CHLOROBENZYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YLAMINE
2411, 2vo3A, 0.7822, 2.90, 0.248, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE
2412, 2vnyA, 0.7822, 2.89, 0.244, 334, 254, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)AMINE
2413, 2uw8A, 0.7822, 2.98, 0.251, 334, 255, STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO- PHENYL)-2-PHENYL-ETHYLAMINE
2414, 2qu6B, 0.7822, 2.45, 0.327, 260, 245, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
2415, 2jedB, 0.7822, 3.03, 0.267, 320, 258, THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2416, 1jamA, 0.7822, 3.08, 0.188, 327, 260, CRYSTAL STRUCTURE OF APO-FORM OF Z. MAYS CK2 PROTEIN KINASE ALPHA SUBUNIT
2417, 1fmoE, 0.7822, 2.86, 0.240, 336, 254, CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE
2418, 5uzkA, 0.7821, 2.98, 0.259, 335, 255, CRYSTAL STRUCTURE OF PKA BOUND TO AN PYRROLO PYRIDINE INHIBITOR
2419, 5ia4A, 0.7821, 2.91, 0.327, 269, 254, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH FORETINIB (XL880)
2420, 4gu6B, 0.7821, 2.62, 0.364, 258, 250, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO- 2-PHENYL-1H-PYRROLO[23-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}- N-METHYL-METHANESULFONAMIDE
2421, 4ehgA, 0.7821, 2.48, 0.260, 262, 250, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOPYRIDIMINE-BASED INHIBITOR
2422, 4dh1A, 0.7821, 2.96, 0.247, 333, 255, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH LOW MG2+ ATP AND IP20
2423, 4anmA, 0.7821, 3.08, 0.188, 328, 260, COMPLEX OF CK2 WITH A CDC7 INHIBITOR
2424, 3ow3A, 0.7821, 2.98, 0.247, 334, 255, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
2425, 3e8cF, 0.7821, 2.99, 0.263, 341, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2426, 3e8cE, 0.7821, 2.99, 0.263, 336, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2427, 3b8rB, 0.7821, 2.58, 0.340, 267, 247, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
2428, 3agmA, 0.7821, 2.99, 0.263, 337, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-670
2429, 2wtkE, 0.7821, 2.86, 0.191, 308, 256, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
2430, 2vo7A, 0.7821, 2.88, 0.252, 335, 254, STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H- PYRROLO(23-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
2431, 2fgiB, 0.7821, 3.05, 0.375, 272, 256, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
2432, 1xh6A, 0.7821, 2.90, 0.252, 331, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2433, 1atpE, 0.7821, 2.93, 0.247, 334, 255, 2.2 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR
2434, 5nk9A, 0.7820, 2.83, 0.328, 285, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2E
2435, 5n3sA, 0.7820, 3.01, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-HYDROXYBENZAMIDE
2436, 5hesA, 0.7820, 2.40, 0.324, 287, 247, HUMAN LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE (ZAK MLT HCCS-4 MRK AZK MLTK) IN COMPLEX WITH VEMURAFENIB
2437, 4wb8A, 0.7820, 2.97, 0.255, 334, 255, CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT) EXON 1 DELETION
2438, 4ra4A, 0.7820, 2.91, 0.245, 317, 257, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE C ALPHA IN COMPLEX WITH COMPOUND 28 ((R)-6-((3S4S)-13-DIMETHYL-PIPERIDIN-4-YL)-7-(2-FLUORO- PHENYL)-4-METHYL-210-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
2439, 4dh3A, 0.7820, 2.96, 0.247, 333, 255, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ ATP AND IP20
2440, 4cfuC, 0.7820, 2.91, 0.210, 272, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2441, 3oezB, 0.7820, 2.30, 0.340, 261, 244, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH IMATINIB
2442, 3f5pI, 0.7820, 2.99, 0.309, 294, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2443, 2xzsB, 0.7820, 3.18, 0.226, 293, 261, DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
2444, 1lr4A, 0.7820, 3.14, 0.184, 327, 261, ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
2445, 1h1pC, 0.7820, 2.82, 0.211, 296, 256, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
2446, 5n3pA, 0.7819, 3.01, 0.255, 336, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 1H-INDOL-5-OL
2447, 5i9xA, 0.7819, 2.82, 0.328, 284, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH BOSUTINIB (SKI-606)
2448, 5ct0B, 0.7819, 2.85, 0.184, 326, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH 3-(3-CHLORO-4-(PHENYL)BENZYLAMINO) PROPAN-1-OL BOUND
2449, 4wsqB, 0.7819, 2.70, 0.199, 310, 251, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
2450, 4wb5A, 0.7819, 2.97, 0.255, 335, 255, CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2451, 4kioA, 0.7819, 1.83, 0.319, 240, 238, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
2452, 4kaoB, 0.7819, 2.49, 0.359, 254, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-TERT- BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-(4-PYRIDIN-3- YL-PHENYL)-UREA
2453, 4dh7A, 0.7819, 2.97, 0.247, 333, 255, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ AMP-PNP AND IP20 
2454, 4aojB, 0.7819, 2.38, 0.381, 258, 247, HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
2455, 3f5pA, 0.7819, 2.99, 0.309, 299, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2456, 3e8cD, 0.7819, 3.00, 0.263, 344, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2457, 3c1xA, 0.7819, 2.69, 0.323, 290, 251, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR
2458, 1cdkB, 0.7819, 2.93, 0.255, 342, 255, CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
2459, 5oyfA, 0.7818, 2.88, 0.188, 327, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 31
2460, 5nk7A, 0.7818, 2.85, 0.328, 284, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2A
2461, 4kioD, 0.7818, 2.03, 0.325, 242, 240, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
2462, 4eheA, 0.7818, 2.84, 0.268, 266, 254, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOTHIENOPYRIMIDINE-BASED INHIBITOR
2463, 3mvjE, 0.7818, 2.89, 0.247, 334, 255, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
2464, 3f5pD, 0.7818, 3.00, 0.309, 297, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2465, 3e8cB, 0.7818, 3.00, 0.263, 344, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2466, 3bysA, 0.7818, 2.47, 0.355, 255, 245, CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B
2467, 5vhbA, 0.7817, 2.90, 0.252, 325, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AMINOBENZOTHIAZOLE BASED INHIBITOR
2468, 5n3jA, 0.7817, 3.02, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-NITROBENZOIC ACID
2469, 4u40A, 0.7817, 2.84, 0.236, 295, 254, MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4 (MAP4K4) BOUND TO AMPPNP
2470, 4ra5B, 0.7817, 3.04, 0.268, 310, 257, HUMAN PROTEIN KINASE C THETA IN COMPLEX WITH LIGAND COMPOUND 11A (6- [(13-DIMETHYL-AZETIDIN-3-YL)-METHYL-AMINO]-4(R)-METHYL-7-PHENYL-2 10-DIHYDRO-9-OXA-124A-TRIAZA-PHENANTHREN-3-ONE)
2471, 4knbB, 0.7817, 2.32, 0.335, 256, 242, C-MET IN COMPLEX WITH OSI LIGAND
2472, 4ib3A, 0.7817, 2.94, 0.243, 336, 255, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH ADP PHOSPHORYLATED PEPTIDE PSP20 AND NO METAL
2473, 4ib1A, 0.7817, 2.97, 0.247, 335, 255, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH K+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2474, 3priB, 0.7817, 2.46, 0.260, 264, 250, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
2475, 3hrcA, 0.7817, 2.99, 0.235, 279, 255, CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP
2476, 2gngA, 0.7817, 2.93, 0.259, 338, 255, PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE
2477, 1p4fA, 0.7817, 2.69, 0.219, 269, 251, DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT
2478, 5nk1A, 0.7816, 2.84, 0.328, 284, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1K
2479, 5n3kA, 0.7816, 3.01, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE O-GUANIDINO-L-HOMOSERINE
2480, 5m4uA, 0.7816, 3.01, 0.201, 332, 259, ORTHORHOMBIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
2481, 5i9zA, 0.7816, 2.69, 0.315, 273, 251, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH DANUSERTIB (PHA739358)
2482, 4rewA, 0.7816, 2.89, 0.270, 411, 256, CRYSTAL STRUCTURE OF THE NON-PHOSPHORYLATED HUMAN ALPHA1 BETA2 GAMMA1 HOLO-AMPK COMPLEX
2483, 4obpA, 0.7816, 2.67, 0.237, 285, 253, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 29) 6-(2-FLUOROPYRIDIN-4- YL)PYRIDO[32-D]PYRIMIDIN-4-AMINE
2484, 4dh8A, 0.7816, 2.96, 0.247, 333, 255, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+ AMP-PNP AND IP20
2485, 3priA, 0.7816, 2.46, 0.260, 264, 250, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
2486, 3ngaA, 0.7816, 2.96, 0.183, 331, 257, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
2487, 3g6gA, 0.7816, 2.48, 0.340, 264, 247, EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
2488, 3f5pS, 0.7816, 2.99, 0.309, 295, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2489, 3f5pB, 0.7816, 3.00, 0.309, 298, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2490, 3be9A, 0.7816, 3.20, 0.188, 327, 261, STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL MACROCYCLIC PYRAZOLO[15-A] [135]TRIAZINE COMPOUNDS AS POTENT INHIBITORS OF PROTEIN KINASE CK2 AND THEIR ANTICANCER ACTIVITIES
2491, 2c1bA, 0.7816, 2.98, 0.251, 335, 255, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ( 4R2S)-5 -(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2- YLMETHANESULFONYL)ISOQUINOLINE
2492, 1m2qA, 0.7816, 3.09, 0.181, 327, 260, CRYSTAL STRUCTURE OF 18-DI-HYDROXY-4-NITRO-XANTEN-9- ONE/CK2 KINASE COMPLEX
2493, 6c3eA, 0.7815, 2.37, 0.276, 258, 246, CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR
2494, 5wijA, 0.7815, 2.85, 0.264, 274, 254, JAK2 PSEUDOKINASE IN COMPLEX WITH NU6140 
2495, 5n3qA, 0.7815, 3.01, 0.259, 336, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINOBENZAMIDE
2496, 5n3hA, 0.7815, 3.01, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE PYRIDINE-3-CARBOXAMIDE
2497, 5m56A, 0.7815, 3.15, 0.207, 331, 261, MONOCLINIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO- FLAVONOL (FLC21)
2498, 5hvkA, 0.7815, 3.01, 0.256, 297, 258, CRYSTAL STRUCTURE OF LIMK1 MUTANT D460N IN COMPLEX WITH FULL-LENGTH COFILIN-1
2499, 4wb7B, 0.7815, 2.97, 0.255, 402, 255, CRYSTAL STRUCTURE OF A CHIMERIC FUSION OF HUMAN DNAJ (HSP40) AND CAMP- DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2500, 4wb7A, 0.7815, 2.96, 0.255, 402, 255, CRYSTAL STRUCTURE OF A CHIMERIC FUSION OF HUMAN DNAJ (HSP40) AND CAMP- DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)
2501, 4iafA, 0.7815, 2.96, 0.247, 333, 255, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2502, 4fnzA, 0.7815, 2.45, 0.298, 287, 248, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PIPERIDINE-CARBOXAMIDE INHIBITOR 2
2503, 4f0iA, 0.7815, 2.74, 0.384, 284, 250, CRYSTAL STRUCTURE OF APO TRKA
2504, 4cfvA, 0.7815, 3.01, 0.209, 300, 258, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2505, 4c38A, 0.7815, 2.97, 0.247, 334, 255, PKA-S6K1 CHIMERA WITH COMPOUND 21E (CCT239066) BOUND
2506, 3qgyA, 0.7815, 2.22, 0.322, 246, 242, CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
2507, 3ow4A, 0.7815, 3.00, 0.254, 317, 256, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
2508, 3f5pL, 0.7815, 3.01, 0.309, 293, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2509, 3f5pG, 0.7815, 3.01, 0.309, 299, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2510, 1oguC, 0.7815, 2.88, 0.206, 272, 257, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
2511, 1lpuA, 0.7815, 3.17, 0.184, 327, 261, LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
2512, 5vilB, 0.7814, 3.07, 0.226, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 6)
2513, 5vibA, 0.7814, 2.82, 0.252, 308, 254, CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH THE PKI PEPTIDE AND AMINOBENZOTHIAZOLE BASED INHIBITORS
2514, 5n7pA, 0.7814, 2.91, 0.232, 350, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(PYRROLIDIN-1-YL)-1H-PYRAZOLE- 4-CARBONITRILE
2515, 5n3tA, 0.7814, 3.02, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 5-CHLOROTHIOPHENE-2-SULFONAMIDE
2516, 5i3oB, 0.7814, 3.00, 0.209, 302, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2517, 5dt4A, 0.7814, 2.69, 0.228, 259, 250, AURORA A KINASE IN COMPLEX WITH AA35 AND ATP IN SPACE GROUP P6122
2518, 4o21A, 0.7814, 2.98, 0.247, 333, 255, PRODUCT COMPLEX OF METAL-FREE PKAC ATP-GAMMA-S AND SP20.
2519, 4c36A, 0.7814, 2.95, 0.243, 335, 255, PKA-S6K1 CHIMERA WITH COMPOUND 15E (CCT147581) BOUND
2520, 3zo1A, 0.7814, 2.91, 0.252, 339, 254, THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS
2521, 3mssB, 0.7814, 2.36, 0.343, 264, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
2522, 3kxhA, 0.7814, 3.18, 0.184, 326, 261, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR (2-DYMETHYLAMMINO-4567-TETRABROMOBENZOIMIDAZOL-1YL- ACETIC ACID (K66)
2523, 3gniB, 0.7814, 2.74, 0.190, 304, 253, STRUCTURE OF STRAD AND MO25
2524, 3f5pH, 0.7814, 3.00, 0.309, 299, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2525, 3f5pC, 0.7814, 3.00, 0.305, 301, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2526, 1zwsE, 0.7814, 3.14, 0.215, 278, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2527, 1u5rA, 0.7814, 3.03, 0.260, 308, 258, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2528, 1q8uA, 0.7814, 2.97, 0.259, 341, 255, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P
2529, 1m2pA, 0.7814, 3.09, 0.188, 325, 260, CRYSTAL STRUCTURE OF 18-DI-HYDROXY-4-NITRO- ANTHRAQUINONE/CK2 KINASE COMPLEX
2530, 5wimA, 0.7813, 2.81, 0.265, 274, 253, JAK2 PSEUDOKINASE IN COMPLEX WITH AT9283 
2531, 5os7A, 0.7813, 2.83, 0.188, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 4
2532, 5jrqA, 0.7813, 2.50, 0.264, 258, 250, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-6-VEM
2533, 4dglD, 0.7813, 3.00, 0.197, 328, 259, CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME
2534, 3q9zA, 0.7813, 3.09, 0.196, 332, 260, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5
2535, 3fl5A, 0.7813, 2.99, 0.185, 324, 259, PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR QUINALIZARIN
2536, 3dj7A, 0.7813, 2.59, 0.224, 257, 250, CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY LYS240->ARG MET302->LEU) IN COMPLEX WITH COMPOUND 130.
2537, 3cp9B, 0.7813, 2.63, 0.340, 269, 247, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
2538, 5n3nA, 0.7812, 3.02, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE [(2R)-24-DIHYDROXY-4-OXOBUTYL]- TRIMETHYLAZANIUM
2539, 3tucA, 0.7812, 2.61, 0.340, 257, 250, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-(67- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-12-DIHYDROPYRIDINE-3- CARBOXAMIDE
2540, 3pzhA, 0.7812, 3.08, 0.188, 327, 260, CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH EMODIN AT 1.92 A RESOLUTION
2541, 3pvgA, 0.7812, 3.08, 0.188, 326, 260, CRYSTAL STRUCTURE OF Z. MAYS CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMO-1-CARBOXYMETHYLBENZIMIDAZOLE (K68)
2542, 3blhA, 0.7812, 2.78, 0.189, 291, 254, CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1
2543, 2cpkE, 0.7812, 2.90, 0.240, 333, 254, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN KINASE
2544, 1stcE, 0.7812, 2.99, 0.262, 334, 256, CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
2545, 1om1A, 0.7812, 3.08, 0.185, 325, 260, CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA
2546, 6gmdB, 0.7811, 2.84, 0.188, 326, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3 
2547, 5vioB, 0.7811, 3.08, 0.222, 271, 257, CRYSTAL STRUCTURE OF ASK1 KINASE DOMAIN WITH A POTENT INHIBITOR (ANALOG 13)
2548, 5n3mA, 0.7811, 3.02, 0.255, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE D-ARGININE
2549, 5mhiA, 0.7811, 2.99, 0.243, 348, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE
2550, 4ualA, 0.7811, 3.13, 0.200, 403, 260, MRCK BETA IN COMPLEX WITH BDP00005290
2551, 4fx3C, 0.7811, 2.71, 0.205, 298, 254, CRYSTAL STRUCTURE OF THE CDK2/CYCLIN A COMPLEX WITH OXINDOLE INHIBITOR
2552, 4eooC, 0.7811, 2.88, 0.203, 297, 256, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
2553, 3qriA, 0.7811, 2.61, 0.344, 275, 250, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC- 2036
2554, 3ocbB, 0.7811, 3.05, 0.245, 319, 257, AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
2555, 3mssA, 0.7811, 2.34, 0.343, 264, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
2556, 3f5pM, 0.7811, 3.02, 0.305, 295, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2557, 2jdoA, 0.7811, 3.00, 0.241, 314, 257, STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2558, 1xh4A, 0.7811, 2.90, 0.248, 334, 254, CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
2559, 1ds5B, 0.7811, 3.20, 0.184, 328, 261, DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
2560, 5n37A, 0.7810, 2.93, 0.248, 347, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(13-BENZODIOXOL-5-YLMETHYL) CYCLOPENTANAMINE
2561, 5lihA, 0.7810, 2.83, 0.205, 324, 254, STRUCTURE OF A PEPTIDE-SUBSTRATE BOUND TO PKCIOTA CORE KINASE DOMAIN
2562, 5lcpA, 0.7810, 2.93, 0.246, 350, 256, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH FASUDIL (M77)
2563, 5jr7A, 0.7810, 3.01, 0.246, 335, 256, CRYSTAL STRUCTURE OF AN ACRDYS HETERODIMER [RIA(92-365):C] OF PKA
2564, 5h8bB, 0.7810, 2.96, 0.183, 331, 257, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 2
2565, 5cu0A, 0.7810, 2.94, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND
2566, 4iebA, 0.7810, 3.23, 0.252, 472, 262, CRYSTAL STRUCTURE OF A GLY128MET MUTANT OF THE TOXOPLASMA CDPK TGME49_101440
2567, 4iaiA, 0.7810, 2.98, 0.247, 333, 255, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH CA2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2568, 3en4A, 0.7810, 2.26, 0.346, 257, 243, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121 A MULTITARGETED KINASE INHIBITOR
2569, 2cciC, 0.7810, 2.84, 0.204, 296, 255, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2570, 2bkzC, 0.7810, 2.94, 0.214, 298, 257, STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2571, 1unlB, 0.7810, 2.94, 0.203, 292, 256, STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE ALOISINE AND INDIRUBIN.
2572, 1qmzA, 0.7810, 2.80, 0.204, 296, 255, PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
2573, 1l3rE, 0.7810, 2.98, 0.247, 338, 255, CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
2574, 1cdkA, 0.7810, 2.93, 0.251, 342, 255, CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
2575, 5oszA, 0.7809, 2.96, 0.187, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 23
2576, 5ek7B, 0.7809, 2.86, 0.328, 286, 253, STRUCTURE OF THE AUTOINHIBITED EPHA2 JMS-KD
2577, 5bvkA, 0.7809, 2.84, 0.353, 278, 252, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
2578, 4y83A, 0.7809, 2.62, 0.190, 299, 252, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
2579, 4w9xA, 0.7809, 3.01, 0.205, 300, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH BARICITINIB
2580, 4ib0A, 0.7809, 2.98, 0.247, 334, 255, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH NA+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2581, 4g3dD, 0.7809, 2.32, 0.223, 290, 247, CRYSTAL STRUCTURE OF HUMAN NF-KAPPAB INDUCING KINASE (NIK)
2582, 3x2wA, 0.7809, 2.91, 0.240, 336, 254, MICHAELIS COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
2583, 3x2uA, 0.7809, 3.00, 0.247, 336, 255, MICHAELIS-LIKE INITIAL COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT.
2584, 3warA, 0.7809, 3.19, 0.188, 334, 261, CRYSTAL STRUCTURE OF HUMAN CK2A
2585, 3qgwA, 0.7809, 2.16, 0.320, 244, 241, CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
2586, 3oezA, 0.7809, 2.28, 0.332, 261, 244, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH IMATINIB
2587, 3mvhA, 0.7809, 3.02, 0.246, 311, 256, CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
2588, 3ms9A, 0.7809, 2.34, 0.343, 265, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
2589, 3e8eP, 0.7809, 3.00, 0.263, 341, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2590, 6cmjA, 0.7808, 3.03, 0.230, 285, 256, HUMAN CAMKK2 WITH GSK650393
2591, 5uy6A, 0.7808, 3.02, 0.227, 282, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B
2592, 5orhB, 0.7808, 2.84, 0.188, 325, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 2
2593, 5moeA, 0.7808, 2.93, 0.191, 325, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2594, 5ew3B, 0.7808, 2.57, 0.333, 266, 246, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN IN COMPLEX WITH AAL993
2595, 5ar3A, 0.7808, 2.44, 0.250, 279, 248, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH AMP-PCP
2596, 4ysmB, 0.7808, 3.12, 0.240, 475, 262, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA
2597, 4ithB, 0.7808, 2.29, 0.268, 270, 246, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-1 ANALOG
2598, 3p0mA, 0.7808, 3.09, 0.254, 335, 256, HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
2599, 3my0P, 0.7808, 3.50, 0.234, 290, 265, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2600, 3at2A, 0.7808, 2.98, 0.183, 334, 257, CRYSTAL STRUCTURE OF CK2ALPHA
2601, 1ydtE, 0.7808, 2.99, 0.255, 334, 255, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2- (4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE
2602, 1qmzC, 0.7808, 2.81, 0.204, 296, 255, PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
2603, 6ehuB, 0.7807, 3.04, 0.194, 327, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 32
2604, 6c4dA, 0.7807, 2.36, 0.280, 267, 246, STRUCTURE BASED DESIGN OF RIP1 KINASE INHIBITORS
2605, 5ut4A, 0.7807, 2.82, 0.264, 273, 254, JAK2 JH2 IN COMPLEX WITH NVP-BSK805
2606, 5orhA, 0.7807, 3.07, 0.197, 324, 259, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 2
2607, 5nk3A, 0.7807, 3.14, 0.323, 281, 257, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1L
2608, 5kwhB, 0.7807, 3.10, 0.192, 331, 260, CRYSTAL STRUCTURE OF CK2
2609, 5dosA, 0.7807, 2.70, 0.228, 259, 250, AURORA A KINASE IN COMPLEX WITH AA35 AND ATP IN SPACE GROUP P6122
2610, 5cyiC, 0.7807, 2.79, 0.204, 296, 255, CDK2/CYCLIN A COVALENT COMPLEX WITH 6-(CYCLOHEXYLMETHOXY)-N-(4- (VINYLSULFONYL)PHENYL)-9H-PURIN-2-AMINE (NU6300)
2611, 4hpuE, 0.7807, 3.00, 0.247, 336, 255, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING PARTIAL PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE
2612, 3tv4A, 0.7807, 2.64, 0.282, 264, 252, HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN BROMOPYRIDINE BENZAMIDE INHIBITOR
2613, 3mvjA, 0.7807, 2.97, 0.255, 334, 255, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
2614, 3dndA, 0.7807, 2.98, 0.259, 334, 255, CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2615, 3a7gA, 0.7807, 3.36, 0.284, 289, 261, HUMAN MST3 KINASE
2616, 1u5qA, 0.7807, 3.09, 0.263, 308, 259, CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2617, 5nkcA, 0.7806, 2.85, 0.320, 286, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2H
2618, 5n3cA, 0.7806, 3.02, 0.255, 348, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE THIOPHENE-3-CARBOXIMIDAMIDE
2619, 5clpB, 0.7806, 2.85, 0.184, 327, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH 34-DICHLOROPHENETHYLAMINE BOUND
2620, 4eopA, 0.7806, 2.76, 0.204, 297, 255, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2621, 3x2vA, 0.7806, 3.00, 0.243, 331, 255, MICHAELIS-LIKE COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
2622, 3qlgA, 0.7806, 2.45, 0.339, 259, 245, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH DASATINIB
2623, 3mssD, 0.7806, 2.37, 0.343, 264, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
2624, 2c5vA, 0.7806, 2.79, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2625, 1dawA, 0.7806, 3.18, 0.184, 327, 261, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-AMPPNP
2626, 5nk4A, 0.7805, 2.80, 0.329, 290, 252, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2C
2627, 5n3iA, 0.7805, 3.03, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE METHYL (2S)-2-AMINO-3-PHENYLPROPANOATE
2628, 5n3gA, 0.7805, 3.03, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (R)-14-OXAZEPAN-6-OL
2629, 5n33A, 0.7805, 2.98, 0.243, 347, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(TRIFLUOROMETHYL)-1H-PYRIDIN-2- ONE
2630, 4o22A, 0.7805, 3.00, 0.247, 336, 255, BINARY COMPLEX OF METAL-FREE PKAC WITH SP20.
2631, 3pyyA, 0.7805, 2.57, 0.341, 265, 249, DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE SMALL-MOLECULE C- ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
2632, 3mssC, 0.7805, 2.35, 0.343, 264, 245, ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
2633, 2wpaC, 0.7805, 2.94, 0.214, 299, 257, OPTIMISATION OF 66-DIMETHYL PYRROLO 34-C PYRAZOLES: IDENTIFICATION OF PHA-793887 A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2634, 2f2cB, 0.7805, 2.74, 0.206, 280, 253, X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE INHIBITOR AMINOPURVALANOL
2635, 6cmjB, 0.7804, 3.03, 0.230, 284, 256, HUMAN CAMKK2 WITH GSK650393
2636, 6ccfA, 0.7804, 2.91, 0.236, 260, 254, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH HESPERADIN
2637, 5n1vB, 0.7804, 2.99, 0.183, 331, 257, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH PYRAZOLO-PYRIMIDINE MACROCYCLIC LIGAND
2638, 5moeB, 0.7804, 3.01, 0.198, 323, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2639, 5lqfA, 0.7804, 2.68, 0.202, 287, 252, CDK1/CYCLINB1/CKS2 IN COMPLEX WITH NU6102
2640, 5ku8A, 0.7804, 3.01, 0.195, 328, 256, CRYSTAL STRUCTURE OF CK2
2641, 5kmkA, 0.7804, 2.82, 0.382, 304, 251, TRKA JM-KINASE WITH 2-FLUORO-{N}-[2-(4-FLUOROPHENYL)-6-METHYL-3- PYRIDYL]-4-(TRIFLUOROMETHYL)BENZAMIDE
2642, 5i3rB, 0.7804, 3.03, 0.205, 302, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2643, 5h8eB, 0.7804, 3.19, 0.199, 331, 261, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7H
2644, 5dylA, 0.7804, 2.96, 0.222, 802, 257, CRYSTAL STRUCTURE OF PVX_084705
2645, 5cenA, 0.7804, 2.37, 0.300, 281, 247, CRYSTAL STRUCTURE OF DLK (KINASE DOMAIN)
2646, 4dg3E, 0.7804, 2.99, 0.243, 335, 255, CRYSTAL STRUCTURE OF R336A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE WITH UNPHOSPHORYLATED TURN MOTIF.
2647, 4crsA, 0.7804, 2.88, 0.264, 331, 254, HUMAN PROTEIN KINASE N2 (PKN2 PRKCL2) IN COMPLEX WITH ATPGAMMAS
2648, 4c35A, 0.7804, 2.96, 0.247, 337, 255, PKA-S6K1 CHIMERA WITH COMPOUND 1 (NU1085) BOUND
2649, 3ow4B, 0.7804, 3.01, 0.254, 317, 256, DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
2650, 3ocbA, 0.7804, 3.07, 0.245, 315, 257, AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
2651, 3bwjA, 0.7804, 3.01, 0.255, 338, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR LEAD COMPOUND ARC-1034
2652, 2f57B, 0.7804, 3.17, 0.216, 299, 259, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
2653, 1dayA, 0.7804, 3.19, 0.188, 327, 261, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-GMPPNP
2654, 6c4dD, 0.7803, 2.46, 0.279, 266, 247, STRUCTURE BASED DESIGN OF RIP1 KINASE INHIBITORS
2655, 6c0uA, 0.7803, 2.95, 0.242, 338, 256, CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CALPHA SUBUNIT BOUND WITH N46 
2656, 5w5qA, 0.7803, 2.88, 0.232, 291, 254, MAP4K4 IN COMPLEX WITH INHIBITOR COMPOUND 12 (N3-METHYL-10-(3-METHYL- 3-(5-METHYLOXAZOL-2-YL)BUT-1-YN-1-YL)-6;7-DIHYDRO-5H-5;7- METHANOBENZO[C]IMIDAZO[1;2-A]AZEPINE-2;3-DICARBOXAMIDE) 
2657, 5n7uA, 0.7803, 3.00, 0.235, 350, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-BROMO-35-DIMETHYL-1H-PYRAZOLE
2658, 5jr7C, 0.7803, 2.92, 0.247, 335, 255, CRYSTAL STRUCTURE OF AN ACRDYS HETERODIMER [RIA(92-365):C] OF PKA
2659, 4iazA, 0.7803, 3.02, 0.243, 334, 255, STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH BA2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2660, 3v5jB, 0.7803, 1.90, 0.311, 241, 238, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090
2661, 3qkkA, 0.7803, 3.02, 0.254, 326, 256, SPIROCHROMANE AKT INHIBITORS
2662, 3idcA, 0.7803, 2.98, 0.235, 341, 255, CRYSTAL STRUCTURE OF (102-265)RIIB:C HOLOENZYME OF CAMP- DEPENDENT PROTEIN KINASE
2663, 3hx4A, 0.7803, 3.02, 0.252, 467, 258, CRYSTAL STRUCTURE OF CDPK1 OF TOXOPLASMA GONDII TGME49_101440 IN PRESENCE OF CALCIUM
2664, 3bhtA, 0.7803, 2.91, 0.223, 297, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
2665, 2clqA, 0.7803, 2.59, 0.228, 263, 250, STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2 5
2666, 2bpmA, 0.7803, 3.08, 0.208, 302, 259, STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2667, 6cd6D, 0.7802, 2.99, 0.215, 267, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2668, 5oniA, 0.7802, 2.98, 0.187, 334, 257, LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2669, 5nkbA, 0.7802, 2.85, 0.328, 285, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 4A
2670, 4yhtA, 0.7802, 2.36, 0.274, 256, 248, BRAF COMPLEXED WITH AN INHIBITOR
2671, 4p2kA, 0.7802, 2.66, 0.328, 259, 250, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
2672, 4itiA, 0.7802, 2.42, 0.262, 272, 248, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG
2673, 4iakA, 0.7802, 2.99, 0.243, 334, 255, LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2674, 4c33A, 0.7802, 3.01, 0.247, 335, 255, PKA-S6K1 CHIMERA APO
2675, 3sc1A, 0.7802, 2.81, 0.213, 278, 253, NOVEL ISOQUINOLONE PDK1 INHIBITORS DISCOVERED THROUGH FRAGMENT-BASED LEAD DISCOVERY
2676, 3iecD, 0.7802, 2.77, 0.292, 311, 253, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
2677, 3hgkD, 0.7802, 3.05, 0.234, 286, 256, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
2678, 3hgkA, 0.7802, 3.04, 0.238, 286, 256, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
2679, 2c5nA, 0.7802, 2.90, 0.215, 296, 256, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2680, 1lp4A, 0.7802, 3.21, 0.184, 327, 261, CRYSTAL STRUCTURE OF A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 WITH MG-AMPPNP
2681, 5m6yA, 0.7801, 2.90, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A METHYLISOQUINOLINE FASUDIL-DERIVATIVE 
2682, 5l6wL, 0.7801, 2.99, 0.268, 290, 257, STRUCTURE OF THE LIMK1-ATPGAMMAS-CFL1 COMPLEX
2683, 5ho7A, 0.7801, 2.81, 0.213, 280, 253, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2684, 5hngA, 0.7801, 2.82, 0.213, 280, 253, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2685, 5drdA, 0.7801, 2.73, 0.227, 259, 251, AURORA A KINASE IN COMPLEX WITH ATP IN SPACE GROUP P6122
2686, 5cu2A, 0.7801, 2.94, 0.187, 328, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND (METHYL 4-((3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)AMINO)-4- OXOBUTANOAT BOUND
2687, 4oh4A, 0.7801, 2.91, 0.236, 299, 254, CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1
2688, 4nh1B, 0.7801, 3.06, 0.190, 332, 258, CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION
2689, 4ii5C, 0.7801, 2.83, 0.209, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 1 MAGNESIUM ION
2690, 4ii5A, 0.7801, 2.83, 0.209, 295, 254, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 1 MAGNESIUM ION
2691, 4ib5C, 0.7801, 3.17, 0.195, 332, 261, STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE
2692, 4f65A, 0.7801, 2.77, 0.355, 279, 251, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 8
2693, 4eonC, 0.7801, 2.84, 0.203, 298, 256, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2694, 4dg2E, 0.7801, 2.92, 0.244, 347, 254, CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20
2695, 3f5pJ, 0.7801, 3.04, 0.305, 293, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2696, 3bhuA, 0.7801, 2.84, 0.212, 297, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
2697, 2uzdA, 0.7801, 2.75, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2698, 1zrzA, 0.7801, 3.06, 0.202, 310, 258, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA
2699, 1z9xC, 0.7801, 3.18, 0.202, 303, 263, HUMAN DRP-1 KINASE W305S S308A D40 MUTANT CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
2700, 6gt1C, 0.7800, 2.39, 0.239, 257, 247, NEK7 BOUND TO PURINE INHIBITOR 
2701, 5oslA, 0.7800, 3.01, 0.191, 328, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 7
2702, 5n1fA, 0.7800, 3.04, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-QUINOLIN-5-YLPYRIDINE-3-CARBOXAMIDE
2703, 5ia0B, 0.7800, 2.79, 0.312, 266, 253, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
2704, 5hvkC, 0.7800, 2.97, 0.261, 291, 257, CRYSTAL STRUCTURE OF LIMK1 MUTANT D460N IN COMPLEX WITH FULL-LENGTH COFILIN-1
2705, 5cu2B, 0.7800, 3.01, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND (METHYL 4-((3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)AMINO)-4- OXOBUTANOAT BOUND
2706, 5cu0B, 0.7800, 3.08, 0.193, 325, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH 2-HYDROXY-5-METHYLBENZOIC ACID AND N-(3-(3-CHLORO-4-(PHENYL)BENZYLAMINO)PROPYL)ACETAMIDE BOUND
2707, 4cfxC, 0.7800, 2.79, 0.200, 298, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2708, 3cs9D, 0.7800, 2.54, 0.347, 263, 248, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
2709, 3cp9A, 0.7800, 2.54, 0.329, 288, 246, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
2710, 5n1gA, 0.7799, 3.04, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-(2-AMINO-13-THIAZOL-4-YL)-1- OXASPIRO[4.5]DECAN-2-ONE
2711, 5lcuA, 0.7799, 2.89, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A S-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 01)
2712, 4iayA, 0.7799, 3.00, 0.243, 333, 255, ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION ADP AND PHOSPHORYLATED PEPTIDE PSP20
2713, 4iacA, 0.7799, 3.01, 0.247, 333, 255, X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION AMP-PCP AND PSEUDO-SUBSTRATE PEPTIDE SP20
2714, 3s95B, 0.7799, 2.89, 0.268, 290, 254, CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
2715, 3dtwB, 0.7799, 2.71, 0.339, 269, 248, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
2716, 3bhuC, 0.7799, 2.88, 0.211, 271, 256, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
2717, 2qo9A, 0.7799, 2.98, 0.314, 277, 255, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION PHOSPHORYLATED AMP-PNP BOUND
2718, 6eiiA, 0.7798, 2.78, 0.189, 326, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 18
2719, 6bkuA, 0.7798, 2.96, 0.231, 267, 255, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B BOUND TO GSK650394
2720, 5n1lA, 0.7798, 2.95, 0.236, 347, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 25-DIMETHYL-N-PYRIDIN-4-YLFURAN-3- CARBOXAMIDE
2721, 5n1hA, 0.7798, 3.04, 0.259, 337, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE METHYL 4-(AMINOMETHYL)BENZOATE
2722, 5ku8B, 0.7798, 3.24, 0.199, 331, 261, CRYSTAL STRUCTURE OF CK2
2723, 5dykA, 0.7798, 3.02, 0.220, 809, 259, CRYSTAL STRUCTURE OF PF3D7_1436600
2724, 5cu4A, 0.7798, 3.01, 0.191, 327, 257, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
2725, 4xw4A, 0.7798, 3.01, 0.247, 334, 255, X-RAY STRUCTURE OF PKAC WITH AMPPNP SP20 CALCIUM IONS
2726, 4h58B, 0.7798, 2.44, 0.265, 262, 249, BRAF IN COMPLEX WITH COMPOUND 3
2727, 4dfxE, 0.7798, 2.93, 0.240, 347, 254, CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP
2728, 4bcnC, 0.7798, 2.87, 0.203, 295, 256, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2729, 3tz8B, 0.7798, 2.56, 0.340, 263, 247, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104
2730, 3pwyA, 0.7798, 2.98, 0.224, 281, 255, CRYSTAL STRUCTURE OF AN EXTENDER (SPD28345)-MODIFIED HUMAN PDK1 COMPLEX 2
2731, 3ky2B, 0.7798, 2.90, 0.366, 280, 254, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
2732, 3kkvA, 0.7798, 3.01, 0.255, 335, 255, STRUCTURE OF PKA WITH A PROTEIN KINASE B-SELECTIVE INHIBITOR.
2733, 3ej1A, 0.7798, 2.72, 0.213, 295, 253, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
2734, 3cqwA, 0.7798, 3.06, 0.245, 318, 257, CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
2735, 2wipA, 0.7798, 2.77, 0.201, 297, 254, STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-45-DIHYDRO-1H-PYRAZOLO[43-H] QUINAZOLINE-3- CARBOXYLIC ACID
2736, 5ooiA, 0.7797, 3.10, 0.200, 329, 260, STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA ) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P
2737, 5n32A, 0.7797, 2.95, 0.232, 345, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-CHLOROBENZYL CARBAMIMIDOTHIOATE
2738, 5m71A, 0.7797, 2.95, 0.246, 350, 256, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH AN (R)-METHYL SUBSTITUED FASUDIL-DERIVATIVE. 
2739, 5l2qD, 0.7797, 3.00, 0.171, 294, 258, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
2740, 4y83C, 0.7797, 2.66, 0.190, 293, 252, CRYSTAL STRUCTURE OF COT KINASE DOMAIN IN COMPLEX WITH 5-(2-AMINO-5- (QUINOLIN-3-YL)PYRIDIN-3-YL)-134-OXADIAZOLE-2(3H)-THIONE
2741, 5mpjA, 0.7796, 3.02, 0.191, 326, 257, 1-(2-CHLORO-[11 -BIPHENYL]-4-YL)-N-METHYLETHANAMINE
2742, 4nh1A, 0.7796, 3.07, 0.186, 330, 258, CRYSTAL STRUCTURE OF A HETEROTETRAMERIC CK2 HOLOENZYME COMPLEX CARRYING THE ANDANTE-MUTATION IN CK2BETA AND CONSISTENT WITH PROPOSED MODELS OF AUTOINHIBITION AND TRANS-AUTOPHOSPHORYLATION
2743, 4kioB, 0.7796, 1.81, 0.321, 239, 237, KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
2744, 3f5pR, 0.7796, 3.03, 0.305, 294, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2745, 3f5pF, 0.7796, 3.02, 0.309, 299, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2746, 2qkwB, 0.7796, 3.05, 0.238, 290, 256, STRUCTURAL BASIS FOR ACTIVATION OF PLANT IMMUNITY BY BACTERIAL EFFECTOR PROTEIN AVRPTO
2747, 1urcC, 0.7796, 2.75, 0.205, 296, 254, CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
2748, 5nkdA, 0.7795, 2.80, 0.325, 287, 252, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2I
2749, 5mmrB, 0.7795, 3.01, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-((2-CHLORO-[11 -BIPHENYL]-4-YL) METHYL)BUTANE-14-DIAMINE BOUND
2750, 4dg0E, 0.7795, 3.02, 0.247, 338, 255, CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP
2751, 3e8eL, 0.7795, 3.03, 0.263, 336, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2752, 2reiA, 0.7795, 2.71, 0.309, 277, 249, KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2753, 5o0eA, 0.7794, 2.96, 0.246, 349, 256, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND FASUDIL 
2754, 5mo5A, 0.7794, 2.79, 0.189, 326, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2755, 5mmrA, 0.7794, 3.12, 0.197, 326, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-((2-CHLORO-[11 -BIPHENYL]-4-YL) METHYL)BUTANE-14-DIAMINE BOUND
2756, 5d7aB, 0.7794, 2.61, 0.212, 286, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
2757, 4ysmA, 0.7794, 3.10, 0.230, 475, 261, CALCIUM-DEPENDENT PROTEIN KINASE FROM EIMERIA TENELLA
2758, 4i3zC, 0.7794, 2.77, 0.209, 295, 253, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
2759, 3psbA, 0.7794, 2.36, 0.266, 262, 248, FURO[23-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B- RAF INHIBITORS
2760, 3ppkA, 0.7794, 2.45, 0.265, 262, 249, HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
2761, 3ppjA, 0.7794, 2.45, 0.265, 262, 249, HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR
2762, 3hgkB, 0.7794, 3.05, 0.238, 286, 256, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
2763, 2jdsA, 0.7794, 3.04, 0.255, 334, 255, STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A- 443654
2764, 6bqpA, 0.7793, 2.95, 0.231, 263, 255, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH CRENOLANIB
2765, 4krcA, 0.7793, 2.99, 0.206, 297, 257, CRYSTAL STRUCTURE OF PHO85-PCL10-ATP-GAMMA-S COMPLEX
2766, 4i3zA, 0.7793, 2.77, 0.209, 295, 253, STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
2767, 4fx3A, 0.7793, 2.87, 0.212, 298, 255, CRYSTAL STRUCTURE OF THE CDK2/CYCLIN A COMPLEX WITH OXINDOLE INHIBITOR
2768, 4c34A, 0.7793, 3.00, 0.247, 336, 255, PKA-S6K1 CHIMERA WITH STAUROSPORINE BOUND
2769, 3wzdA, 0.7793, 2.71, 0.341, 278, 249, KDR IN COMPLEX WITH LIGAND LENVATINIB
2770, 3qrjA, 0.7793, 2.25, 0.346, 258, 243, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
2771, 1sm2B, 0.7793, 1.98, 0.319, 241, 238, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2772, 1jwhB, 0.7793, 3.10, 0.192, 335, 260, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
2773, 6cd6C, 0.7792, 2.95, 0.238, 265, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2774, 6cd6B, 0.7792, 3.00, 0.215, 266, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
2775, 5wikB, 0.7792, 2.83, 0.261, 274, 253, JAK2 PSEUDOKINASE IN COMPLEX WITH BI-D1870 
2776, 5n1nA, 0.7792, 3.05, 0.239, 348, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-9-PROPAN-2-YLPURINE
2777, 4qo9B, 0.7792, 3.42, 0.280, 285, 261, MST3 IN COMPLEX WITH DANUSERTIB
2778, 3o7lB, 0.7792, 2.79, 0.234, 326, 252, CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX
2779, 3e8eE, 0.7792, 3.05, 0.259, 341, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2780, 3bhyA, 0.7792, 2.81, 0.222, 268, 252, CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND
2781, 2wxvC, 0.7792, 2.96, 0.214, 299, 257, STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(43-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2782, 2c5vC, 0.7792, 2.82, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2783, 5vjaD, 0.7791, 2.81, 0.209, 261, 254, CRYSTAL STRUCTURE OF HUMAN ZIPPER-INTERACTING PROTEIN KINASE (ZIPK; ALIAS DAPK3) IN COMPLEX WITH A PYRAZOLO[3;4-D]PYRIMIDINONE LIGAND (HS38) 
2784, 5t1hB, 0.7791, 3.24, 0.192, 331, 261, CRYSTAL STRUCTURE OF CK2
2785, 5orjB, 0.7791, 3.10, 0.201, 324, 259, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3
2786, 5f9eB, 0.7791, 3.03, 0.268, 293, 257, STRUCTURE OF PROTEIN KINASE C THETA WITH COMPOUND 10: 22-DIMETHYL-7- (2-OXIDANYLIDENE-3~{H}-IMIDAZO[45-B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)- 3~{H}-QUINAZOLIN-4-ONE
2787, 5cquA, 0.7791, 2.92, 0.180, 328, 256, MONOCLINIC COMPLEX STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A BENZOTRIAZOLE-BASED INHIBITOR GENERATED BY CLICK-CHEMISTRY
2788, 4eopC, 0.7791, 2.81, 0.204, 296, 255, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2789, 4eolA, 0.7791, 2.68, 0.206, 294, 253, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2790, 4dfzE, 0.7791, 2.92, 0.244, 347, 254, CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20
2791, 3v5jA, 0.7791, 1.99, 0.318, 241, 239, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090
2792, 3at4A, 0.7791, 3.10, 0.193, 331, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVERTIVE
2793, 1uu8A, 0.7791, 2.95, 0.224, 277, 254, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1
2794, 1h1sC, 0.7791, 2.80, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
2795, 5lctA, 0.7790, 2.91, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A R-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 02)
2796, 5hx6A, 0.7790, 2.29, 0.287, 259, 244, CRYSTAL STRUCTURE OF RIP1 KINASE WITH A BENZO[B][14]OXAZEPIN-4-ONE
2797, 4mh7B, 0.7790, 2.18, 0.329, 255, 243, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1896
2798, 4dhfB, 0.7790, 2.76, 0.227, 258, 251, STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
2799, 4dawA, 0.7790, 3.30, 0.210, 293, 262, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH THE RUTHENIUM PHTHALIMIDE COMPLEX
2800, 3zfxC, 0.7790, 1.98, 0.301, 248, 239, CRYSTAL STRUCTURE OF EPHB1
2801, 3ndmA, 0.7790, 3.14, 0.208, 383, 259, CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT ISOQUINOLONE DERIVATIVE
2802, 3kmwA, 0.7790, 2.83, 0.268, 268, 254, CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP)
2803, 2xh5A, 0.7790, 3.04, 0.250, 316, 256, STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(23-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
2804, 2wqbA, 0.7790, 2.65, 0.323, 289, 251, STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
2805, 6bleA, 0.7789, 2.86, 0.232, 265, 254, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH CP673451
2806, 5ia0C, 0.7789, 2.65, 0.321, 269, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
2807, 4aw5A, 0.7789, 2.64, 0.281, 261, 249, COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITOR
2808, 3iecC, 0.7789, 2.77, 0.292, 311, 253, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
2809, 3hgkC, 0.7789, 3.06, 0.238, 284, 256, CRYSTAL STRUCTURE OF EFFECT PROTEIN AVRPTOB COMPLEXED WITH KINASE PTO
2810, 2wevA, 0.7789, 2.83, 0.208, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2811, 5xvuC, 0.7788, 2.88, 0.177, 321, 254, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
2812, 5ng3C, 0.7788, 2.44, 0.255, 272, 247, STRUCTURE OF INACTIVE KINASE RIP2K(K47R)
2813, 5cshA, 0.7788, 2.94, 0.191, 324, 257, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 4 BOUND
2814, 3skcA, 0.7788, 2.52, 0.277, 260, 249, HUMAN B-RAF KINASE IN COMPLEX WITH AN AMIDE LINKED PYRAZOLOPYRIDINE INHIBITOR
2815, 1h1pA, 0.7788, 2.95, 0.209, 296, 258, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
2816, 5ok3A, 0.7787, 2.91, 0.259, 349, 255, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP241 AND FASUDIL 
2817, 5lcrA, 0.7787, 2.95, 0.259, 350, 255, COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH OPEN-CHAIN FASUDIL-DERIVATIVE (LIGAND 04)
2818, 5ek7A, 0.7787, 2.88, 0.328, 286, 253, STRUCTURE OF THE AUTOINHIBITED EPHA2 JMS-KD
2819, 4pmsA, 0.7787, 2.76, 0.384, 283, 250, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR 4-NAPHTHALEN-1-YL- 1-[(5-PHENYL-124-OXADIAZOL-3-YL)METHYL]-1H-PYRROLO[32-C]PYRIDINE- 2-CARBOXYLIC ACID
2820, 4dhfA, 0.7787, 2.80, 0.235, 258, 251, STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
2821, 3of0A, 0.7787, 2.48, 0.339, 260, 245, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN
2822, 3f3uA, 0.7787, 2.41, 0.339, 261, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III)
2823, 3e8eI, 0.7787, 3.03, 0.259, 345, 255, CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS
2824, 2xchA, 0.7787, 2.95, 0.224, 278, 254, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2825, 6b3eA, 0.7786, 3.09, 0.246, 309, 260, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLINK IN COMPLEX WITH AN INHIBITOR
2826, 5otrA, 0.7786, 3.08, 0.191, 327, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 14
2827, 5n3eA, 0.7786, 3.07, 0.251, 348, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 6-DIMETHYLAMINOPYRIDINE-3-CARBOXYLIC ACID
2828, 5n3bA, 0.7786, 3.06, 0.251, 342, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(PYRIDIN-3-YL)ETHANAMINE
2829, 5fetA, 0.7786, 2.79, 0.216, 802, 255, CRYSTAL STRUCTURE OF PVX_084705 IN PRESENCE OF COMPOUND 2
2830, 3f5pE, 0.7786, 3.04, 0.309, 299, 259, COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3- CYANOQUINOLINE INHIBITOR
2831, 3c13A, 0.7786, 2.95, 0.187, 328, 256, LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
2832, 1snuB, 0.7786, 1.98, 0.315, 241, 238, CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
2833, 5n36A, 0.7785, 3.07, 0.243, 347, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3H-ISOINDOL-2-IUM-1-AMINE
2834, 5n1mA, 0.7785, 3.05, 0.239, 347, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE
2835, 5mo7A, 0.7785, 2.99, 0.184, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2836, 5j79A, 0.7785, 2.54, 0.273, 283, 249, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE COMPOUND 3 COMPLEX
2837, 5ia3A, 0.7785, 2.73, 0.328, 275, 250, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH PD173955
2838, 4fmqA, 0.7785, 3.15, 0.217, 350, 258, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
2839, 3repA, 0.7785, 2.84, 0.268, 268, 254, CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP)
2840, 3eflB, 0.7785, 2.60, 0.337, 263, 246, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
2841, 5n3aA, 0.7784, 3.05, 0.247, 349, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-METHYL-5-(1-METHYLIMIDAZOL-2-YL)-13- THIAZOL-2-AMINE
2842, 4zp5A, 0.7784, 2.61, 0.224, 284, 250, MAP4K4 IN COMPLEX WITH INHIBITOR
2843, 4v04A, 0.7784, 2.66, 0.360, 290, 250, FGFR1 IN COMPLEX WITH PONATINIB.
2844, 4tygA, 0.7784, 3.15, 0.374, 293, 257, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
2845, 3w8lA, 0.7784, 3.01, 0.187, 326, 257, CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE
2846, 3v5lA, 0.7784, 1.93, 0.319, 240, 238, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
2847, 3bqcA, 0.7784, 2.97, 0.187, 328, 256, HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
2848, 3bhvC, 0.7784, 3.02, 0.218, 271, 257, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
2849, 2qurA, 0.7784, 3.03, 0.247, 338, 255, CRYSTAL STRUCTURE OF F327A/K285P MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
2850, 2fb8A, 0.7784, 2.38, 0.266, 259, 248, STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2851, 2cchA, 0.7784, 2.92, 0.212, 296, 255, THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA- LINKED ATP ANALOGUE
2852, 1r1wA, 0.7784, 2.54, 0.350, 287, 246, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
2853, 5w7tB, 0.7783, 2.81, 0.245, 276, 253, STRUCTURE OF PHOSPHORYLATED WNK1 
2854, 5otqA, 0.7783, 2.99, 0.187, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 33
2855, 5nw8A, 0.7783, 2.98, 0.259, 337, 255, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP032 AND FASUDIL 
2856, 5mmfB, 0.7783, 3.06, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 7 BOUND
2857, 5kmiA, 0.7783, 2.85, 0.382, 300, 251, TRKA JM-KINASE WITH 1-(9{H}-FLUOREN-9-YL)-3-(2-METHYL-4-PHENYL- PYRIMIDIN-5-YL)UREA
2858, 5ct0A, 0.7783, 3.03, 0.198, 326, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH 3-(3-CHLORO-4-(PHENYL)BENZYLAMINO) PROPAN-1-OL BOUND
2859, 4fvpA, 0.7783, 2.87, 0.264, 274, 254, CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (APO FORM)
2860, 4e26B, 0.7783, 2.63, 0.262, 264, 252, BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
2861, 4cfwC, 0.7783, 3.02, 0.210, 297, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
2862, 3pixA, 0.7783, 2.79, 0.333, 268, 252, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7- (4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H- PHTHALAZIN-1-ONE
2863, 5xvuA, 0.7782, 2.79, 0.178, 321, 253, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
2864, 5uq1C, 0.7782, 3.00, 0.215, 289, 256, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
2865, 5uq0A, 0.7782, 2.55, 0.381, 266, 247, FGFR1 KINASE DOMAIN COMPLEX WITH FRAGMENT 22-DIMETHYL-23- DIHYDROBENZOFURAN-7-CARBOXAMIDE
2866, 5orjA, 0.7782, 3.11, 0.201, 325, 259, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3
2867, 5n3dA, 0.7782, 3.08, 0.255, 346, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-(TRIFLUOROMETHYL)BENZENECARBOXIMIDAMIDE
2868, 4jqeA, 0.7782, 3.16, 0.196, 369, 260, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH AMPPN
2869, 3bhtC, 0.7782, 2.86, 0.208, 270, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
2870, 2g9xC, 0.7782, 2.84, 0.208, 274, 255, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2871, 2c5oA, 0.7782, 2.84, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2872, 1oiyC, 0.7782, 2.83, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2873, 5mpjB, 0.7781, 3.01, 0.194, 324, 258, 1-(2-CHLORO-[11 -BIPHENYL]-4-YL)-N-METHYLETHANAMINE
2874, 5ikwA, 0.7781, 3.01, 0.209, 297, 254, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2875, 5ar2A, 0.7781, 2.17, 0.246, 277, 244, RIP2 KINASE CATALYTIC DOMAIN (1 - 310)
2876, 3psdA, 0.7781, 2.38, 0.266, 262, 248, NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE
2877, 3axwA, 0.7781, 3.08, 0.190, 329, 258, CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR
2878, 2c5oC, 0.7781, 2.84, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2879, 5ot6B, 0.7780, 2.81, 0.185, 326, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 19
2880, 5n1eA, 0.7780, 2.84, 0.246, 347, 252, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(13-BENZODIOXOL-5-YL)-2-PIPERIDIN-1- YLACETAMIDE
2881, 5kmmA, 0.7780, 2.84, 0.382, 301, 251, TRKA JM-KINASE WITH 1-(2-METHYL-4-PHENYL-PYRIMIDIN-5-YL)-3-(1- NAPHTHYL)UREA
2882, 4xufB, 0.7780, 2.91, 0.343, 274, 251, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR QUIZARTINIB (AC220)
2883, 3miyA, 0.7780, 1.81, 0.316, 239, 237, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
2884, 3ddpC, 0.7780, 2.76, 0.201, 298, 254, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
2885, 3d15A, 0.7780, 2.70, 0.236, 256, 250, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240->ARG MET302- >LEU) IN COMPLEX WITH 1-(3-CHLORO-PHENYL)-3-{5-[2-(THIENO[32- D]PYRIMIDIN-4-YLAMINO)- ETHYL]-THIAZOL-2-YL}-UREA [SNS-314]
2886, 3cpbA, 0.7780, 2.53, 0.322, 285, 245, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
2887, 3a7hA, 0.7780, 3.40, 0.272, 289, 261, HUMAN MST3 KINASE IN COMPLEX WITH ATP
2888, 2qi8A, 0.7780, 2.06, 0.354, 255, 240, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
2889, 6eiiB, 0.7779, 2.80, 0.189, 326, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 18
2890, 5n3rA, 0.7779, 3.07, 0.259, 336, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(CARBAMOYLAMINO)-4- METHYLSULFANYLBUTANOIC ACID
2891, 3tl8D, 0.7779, 2.82, 0.266, 306, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
2892, 3prfA, 0.7779, 2.47, 0.257, 262, 249, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON- OXIME FUROPYRIDINE INHIBITOR
2893, 3f3uB, 0.7779, 2.41, 0.340, 259, 244, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE III)
2894, 3aglA, 0.7779, 2.96, 0.243, 338, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
2895, 2uzlA, 0.7779, 2.76, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2896, 5oumB, 0.7778, 2.79, 0.185, 326, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 21
2897, 5nkaA, 0.7778, 2.68, 0.321, 271, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2G
2898, 5n39A, 0.7778, 3.07, 0.239, 347, 255, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(23-DIHYDROBENZO[B][14]DIOXIN-6-YL) PYRROLIDINE
2899, 5m4fA, 0.7778, 3.07, 0.190, 330, 258, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH THE INHIBITOR 4 -CARBOXY-68-CHLORO-FLAVONOL (FLC21) CRYSTALLIZED UNDER LOW-SALT CONDITIONS
2900, 4wunB, 0.7778, 2.69, 0.384, 268, 250, STRUCTURE OF FGFR1 IN COMPLEX WITH AZD4547 (N-{3-[2-(35- DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R5S)-35- DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) AT 1.65 ANGSTROM
2901, 4pmtA, 0.7778, 2.46, 0.380, 273, 245, THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR N~4~-(4-MORPHOLIN- 4-YLPHENYL)-N~6~-(PYRIDIN-3-YLMETHYL)PYRIDO[32-D]PYRIMIDINE-46- DIAMINE
2902, 4eomA, 0.7778, 2.86, 0.216, 296, 255, THR 160 PHOSPHORYLATED CDK2 H84S Q85M Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
2903, 4cnhA, 0.7778, 2.66, 0.298, 285, 248, STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2- METHOXYPHENYL)ETHOXY)-5-(1-METHYL-1H-123-TRIAZOL-5-YL) PYRIDIN-2-AMINE
2904, 4bcmC, 0.7778, 2.99, 0.211, 294, 256, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2905, 3q9wA, 0.7778, 2.95, 0.187, 328, 256, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 8.5
2906, 3my0W, 0.7778, 3.30, 0.242, 281, 260, CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN- 193189
2907, 5xvuB, 0.7777, 2.79, 0.178, 321, 253, CRYSTAL STRUCTURE OF THE PROTEIN KINASE CK2 CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM BOUND TO ATP
2908, 5oueA, 0.7777, 3.01, 0.187, 328, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 20
2909, 5jsmB, 0.7777, 2.57, 0.267, 263, 251, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
2910, 5d7aC, 0.7777, 2.68, 0.212, 286, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
2911, 4wo5B, 0.7777, 2.34, 0.259, 257, 247, CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER
2912, 3qcqA, 0.7777, 2.83, 0.214, 276, 252, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-(3- AMINO-1H-INDAZOL-6-YL)-N4-ETHYL-24-PYRIMIDINEDIAMINE
2913, 3nunA, 0.7777, 2.94, 0.225, 278, 253, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH LEAD COMPOUND
2914, 3at3A, 0.7777, 3.10, 0.185, 332, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVATIVE
2915, 2iw8A, 0.7777, 2.83, 0.208, 297, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V- H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2916, 1ol1C, 0.7777, 2.87, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
2917, 1gy3A, 0.7777, 2.79, 0.205, 295, 254, PCDK2/CYCLIN A IN COMPLEX WITH MGADP NITRATE AND PEPTIDE SUBSTRATE
2918, 5oquB, 0.7776, 3.06, 0.194, 324, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 5
2919, 5l2qB, 0.7776, 3.03, 0.173, 282, 260, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
2920, 4bcoC, 0.7776, 2.87, 0.204, 269, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2921, 3rwpA, 0.7776, 2.93, 0.225, 277, 253, DISCOVERY OF A NOVEL POTENT AND SELECTIVE INHIBITOR OF 3- PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
2922, 3qcsA, 0.7776, 2.83, 0.214, 276, 252, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-[2- AMINO-6-(4-MORPHOLINYL)-4-PYRIMIDINYL]-1H-INDAZOL-3-AMINE
2923, 3bhvA, 0.7776, 2.87, 0.216, 297, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
2924, 3a7gB, 0.7776, 3.21, 0.281, 290, 260, HUMAN MST3 KINASE
2925, 2uzeA, 0.7776, 2.77, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2926, 1oiuA, 0.7776, 2.84, 0.216, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
2927, 5swhB, 0.7775, 2.47, 0.340, 261, 244, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
2928, 5if1A, 0.7775, 2.77, 0.201, 298, 254, CRYSTAL STRUCTURE APO CDK2/CYCLIN A
2929, 5i3oA, 0.7775, 2.83, 0.194, 302, 252, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
2930, 4rerA, 0.7775, 2.77, 0.272, 458, 254, CRYSTAL STRUCTURE OF THE PHOSPHORYLATED HUMAN ALPHA1 BETA2 GAMMA1 HOLO-AMPK COMPLEX BOUND TO AMP AND CYCLODEXTRIN
2931, 4eqcA, 0.7775, 3.45, 0.216, 296, 264, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN IN COMPLEX WITH FRAX597 INHIBITOR
2932, 4eosC, 0.7775, 2.83, 0.204, 296, 255, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2933, 4aszA, 0.7775, 2.83, 0.378, 289, 251, CRYSTAL STRUCTURE OF APO TRKB KINASE DOMAIN
2934, 3lm0A, 0.7775, 2.93, 0.202, 278, 253, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B)
2935, 6ehkA, 0.7774, 2.98, 0.184, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH CAM4712 AND COMPOUND 37
2936, 5l8lA, 0.7774, 3.01, 0.234, 263, 256, AURORA-A KINASE DOMAIN IN COMPLEX WITH VNAR-D01 (CRYSTAL FORM 1)
2937, 4at4A, 0.7774, 3.08, 0.370, 292, 254, CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429
2938, 3prfB, 0.7774, 2.46, 0.257, 262, 249, CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON- OXIME FUROPYRIDINE INHIBITOR
2939, 3cpcA, 0.7774, 2.65, 0.312, 284, 247, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
2940, 3ag9B, 0.7774, 3.05, 0.263, 317, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1012
2941, 1h1qC, 0.7774, 2.81, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
2942, 1fq1B, 0.7774, 2.71, 0.213, 295, 253, CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
2943, 6fnjA, 0.7773, 2.85, 0.283, 262, 251, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
2944, 5ot6A, 0.7773, 2.89, 0.188, 327, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 19
2945, 5ho8A, 0.7773, 2.81, 0.214, 278, 252, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
2946, 5dt0A, 0.7773, 2.85, 0.235, 259, 251, AURORA A KINASE IN COMPLEX WITH JNJ-7706621 IN SPACE GROUP P6122
2947, 4uwyB, 0.7773, 2.75, 0.371, 273, 251, FGFR1 APO STRUCTURE
2948, 4bcmA, 0.7773, 2.87, 0.212, 295, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2949, 3v5qA, 0.7773, 2.42, 0.404, 263, 245, DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS
2950, 6c3eB, 0.7772, 2.38, 0.298, 259, 245, CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR
2951, 5l2wA, 0.7772, 2.77, 0.201, 297, 254, THE X-RAY CO-CRYSTAL STRUCTURE OF HUMAN CDK2/CYCLINE AND DINACICLIB.
2952, 4xufA, 0.7772, 2.94, 0.339, 270, 251, CRYSTAL STRUCTURE OF THE FLT3 KINASE DOMAIN BOUND TO THE INHIBITOR QUIZARTINIB (AC220)
2953, 4kwpA, 0.7772, 3.07, 0.185, 329, 259, CRYSTAL STRUCTURE OF HUMAN CK2-ALPHA IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR (K164) AT 1.25 A RESOLUTION
2954, 4i6fA, 0.7772, 3.11, 0.213, 285, 258, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
2955, 3svvB, 0.7772, 2.13, 0.336, 257, 241, CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE- PYRAZOLOPYRIMIDINE 9
2956, 3qcxA, 0.7772, 2.83, 0.214, 276, 252, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-{2- AMINO-6-[(3R)-3-METHYL-4-MORPHOLINYL]-4-PYRIMIDINYL}-1H-INDAZOL-3- AMINE
2957, 3ewhA, 0.7772, 3.21, 0.341, 300, 255, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDYL-PYRIMIDINE BENZIMIDAZOLE INHIBITOR
2958, 2uzlC, 0.7772, 2.78, 0.201, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2959, 2cciA, 0.7772, 2.88, 0.204, 296, 255, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2960, 1vywC, 0.7772, 3.00, 0.214, 299, 257, STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
2961, 6cz3A, 0.7771, 2.85, 0.337, 262, 249, STRUCTURE OF THE PTK6 KINASE DOMAIN BOUND TO A TYPE I INHIBITOR (3- FLUORO-4-{[6-METHYL-3-(1H-PYRAZOL-4-YL)IMIDAZO[1;2-A]PYRAZIN-8- YL]AMINO}PHENYL)(MORPHOLIN-4-YL)METHANONE 
2962, 5uabA, 0.7771, 2.37, 0.357, 288, 241, MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN HGF ANTIBODY
2963, 5oueB, 0.7771, 2.83, 0.185, 326, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 20
2964, 5mo8B, 0.7771, 2.81, 0.189, 324, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2965, 5cx9A, 0.7771, 2.94, 0.192, 328, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH (METHYL 4-((3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)AMINO)-4-OXOBUTANOATE BOUND
2966, 4eoiC, 0.7771, 2.85, 0.204, 296, 255, THR 160 PHOSPHORYLATED CDK2 K89D Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
2967, 3nusA, 0.7771, 2.82, 0.214, 276, 252, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT8
2968, 3cs9B, 0.7771, 2.22, 0.342, 247, 243, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
2969, 5tehA, 0.7770, 2.40, 0.335, 261, 245, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-156
2970, 4rz7A, 0.7770, 2.94, 0.218, 801, 257, CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND PCI32765
2971, 3lm5A, 0.7770, 2.95, 0.190, 274, 253, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B) IN COMPLEX WITH QUERCETIN
2972, 3ggfA, 0.7770, 2.73, 0.259, 275, 251, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE MST4 IN COMPLEX WITH AN QUINAZOLIN
2973, 2wmbC, 0.7770, 2.72, 0.209, 266, 253, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
2974, 2c5xA, 0.7770, 2.86, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2975, 1xjdA, 0.7770, 2.79, 0.265, 280, 253, CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION
2976, 5sysA, 0.7769, 2.45, 0.340, 258, 244, C-SRC V281C BOUND TO N-[3-({6-[(1E)-2-CYANO-3-(METHYLAMINO)-3-OXOPROP- 1-EN-1-YL]-7-(2-METHOXYETHYL)-7H-PYRROLO[23-D]PYRIMIDIN-5- YL}ETHYNYL)-4-METHYLPHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE INHIBITOR
2977, 5n1kA, 0.7769, 3.05, 0.256, 341, 254, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-AMINO-1-(4-FLUOROPHENYL)ETHANOL
2978, 5modB, 0.7769, 2.82, 0.185, 324, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2979, 5mo7B, 0.7769, 3.06, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
2980, 4mneD, 0.7769, 3.15, 0.199, 285, 256, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
2981, 4krdA, 0.7769, 3.06, 0.210, 294, 257, CRYSTAL STRUCTURE OF PHO85-PCL10 COMPLEX
2982, 4bcoA, 0.7769, 2.78, 0.197, 298, 254, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
2983, 3orzD, 0.7769, 3.07, 0.244, 278, 254, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
2984, 3f69B, 0.7769, 2.99, 0.210, 282, 257, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
2985, 2pl0A, 0.7769, 2.71, 0.364, 268, 247, LCK BOUND TO IMATINIB
2986, 2c5xC, 0.7769, 2.87, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2987, 5ot5B, 0.7768, 2.97, 0.198, 325, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 24
2988, 5m0uA, 0.7768, 2.72, 0.255, 346, 251, APOSTRUCTURE STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) FROM CHO CELLS WITH A PEPTIDIC INHIBITOR FRAGMENT 
2989, 5cx9B, 0.7768, 3.05, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH (METHYL 4-((3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)AMINO)-4-OXOBUTANOATE BOUND
2990, 4ybjA, 0.7768, 2.23, 0.339, 255, 242, TYPE II DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
2991, 4o0wA, 0.7768, 2.75, 0.236, 259, 250, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
2992, 4cxaA, 0.7768, 3.16, 0.249, 329, 261, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLIN K COMPLEX BOUND TO AMPPNP
2993, 3krxA, 0.7768, 3.25, 0.195, 618, 261, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
2994, 3g6hB, 0.7768, 2.50, 0.347, 259, 245, SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
2995, 1okwC, 0.7768, 2.86, 0.204, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
2996, 1h1rA, 0.7768, 2.84, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
2997, 1gy3C, 0.7768, 2.82, 0.205, 295, 254, PCDK2/CYCLIN A IN COMPLEX WITH MGADP NITRATE AND PEPTIDE SUBSTRATE
2998, 5te0A, 0.7767, 3.13, 0.205, 316, 254, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE (AAK1) IN COMPLEX WITH BIBF 1120
2999, 5otzA, 0.7767, 3.07, 0.191, 327, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 1
3000, 5os8A, 0.7767, 3.06, 0.191, 327, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 11
3001, 5orkA, 0.7767, 3.06, 0.190, 324, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 6
3002, 5cyiA, 0.7767, 2.78, 0.201, 298, 254, CDK2/CYCLIN A COVALENT COMPLEX WITH 6-(CYCLOHEXYLMETHOXY)-N-(4- (VINYLSULFONYL)PHENYL)-9H-PURIN-2-AMINE (NU6300)
3003, 5cwzB, 0.7767, 2.67, 0.212, 284, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE
3004, 3wilA, 0.7767, 3.10, 0.189, 331, 259, CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND3 COMPLEX
3005, 3orzB, 0.7767, 3.07, 0.244, 278, 254, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3006, 2oxyB, 0.7767, 3.07, 0.179, 327, 257, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
3007, 1k9aD, 0.7767, 2.72, 0.376, 433, 250, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
3008, 5k0xB, 0.7766, 1.84, 0.331, 254, 236, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2541
3009, 4i6hA, 0.7766, 3.18, 0.224, 285, 259, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE ALPHA-SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3010, 4eosA, 0.7766, 2.85, 0.220, 296, 255, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
3011, 3q9yA, 0.7766, 2.96, 0.187, 327, 256, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 8.5
3012, 3iecB, 0.7766, 2.87, 0.290, 313, 255, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3013, 1urcA, 0.7766, 2.86, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
3014, 1ol1A, 0.7766, 2.86, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
3015, 6fnjB, 0.7765, 2.86, 0.283, 262, 251, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
3016, 6fnhC, 0.7765, 2.61, 0.319, 270, 248, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH A PYRAZOLO[3;4-D]PYRIMIDINE FRAGMENT OF NVP-BHG712 
3017, 5mo6B, 0.7765, 2.98, 0.191, 324, 257, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3018, 5isoC, 0.7765, 2.83, 0.271, 429, 255, STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3019, 5i3rA, 0.7765, 2.86, 0.194, 302, 252, CRYSTAL STRUCTURE OF BMP-2-INDUCIBLE KINASE IN COMPLEX WITH AN INDAZOLE INHIBITOR
3020, 4l00B, 0.7765, 2.83, 0.224, 278, 255, CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN
3021, 4l00A, 0.7765, 2.77, 0.233, 277, 253, CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN
3022, 3lw0A, 0.7765, 2.71, 0.312, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3023, 3krwA, 0.7765, 3.25, 0.195, 618, 261, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
3024, 3bhhC, 0.7765, 2.73, 0.217, 285, 254, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
3025, 2uzbA, 0.7765, 2.83, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
3026, 2qu6A, 0.7765, 2.39, 0.337, 283, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
3027, 2c6tA, 0.7765, 2.81, 0.205, 295, 254, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
3028, 1szmA, 0.7765, 2.93, 0.259, 317, 255, DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
3029, 1oguA, 0.7765, 2.85, 0.216, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
3030, 5tx5A, 0.7764, 2.33, 0.287, 259, 244, RIP1 KINASE ( FLAG 1-294 C34A C127A C233A C240A) WITH GSK772
3031, 5mo6A, 0.7764, 2.83, 0.189, 325, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3032, 4qo9A, 0.7764, 3.13, 0.277, 280, 256, MST3 IN COMPLEX WITH DANUSERTIB
3033, 4i6bA, 0.7764, 3.24, 0.215, 285, 260, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3034, 4f1oA, 0.7764, 3.09, 0.254, 276, 256, CRYSTAL STRUCTURE OF THE L1180T MUTANT ROCO4 KINASE DOMAIN FROM D. DISCOIDEUM BOUND TO APPCP
3035, 3q4cA, 0.7764, 2.82, 0.269, 264, 253, CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292
3036, 3nuyA, 0.7764, 2.95, 0.225, 276, 253, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT17
3037, 3lw0D, 0.7764, 2.71, 0.312, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3038, 3lw0C, 0.7764, 2.71, 0.312, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3039, 2v22C, 0.7764, 2.87, 0.204, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3040, 2uzeC, 0.7764, 2.81, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
3041, 1okzA, 0.7764, 2.82, 0.214, 276, 252, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01
3042, 5mo5B, 0.7763, 3.07, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3043, 4twoA, 0.7763, 2.84, 0.306, 278, 252, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 164
3044, 3q04A, 0.7763, 3.09, 0.189, 328, 259, CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 8.5
3045, 3lw0B, 0.7763, 2.72, 0.312, 292, 250, IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3046, 2wfyC, 0.7763, 2.86, 0.204, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3047, 1rjbA, 0.7763, 2.94, 0.341, 298, 249, CRYSTAL STRUCTURE OF FLT3
3048, 1oi9C, 0.7763, 2.85, 0.208, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
3049, 5lqfD, 0.7762, 2.76, 0.207, 285, 251, CDK1/CYCLINB1/CKS2 IN COMPLEX WITH NU6102
3050, 5dpvA, 0.7762, 2.80, 0.240, 257, 250, AURORA A KINASE IN COMPLEX WITH AA35 AND JNJ-7706621 IN SPACE GROUP P6122
3051, 5bvwA, 0.7762, 2.82, 0.355, 274, 251, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
3052, 4mnfB, 0.7762, 2.39, 0.259, 257, 247, CRYSTAL STRUCTURE OF BRAF-V600E BOUND TO GDC0879
3053, 3qupA, 0.7762, 1.84, 0.335, 241, 236, INHIBITOR BOUND STRUCTURE OF THE KINASE DOMAIN OF THE MURINE RECEPTOR TYROSINE KINASE TYRO3 (SKY)
3054, 3qtiB, 0.7762, 2.49, 0.344, 280, 244, C-MET KINASE IN COMPLEX WITH NVP-BVU972
3055, 1jwhA, 0.7762, 3.14, 0.190, 336, 258, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
3056, 1fvvC, 0.7762, 2.95, 0.215, 298, 256, THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
3057, 1finA, 0.7762, 3.01, 0.215, 298, 256, CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
3058, 6cpfA, 0.7761, 2.76, 0.237, 259, 249, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP IN AN ACTIVE CONFORMATION 
3059, 5m4cA, 0.7761, 3.04, 0.183, 329, 257, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A THIENO[23-D]PYRIMIDIN INHIBITOR CRYSTALLIZED UNDER LOW-SALT CONDITIONS
3060, 5cvhB, 0.7761, 2.96, 0.183, 324, 257, CRYSTAL STRUCTURE OF CK2ALPHA
3061, 5ctpA, 0.7761, 2.84, 0.185, 324, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)ACETAMIDE BOUND
3062, 4itjA, 0.7761, 2.38, 0.290, 261, 245, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4
3063, 4dinA, 0.7761, 3.04, 0.234, 340, 256, NOVEL LOCALIZATION AND QUATERNARY STRUCTURE OF THE PKA RI BETA HOLOENZYME
3064, 4bcpA, 0.7761, 2.81, 0.201, 298, 254, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3065, 3nuuA, 0.7761, 2.82, 0.214, 276, 252, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT11
3066, 5njzA, 0.7760, 2.72, 0.324, 273, 250, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1G
3067, 5jsmC, 0.7760, 2.38, 0.263, 262, 247, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
3068, 5ar5B, 0.7760, 2.36, 0.252, 279, 246, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BENZIMIDAZOLE
3069, 4csvA, 0.7760, 2.28, 0.372, 244, 242, TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL BOUND TO GLEEVEC
3070, 4cfxA, 0.7760, 2.96, 0.208, 298, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3071, 3ofmA, 0.7760, 3.23, 0.203, 325, 261, STRUCTURE OF A HUMAN CK2ALPHA PRIME THE PARALOG ISOFORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM HOMO SAPIENS
3072, 3f3vB, 0.7760, 2.57, 0.337, 262, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3073, 3dzqA, 0.7760, 2.73, 0.308, 268, 250, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II- 38.3
3074, 2wmbA, 0.7760, 2.87, 0.204, 296, 255, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3075, 2p2iB, 0.7760, 2.50, 0.328, 263, 244, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
3076, 1h1rC, 0.7760, 2.84, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
3077, 6ccfB, 0.7759, 3.06, 0.234, 262, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH HESPERADIN
3078, 5ur1A, 0.7759, 2.64, 0.375, 278, 248, FGFR1 KINASE DOMAIN COMPLEX WITH SN37333 IN REVERSIBLE BINDING MODE
3079, 5mmfA, 0.7759, 3.17, 0.197, 326, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 7 BOUND
3080, 4mneH, 0.7759, 3.09, 0.200, 275, 255, CRYSTAL STRUCTURE OF THE BRAF:MEK1 COMPLEX
3081, 3eocA, 0.7759, 2.70, 0.206, 295, 252, CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
3082, 3ddpA, 0.7759, 2.87, 0.204, 297, 255, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
3083, 3c4yB, 0.7759, 2.96, 0.218, 466, 257, CRYSTAL STRUCTURE OF APO FORM OF G PROTEIN COUPLED RECEPTOR KINASE 1 AT 7.51A
3084, 1h1sA, 0.7759, 2.84, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
3085, 5mp8A, 0.7758, 3.06, 0.194, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3086, 5mohA, 0.7758, 3.19, 0.188, 326, 260, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0583 BOUND.
3087, 5lvpD, 0.7758, 2.92, 0.233, 276, 253, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3088, 5kbqA, 0.7758, 3.19, 0.218, 289, 261, PAK1 IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
3089, 5cwzA, 0.7758, 2.58, 0.213, 284, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE
3090, 5cspA, 0.7758, 2.97, 0.180, 327, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 5 BOUND
3091, 2wihC, 0.7758, 3.00, 0.214, 299, 257, STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
3092, 2whbC, 0.7758, 2.86, 0.204, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3093, 6fypA, 0.7757, 2.98, 0.197, 348, 254, X-RAY STRUCTURE OF CLK3-KD(GP-[275-632]; NON-PHOS.)/CX-4945 AT 2.29A 
3094, 5n3fA, 0.7757, 2.91, 0.230, 318, 252, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-[3-(AMINOMETHYL)PHENYL]ACETAMIDE
3095, 5l2qA, 0.7757, 3.06, 0.174, 293, 259, SERINE/THREONINE-PROTEIN KINASE 40 (STK40) KINASE HOMOLOGY DOMAIN
3096, 4mnfA, 0.7757, 2.32, 0.268, 257, 246, CRYSTAL STRUCTURE OF BRAF-V600E BOUND TO GDC0879
3097, 3my5A, 0.7757, 2.86, 0.217, 296, 254, CDK2/CYCLINA IN COMPLEX WITH DRB
3098, 3f3wA, 0.7757, 2.44, 0.331, 261, 245, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3099, 3a7hB, 0.7757, 3.22, 0.269, 290, 260, HUMAN MST3 KINASE IN COMPLEX WITH ATP
3100, 2x1nC, 0.7757, 2.90, 0.208, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3101, 6gt1D, 0.7756, 2.54, 0.239, 260, 247, NEK7 BOUND TO PURINE INHIBITOR 
3102, 5orkB, 0.7756, 3.12, 0.198, 323, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 6
3103, 5d11B, 0.7756, 2.15, 0.350, 255, 240, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL235
3104, 4i4fA, 0.7756, 2.66, 0.364, 255, 247, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH AN ALLOSTERIC BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
3105, 3d2iA, 0.7756, 2.68, 0.241, 255, 249, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240- >ARG MET302->LEU) IN COMPLEX WITH 1-{5-[2-(1-METHYL-1H- PYRAZOLO[43-D]PYRIMIDIN-7-YLAMINO)-ETHYL]-THIAZOL-2-YL}-3- (3-TRIFLUOROMETHYL-PHENYL)-UREA
3106, 2jkoA, 0.7756, 2.59, 0.367, 256, 248, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS- ANILINO PYRIMIDINE INHIBITOR
3107, 1yhwA, 0.7756, 3.34, 0.213, 293, 263, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R)
3108, 1h28C, 0.7756, 2.89, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
3109, 6cpeA, 0.7755, 2.72, 0.229, 256, 249, STRUCTURE OF APO; DEPHOSPHORYLATED AURORA A (122-403) IN AN ACTIVE CONFORMATION 
3110, 5ouuB, 0.7755, 3.00, 0.198, 325, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 22
3111, 5otyA, 0.7755, 3.00, 0.184, 327, 256, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH CAM4712
3112, 5n9lA, 0.7755, 3.09, 0.185, 329, 259, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE DIBENZOFURAN INHIBITOR TF (4B)
3113, 5izjA, 0.7755, 2.93, 0.255, 328, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1411
3114, 4f65B, 0.7755, 2.77, 0.355, 279, 251, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 8
3115, 4cfmA, 0.7755, 2.88, 0.200, 296, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3116, 3mpmA, 0.7755, 2.61, 0.354, 257, 246, LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE
3117, 3h9oA, 0.7755, 2.82, 0.215, 275, 251, PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9
3118, 5ut5A, 0.7754, 2.85, 0.265, 272, 253, JAK2 JH2 IN COMPLEX WITH GLPG0634
3119, 5ut0A, 0.7754, 2.81, 0.262, 272, 252, JAK2 JH2 IN COMPLEX WITH AT9283
3120, 5tc0B, 0.7754, 2.13, 0.325, 250, 240, STRUCTURE-BASED OPTIMIZATION OF 1H-IMIDAZOLE-2-CARBOXAMIDES AS AXL KINASE INHIBITORS UTILIZING A MER MUTANT SURROGATE
3121, 5swhA, 0.7754, 2.49, 0.340, 258, 244, C-SRC V281C KINASE DOMAIN IN COMPLEX WITH RAO-IV-151
3122, 4f1mA, 0.7754, 3.08, 0.262, 278, 256, CRYSTAL STRUCTURE OF THE G1179S ROCO4 KINASE DOMAIN BOUND TO APPCP FROM D. DISCOIDEUM.
3123, 4cfhA, 0.7754, 2.80, 0.276, 401, 254, STRUCTURE OF AN ACTIVE FORM OF MAMMALIAN AMPK
3124, 3r0tA, 0.7754, 3.10, 0.189, 327, 259, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-5279
3125, 2whbA, 0.7754, 2.89, 0.208, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3126, 2fb8B, 0.7754, 2.50, 0.265, 259, 249, STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
3127, 1q8wA, 0.7754, 3.01, 0.263, 334, 255, THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)
3128, 1h1qA, 0.7754, 2.85, 0.204, 296, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
3129, 5jznA, 0.7753, 2.81, 0.225, 268, 253, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH NVP-TAE684
3130, 5if1C, 0.7753, 2.86, 0.208, 296, 255, CRYSTAL STRUCTURE APO CDK2/CYCLIN A
3131, 5cvhA, 0.7753, 3.23, 0.192, 327, 260, CRYSTAL STRUCTURE OF CK2ALPHA
3132, 3qd3A, 0.7753, 2.98, 0.225, 278, 253, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 11- DIMETHYLETHYL {(3R6S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4- PYRIMIDINYL]-6-METHYL-3-PIPERIDINYL}CARBAMATE
3133, 2xbaA, 0.7753, 2.60, 0.300, 283, 247, STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
3134, 3wowA, 0.7752, 3.20, 0.188, 334, 260, CRYSTAL STRUCTURE OF HUMAN CK2A WITH AMPPNP
3135, 3dlsD, 0.7752, 2.92, 0.237, 284, 253, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3136, 2wevC, 0.7752, 2.91, 0.208, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3137, 1pjkA, 0.7752, 3.01, 0.191, 331, 256, CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3138, 1e9hC, 0.7752, 2.97, 0.211, 296, 256, THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
3139, 5otoA, 0.7751, 2.91, 0.193, 327, 254, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 30
3140, 5oquA, 0.7751, 3.06, 0.194, 324, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 5
3141, 3otuA, 0.7751, 2.89, 0.235, 276, 251, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR JS30
3142, 1yhvA, 0.7751, 3.35, 0.213, 293, 263, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R T423E)
3143, 5ut1A, 0.7750, 2.86, 0.265, 272, 253, JAK2 JH2 IN COMPLEX WITH BI-D1870
3144, 5mo4A, 0.7750, 2.31, 0.344, 429, 244, ABL1 KINASE (T334I_D382N) IN COMPLEX WITH ASCIMINIB AND NILOTINIB
3145, 5d7aA, 0.7750, 2.55, 0.217, 289, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TRAF2 AND NCK-INTERACTING PROTEIN KINASE WITH NCB-0846
3146, 3wikA, 0.7750, 3.28, 0.195, 334, 261, CRYSTAL STRUCTURE OF THE CK2ALPHA/COMPOUND10 COMPLEX
3147, 2uzbC, 0.7750, 2.69, 0.199, 292, 251, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
3148, 1yomB, 0.7750, 2.43, 0.340, 261, 244, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
3149, 1h26A, 0.7750, 2.90, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
3150, 6cd6A, 0.7749, 2.95, 0.239, 264, 255, CRYSTAL STRUCTURE OF THE HUMAN CAMKK1A IN COMPLEX WITH GSK650394
3151, 6b1uA, 0.7749, 2.83, 0.272, 441, 254, STRUCTURE OF FULL-LENGTH HUMAN AMPK (A2B1G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4 
3152, 5nevA, 0.7749, 2.86, 0.204, 295, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
3153, 5cu3B, 0.7749, 3.08, 0.194, 324, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
3154, 4i5pA, 0.7749, 3.18, 0.216, 284, 259, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
3155, 4grbA, 0.7749, 2.94, 0.180, 327, 255, CASEIN KINASE 2 (CK2) BOUND TO INHIBITOR
3156, 4cfnA, 0.7749, 2.87, 0.208, 296, 255, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3157, 3nszA, 0.7749, 2.93, 0.184, 327, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH AMPPN
3158, 3gqlB, 0.7749, 2.72, 0.372, 276, 250, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3159, 2yn8B, 0.7749, 2.64, 0.286, 260, 248, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3160, 2wipC, 0.7749, 2.71, 0.206, 292, 252, STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-45-DIHYDRO-1H-PYRAZOLO[43-H] QUINAZOLINE-3- CARBOXYLIC ACID
3161, 2welA, 0.7749, 2.93, 0.218, 304, 257, CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN- DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN
3162, 2v22A, 0.7749, 2.88, 0.208, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3163, 6fnlA, 0.7748, 2.71, 0.297, 262, 249, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE 
3164, 5oumA, 0.7748, 3.17, 0.197, 326, 259, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 21
3165, 5othB, 0.7748, 3.01, 0.198, 324, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 26
3166, 4f1tA, 0.7748, 3.08, 0.265, 269, 257, CRYSTAL STRUCTURE OF THE ROCO4 KINASE DOMAIN FROM D. DISCOIDEUM BOUND TO THE ROCK INHIBITOR H1152
3167, 3pe2A, 0.7748, 3.02, 0.182, 327, 258, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR CX-5011
3168, 3d7uB, 0.7748, 2.38, 0.337, 258, 243, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3169, 3a8xB, 0.7748, 3.00, 0.202, 329, 257, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3170, 2x1nA, 0.7748, 2.91, 0.208, 296, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3171, 2iw6C, 0.7748, 2.87, 0.200, 295, 255, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
3172, 2g9xA, 0.7748, 2.89, 0.204, 298, 255, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
3173, 6cz2A, 0.7747, 2.53, 0.335, 261, 245, STRUCTURE OF THE PTK6 KINASE DOMAIN 
3174, 6bqqA, 0.7747, 3.13, 0.234, 271, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH BI2526
3175, 5uszA, 0.7747, 2.85, 0.265, 272, 253, JAK2 JH2 IN COMPLEX WITH JNJ-7706621
3176, 4u45A, 0.7747, 2.77, 0.234, 289, 252, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 25)
3177, 1uu9A, 0.7747, 2.96, 0.225, 276, 253, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3
3178, 5ut6A, 0.7746, 2.88, 0.265, 272, 253, JAK2 JH2 IN COMPLEX WITH A DIAMINOPYRIMIDINE
3179, 5o5mA, 0.7746, 3.05, 0.259, 336, 255, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND RKP117 
3180, 5nwzB, 0.7746, 2.72, 0.372, 268, 250, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
3181, 4p5qA, 0.7746, 2.89, 0.306, 275, 252, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
3182, 4ehgB, 0.7746, 2.49, 0.266, 260, 248, B-RAF KINASE DOMAIN IN COMPLEX WITH AN AMINOPYRIDIMINE-BASED INHIBITOR
3183, 4bcnA, 0.7746, 2.79, 0.206, 296, 253, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3184, 3miyB, 0.7746, 1.92, 0.315, 240, 238, X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
3185, 5ia1A, 0.7745, 2.50, 0.320, 261, 247, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH MLN8054
3186, 4bcpC, 0.7745, 2.78, 0.209, 267, 253, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3187, 3tt0B, 0.7745, 2.82, 0.372, 272, 250, CO-STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN WITH 3-(26-DICHLORO-35-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1- YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA (BGJ398)
3188, 3q52A, 0.7745, 3.32, 0.221, 292, 262, STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN
3189, 3f3vA, 0.7745, 2.59, 0.337, 261, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3190, 2pmlX, 0.7745, 3.04, 0.190, 340, 258, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH AN ATP ANALOGUE
3191, 1ol2C, 0.7745, 2.89, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
3192, 5lqeA, 0.7744, 2.87, 0.204, 295, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
3193, 5lpvA, 0.7744, 2.89, 0.242, 282, 252, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH AMPPNP AND MN FROM ARABIDOPSIS THALIANA
3194, 5jrsB, 0.7744, 2.17, 0.322, 240, 239, CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -34-DIHYDROQUINAZOLIN-3-YL) PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE
3195, 4gubA, 0.7744, 3.07, 0.178, 329, 258, CASEIN KINASE II BOUND TO INHIBITOR
3196, 3q4cB, 0.7744, 2.78, 0.270, 264, 252, CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292
3197, 3pe1A, 0.7744, 3.11, 0.181, 327, 259, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-4945
3198, 3orzC, 0.7744, 3.10, 0.236, 276, 254, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3199, 2wfyA, 0.7744, 2.89, 0.204, 295, 255, TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2 CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
3200, 1oi9A, 0.7744, 2.82, 0.201, 295, 254, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
3201, 5ut3A, 0.7743, 2.87, 0.265, 272, 253, JAK2 JH2 IN COMPLEX WITH IKK-2 INHIBITOR VI
3202, 4xv9A, 0.7743, 2.49, 0.254, 261, 248, B-RAF KINASE DOMAIN IN COMPLEX WITH PLX5568
3203, 3my5C, 0.7743, 2.83, 0.206, 266, 253, CDK2/CYCLINA IN COMPLEX WITH DRB
3204, 3krlA, 0.7743, 2.96, 0.336, 281, 250, CFMS TYROSINE KINASE IN COMPLEX WITH 5-CYANO-FURAN-2-CARBOXYLIC ACID [4-(4-METHYL-PIPERAZIN-1-YL)-2-PIPERIDIN-1-YL-PHENYL]-AMIDE
3205, 2uueC, 0.7743, 2.92, 0.208, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3206, 1h28A, 0.7743, 2.90, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
3207, 1eh4A, 0.7743, 3.25, 0.159, 293, 264, BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR IC261
3208, 5otdA, 0.7742, 2.96, 0.192, 327, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 25
3209, 5n9nA, 0.7742, 3.12, 0.189, 329, 259, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE TIGHT-BINDING DIBENZOFURAN INHIBITOR TF85 (4A)
3210, 5modA, 0.7742, 2.81, 0.190, 327, 253, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3211, 5m44A, 0.7742, 2.95, 0.196, 329, 255, COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A THIENO[23-D]PYRIMIDIN INHIBITOR CRYSTALLIZED UNDER HIGH-SALT CONDITIONS
3212, 5ax9C, 0.7742, 2.65, 0.213, 282, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
3213, 3tl8G, 0.7742, 2.85, 0.270, 301, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3214, 3fzoA, 0.7742, 3.01, 0.328, 262, 253, CRYSTAL STRUCTURE OF PYK2-APO PROLINE-RICH TYROSINE KINASE
3215, 3dogA, 0.7742, 2.85, 0.201, 297, 254, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3216, 1yomA, 0.7742, 2.37, 0.337, 260, 243, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
3217, 5mowB, 0.7741, 3.10, 0.198, 324, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3218, 5he1A, 0.7741, 3.27, 0.192, 618, 261, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224062
3219, 4i4eA, 0.7741, 2.55, 0.360, 254, 247, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH HINGE BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
3220, 3orzA, 0.7741, 3.02, 0.237, 276, 253, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3221, 2r7iA, 0.7741, 2.92, 0.193, 322, 254, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3222, 1okvC, 0.7741, 2.88, 0.204, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
3223, 5deyA, 0.7740, 3.41, 0.217, 295, 263, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND G-5555
3224, 5ar3B, 0.7740, 2.44, 0.268, 276, 246, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH AMP-PCP
3225, 4rllA, 0.7740, 3.12, 0.189, 329, 259, CRYSTAL STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP- COMPETITIVE INHIBITOR 4-[(E)-(FLUOREN-9-YLIDENEHYDRAZINYLIDENE)- METHYL] BENZOATE
3226, 3zrkB, 0.7740, 3.03, 0.230, 348, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3227, 3tz7A, 0.7740, 2.43, 0.340, 260, 244, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL103
3228, 3mb6A, 0.7740, 3.13, 0.189, 329, 259, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (CPA)
3229, 2oxyA, 0.7740, 3.19, 0.177, 327, 260, PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17 K22 AND K32
3230, 1h27C, 0.7740, 2.89, 0.204, 291, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
3231, 5oulA, 0.7739, 3.13, 0.191, 327, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 9
3232, 5nevC, 0.7739, 2.87, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
3233, 5i8aA, 0.7739, 2.20, 0.378, 269, 241, TRKA WITH (6~{R})-3-METHYLSULFANYL-6-PHENYL-1-(1~{H}-PYRAZOL-3-YL)-6 7-DIHYDRO-5~{H}-THIENO[34-C]PYRIDIN-4-ONE
3234, 5dfpA, 0.7739, 3.25, 0.215, 292, 261, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND FRAX1036
3235, 4jr7A, 0.7739, 3.04, 0.199, 367, 256, CRYSTAL STRUCTURE OF SCCK2 ALPHA IN COMPLEX WITH GMPPNP
3236, 4eoqA, 0.7739, 2.89, 0.220, 295, 254, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH ATP
3237, 3iopA, 0.7739, 2.96, 0.226, 275, 252, PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I
3238, 2xckA, 0.7739, 2.97, 0.222, 275, 252, CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
3239, 2i40C, 0.7739, 2.94, 0.216, 296, 255, CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
3240, 1yolB, 0.7739, 2.12, 0.333, 253, 240, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
3241, 1bygA, 0.7739, 2.12, 0.373, 246, 241, KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
3242, 6b3eC, 0.7738, 3.08, 0.247, 307, 259, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLINK IN COMPLEX WITH AN INHIBITOR
3243, 5ut2A, 0.7738, 2.87, 0.265, 273, 253, JAK2 JH2 IN COMPLEX WITH PRT062607
3244, 5mo8A, 0.7738, 3.01, 0.191, 325, 257, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(((2-CHLORO-[11 -BIPHENYL]-4- YL)METHYL)AMINO)PROPYL)METHANESULFONAMIDE BOUND
3245, 5d11A, 0.7738, 2.19, 0.350, 254, 240, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL235
3246, 5csvA, 0.7738, 3.14, 0.189, 327, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 6 BOUND
3247, 4c3fA, 0.7738, 2.63, 0.354, 257, 246, STRUCTURE OF LCK IN COMPLEX WITH A COMPOUND DISCOVERED BY VIRTUAL FRAGMENT LINKING
3248, 3cpcB, 0.7738, 2.48, 0.337, 262, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3249, 2pe0A, 0.7738, 2.83, 0.219, 275, 251, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-13-DIHYDRO- INDOL-2-ONE COMPLEX
3250, 2jgzA, 0.7738, 2.79, 0.202, 288, 253, CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
3251, 1z5mA, 0.7738, 2.82, 0.219, 275, 251, CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-22- DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1
3252, 1jstC, 0.7738, 2.97, 0.212, 297, 255, PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
3253, 5u94A, 0.7737, 2.73, 0.233, 263, 249, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PASTA KINASE PKNB IN COMPLEX WITH THE POTENTIAL THERAPUTIC KINASE INHIBITOR GSK690693.
3254, 5otdB, 0.7737, 3.03, 0.198, 324, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 25
3255, 5dr9A, 0.7737, 2.77, 0.241, 257, 249, AURORA A KINASE IN COMPLEX WITH AA29 AND JNJ-7706621 IN SPACE GROUP P6122
3256, 4pnkA, 0.7737, 3.26, 0.191, 625, 262, G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GSK180736A
3257, 4f0fA, 0.7737, 3.07, 0.250, 276, 256, CRYSTAL STRUCTURE OF THE ROCO4 KINASE DOMAIN BOUND TO APPCP FROM D. DISCOIDEUM
3258, 3uqfB, 0.7737, 1.94, 0.346, 253, 237, C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89
3259, 2uueA, 0.7737, 2.91, 0.204, 296, 255, REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
3260, 5vamB, 0.7736, 2.73, 0.264, 260, 250, BRAF IN COMPLEX WITH RAF709
3261, 5lvpB, 0.7736, 2.95, 0.233, 276, 253, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3262, 3iecA, 0.7736, 2.82, 0.292, 311, 253, HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
3263, 2o5kA, 0.7736, 3.04, 0.230, 350, 257, CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR
3264, 2c5nC, 0.7736, 2.92, 0.208, 296, 255, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND  INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
3265, 1uv5A, 0.7736, 2.97, 0.223, 348, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3 -OXIME
3266, 5nk0A, 0.7735, 2.79, 0.329, 273, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 1J
3267, 5dr6A, 0.7735, 2.77, 0.237, 257, 249, AURORA A KINASE IN COMPLEX WITH AA30 AND JNJ-7706621 IN SPACE GROUP P6122
3268, 2np8A, 0.7735, 2.70, 0.229, 256, 249, STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS
3269, 1p5eC, 0.7735, 3.05, 0.211, 296, 256, THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMOBENZOTRIAZOLE (TBS)
3270, 1p5eA, 0.7735, 2.96, 0.204, 296, 255, THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4567-TETRABROMOBENZOTRIAZOLE (TBS)
3271, 1j91A, 0.7735, 3.18, 0.174, 327, 258, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4567- TETRABROMOBENZOTRIAZOLE
3272, 5y9mX, 0.7734, 3.01, 0.203, 319, 256, CRYSTAL STRUCTURE OF CK2A2 FORM 3 
3273, 5otoB, 0.7734, 3.04, 0.195, 324, 257, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 30
3274, 5n9kA, 0.7734, 3.14, 0.189, 329, 259, CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE TIGHT-BINDING DIBENZOFURAN INHIBITOR TF107 (5)
3275, 5motA, 0.7734, 3.16, 0.189, 328, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0627 BOUND
3276, 5i9wA, 0.7734, 2.53, 0.313, 267, 246, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ANP
3277, 5ctpB, 0.7734, 3.14, 0.194, 327, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH N-(3-(3-CHLORO-4-(PHENYL) BENZYLAMINO)PROPYL)ACETAMIDE BOUND
3278, 4u44A, 0.7734, 2.70, 0.235, 286, 251, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 16)
3279, 3f3tA, 0.7734, 2.48, 0.339, 261, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE III)
3280, 5lqeC, 0.7733, 2.89, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73
3281, 3zrlB, 0.7733, 3.05, 0.230, 347, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3282, 3tz8A, 0.7733, 2.52, 0.339, 261, 245, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104
3283, 3sayA, 0.7733, 3.05, 0.230, 347, 256, CRYSTAL STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH INHIBITOR 142
3284, 1z57A, 0.7733, 3.12, 0.239, 333, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z-HYMENIALDISINE
3285, 6brcA, 0.7732, 3.09, 0.227, 265, 255, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH AP26113-ANALOG (ALK-IN-1)
3286, 5n1oA, 0.7732, 2.98, 0.234, 335, 252, CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-4-(CHLOROMETHYL)-5- HYDROXYPHENYL)ETHAN-1-ONE
3287, 5lvpC, 0.7732, 2.94, 0.238, 275, 252, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3288, 5jzjA, 0.7732, 2.75, 0.227, 271, 251, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH AMPPN
3289, 4eokA, 0.7732, 2.70, 0.207, 293, 251, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
3290, 3ionA, 0.7732, 2.82, 0.216, 274, 250, PDK1 IN COMPLEX WITH COMPOUND 8H
3291, 3e3bX, 0.7732, 3.14, 0.201, 334, 259, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2ALPHA PRIME WITH A POTENT INDAZOLE-DERIVATIVE INHIBITOR
3292, 2y9qA, 0.7732, 3.11, 0.211, 349, 256, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
3293, 2iw9C, 0.7732, 2.83, 0.209, 268, 253, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
3294, 2c6tC, 0.7732, 2.86, 0.205, 295, 254, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
3295, 1ol2A, 0.7732, 2.91, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
3296, 5v61A, 0.7731, 3.23, 0.212, 348, 259, PHOSPHO-ERK2 BOUND TO BIVALENT INHIBITOR SBP2
3297, 5otlB, 0.7731, 3.21, 0.197, 326, 259, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 29
3298, 5otiA, 0.7731, 3.27, 0.192, 327, 260, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 27
3299, 4nzwB, 0.7731, 2.74, 0.267, 266, 247, CRYSTAL STRUCTURE OF STK25-MO25 COMPLEX
3300, 4b8mB, 0.7731, 3.08, 0.210, 279, 257, AURORA B KINASE IN COMPLEX WITH VX-680
3301, 3zrmB, 0.7731, 3.05, 0.230, 347, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK- 3BETA INHIBITORS
3302, 3fztA, 0.7731, 2.65, 0.361, 259, 249, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
3303, 3f5xC, 0.7731, 3.04, 0.215, 298, 256, CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3304, 3ej1C, 0.7731, 2.81, 0.213, 294, 253, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3305, 1pkdC, 0.7731, 2.94, 0.204, 296, 255, THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A
3306, 1na7A, 0.7731, 3.14, 0.189, 326, 259, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2
3307, 6fyvA, 0.7730, 3.01, 0.224, 329, 254, X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A 
3308, 4u6rA, 0.7730, 2.94, 0.220, 403, 255, CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC DOMAINS IN COMPLEX WITH A SULFONAMIDE INHIBITOR.
3309, 4l01A, 0.7730, 2.78, 0.233, 274, 253, CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN
3310, 2uzdC, 0.7730, 2.88, 0.205, 295, 254, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
3311, 2iw6A, 0.7730, 2.83, 0.213, 292, 253, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
3312, 1pkdA, 0.7730, 2.95, 0.204, 296, 255, THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A
3313, 5ot5A, 0.7729, 3.11, 0.198, 326, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 24
3314, 5mowA, 0.7729, 3.11, 0.190, 328, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3315, 5cu3A, 0.7729, 3.02, 0.191, 325, 257, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 10 BOUND
3316, 3tz9A, 0.7729, 2.63, 0.337, 261, 246, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130
3317, 3tnwC, 0.7729, 2.79, 0.206, 291, 253, STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508
3318, 3c4cA, 0.7729, 2.46, 0.255, 258, 247, B-RAF KINASE IN COMPLEX WITH PLX4720
3319, 2pe1A, 0.7729, 2.84, 0.223, 275, 251, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-23-DIHYDRO-1H- INDOL-5-YL}-UREA {BX-517} COMPLEX
3320, 6ft8A, 0.7728, 3.13, 0.239, 338, 255, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 8G 
3321, 5v60A, 0.7728, 3.19, 0.213, 347, 258, PHOSPHO-ERK2 BOUND TO AMP-PCP
3322, 5t5tA, 0.7728, 2.85, 0.272, 368, 254, AMPK BOUND TO ALLOSTERIC ACTIVATOR
3323, 5hhwA, 0.7728, 2.82, 0.321, 306, 252, CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH CIS-(R)-7-(3-(AZETIDIN-1-YLMETHYL)CYCLOBUTYL)-5-(3-((TETRAHYDRO-2H- PYRAN-2-YL)METHOXY)PHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE.
3324, 5g15A, 0.7728, 3.21, 0.222, 265, 257, STRUCTURE AURORA A (122-403) BOUND TO ACTIVATING MONOBODY MB1 AND AMPPCP
3325, 4nttB, 0.7728, 3.00, 0.251, 339, 255, STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE BOUND TO ADP AND ONE MAGNESIUM ION
3326, 4eojA, 0.7728, 2.85, 0.225, 295, 253, THR 160 PHOSPHORYLATED CDK2 H84S Q85M K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP
3327, 4cfwA, 0.7728, 3.08, 0.210, 299, 257, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3328, 4cfeC, 0.7728, 2.81, 0.272, 403, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3329, 3qcyA, 0.7728, 2.85, 0.215, 275, 251, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 4-[2- AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-N-PHENYL-2- MORPHOLINECARBOXAMIDE
3330, 3f3zA, 0.7728, 3.02, 0.210, 271, 257, CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840 IN PRESENCE OF INDIRUBIN E804
3331, 3ddqA, 0.7728, 2.82, 0.206, 296, 253, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3332, 2gphA, 0.7728, 3.16, 0.209, 345, 258, DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2
3333, 1h25A, 0.7728, 2.93, 0.204, 293, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
3334, 6g33B, 0.7727, 2.98, 0.209, 337, 253, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
3335, 5w7tA, 0.7727, 2.96, 0.241, 276, 253, STRUCTURE OF PHOSPHORYLATED WNK1 
3336, 4eooA, 0.7727, 2.85, 0.217, 294, 253, THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
3337, 4ebwA, 0.7727, 2.74, 0.359, 259, 248, STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
3338, 3qriB, 0.7727, 2.48, 0.343, 262, 245, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC- 2036
3339, 1xr1A, 0.7727, 2.70, 0.225, 277, 249, CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION
3340, 1j91B, 0.7727, 2.97, 0.183, 327, 257, CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4567- TETRABROMOBENZOTRIAZOLE
3341, 1h27A, 0.7727, 2.94, 0.204, 296, 255, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
3342, 1fmkA, 0.7727, 2.54, 0.336, 437, 247, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
3343, 5mp8B, 0.7726, 3.02, 0.199, 323, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0432 BOUND
3344, 4pdoB, 0.7726, 2.41, 0.321, 261, 243, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
3345, 3qrkA, 0.7726, 2.64, 0.347, 270, 248, THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP- 987
3346, 2bpmC, 0.7726, 3.06, 0.214, 299, 257, STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
3347, 5b0xA, 0.7725, 3.21, 0.188, 329, 260, CRYSTAL STRUCTURE OF THE CK2A/BENZOIC ACID DERIVATIVE COMPLEX
3348, 4zhxA, 0.7725, 2.85, 0.272, 408, 254, NOVEL BINDING SITE FOR ALLOSTERIC ACTIVATION OF AMPK
3349, 4qfgA, 0.7725, 2.85, 0.272, 365, 254, STRUCTURE OF AMPK IN COMPLEX WITH STAUROSPORINE INHIBITOR AND IN THE ABSENCE OF A SYNTHETIC ACTIVATOR
3350, 4cffA, 0.7725, 2.82, 0.272, 424, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A THIENOPYRIDONE DERIVATIVE (A-769662)
3351, 3dlsE, 0.7725, 3.00, 0.241, 282, 253, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3352, 2r7iB, 0.7725, 2.96, 0.193, 322, 254, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3353, 6fnfA, 0.7724, 2.56, 0.309, 267, 246, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH NVP-BHG712 
3354, 5y9mA, 0.7724, 3.07, 0.202, 320, 257, CRYSTAL STRUCTURE OF CK2A2 FORM 3 
3355, 5j1wC, 0.7724, 3.15, 0.227, 316, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
3356, 4pdoA, 0.7724, 2.42, 0.321, 261, 243, STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2
3357, 2qokA, 0.7724, 3.11, 0.319, 281, 254, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:S768A TRIPLE MUTANT
3358, 4eorC, 0.7723, 2.88, 0.209, 270, 254, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
3359, 3jy0A, 0.7723, 2.65, 0.226, 275, 248, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3360, 1h26C, 0.7723, 2.84, 0.209, 267, 253, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
3361, 5movA, 0.7722, 3.14, 0.189, 325, 259, CRYSTAL STRUCTURE OF CK2ALPHA WITH ZT0633 BOUND
3362, 4cffC, 0.7722, 2.84, 0.272, 422, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A THIENOPYRIDONE DERIVATIVE (A-769662)
3363, 4bicA, 0.7722, 2.59, 0.239, 260, 247, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3364, 2pmnX, 0.7722, 3.09, 0.190, 340, 258, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH AN ATP-SITE INHIBITOR
3365, 2iw8C, 0.7722, 2.79, 0.214, 265, 252, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V- H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
3366, 4u43A, 0.7721, 2.77, 0.215, 287, 251, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 6)
3367, 3owjA, 0.7721, 2.93, 0.180, 328, 255, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A PYRIDOCARBAZOLE DERIVATIVE INHIBITOR
3368, 3dlsF, 0.7721, 2.98, 0.241, 281, 253, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3369, 3dlsA, 0.7721, 2.96, 0.232, 285, 254, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3370, 2r7iD, 0.7721, 2.96, 0.197, 322, 254, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3371, 2pe2A, 0.7721, 2.86, 0.223, 275, 251, CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-12-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H- PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX
3372, 1okwA, 0.7721, 2.93, 0.208, 296, 255, CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
3373, 5sysB, 0.7720, 2.41, 0.333, 258, 243, C-SRC V281C BOUND TO N-[3-({6-[(1E)-2-CYANO-3-(METHYLAMINO)-3-OXOPROP- 1-EN-1-YL]-7-(2-METHOXYETHYL)-7H-PYRROLO[23-D]PYRIMIDIN-5- YL}ETHYNYL)-4-METHYLPHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE INHIBITOR
3374, 5cs6A, 0.7720, 2.95, 0.189, 327, 254, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 3 BOUND
3375, 4ybjB, 0.7720, 2.20, 0.342, 253, 240, TYPE II DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE
3376, 3ggfB, 0.7720, 2.76, 0.263, 270, 251, CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE MST4 IN COMPLEX WITH AN QUINAZOLIN
3377, 5l8kA, 0.7719, 3.04, 0.215, 266, 256, AURORA-A KINASE DOMAIN IN COMPLEX WITH VNAR-D01 (CRYSTAL FORM 2)
3378, 4nstA, 0.7719, 3.11, 0.263, 322, 259, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3379, 4ibmA, 0.7719, 2.92, 0.317, 301, 252, CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH AN INHIBITOR IRFIN-1
3380, 4h3qA, 0.7719, 3.13, 0.202, 352, 257, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
3381, 4byiA, 0.7719, 2.84, 0.241, 254, 249, AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
3382, 3owlA, 0.7719, 3.07, 0.182, 330, 258, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3383, 1mruB, 0.7719, 2.75, 0.229, 271, 249, INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
3384, 6ft9C, 0.7718, 3.07, 0.224, 337, 254, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
3385, 5efqA, 0.7718, 3.09, 0.256, 321, 258, CRYSTAL STRUCTURE OF HUMAN CDK13/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3386, 4fk3B, 0.7718, 2.70, 0.276, 257, 250, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
3387, 3d5xA, 0.7718, 2.97, 0.253, 279, 253, CRYSTAL STRUCTURE OF AN ACTIVATED (THR->ASP) POLO-LIKE KINASE 1 (PLK1) CATALYTIC DOMAIN IN COMPLEX WITH WORTMANNIN.
3388, 2zv2A, 0.7718, 2.81, 0.232, 256, 250, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2 BETA CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609
3389, 2wmaA, 0.7718, 3.02, 0.220, 296, 255, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3390, 2pvrA, 0.7718, 3.17, 0.189, 328, 259, CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C- TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS
3391, 5v62A, 0.7717, 3.43, 0.214, 349, 262, PHOSPHO-ERK2 BOUND TO BIVALENT INHIBITOR SBP3
3392, 5othA, 0.7717, 3.14, 0.198, 326, 258, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 26
3393, 5lmkA, 0.7717, 2.83, 0.206, 296, 253, STRUCTURE OF PHOPSHO-CDK2-CYCLIN A IN COMPLEX WITH AN ATP-COMPETITIVE INHIBITOR
3394, 5ia0A, 0.7717, 2.63, 0.316, 263, 247, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH ALISERTIB (MLN8237)
3395, 5he0A, 0.7717, 3.30, 0.195, 621, 261, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG215022
3396, 5cu6A, 0.7717, 3.20, 0.189, 327, 259, CRYSTAL STRUCTURE OF CK2ALPHA
3397, 4c2vB, 0.7717, 3.00, 0.211, 280, 256, AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB
3398, 3eocC, 0.7717, 2.76, 0.206, 293, 252, CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE
3399, 2qq7A, 0.7717, 1.94, 0.352, 251, 236, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
3400, 2pmoX, 0.7717, 3.07, 0.190, 340, 258, CRYSTAL STRUCTURE OF PFPK7 IN COMPLEX WITH HYMENIALDISINE
3401, 2fysA, 0.7717, 3.22, 0.189, 348, 259, CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3
3402, 6es0B, 0.7716, 2.57, 0.263, 287, 247, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE ACTIVATION LOOP TARGETING INHIBITOR CS-R35
3403, 6e4wA, 0.7716, 2.89, 0.272, 361, 254, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
3404, 6e4tA, 0.7716, 2.88, 0.272, 361, 254, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
3405, 5aafA, 0.7716, 2.77, 0.242, 254, 248, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14A)
3406, 4nksA, 0.7716, 2.66, 0.367, 265, 248, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3
3407, 4iz5D, 0.7716, 3.12, 0.206, 347, 257, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3408, 4iz5C, 0.7716, 3.12, 0.206, 347, 257, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3409, 3piyA, 0.7716, 2.52, 0.335, 262, 245, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406
3410, 3fxzA, 0.7716, 3.39, 0.214, 292, 262, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX LAMBDA-FL172
3411, 2qobA, 0.7716, 2.98, 0.304, 279, 253, HUMAN EPHA3 KINASE DOMAIN BASE STRUCTURE
3412, 1h25C, 0.7716, 2.86, 0.206, 278, 253, CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
3413, 5li9A, 0.7715, 3.20, 0.198, 329, 257, STRUCTURE OF A NUCLEOTIDE-BOUND FORM OF PKCIOTA CORE KINASE DOMAIN
3414, 5ezvA, 0.7715, 2.88, 0.268, 441, 254, X-RAY CRYSTAL STRUCTURE OF AMP-ACTIVATED PROTEIN KINASE ALPHA-2/ALPHA- 1 RIM CHIMAERA (ALPHA-2(1-347)/ALPHA-1(349-401)/ALPHA-2(397-END) BETA-1 GAMMA-1) CO-CRYSTALLIZED WITH C2 (5-(5-HYDROXYL-ISOXAZOL-3- YL)-FURAN-2-PHOSPHONIC ACID)
3415, 4iz5B, 0.7715, 3.12, 0.206, 347, 257, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3416, 4iz5A, 0.7715, 3.13, 0.206, 347, 257, STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
3417, 3zewB, 0.7715, 2.42, 0.288, 252, 243, CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE
3418, 3dogC, 0.7715, 2.81, 0.210, 267, 252, STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3419, 6fyoA, 0.7714, 3.17, 0.231, 331, 255, X-RAY STRUCTURE OF CLK1-KD(148-484)/CPD-2 AT 2.32A 
3420, 6fngA, 0.7714, 2.67, 0.308, 277, 247, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH AN ISOMER OF NVP-BHG712 
3421, 4c57A, 0.7714, 3.10, 0.211, 310, 256, STRUCTURE OF GAK KINASE IN COMPLEX WITH A NANOBODY
3422, 3qd2B, 0.7714, 2.81, 0.195, 271, 251, CRSYTAL STRUCTURE OF MOUSE PERK KINASE DOMAIN
3423, 3el7A, 0.7714, 2.10, 0.339, 254, 239, CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 3
3424, 1h24C, 0.7714, 2.97, 0.204, 293, 255, CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
3425, 1csnA, 0.7714, 3.44, 0.174, 293, 265, BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP
3426, 5jsmD, 0.7713, 2.46, 0.267, 259, 247, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-3-VEM
3427, 5isoA, 0.7713, 2.86, 0.267, 453, 255, STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3428, 4nm0A, 0.7713, 3.13, 0.230, 356, 257, CRYSTAL STRUCTURE OF PEPTIDE INHIBITOR-FREE GSK-3/AXIN COMPLEX
3429, 4nifE, 0.7713, 3.17, 0.214, 348, 257, HETERODIMERIC STRUCTURE OF ERK2 AND RSK1
3430, 3owkA, 0.7713, 3.17, 0.189, 330, 259, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3431, 1oiuC, 0.7713, 2.82, 0.210, 265, 252, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
3432, 5vcwB, 0.7712, 3.06, 0.231, 285, 255, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PELITINIB
3433, 4zy4A, 0.7712, 3.09, 0.222, 288, 257, CRYSTAL STRUCTURE OF P21 ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 4
3434, 4qteA, 0.7712, 3.21, 0.202, 348, 258, STRUCTURE OF ERK2 IN COMPLEX WITH VTX-11E 4-{2-[(2-CHLORO-4- FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3- CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE
3435, 4nifB, 0.7712, 3.18, 0.214, 349, 257, HETERODIMERIC STRUCTURE OF ERK2 AND RSK1
3436, 4gk2A, 0.7712, 2.81, 0.309, 265, 249, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 66
3437, 3qd4A, 0.7712, 2.83, 0.216, 276, 250, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 11- DIMETHYLETHYL{(3R5R)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4- PYRIMIDINYL]-5-METHYL-3-PIPERIDINYL}CARBAMATE
3438, 3nr9A, 0.7712, 3.17, 0.216, 341, 255, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
3439, 2vgpB, 0.7712, 3.18, 0.198, 277, 258, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
3440, 5v24B, 0.7711, 2.72, 0.233, 263, 249, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
3441, 4u42A, 0.7711, 2.56, 0.226, 282, 248, MAP4K4 T181E MUTANT BOUND TO INHIBITOR COMPOUND 1
3442, 4mk0A, 0.7711, 3.27, 0.184, 631, 261, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH A A RATIONALLY DESIGNED PAROXETINE DERIVATIVE
3443, 3o17B, 0.7711, 3.18, 0.201, 357, 259, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM
3444, 3cjfA, 0.7711, 2.98, 0.336, 276, 250, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 345-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3445, 2rl5A, 0.7711, 2.91, 0.340, 294, 250, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 23-DIHYDRO-14-BENZOXAZINE INHIBITOR
3446, 6gihA, 0.7710, 3.10, 0.191, 324, 256, CRYSTAL STRUCTURE OF CK2ALPHA WITH CAM187 BOUND 
3447, 5lpzA, 0.7710, 2.84, 0.252, 283, 250, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1196) IN COMPLEX WITH ADP FROM ARABIDOPSIS THALIANA
3448, 2wu6A, 0.7710, 3.20, 0.180, 350, 256, CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI
3449, 1oiyA, 0.7710, 2.84, 0.217, 293, 253, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
3450, 6g33C, 0.7709, 3.18, 0.231, 336, 255, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
3451, 5hesB, 0.7709, 2.20, 0.329, 278, 240, HUMAN LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE (ZAK MLT HCCS-4 MRK AZK MLTK) IN COMPLEX WITH VEMURAFENIB
3452, 3rawA, 0.7709, 3.07, 0.197, 351, 254, CRYSTAL STRUCTURE OF HUMAN CDC-LIKE KINASE 3 ISOFORM IN COMPLEX WITH LEUCETTINE L41
3453, 3ddqC, 0.7709, 2.82, 0.210, 266, 252, STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3454, 2vwvA, 0.7709, 2.62, 0.276, 255, 246, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3455, 6c4dB, 0.7708, 2.56, 0.291, 266, 247, STRUCTURE BASED DESIGN OF RIP1 KINASE INHIBITORS
3456, 5w5oM, 0.7708, 2.28, 0.251, 276, 243, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3457, 4lueB, 0.7708, 2.05, 0.356, 417, 236, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
3458, 4gt4B, 0.7708, 2.69, 0.274, 273, 248, STRUCTURE OF UNLIGANDED INACTIVE ROR2 KINASE DOMAIN
3459, 3sayB, 0.7708, 3.09, 0.230, 347, 256, CRYSTAL STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH INHIBITOR 142
3460, 3qgwB, 0.7708, 2.10, 0.321, 240, 237, CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
3461, 3ctjA, 0.7708, 2.95, 0.323, 289, 251, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3462, 2r7iC, 0.7708, 2.93, 0.198, 321, 253, CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3463, 5vamA, 0.7707, 3.01, 0.255, 269, 255, BRAF IN COMPLEX WITH RAF709
3464, 3nayB, 0.7707, 2.74, 0.216, 278, 250, PDK1 IN COMPLEX WITH INHIBITOR MP6
3465, 3gqlC, 0.7707, 2.91, 0.382, 275, 251, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3466, 1uu3A, 0.7707, 2.97, 0.226, 276, 252, STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531
3467, 5xfjA, 0.7706, 2.71, 0.355, 266, 248, CRYSTAL STRUCTURE OF LY2874455 IN COMPLEX OF FGFR4 GATEKEEPER MUTATION (V550M) 
3468, 3tz9B, 0.7706, 2.42, 0.321, 259, 243, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130
3469, 3tl8A, 0.7706, 2.89, 0.266, 300, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3470, 6e4uA, 0.7705, 2.89, 0.272, 365, 254, STRUCTURE OF AMPK BOUND TO ACTIVATOR 
3471, 5o0yA, 0.7705, 3.38, 0.223, 288, 265, TLK2 KINASE DOMAIN FROM HUMAN 
3472, 5itaB, 0.7705, 2.30, 0.258, 252, 244, CRYSTAL STRUCTURE OF BRAF KINASE DOMAIN BOUND TO AZ-VEM
3473, 3mb7A, 0.7705, 3.18, 0.185, 330, 259, HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (AMR)
3474, 1pyxA, 0.7705, 3.11, 0.233, 343, 257, GSK-3 BETA COMPLEXED WITH AMP-PNP
3475, 5uoxA, 0.7704, 2.84, 0.232, 263, 250, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
3476, 5he2A, 0.7704, 3.32, 0.199, 628, 261, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224406
3477, 3ztxA, 0.7704, 3.03, 0.216, 269, 255, AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN.
3478, 2henB, 0.7704, 2.69, 0.296, 259, 247, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
3479, 5hlnB, 0.7703, 3.13, 0.236, 346, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021
3480, 4c2wB, 0.7703, 3.02, 0.211, 277, 256, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH AMP-PNP
3481, 3f3wB, 0.7703, 2.53, 0.331, 260, 245, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR RL45 (TYPE II)
3482, 1okvA, 0.7703, 2.93, 0.204, 295, 255, CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
3483, 5vd1A, 0.7702, 3.11, 0.228, 295, 254, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PHA- 848125
3484, 5lmkC, 0.7702, 2.75, 0.211, 265, 251, STRUCTURE OF PHOPSHO-CDK2-CYCLIN A IN COMPLEX WITH AN ATP-COMPETITIVE INHIBITOR
3485, 5hkmA, 0.7702, 2.80, 0.217, 272, 249, DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS
3486, 4apcB, 0.7702, 2.77, 0.203, 296, 251, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1)
3487, 3zrkA, 0.7702, 3.10, 0.230, 345, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3488, 3qd0A, 0.7702, 2.96, 0.227, 274, 251, PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH (2R5S)- 1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-N- PHENYL-3-PIPERIDINECARBOXAMIDE
3489, 3f5xA, 0.7702, 3.04, 0.216, 297, 255, CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3490, 2og8A, 0.7702, 2.34, 0.357, 246, 241, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
3491, 5kq5A, 0.7701, 2.89, 0.272, 362, 254, AMPK BOUND TO ALLOSTERIC ACTIVATOR
3492, 5j1wA, 0.7701, 3.19, 0.231, 338, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
3493, 1q5kA, 0.7701, 3.12, 0.230, 345, 257, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
3494, 1mruA, 0.7701, 2.72, 0.234, 269, 248, INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
3495, 6fykA, 0.7700, 3.19, 0.216, 349, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
3496, 5vcxA, 0.7700, 3.07, 0.221, 287, 253, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (UNTREATED) IN COMPLEX WITH SARACATINIB
3497, 5lihB, 0.7700, 2.71, 0.202, 318, 248, STRUCTURE OF A PEPTIDE-SUBSTRATE BOUND TO PKCIOTA CORE KINASE DOMAIN
3498, 5itaA, 0.7700, 2.32, 0.263, 250, 243, CRYSTAL STRUCTURE OF BRAF KINASE DOMAIN BOUND TO AZ-VEM
3499, 4prjA, 0.7700, 2.58, 0.229, 251, 245, AURORA A KINASE DOMAIN WITH COMPOUND 2 (N-[1-(3-CYANOBENZYL)-1H- PYRAZOL-4-YL]-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)
3500, 4cfeA, 0.7700, 2.85, 0.272, 425, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR A BENZIMIDAZOLE DERIVATIVE (991)
3501, 3sdjK, 0.7700, 2.87, 0.230, 422, 252, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3502, 3sdjD, 0.7700, 2.87, 0.230, 422, 252, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3503, 3pvuA, 0.7700, 3.21, 0.184, 609, 261, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD101)
3504, 2i0eA, 0.7700, 3.04, 0.239, 326, 255, STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
3505, 2csnA, 0.7700, 3.50, 0.173, 293, 266, BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7
3506, 1j1bA, 0.7700, 3.13, 0.230, 354, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
3507, 4yc3A, 0.7699, 3.07, 0.211, 295, 256, CDK1/CYCLINB1/CKS2 APO
3508, 4qfsA, 0.7699, 2.90, 0.272, 361, 254, STRUCTURE OF AMPK IN COMPLEX WITH BR2-A769662CORE ACTIVATOR AND STAUROSPORINE INHIBITOR
3509, 3fbvK, 0.7699, 2.85, 0.218, 422, 252, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3510, 3dpkA, 0.7699, 2.93, 0.339, 279, 248, CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3511, 2henD, 0.7699, 2.70, 0.296, 259, 247, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
3512, 5jznB, 0.7698, 2.78, 0.227, 266, 251, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH NVP-TAE684
3513, 5j1wB, 0.7698, 3.20, 0.231, 337, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW31 (COMPOUND 14)
3514, 4qnyA, 0.7698, 3.04, 0.207, 333, 256, CRYSTAL STRUCTURE OF MAPK FROM LEISHMANIA DONOVANI LDBPK_331470
3515, 4qfrA, 0.7698, 2.89, 0.272, 361, 254, STRUCTURE OF AMPK IN COMPLEX WITH CL-A769662 ACTIVATOR AND STAUROSPORINE INHIBITOR
3516, 4neuA, 0.7698, 2.97, 0.287, 286, 254, X-RAY STRUCTURE OF RECEPTOR INTERACTING PROTEIN 1 (RIP1)KINASE DOMAIN WITH A 1-AMINOISOQUINOLINE INHIBITOR
3517, 4c8bB, 0.7698, 2.33, 0.235, 281, 243, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH PONATINIB
3518, 3u4uA, 0.7698, 3.14, 0.186, 327, 258, CASEIN KINASE 2 IN COMPLEX WITH AZ-INHIBITOR
3519, 3tl8H, 0.7698, 2.93, 0.266, 303, 252, THE AVRPTOB-BAK1 COMPLEX REVEALS TWO STRUCTURALLY SIMILAR KINASEINTERACTING DOMAINS IN A SINGLE TYPE III EFFECTOR
3520, 3rawB, 0.7698, 3.09, 0.197, 349, 254, CRYSTAL STRUCTURE OF HUMAN CDC-LIKE KINASE 3 ISOFORM IN COMPLEX WITH LEUCETTINE L41
3521, 3fy0A, 0.7698, 3.40, 0.207, 292, 261, CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX DW1
3522, 2iw9A, 0.7698, 2.82, 0.218, 293, 252, STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
3523, 5vd3A, 0.7697, 3.00, 0.233, 293, 253, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (DE-PHOSPHORYLATED) IN COMPLEX WITH SARACATINIB
3524, 5vczA, 0.7697, 3.03, 0.228, 294, 254, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB ISOMER
3525, 5uq2A, 0.7697, 3.05, 0.211, 296, 256, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
3526, 4cfvC, 0.7697, 2.79, 0.207, 264, 251, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3527, 4c57B, 0.7697, 3.11, 0.215, 308, 256, STRUCTURE OF GAK KINASE IN COMPLEX WITH A NANOBODY
3528, 3sdmG, 0.7697, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3529, 3sdmD, 0.7697, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3530, 3sdmC, 0.7697, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3531, 3sdmA, 0.7697, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3532, 3s95A, 0.7697, 3.03, 0.269, 290, 253, CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
3533, 3pfqA, 0.7697, 3.03, 0.244, 520, 254, CRYSTAL STRUCTURE AND ALLOSTERIC ACTIVATION OF PROTEIN KINASE C BETA II
3534, 3fbvC, 0.7697, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3535, 5ufuA, 0.7696, 2.90, 0.272, 368, 254, STRUCTURE OF AMPK BOUND TO ACTIVATOR
3536, 5mxxA, 0.7696, 3.37, 0.196, 361, 260, CRYSTAL STRUCTURE OF HUMAN SR PROTEIN KINASE 1 (SRPK1) IN COMPLEX WITH COMPOUND 1
3537, 5cvfA, 0.7696, 3.16, 0.209, 325, 258, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 5 BOUND
3538, 3sdmF, 0.7696, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3539, 3sdmE, 0.7696, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3540, 3sdmB, 0.7696, 2.81, 0.231, 415, 251, STRUCTURE OF OLIGOMERIC KINASE/RNASE IRE1 IN COMPLEX WITH AN OLIGONUCLEOTIDE
3541, 3fbvB, 0.7696, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3542, 3cpbB, 0.7696, 2.58, 0.337, 263, 243, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
3543, 5w5oL, 0.7695, 2.43, 0.262, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3544, 4qnyB, 0.7695, 3.09, 0.206, 339, 257, CRYSTAL STRUCTURE OF MAPK FROM LEISHMANIA DONOVANI LDBPK_331470
3545, 4nstC, 0.7695, 3.15, 0.251, 317, 259, CRYSTAL STRUCTURE OF HUMAN CDK12/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3546, 4kd1A, 0.7695, 3.02, 0.225, 298, 253, CDK2 IN COMPLEX WITH DINACICLIB
3547, 4gcjA, 0.7695, 2.84, 0.204, 304, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
3548, 3fbvM, 0.7695, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3549, 3fbvL, 0.7695, 2.82, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3550, 3fbvH, 0.7695, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3551, 3fbvG, 0.7695, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3552, 3fbvA, 0.7695, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3553, 1h24A, 0.7695, 3.00, 0.204, 293, 255, CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
3554, 5j79B, 0.7694, 2.45, 0.261, 277, 245, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE COMPOUND 3 COMPLEX
3555, 4bicB, 0.7694, 2.52, 0.236, 259, 246, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3556, 3fbvN, 0.7694, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3557, 3fbvF, 0.7694, 2.81, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3558, 3fbvE, 0.7694, 2.82, 0.231, 415, 251, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3559, 3a99A, 0.7694, 2.69, 0.234, 273, 248, STRUCTURE OF PIM-1 KINASE CRYSTALLIZED IN THE PRESENCE OF P27KIP1 CARBOXY-TERMINAL PEPTIDE
3560, 2zoqB, 0.7694, 3.37, 0.203, 351, 261, STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
3561, 2gsfA, 0.7694, 2.92, 0.307, 281, 251, THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
3562, 1pyxB, 0.7694, 3.12, 0.233, 338, 257, GSK-3 BETA COMPLEXED WITH AMP-PNP
3563, 5w5oO, 0.7693, 2.31, 0.251, 276, 243, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3564, 4c2vA, 0.7693, 2.91, 0.205, 270, 254, AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB
3565, 3sdjB, 0.7693, 2.81, 0.231, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3566, 3nayA, 0.7693, 2.77, 0.216, 278, 250, PDK1 IN COMPLEX WITH INHIBITOR MP6
3567, 3l1sB, 0.7693, 3.13, 0.233, 330, 257, 3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
3568, 3fbvD, 0.7693, 2.86, 0.218, 422, 252, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3569, 3eidA, 0.7693, 2.75, 0.208, 292, 250, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3570, 3a8wA, 0.7693, 3.09, 0.199, 326, 256, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3571, 2o3pA, 0.7693, 2.71, 0.234, 274, 248, CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN
3572, 2cjmC, 0.7693, 2.94, 0.205, 294, 254, MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
3573, 5bvoA, 0.7692, 2.85, 0.359, 276, 251, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
3574, 5aagA, 0.7692, 2.74, 0.243, 253, 247, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14B)
3575, 4nu1A, 0.7692, 3.10, 0.233, 356, 257, CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N-TERMINAL AUTO-INHIBITORY PS9 PEPTIDE
3576, 3zdiA, 0.7692, 3.00, 0.224, 348, 255, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE AND INHIBITOR 7D
3577, 2r7bA, 0.7692, 2.84, 0.220, 274, 250, CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE- 1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR
3578, 6c4dC, 0.7691, 2.34, 0.292, 258, 243, STRUCTURE BASED DESIGN OF RIP1 KINASE INHIBITORS
3579, 5telA, 0.7691, 2.70, 0.230, 273, 248, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
3580, 5l6oA, 0.7691, 2.54, 0.287, 267, 244, EPHB3 KINASE DOMAIN COVALENTLY BOUND TO AN IRREVERSIBLE INHIBITOR (COMPOUND 3)
3581, 3sdjH, 0.7691, 2.82, 0.231, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3582, 3sdjF, 0.7691, 2.82, 0.231, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3583, 3jyaA, 0.7691, 2.71, 0.238, 274, 248, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3584, 2nryA, 0.7691, 3.04, 0.259, 286, 251, CRYSTAL STRUCTURE OF IRAK-4
3585, 2clqB, 0.7691, 2.53, 0.232, 259, 246, STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2 5
3586, 2aypA, 0.7691, 3.45, 0.256, 268, 258, CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR
3587, 1k9aC, 0.7691, 2.75, 0.379, 438, 248, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
3588, 1e9hA, 0.7691, 2.95, 0.205, 295, 254, THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
3589, 5efqC, 0.7690, 3.13, 0.256, 325, 258, CRYSTAL STRUCTURE OF HUMAN CDK13/CYCLIN K IN COMPLEX WITH ADP-ALUMINUM FLUORIDE
3590, 3sdjN, 0.7690, 2.82, 0.231, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3591, 3sdjM, 0.7690, 2.82, 0.231, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3592, 3nr9B, 0.7690, 3.10, 0.220, 347, 254, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
3593, 5vcyA, 0.7689, 3.14, 0.227, 296, 255, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB
3594, 5ar8B, 0.7689, 2.24, 0.256, 274, 242, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIPHENYLSULFONAMIDE
3595, 2o64A, 0.7689, 2.82, 0.225, 274, 249, CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN
3596, 6fykB, 0.7688, 3.05, 0.209, 349, 253, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
3597, 5uvcA, 0.7688, 3.37, 0.206, 457, 262, DESIGN SYNTHESIS AND EVALUATION OF THE FIRST SELECTIVE AND POTENT G- PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE
3598, 5jgbA, 0.7688, 2.30, 0.264, 295, 242, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 10
3599, 3sdjC, 0.7688, 2.80, 0.223, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3600, 3o2mB, 0.7688, 3.28, 0.197, 358, 259, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
3601, 3nieA, 0.7688, 3.57, 0.203, 369, 261, CRYSTAL STRUCTURE OF PF11_0147
3602, 3a8wB, 0.7688, 3.11, 0.207, 327, 256, CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3603, 2fumA, 0.7688, 2.73, 0.225, 263, 249, CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
3604, 6es0A, 0.7687, 2.73, 0.246, 288, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE ACTIVATION LOOP TARGETING INHIBITOR CS-R35
3605, 6bqlA, 0.7687, 3.29, 0.230, 278, 256, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH TAE-226
3606, 5u6iA, 0.7687, 3.33, 0.203, 339, 261, DISCOVERY OF MLI-2 AN ORALLY AVAILABLE AND SELECTIVE LRRK2 INHIBITOR THAT REDUCES BRAIN KINASE ACTIVITY
3607, 5o26A, 0.7687, 3.02, 0.245, 271, 257, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A DIPHOSPHORYLATED STATE AND IN COMPLEX WITH AMP-PNP/MG2+
3608, 5ci7A, 0.7687, 3.20, 0.268, 276, 257, STRUCTURE OF ULK1 BOUND TO A SELECTIVE INHIBITOR
3609, 3t9iA, 0.7687, 2.60, 0.227, 273, 247, PIM1 COMPLEXED WITH A NOVEL 36-DISUBSTITUTED INDOLE AT 2.6 ANG RESOLUTION
3610, 3sdjA, 0.7687, 2.80, 0.223, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3611, 3m1sB, 0.7687, 3.13, 0.230, 349, 257, STRUCTURE OF RUTHENIUM HALF-SANDWICH COMPLEX BOUND TO GLYCOGEN SYNTHASE KINASE 3
3612, 3m1sA, 0.7687, 3.11, 0.230, 348, 257, STRUCTURE OF RUTHENIUM HALF-SANDWICH COMPLEX BOUND TO GLYCOGEN SYNTHASE KINASE 3
3613, 3c4yA, 0.7687, 3.38, 0.243, 478, 263, CRYSTAL STRUCTURE OF APO FORM OF G PROTEIN COUPLED RECEPTOR KINASE 1 AT 7.51A
3614, 2fumB, 0.7687, 2.66, 0.230, 262, 248, CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
3615, 1j1bB, 0.7687, 3.14, 0.230, 364, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
3616, 6gwrA, 0.7686, 3.35, 0.366, 300, 257, STRUCTURE OF THE KINASE DOMAIN OF HUMAN DDR1 IN COMPLEX WITH A POTENT AND SELECTIVE INHIBITOR OF DDR1 AND DDR2 
3617, 6g33A, 0.7686, 3.05, 0.222, 335, 252, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH 5-IODOTUBERCIDIN 
3618, 6fykC, 0.7686, 3.06, 0.209, 349, 253, X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A 
3619, 6ft9B, 0.7686, 3.20, 0.231, 337, 255, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
3620, 5ouuA, 0.7686, 3.05, 0.200, 324, 255, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 22
3621, 5j1vB, 0.7686, 3.24, 0.227, 337, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
3622, 4u40B, 0.7686, 3.00, 0.223, 299, 256, MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4 (MAP4K4) BOUND TO AMPPNP
3623, 4eoiA, 0.7686, 2.84, 0.222, 294, 252, THR 160 PHOSPHORYLATED CDK2 K89D Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
3624, 2oh4A, 0.7686, 3.24, 0.336, 297, 253, CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
3625, 2i0eB, 0.7686, 3.01, 0.239, 300, 255, STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
3626, 1yxvA, 0.7686, 2.71, 0.226, 274, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 34-DIHYDROXY-1- METHYLQUINOLIN-2(1H)-ONE
3627, 1j1cA, 0.7686, 3.15, 0.230, 354, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
3628, 4rvtA, 0.7685, 2.69, 0.238, 281, 248, MAP4K4 IN COMPLEX WITH A PYRIDIN-2(1H)-ONE DERIVATIVE
3629, 3sdjL, 0.7685, 2.82, 0.223, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3630, 3sdjG, 0.7685, 2.81, 0.223, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3631, 3sdjE, 0.7685, 2.81, 0.223, 415, 251, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3632, 3r01A, 0.7685, 2.71, 0.230, 274, 248, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3633, 2xyuA, 0.7685, 2.93, 0.312, 260, 250, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF 12058
3634, 2vgoB, 0.7685, 3.12, 0.191, 277, 257, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
3635, 1yolA, 0.7685, 2.29, 0.329, 256, 240, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
3636, 6fc8A, 0.7684, 3.30, 0.253, 269, 257, CHK1 KINASE IN COMPLEX WITH COMPOUND 13
3637, 5w5oI, 0.7684, 2.24, 0.252, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3638, 5j1vA, 0.7684, 3.23, 0.227, 338, 255, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
3639, 4o0uA, 0.7684, 2.82, 0.236, 259, 250, CRYSTAL STRUCTURES OF HUMAN KINASE AURORA A
3640, 4b9dB, 0.7684, 2.78, 0.203, 295, 251, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) WITH INHIBITOR.
3641, 3pvwA, 0.7684, 3.28, 0.199, 613, 261, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD103A)
3642, 3ii5A, 0.7684, 2.84, 0.268, 262, 250, THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3643, 2p2hA, 0.7684, 2.91, 0.332, 292, 250, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
3644, 2p0cA, 0.7684, 2.07, 0.338, 249, 237, CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
3645, 6b1uC, 0.7683, 2.88, 0.268, 459, 254, STRUCTURE OF FULL-LENGTH HUMAN AMPK (A2B1G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4 
3646, 5diaA, 0.7683, 2.72, 0.226, 273, 248, PIM1 IN COMPLEX WITH CPD36 ((1S3S)-N1-(6-(5-(PYRIDIN-3-YL)-1H- PYRAZOLO[34-C]PYRIDIN-3-YL)PYRIDIN-2-YL)CYCLOHEXANE-13-DIAMINE)
3647, 5clpA, 0.7683, 3.16, 0.200, 322, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH 34-DICHLOROPHENETHYLAMINE BOUND
3648, 4b7tA, 0.7683, 3.15, 0.230, 350, 257, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE AND LEUCETTINE L4
3649, 3d7tA, 0.7683, 2.41, 0.374, 249, 243, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3650, 5jgaA, 0.7682, 2.64, 0.286, 296, 245, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 11C
3651, 5bvnA, 0.7682, 2.91, 0.349, 278, 252, FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS
3652, 4zhxC, 0.7682, 2.88, 0.268, 452, 254, NOVEL BINDING SITE FOR ALLOSTERIC ACTIVATION OF AMPK
3653, 4cfmC, 0.7682, 2.82, 0.203, 266, 251, STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
3654, 3pj2A, 0.7682, 2.26, 0.318, 248, 242, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2- DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H- PYRIDO[23-D]PYRIMIDIN-7-ONE
3655, 3fdnA, 0.7682, 2.82, 0.233, 261, 249, STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
3656, 3dlsC, 0.7682, 2.84, 0.235, 281, 251, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3657, 2e9uA, 0.7682, 3.48, 0.256, 269, 258, STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
3658, 2e9oA, 0.7682, 3.57, 0.259, 269, 259, STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
3659, 2bfxA, 0.7682, 3.12, 0.215, 269, 256, MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
3660, 1yxxA, 0.7682, 2.72, 0.226, 274, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4- HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
3661, 1mqbA, 0.7682, 2.75, 0.321, 263, 249, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
3662, 1j1cB, 0.7682, 3.16, 0.230, 364, 257, BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
3663, 6ft9A, 0.7681, 3.19, 0.231, 336, 255, CRYSTAL STRUCTURE OF CLK1 IN COMPLEX WITH INHIBITOR 16 
3664, 5texA, 0.7681, 2.82, 0.237, 274, 249, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
3665, 5kggA, 0.7681, 2.72, 0.226, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 2-(5-CHLORANYL-1~{H}-INDOL- 3-YL)ETHANAMINE
3666, 3f88A, 0.7681, 3.04, 0.235, 340, 255, GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
3667, 6fylA, 0.7680, 3.18, 0.216, 340, 255, X-RAY STRUCTURE OF CLK2-KD(136-496)/CX-4945 AT 1.95A 
3668, 6c2yA, 0.7680, 3.27, 0.201, 617, 259, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257142 
3669, 4aluA, 0.7680, 2.72, 0.222, 274, 248, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
3670, 2qonA, 0.7680, 3.03, 0.311, 281, 251, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:Y742A TRIPLE MUTANT
3671, 1finC, 0.7680, 3.10, 0.215, 298, 256, CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
3672, 6b2eA, 0.7679, 2.89, 0.272, 442, 254, STRUCTURE OF FULL LENGTH HUMAN AMPK (A2B2G1) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR SC4. 
3673, 5yf9X, 0.7679, 3.05, 0.200, 319, 255, CRYSTAL STRUCTURE OF CK2A2 FORM-2 
3674, 5x5oA, 0.7679, 2.90, 0.320, 291, 247, CRYSTAL STRUCTURE OF ZAK IN COMPLEX WITH COMPOUND D2829
3675, 5ntjA, 0.7679, 3.03, 0.252, 346, 254, CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUND RKP032 
3676, 5lvpA, 0.7679, 3.01, 0.238, 275, 252, HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET
3677, 5kgeA, 0.7679, 2.72, 0.226, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 5-(34-DICHLOROPHENYL)- 1~{H}-PYRAZOL-3-AMINE
3678, 5he3A, 0.7679, 3.36, 0.195, 623, 261, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224411
3679, 4ztlD, 0.7679, 3.07, 0.267, 285, 251, IRAK4-INHIBITOR CO-STRUCTURE
3680, 4eorA, 0.7679, 2.79, 0.203, 293, 251, THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
3681, 3zrmA, 0.7679, 3.14, 0.230, 344, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK- 3BETA INHIBITORS
3682, 3zrlA, 0.7679, 3.15, 0.230, 345, 256, IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3683, 3nczB, 0.7679, 3.08, 0.209, 379, 254, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A POTENT 2H-ISOQUINOLIN-1-ONE INHIBITOR
3684, 3be2A, 0.7679, 2.96, 0.341, 290, 249, CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR
3685, 2bcjA, 0.7679, 3.36, 0.195, 624, 261, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS
3686, 5v80A, 0.7678, 2.72, 0.234, 273, 248, PIM1 KINASE IN COMPLEX WITH CPD1 (1-METHYL-4-(3-(6-(PIPERAZIN-1-YL) PYRIDIN-2-YL)-1H-PYRAZOLO[3;4-C]PYRIDIN-5-YL)PIPERAZIN-2-ONE) 
3687, 5dewA, 0.7678, 3.32, 0.223, 295, 260, CRYSTAL STRUCTURE OF PAK1 IN COMPLEX WITH AN INHIBITOR COMPOUND 5
3688, 4q9sA, 0.7678, 2.54, 0.358, 252, 246, CRYSTAL STRUCTURE OF HUMAN FOCAL ADHESION KINASE (FAK) BOUND TO COMPOUND1 (35-DIHYDRO[124]TRIAZINO[34-C][14]BENZOXAZIN-2(1H)- ONE)
3689, 4f9aC, 0.7678, 3.44, 0.195, 317, 261, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3690, 3nr9C, 0.7678, 3.12, 0.217, 347, 254, STRUCTURE OF HUMAN CDC2-LIKE KINASE 2 (CLK2)
3691, 3d7uD, 0.7678, 2.52, 0.333, 248, 243, STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3692, 2oibD, 0.7678, 2.95, 0.267, 288, 251, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
3693, 2og8B, 0.7678, 2.46, 0.360, 249, 242, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
3694, 6brcB, 0.7677, 3.14, 0.232, 260, 254, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B IN COMPLEX WITH AP26113-ANALOG (ALK-IN-1)
3695, 5jkgA, 0.7677, 2.79, 0.367, 266, 248, THE CRYSTAL STRUCTURE OF FGFR4 KINASE DOMAIN IN COMPLEX WITH LY2874455
3696, 5izjB, 0.7677, 3.02, 0.251, 325, 255, COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1411
3697, 4mbiA, 0.7677, 2.72, 0.226, 274, 248, DISCOVERY OF PYRAZOLO[15A]PYRIMIDINE-BASED PIM1 INHIBITORS
3698, 3r00A, 0.7677, 2.72, 0.230, 274, 248, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3699, 2erkA, 0.7677, 3.21, 0.202, 351, 258, PHOSPHORYLATED MAP KINASE ERK2
3700, 5x8iB, 0.7676, 3.11, 0.224, 327, 254, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH COMPOUND 25
3701, 5x8iA, 0.7676, 3.11, 0.224, 328, 254, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH COMPOUND 25
3702, 5vd0A, 0.7676, 3.11, 0.232, 293, 254, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH MK1775
3703, 5uuuA, 0.7676, 3.28, 0.176, 414, 261, DESIGN SYNTHESIS AND EVALUATION OF THE FIRST SELECTIVE AND POTENT G- PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE
3704, 5k3yB, 0.7676, 3.18, 0.195, 277, 257, CRYSTAL STRUCTURE OF AURORAB/INCENP IN COMPLEX WITH BI 811283
3705, 4iw0A, 0.7676, 3.22, 0.186, 647, 263, CRYSTAL STRUCTURE AND MECHANISM OF ACTIVATION OF TBK1
3706, 3tz7B, 0.7676, 2.43, 0.337, 260, 243, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL103
3707, 3r22A, 0.7676, 2.78, 0.230, 255, 248, DESIGN SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE- SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3708, 3og7B, 0.7676, 2.60, 0.262, 254, 248, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
3709, 3of0B, 0.7676, 2.03, 0.343, 251, 236, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN
3710, 3c4eB, 0.7676, 2.81, 0.225, 273, 249, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
3711, 1yxtA, 0.7676, 2.74, 0.222, 274, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
3712, 1uwhA, 0.7676, 2.95, 0.263, 264, 251, THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
3713, 6fckA, 0.7675, 3.45, 0.255, 269, 259, CHK1 KINASE IN COMPLEX WITH COMPOUND 13
3714, 5v19B, 0.7675, 2.60, 0.228, 260, 246, STRUCTURE-BASED DRUG DESIGN OF NOVEL ASK1 INHIBITORS USING A FULLY INTEGRATED LEAD OPTIMIZATION STRATEGY
3715, 4mtaA, 0.7675, 2.74, 0.226, 273, 248, CRYSTAL STRUCTURE OF PIM-1 KINASE DOMAIN IN COMPLEX WITH 2-METHYL-5- PHENYLFURAN-3-CARBOXYLIC ACID
3716, 4ficA, 0.7675, 1.80, 0.342, 251, 234, KINASE DOMAIN OF CSRC IN COMPLEX WITH A HINGE REGION-BINDING FRAGMENT
3717, 3tnwA, 0.7675, 2.93, 0.217, 295, 253, STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508
3718, 3tcpB, 0.7675, 1.95, 0.323, 250, 235, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC569
3719, 3c4eD, 0.7675, 2.75, 0.226, 273, 248, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
3720, 2wu7A, 0.7675, 3.07, 0.181, 348, 254, CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH V25
3721, 1o9uA, 0.7675, 3.14, 0.234, 349, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
3722, 5vcwA, 0.7674, 3.22, 0.231, 285, 255, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PELITINIB
3723, 5oy4B, 0.7674, 3.19, 0.241, 353, 257, GSK3BETA COMPLEX WITH N-(6-(34-DIHYDROXYPHENYL)-1H-PYRAZOLO[34- B]PYRIDIN-3-YL)ACETAMIDE
3724, 5kgdA, 0.7674, 2.73, 0.226, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 2-PYRIDIN-3-YL-1~{H}- BENZIMIDAZOLE
3725, 4wt6A, 0.7674, 2.74, 0.222, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A THIADIAZOLAMINE-INDOLE INHIBITOR.
3726, 2h96B, 0.7674, 3.24, 0.189, 357, 259, DISCOVERY OF POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
3727, 5uorB, 0.7673, 2.73, 0.234, 262, 248, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
3728, 5k0kB, 0.7673, 1.84, 0.335, 248, 233, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2434
3729, 5eolA, 0.7673, 2.74, 0.226, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A MACROCYCLIC QUINOXALINE-PYRROLODIHYDROPIPERIDINONE INHIBITOR
3730, 4xh6A, 0.7673, 2.73, 0.226, 273, 248, CRYSTAL STRUCTURE OF PROTO-ONCOGENE KINASE PIM1 BOUND TO HISPIDULIN
3731, 4jbqA, 0.7673, 2.78, 0.234, 257, 248, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
3732, 4bckC, 0.7673, 3.06, 0.208, 293, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3733, 3vc4A, 0.7673, 2.74, 0.222, 274, 248, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3734, 3octA, 0.7673, 2.24, 0.314, 244, 242, CRYSTAL STRUCTURE OF BRUTON S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB
3735, 2xj0A, 0.7673, 2.72, 0.238, 274, 248, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
3736, 1ym7D, 0.7673, 3.28, 0.180, 599, 261, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
3737, 1ym7C, 0.7673, 3.29, 0.184, 607, 261, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
3738, 6gn1B, 0.7672, 3.07, 0.238, 339, 256, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3B) IN COMPLEX WITH PIK-75 
3739, 4bckA, 0.7672, 3.01, 0.200, 298, 255, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3740, 3tubA, 0.7672, 2.78, 0.349, 253, 249, CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(67- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R2S)-2- PHENYLCYCLOPROPYL)UREA
3741, 3qwkA, 0.7672, 2.94, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150
3742, 3cikA, 0.7672, 3.40, 0.187, 619, 262, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3743, 2o63A, 0.7672, 2.73, 0.234, 274, 248, CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN
3744, 2nruA, 0.7672, 3.16, 0.263, 293, 255, CRYSTAL STRUCTURE OF IRAK-4
3745, 1yxuB, 0.7672, 2.74, 0.234, 273, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
3746, 6fu5B, 0.7671, 2.46, 0.233, 286, 245, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE INHIBITOR CSLP18 
3747, 5w5oJ, 0.7671, 2.41, 0.247, 275, 243, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3748, 5obrA, 0.7671, 2.85, 0.238, 255, 248, AURORA A KINASE IN COMPLEX WITH 2-(3-CHLORO-5-FLUOROPHENYL)QUINOLINE- 4-CARBOXYLIC ACID AND JNJ-7706621
3749, 5kgiA, 0.7671, 2.73, 0.234, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR 2-[34-BIS(CHLORANYL) PHENOXY]ETHANAMINE
3750, 5cvgA, 0.7671, 2.88, 0.183, 326, 252, CRYSTAL STRUCTURE OF CK2ALPHA WITH A NOVEL CLOSED CONFORMATION OF THE AD LOOP
3751, 4wnoA, 0.7671, 3.29, 0.267, 272, 258, STRUCTURE OF ULK1 BOUND TO AN INHIBITOR
3752, 4jx3A, 0.7671, 2.71, 0.230, 274, 248, CRYSTAL STRUCTURE OF PIM1 KINASE
3753, 4f9bA, 0.7671, 3.45, 0.195, 318, 261, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491
3754, 3jxwA, 0.7671, 2.76, 0.230, 274, 248, DISCOVERY OF 3H-BENZO[45]THIENO[32-D]PYRIMIDIN-4-ONES AS POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3755, 2xruA, 0.7671, 2.81, 0.239, 253, 247, AURORA-A T288E COMPLEXED WITH PHA-828300
3756, 1w98A, 0.7671, 2.99, 0.209, 297, 253, THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
3757, 5nk8A, 0.7670, 2.61, 0.322, 266, 245, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 2F
3758, 5lpwA, 0.7670, 2.86, 0.253, 280, 249, CRYSTAL STRUCTURE OF THE APO-BRI1 KINASE DOMAIN (865-1160)
3759, 5acbC, 0.7670, 3.17, 0.239, 324, 259, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
3760, 4jx7A, 0.7670, 2.74, 0.226, 274, 248, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR 2-[(TRANS- 4-AMINOCYCLOHEXYL)AMINO]-4-{[3-(TRIFLUOROMETHYL) PHENYL]AMINO}PYRIDO[43-D]PYRIMIDIN-5(6H)-ONE
3761, 4itiB, 0.7670, 2.55, 0.272, 270, 246, CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG
3762, 4f9bC, 0.7670, 3.45, 0.195, 316, 261, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491
3763, 4c0tA, 0.7670, 3.68, 0.224, 290, 263, CANDIDA ALBICANS PKH KINASE DOMAIN
3764, 3i4bB, 0.7670, 3.07, 0.223, 347, 256, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
3765, 2wmaC, 0.7670, 2.81, 0.215, 265, 251, STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
3766, 2nruB, 0.7670, 3.17, 0.259, 294, 255, CRYSTAL STRUCTURE OF IRAK-4
3767, 2jd5A, 0.7670, 2.98, 0.209, 353, 253, SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
3768, 2bfyB, 0.7670, 3.08, 0.187, 278, 256, COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
3769, 1ym7A, 0.7670, 3.29, 0.180, 608, 261, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
3770, 6b8jA, 0.7669, 3.14, 0.242, 344, 256, CO-STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE BETA WITH A SELECTIVE (5-IMIDAZOL-2-YL-4-PHENYLPYRIMIDIN-2-YL)[2-(2-PYRIDYLAMINO) ETHYL]AMINE INHIBITOR
3771, 5ipjA, 0.7669, 2.74, 0.226, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A QUINAZOLINONE-PYRROLOPYRROLONE INHIBITOR.
3772, 5ezvC, 0.7669, 2.91, 0.268, 440, 254, X-RAY CRYSTAL STRUCTURE OF AMP-ACTIVATED PROTEIN KINASE ALPHA-2/ALPHA- 1 RIM CHIMAERA (ALPHA-2(1-347)/ALPHA-1(349-401)/ALPHA-2(397-END) BETA-1 GAMMA-1) CO-CRYSTALLIZED WITH C2 (5-(5-HYDROXYL-ISOXAZOL-3- YL)-FURAN-2-PHOSPHONIC ACID)
3773, 5dhjA, 0.7669, 2.73, 0.234, 273, 248, PIM1 IN COMPLEX WITH CPD4 (3-METHYL-5-(PYRIDIN-3-YL)-1H-PYRAZOLO[34- C]PYRIDINE)
3774, 5dgzA, 0.7669, 2.74, 0.222, 273, 248, DISCOVERY OF 35-SUBSTITUTED 6-AZAINDAZOLES AS POTENT PAN-PIM INHIBITORS
3775, 4wsyA, 0.7669, 2.74, 0.226, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A THIAZOLAMINE-INDAZOLE INHIBITOR.
3776, 4wrsA, 0.7669, 2.74, 0.226, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN AZASPIRO PYRAZINYL-INDAZOLE INHIBITOR.
3777, 2f57A, 0.7669, 3.39, 0.200, 297, 260, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
3778, 1ym7B, 0.7669, 3.29, 0.180, 608, 261, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
3779, 1q41B, 0.7669, 3.12, 0.230, 343, 256, GSK-3 BETA COMPLEXED WITH INDIRUBIN-3 -MONOXIME
3780, 1eh4B, 0.7669, 3.39, 0.162, 293, 265, BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR IC261
3781, 5yf9B, 0.7668, 3.06, 0.200, 319, 255, CRYSTAL STRUCTURE OF CK2A2 FORM-2 
3782, 5nhjA, 0.7668, 3.37, 0.203, 345, 261, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3783, 5hlnA, 0.7668, 3.20, 0.236, 346, 259, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021
3784, 5f94B, 0.7668, 3.18, 0.230, 349, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 15: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-METHOXYPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
3785, 4qtbB, 0.7668, 3.39, 0.212, 348, 259, STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET
3786, 4nm7A, 0.7668, 3.22, 0.233, 355, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 E-MOTIF
3787, 4mblA, 0.7668, 2.76, 0.226, 274, 248, DISCOVERY OF PYRAZOLO[15A]PYRIMIDINE-BASED PIM1 INHIBITORS
3788, 4k18A, 0.7668, 2.78, 0.233, 277, 249, STRUCTURE OF PIM-1 KINASE BOUND TO 5-(4-CYANOBENZYL)-N-(4- FLUOROPHENYL)-7-HYDROXYPYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
3789, 4b8mA, 0.7668, 3.08, 0.212, 270, 255, AURORA B KINASE IN COMPLEX WITH VX-680
3790, 3zuvA, 0.7668, 3.27, 0.209, 357, 258, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE PHOSPHORYLATED MAP KINASE ERK2
3791, 3v5wA, 0.7668, 3.41, 0.168, 623, 262, HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE
3792, 3k5uA, 0.7668, 2.81, 0.238, 260, 248, IDENTIFICATION SAR STUDIES AND X-RAY COCRYSTAL ANALYSIS OF A NOVEL FURANO-PYRIMIDINE AURORA KINASE A INHIBITOR
3793, 3eb0A, 0.7668, 2.86, 0.227, 311, 251, CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804
3794, 2ywpA, 0.7668, 3.51, 0.259, 269, 259, CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR
3795, 5d12B, 0.7667, 2.24, 0.351, 253, 239, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40
3796, 4l01B, 0.7667, 2.79, 0.227, 274, 251, CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN
3797, 3v8tA, 0.7667, 2.02, 0.323, 238, 235, CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477
3798, 3n9xB, 0.7667, 3.37, 0.189, 374, 259, CRYSTAL STRUCTURE OF MAP KINASE FROM PLASMODIUM BERGHEI PB000659.00.0
3799, 3m11A, 0.7667, 2.74, 0.239, 256, 247, CRYSTAL STRUCTURE OF AURORA A KINASE COMPLEXED WITH INHIBITOR
3800, 2y6oA, 0.7667, 2.95, 0.312, 263, 250, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.
3801, 2xngA, 0.7667, 2.68, 0.233, 253, 245, STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
3802, 2w1gA, 0.7667, 2.82, 0.243, 254, 247, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
3803, 1q4lB, 0.7667, 3.09, 0.223, 337, 256, GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
3804, 5ax9A, 0.7666, 2.79, 0.233, 282, 249, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
3805, 4wnpD, 0.7666, 3.24, 0.265, 272, 257, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
3806, 4k0yA, 0.7666, 2.74, 0.226, 274, 248, STRUCTURE OF PIM-1 KINASE BOUND TO N-(4-FLUOROPHENYL)-7-HYDROXY-5- (PIPERIDIN-4-YL)PYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
3807, 4bcqC, 0.7666, 2.95, 0.213, 292, 254, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
3808, 3i4bA, 0.7666, 3.08, 0.223, 359, 256, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
3809, 3f88B, 0.7666, 3.05, 0.235, 340, 255, GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
3810, 2wtkC, 0.7666, 3.08, 0.244, 285, 254, STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
3811, 2qi8B, 0.7666, 1.92, 0.349, 249, 235, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
3812, 6gn1A, 0.7665, 3.08, 0.238, 339, 256, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3B) IN COMPLEX WITH PIK-75 
3813, 5w5oF, 0.7665, 2.30, 0.248, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3814, 5w5oC, 0.7665, 2.45, 0.242, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3815, 5nhoA, 0.7665, 3.28, 0.205, 343, 258, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3816, 5nhhA, 0.7665, 3.38, 0.203, 348, 261, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
3817, 5f94A, 0.7665, 3.18, 0.230, 346, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 15: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-METHOXYPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
3818, 4nm3A, 0.7665, 3.19, 0.233, 357, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N- TERMINAL AUTO-INHIBITORY PS9 PEPTIDE
3819, 4m69A, 0.7665, 2.50, 0.269, 284, 245, CRYSTAL STRUCTURE OF THE MOUSE RIP3-MLKL COMPLEX
3820, 4bidB, 0.7665, 2.52, 0.233, 258, 245, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3821, 3zuvC, 0.7665, 3.24, 0.202, 357, 258, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE PHOSPHORYLATED MAP KINASE ERK2
3822, 3rniA, 0.7665, 2.94, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-3-86
3823, 3qruA, 0.7665, 2.96, 0.227, 295, 251, CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12
3824, 6fu5A, 0.7664, 2.50, 0.241, 282, 245, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH THE INHIBITOR CSLP18 
3825, 5toeA, 0.7664, 2.71, 0.231, 272, 247, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
3826, 5lpbA, 0.7664, 2.93, 0.244, 280, 250, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH ADP FROM ARABIDOPSIS THALIANA
3827, 3r8pA, 0.7664, 2.94, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6
3828, 6bskA, 0.7663, 2.74, 0.218, 273, 248, HUMAN PIM1 KINASE IN COMPLEX WITH COMPOUND 12B
3829, 5w5oK, 0.7663, 2.32, 0.248, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3830, 5w5oD, 0.7663, 2.31, 0.248, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3831, 3p86A, 0.7663, 2.47, 0.300, 250, 243, CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COMPLEX WITH STAUROSPORINE
3832, 2yn8A, 0.7663, 2.47, 0.292, 253, 243, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
3833, 2yexA, 0.7663, 3.37, 0.248, 269, 258, SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
3834, 2vagA, 0.7663, 3.13, 0.229, 330, 253, CRYSTAL STRUCTURE OF DI-PHOSPHORYLATED HUMAN CLK1 IN COMPLEX WITH A NOVEL SUBSTITUTED INDOLE INHIBITOR
3835, 1yxuA, 0.7663, 2.75, 0.226, 273, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
3836, 1o6yA, 0.7663, 2.70, 0.236, 260, 246, CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS
3837, 1i09B, 0.7663, 3.19, 0.230, 341, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
3838, 6fdyU, 0.7662, 3.08, 0.220, 261, 255, UNC-51-LIKE KINASE 3 (ULK3) IN COMPLEX WITH BOSUTINIB 
3839, 5otlA, 0.7662, 2.96, 0.194, 320, 253, THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 29
3840, 5h8gA, 0.7662, 3.15, 0.183, 324, 257, CRYSTAL STRUCTURE OF CK2 WITH COMPOUND 7B
3841, 4alvA, 0.7662, 2.75, 0.218, 274, 248, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
3842, 3qziA, 0.7662, 2.92, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126
3843, 3qf9A, 0.7662, 2.79, 0.225, 274, 249, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A FURAN- THIAZOLIDINEDIONE LIGAND
3844, 3lokA, 0.7662, 1.79, 0.348, 248, 233, DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393
3845, 2vrxA, 0.7662, 3.10, 0.216, 268, 255, STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
3846, 2bfxB, 0.7662, 3.18, 0.208, 275, 255, MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
3847, 1q5kB, 0.7662, 3.17, 0.230, 344, 257, CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
3848, 1p4oB, 0.7662, 2.86, 0.312, 314, 250, STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
3849, 5td2B, 0.7661, 2.06, 0.326, 242, 236, STRUCTURE-BASED OPTIMIZATION OF 1H-IMIDAZOLE-2-CARBOXAMIDES AS AXL KINASE INHIBITORS UTILIZING A MER MUTANT SURROGATE
3850, 5kgkA, 0.7661, 2.73, 0.234, 273, 248, CRYSTAL STRUCTURE OF PIM1 WITH INHIBITOR: 3-(4-METHOXYPHENYL)-1~{H}- PYRAZOL-5-AMINE
3851, 3qx4A, 0.7661, 2.92, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78
3852, 2vgoA, 0.7661, 3.09, 0.212, 268, 255, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
3853, 1q4lA, 0.7661, 3.09, 0.219, 342, 256, GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
3854, 1q3wB, 0.7661, 3.19, 0.230, 341, 257, GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
3855, 1p4oA, 0.7661, 2.85, 0.312, 308, 250, STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
3856, 1mp8A, 0.7661, 2.64, 0.358, 252, 246, CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
3857, 1cmkE, 0.7661, 3.15, 0.259, 348, 255, CRYSTAL STRUCTURES OF THE MYRISTYLATED CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE REVEAL OPEN AND CLOSED CONFORMATIONS
3858, 5w5oH, 0.7660, 2.46, 0.242, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3859, 5nudA, 0.7660, 2.84, 0.357, 267, 249, FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527
3860, 5kcxA, 0.7660, 2.72, 0.231, 272, 247, PIM-1 KINASE IN COMPLEX WITH A SELECTIVE N-SUBSTITUTED 7-AZAINDOLE INHIBITOR
3861, 5ar4B, 0.7660, 2.36, 0.238, 279, 244, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH SB-203580
3862, 4g9rA, 0.7660, 2.88, 0.268, 262, 250, B-RAF V600E KINASE DOMAIN BOUND TO A TYPE II DIHYDROQUINAZOLINE INHIBITOR
3863, 4dtkA, 0.7660, 2.75, 0.234, 273, 248, NOVEL AND SELECTIVE PAN-PIM KINASE INHIBITOR
3864, 3r21A, 0.7660, 2.79, 0.243, 254, 247, DESIGN SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE- SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3865, 3c4eA, 0.7660, 2.75, 0.226, 273, 248, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
3866, 2bfyA, 0.7660, 3.11, 0.195, 270, 256, COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
3867, 1yxuC, 0.7660, 2.70, 0.223, 272, 247, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
3868, 1yxsA, 0.7660, 2.75, 0.226, 274, 248, CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
3869, 1ctpE, 0.7660, 3.15, 0.259, 332, 255, STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION
3870, 6bfnA, 0.7659, 3.08, 0.233, 301, 253, CRYSTAL STRUCTURE OF HUMAN IRAK1
3871, 5w5oG, 0.7659, 2.31, 0.244, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3872, 5w5oA, 0.7659, 2.40, 0.255, 275, 243, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3873, 4n70A, 0.7659, 2.77, 0.218, 274, 248, PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
3874, 4izaA, 0.7659, 3.25, 0.206, 346, 257, STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
3875, 3nieB, 0.7659, 3.56, 0.204, 367, 260, CRYSTAL STRUCTURE OF PF11_0147
3876, 2x7fB, 0.7659, 2.79, 0.236, 288, 250, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
3877, 2eu9A, 0.7659, 3.15, 0.201, 345, 254, CRYSTAL STRUCTURE OF CLK3
3878, 2e9nA, 0.7659, 3.50, 0.256, 269, 258, STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
3879, 1xqzA, 0.7659, 2.80, 0.225, 277, 249, CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
3880, 5w5oE, 0.7658, 2.28, 0.252, 275, 242, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3881, 5ukkA, 0.7658, 3.34, 0.196, 613, 260, HUMAN GRK2 IN COMPLEX WITH HUMAN G-BETA-GAMMA SUBUNITS AND CCG211998 (14AK)
3882, 4oh4B, 0.7658, 2.80, 0.238, 289, 248, CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1
3883, 4nm5A, 0.7658, 3.23, 0.233, 361, 257, CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF
3884, 4jbpA, 0.7658, 2.77, 0.243, 255, 247, NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
3885, 2yerA, 0.7658, 3.34, 0.253, 268, 257, SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
3886, 2bzhB, 0.7658, 2.80, 0.229, 275, 249, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
3887, 5turA, 0.7657, 2.71, 0.231, 270, 247, PIM-1 KINASE IN COMPLEX WITH A 7-AZAINDOLE
3888, 5jgdA, 0.7657, 2.58, 0.275, 295, 244, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 12
3889, 5e1sA, 0.7657, 2.74, 0.319, 284, 248, THE CRYSTAL STRUCTURE OF INSR TYROSINE KINASE IN COMPLEX WITH THE INHIBITOR BI 885578
3890, 5csxA, 0.7657, 2.74, 0.261, 261, 249, CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370
3891, 5aaeA, 0.7657, 2.74, 0.240, 252, 246, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (14D)
3892, 3cxwA, 0.7657, 2.78, 0.230, 272, 248, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND I
3893, 6fyrA, 0.7656, 3.15, 0.201, 355, 254, X-RAY STRUCTURE OF CLK3-KD(GP-[275-632]; NON-PHOS.)/CPD-2 AT 1.42A 
3894, 5v82A, 0.7656, 2.70, 0.235, 273, 247, PIM1 KINASE IN COMPLEX WITH CPD17 (1-(6-(44-DIFLUOROPIPERIDIN-3-YL) PYRIDIN-2-YL)-6-(6-METHYLPYRAZIN-2-YL)-1H-PYRAZOLO[43-C]PYRIDINE)
3895, 4k1bA, 0.7656, 2.78, 0.234, 273, 248, STRUCTURE OF PIM-1 KINASE BOUND TO N-(5-(2-FLUOROPHENYL)-1H-PYRROLO[2 3-B]PYRIDIN-3-YL)-5-((((3R4R)-3-FLUOROPIPERIDIN-4-YL)METHYL)AMINO) PYRAZOLO[15-A]PYRIMIDINE-3-CARBOXAMIDE
3896, 3qwjA, 0.7656, 2.92, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142
3897, 3pscA, 0.7656, 3.39, 0.187, 614, 262, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3898, 3f7zA, 0.7656, 3.12, 0.234, 339, 256, X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
3899, 3c4eC, 0.7656, 2.71, 0.227, 272, 247, PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7- AZAINDOLE
3900, 1yxuD, 0.7656, 2.78, 0.226, 273, 248, CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
3901, 5w5oP, 0.7655, 2.36, 0.243, 275, 243, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3902, 5kziA, 0.7655, 2.76, 0.222, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN IMIDAZOPYRIDAZINE INHIBITOR.
3903, 4f9aA, 0.7655, 3.47, 0.195, 315, 261, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3904, 3r1qA, 0.7655, 2.90, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102
3905, 3o0gA, 0.7655, 3.08, 0.200, 289, 255, CRYSTAL STRUCTURE OF CDK5:P25 IN COMPLEX WITH AN ATP ANALOGUE
3906, 2xizA, 0.7655, 2.81, 0.234, 273, 248, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
3907, 2wtwA, 0.7655, 2.95, 0.236, 256, 250, AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM)
3908, 2j4zA, 0.7655, 2.84, 0.242, 263, 248, STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
3909, 2evaA, 0.7655, 2.37, 0.269, 295, 242, STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS ACTIVATING PROTEIN TAB1
3910, 1unlA, 0.7655, 3.10, 0.204, 292, 255, STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE ALOISINE AND INDIRUBIN.
3911, 5j7bA, 0.7654, 2.42, 0.238, 277, 244, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE GSK583 COMPLEX
3912, 4j71A, 0.7654, 3.25, 0.241, 347, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R
3913, 4ic7A, 0.7654, 3.41, 0.207, 355, 261, CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT
3914, 3gb2A, 0.7654, 3.26, 0.245, 340, 257, GSK3BETA INHIBITOR COMPLEX
3915, 3fbvJ, 0.7654, 2.79, 0.229, 413, 249, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3916, 3dcvA, 0.7654, 2.90, 0.225, 273, 249, CRYSTAL STRUCTURE OF HUMAN PIM1 KINASE COMPLEXED WITH 4-(4- HYDROXY-3-METHYL-PHENYL)-6-PHENYLPYRIMIDIN-2(1H)-ONE
3917, 2jldB, 0.7654, 3.16, 0.230, 349, 257, EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
3918, 6aydA, 0.7653, 2.65, 0.231, 272, 247, PIM1 COMPLEXED WITH N-(6-(4-HYDROXYPHENYL)-1H-INDAZOL-3-YL) CYCLOPROPANECARBOXAMIDE
3919, 5jt2B, 0.7653, 2.26, 0.289, 251, 242, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-BISAMIDE
3920, 5hgiA, 0.7653, 2.99, 0.226, 395, 252, CRYSTAL STRUCTURE OF APO HUMAN IRE1 ALPHA
3921, 3fbvI, 0.7653, 2.79, 0.229, 413, 249, CRYSTAL STRUCTURE OF THE OLIGOMER FORMED BY THE KINASE-RIBONUCLEASE DOMAIN OF IRE1
3922, 2i40A, 0.7653, 2.97, 0.235, 291, 251, CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
3923, 2exmA, 0.7653, 2.98, 0.219, 298, 251, HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
3924, 1q41A, 0.7653, 3.13, 0.230, 339, 256, GSK-3 BETA COMPLEXED WITH INDIRUBIN-3 -MONOXIME
3925, 5oq5A, 0.7652, 3.33, 0.271, 265, 255, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- BENZODIAZEPINONE LRRK2 INHIBITOR
3926, 4pteB, 0.7652, 3.20, 0.233, 347, 257, STRUCTURE OF A CARVOXAMIDE COMPOUND (15) (N-[4-(ISOQUINOLIN-7-YL) PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) TO GSK3B
3927, 4cxaC, 0.7652, 3.30, 0.245, 330, 261, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLIN K COMPLEX BOUND TO AMPPNP
3928, 3sdjI, 0.7652, 2.79, 0.229, 413, 249, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3929, 3qqlA, 0.7652, 2.95, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L3
3930, 3qlfA, 0.7652, 2.02, 0.349, 249, 235, CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5
3931, 2b53A, 0.7652, 2.94, 0.217, 294, 249, HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN- 234325
3932, 6fyiA, 0.7651, 3.14, 0.217, 336, 254, X-RAY STRUCTURE OF CLK2-KD(130-496)/TG003 AT 2.6A 
3933, 5w5oB, 0.7651, 2.46, 0.242, 275, 244, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
3934, 5vcvA, 0.7651, 3.16, 0.224, 287, 254, CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH DASATINIB
3935, 5ceoA, 0.7651, 2.29, 0.307, 269, 241, DLK IN COMPLEX WITH INHIBITOR 2-((6-(33-DIFLUOROPYRROLIDIN-1-YL)-4- (1-(OXETAN-3-YL)PIPERIDIN-4-YL)PYRIDIN-2-YL)AMINO)ISONICOTINONITRILE
3936, 4mq2A, 0.7651, 2.86, 0.228, 343, 250, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
3937, 4lv8A, 0.7651, 3.10, 0.151, 360, 259, MURINE IRGA6 BOUND TO TOXOPLASMA ROP5C A PSEUDOKINASE GDI
3938, 4gs6A, 0.7651, 2.33, 0.270, 294, 241, IRREVERSIBLE INHIBITION OF TAK1 KINASE BY 5Z-7-OXOZEAENOL
3939, 3vn9A, 0.7651, 3.19, 0.248, 291, 258, RIFINED CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED MAP2K6 IN A PUTATIVE AUTO-INHIBITION STATE
3940, 3rm7A, 0.7651, 2.93, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91
3941, 3o23A, 0.7651, 3.03, 0.307, 293, 251, HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR
3942, 3du8A, 0.7651, 3.13, 0.230, 336, 256, CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
3943, 2o65A, 0.7651, 2.77, 0.234, 274, 248, CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE
3944, 4pqnA, 0.7650, 2.17, 0.316, 240, 237, ITK KINASE DOMAIN WITH COMPOUND GNE-9822
3945, 3qx2A, 0.7650, 2.96, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190
3946, 3bwfA, 0.7650, 2.76, 0.230, 273, 248, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND
3947, 2oi4X, 0.7650, 2.81, 0.221, 275, 249, CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE
3948, 2bujB, 0.7650, 3.21, 0.190, 286, 258, CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
3949, 1ywvA, 0.7650, 2.76, 0.238, 274, 248, CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA
3950, 5lxcB, 0.7649, 3.09, 0.206, 385, 252, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 5372 (COMPOUND 1)
3951, 5hvjA, 0.7649, 2.98, 0.276, 283, 250, CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP
3952, 4f99A, 0.7649, 3.48, 0.195, 312, 261, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE
3953, 3sdjJ, 0.7649, 2.79, 0.229, 413, 249, STRUCTURE OF RNASE-INACTIVE POINT MUTANT OF OLIGOMERIC KINASE/RNASE IRE1
3954, 3qqfA, 0.7649, 2.93, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L1
3955, 3q3bA, 0.7649, 3.21, 0.233, 344, 257, 6-AMINO-4-(PYRIMIDIN-4-YL)PYRIDONES: NOVEL GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
3956, 2xmyA, 0.7649, 2.99, 0.231, 295, 251, DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
3957, 2hwoA, 0.7649, 1.89, 0.350, 251, 234, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR
3958, 6gwrB, 0.7648, 3.33, 0.365, 285, 255, STRUCTURE OF THE KINASE DOMAIN OF HUMAN DDR1 IN COMPLEX WITH A POTENT AND SELECTIVE INHIBITOR OF DDR1 AND DDR2 
3959, 5ke0A, 0.7648, 3.40, 0.203, 340, 261, DISCOVERY OF 1-1H-PYRAZOLO 43-C PYRIDINE-6-YL UREA INHIBITORS OF EXTRACELLULAR SIGNAL REGULATED KINASE ERK FOR THE TREATMENT OF CANCERS
3960, 5iisA, 0.7648, 2.80, 0.222, 273, 248, DESIGN SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF POTENT PAN- PIM KINASE INHIBITORS DERIVED FROM THE PYRIDYL-AMIDE SCAFFOLD
3961, 5ct7A, 0.7648, 2.89, 0.265, 257, 249, BRAF IN COMPLEX WITH RAF265
3962, 4wnpC, 0.7648, 3.17, 0.266, 271, 256, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
3963, 4un0C, 0.7648, 3.26, 0.254, 308, 260, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
3964, 4j1rC, 0.7648, 3.27, 0.241, 344, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
3965, 4j1rB, 0.7648, 3.26, 0.241, 346, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
3966, 4bznA, 0.7648, 2.75, 0.223, 272, 247, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO(12-A) PYRAZINONE INHIBITOR
3967, 3vbtA, 0.7648, 2.69, 0.228, 267, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3968, 3jpvA, 0.7648, 2.85, 0.221, 273, 249, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[23- A]CARBAZOLE LIGAND
3969, 2xiyA, 0.7648, 2.73, 0.235, 273, 247, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
3970, 4ptcA, 0.7647, 3.19, 0.230, 342, 257, STRUCTURE OF A CARBOXAMIDE COMPOUND (3) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-OXO-4H-1LAMBDA~4~3-THIAZOLE-5-CARBOXAMIDE) TO GSK3B
3971, 3r02A, 0.7647, 2.78, 0.231, 271, 247, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3972, 6ft7B, 0.7646, 3.26, 0.180, 356, 256, CRYSTAL STRUCTURE OF CLK3 IN COMPLEX WITH COMPOUND 8A 
3973, 5x17A, 0.7646, 3.31, 0.214, 290, 262, CRYSTAL STRUCTURE OF MURINE CK1D IN COMPLEX WITH ADP
3974, 5j7bB, 0.7646, 2.41, 0.242, 281, 244, THE IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF 6-(TERT- BUTYLSULFONYL)-N-(5-FLUORO-1H-INDAZOL-3-YL)QUINOLIN-4-AMINE (GSK583) A HIGHLY POTENT AND SELECTIVE INHIBITOR OF RIP2 KINASE GSK583 COMPLEX
3975, 4yu2A, 0.7646, 2.92, 0.227, 348, 251, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
3976, 4ty1A, 0.7646, 2.71, 0.215, 273, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH AN AMINOOXADIAZOLE-INDOLE INHIBITOR.
3977, 3uzpA, 0.7646, 3.41, 0.220, 292, 264, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
3978, 3lltA, 0.7646, 2.99, 0.235, 341, 251, CRYSTAL STRUCTURE OF PF14_0431 KINASE DOMAIN.
3979, 3cy2A, 0.7646, 2.79, 0.226, 271, 248, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND II
3980, 2bzjA, 0.7646, 2.76, 0.230, 273, 248, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3
3981, 5n4xA, 0.7645, 2.76, 0.230, 272, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 45-DIBROMOTHIOPHENE-2- CARBOHYDRAZIDE
3982, 5cshB, 0.7645, 3.13, 0.196, 323, 255, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 4 BOUND
3983, 4rpvA, 0.7645, 2.75, 0.226, 273, 248, CO-CRYSTAL STRUCTURE OF PIM1 WITH COMPOUND 3
3984, 4h1mA, 0.7645, 2.67, 0.329, 256, 246, CRYSTAL STRUCTURE OF PYK2 WITH THE INDOLE 10C
3985, 4gw8A, 0.7645, 2.77, 0.230, 273, 248, HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND LEUCETTINE L41
3986, 4g9cB, 0.7645, 2.87, 0.264, 264, 250, HUMAN B-RAF KINASE DOMAIN BOUND TO A TYPE II PYRAZOLOPYRIDINE INHIBITOR
3987, 4ez7A, 0.7645, 2.95, 0.199, 302, 251, CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANILINO-1- NAPHTHALENE SULFONIC ACID
3988, 3vbvA, 0.7645, 2.70, 0.228, 268, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3989, 3q3bB, 0.7645, 3.22, 0.230, 341, 257, 6-AMINO-4-(PYRIMIDIN-4-YL)PYRIDONES: NOVEL GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
3990, 3orxE, 0.7645, 3.09, 0.242, 274, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3991, 2nruC, 0.7645, 3.21, 0.263, 293, 255, CRYSTAL STRUCTURE OF IRAK-4
3992, 1h8fB, 0.7645, 3.21, 0.230, 350, 257, GLYCOGEN SYNTHASE KINASE 3 BETA.
3993, 5uklA, 0.7644, 3.41, 0.164, 630, 262, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG222886 (14BD)
3994, 5n4nA, 0.7644, 2.75, 0.230, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 34-DIMETHYL-5-(1H-124-TRIAZOL- 3-YL)THIOPHENE-2-CARBONITRILE
3995, 4bibB, 0.7644, 2.55, 0.241, 258, 245, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
3996, 4agwA, 0.7644, 2.56, 0.337, 258, 243, DISCOVERY OF A SMALL MOLECULE TYPE II INHIBITOR OF WILD- TYPE AND GATEKEEPER MUTANTS OF BCR-ABL PDGFRALPHA KIT AND SRC KINASES
3997, 3rm6A, 0.7644, 2.90, 0.225, 293, 249, CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80
3998, 3ql8A, 0.7644, 2.92, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260
3999, 2h96A, 0.7644, 3.34, 0.196, 358, 260, DISCOVERY OF POTENT HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
4000, 1jowB, 0.7644, 2.70, 0.206, 277, 247, CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN
4001, 1ckjA, 0.7644, 3.37, 0.220, 296, 264, CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
4002, 4ptgB, 0.7643, 3.20, 0.230, 332, 257, STRUCTURE OF A CARBOXAMINE COMPOUND (26) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) TO GSK3B
4003, 3qrtA, 0.7643, 2.95, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55
4004, 3bgqA, 0.7643, 2.85, 0.214, 272, 248, HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2
4005, 2jldA, 0.7643, 3.17, 0.230, 349, 257, EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
4006, 2j2iB, 0.7643, 2.75, 0.226, 273, 248, CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
4007, 1q8zB, 0.7643, 3.24, 0.185, 364, 259, THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P
4008, 1h8fA, 0.7643, 3.22, 0.233, 352, 257, GLYCOGEN SYNTHASE KINASE 3 BETA.
4009, 5ndtA, 0.7642, 2.76, 0.230, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-3-(2-(THIOPHEN-2-YL)VINYL)-3; 4-DIHYDROQUINOXALIN-2(1H)-ONE 
4010, 5lpyA, 0.7642, 2.89, 0.245, 282, 249, CRYSTAL STRUCTURE OF THE BRI1 KINASE DOMAIN (865-1160) IN COMPLEX WITH ATP FROM ARABIDOPSIS THALIANA
4011, 5h3qA, 0.7642, 2.87, 0.379, 302, 248, CRYSTAL STRUCTURE OF TRKA KINASE WITH LIGAND
4012, 4tyeA, 0.7642, 3.21, 0.362, 292, 254, STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE
4013, 4rc2A, 0.7642, 2.73, 0.231, 272, 247, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4014, 4acgA, 0.7642, 3.21, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4015, 4a7cA, 0.7642, 2.83, 0.234, 273, 248, CRYSTAL STRUCTURE OF PIM1 KINASE WITH ETP46546
4016, 3we8A, 0.7642, 2.77, 0.230, 273, 248, PIM-1 KINASE IN COMPLEX WITH RUTHENIUM-BASED INHIBITOR
4017, 3r83A, 0.7642, 2.98, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92
4018, 3orxG, 0.7642, 3.10, 0.238, 274, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
4019, 3o2mA, 0.7642, 3.27, 0.189, 358, 259, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
4020, 3cqeA, 0.7642, 2.81, 0.210, 258, 248, WEE1 KINASE COMPLEX WITH INHIBITOR PD074291
4021, 1q99B, 0.7642, 3.32, 0.200, 364, 260, CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE SKY1P COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE AMP-PNP
4022, 5c1qB, 0.7641, 2.77, 0.230, 273, 248, SERINE/THREONINE-PROTEIN KINASE PIM-1
4023, 4j1rD, 0.7641, 3.28, 0.241, 345, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4024, 4j1rA, 0.7641, 3.27, 0.245, 343, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4025, 3qzfA, 0.7641, 2.93, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52
4026, 2e9vA, 0.7641, 3.41, 0.262, 268, 256, STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
4027, 5ukmA, 0.7640, 3.42, 0.164, 621, 262, BOVINE GRK2 IN COMPLEX WITH HUMAN GBETAGAMMA SUBUNITS AND CCG258208 (14AS)
4028, 5oy4A, 0.7640, 3.19, 0.230, 349, 256, GSK3BETA COMPLEX WITH N-(6-(34-DIHYDROXYPHENYL)-1H-PYRAZOLO[34- B]PYRIDIN-3-YL)ACETAMIDE
4029, 4ztmA, 0.7640, 2.78, 0.274, 287, 248, IRAK4-INHIBITOR CO-STRUCTURE
4030, 4twcA, 0.7640, 3.43, 0.216, 293, 264, 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL)THIAZOLE-4- CARBOXAMIDE DERIVATIVES AS POTENT INHIBITORS OF CK1D/E
4031, 4bieA, 0.7640, 2.57, 0.238, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4032, 4bhnB, 0.7640, 2.53, 0.234, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4033, 4alwA, 0.7640, 2.78, 0.227, 273, 247, BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4034, 3vidA, 0.7640, 3.11, 0.337, 299, 249, CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH COMPOUND A.
4035, 3r7vA, 0.7640, 2.94, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9
4036, 3r7eA, 0.7640, 2.95, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67
4037, 5n4yA, 0.7639, 2.77, 0.230, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 25-DIHYDRO-1H-ISOTHIOCHROMENO[3 4-D]PYRAZOL-3-ONE
4038, 5eykB, 0.7639, 3.10, 0.187, 275, 256, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325
4039, 4acgB, 0.7639, 3.19, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4040, 3r04A, 0.7639, 2.80, 0.227, 271, 247, THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
4041, 2a0cX, 0.7639, 2.97, 0.224, 294, 250, HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II A NOVEL 269- TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR
4042, 5up3A, 0.7638, 2.61, 0.237, 258, 245, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
4043, 5ar7B, 0.7638, 2.56, 0.241, 278, 245, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIARYL UREA
4044, 4yzmB, 0.7638, 2.90, 0.257, 262, 249, HUMANIZED ROCO4 BOUND TO LRRK2-IN1
4045, 4wnpA, 0.7638, 3.21, 0.265, 273, 257, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
4046, 4rc3A, 0.7638, 2.67, 0.228, 271, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4047, 4j7bA, 0.7638, 2.95, 0.264, 284, 250, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1
4048, 4ixpA, 0.7638, 3.25, 0.265, 334, 257, CRYSTAL STRUCTURE OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (MELK)
4049, 4euuA, 0.7638, 3.30, 0.183, 307, 262, STRUCTURE OF BX-795 COMPLEXED WITH HUMAN TBK1 KINASE DOMAIN PHOSPHORYLATED ON SER172
4050, 4c8bA, 0.7638, 2.38, 0.236, 279, 242, STRUCTURE OF THE KINASE DOMAIN OF HUMAN RIPK2 IN COMPLEX WITH PONATINIB
4051, 4bzoA, 0.7638, 2.74, 0.223, 272, 247, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO- PYRAZINONE INHIBITOR
4052, 4achB, 0.7638, 3.21, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4053, 3vbxA, 0.7638, 2.71, 0.228, 268, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4054, 3uimA, 0.7638, 2.98, 0.258, 291, 248, STRUCTURAL BASIS FOR THE IMPACT OF PHOSPHORYLATION ON PLANT RECEPTOR- LIKE KINASE BAK1 ACTIVATION
4055, 3orxH, 0.7638, 3.11, 0.238, 274, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
4056, 2vx3A, 0.7638, 2.88, 0.228, 346, 250, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
4057, 2nryB, 0.7638, 3.11, 0.259, 286, 251, CRYSTAL STRUCTURE OF IRAK-4
4058, 2e9vB, 0.7638, 3.41, 0.258, 268, 256, STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
4059, 5nhlA, 0.7637, 3.31, 0.202, 345, 258, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
4060, 5n4vA, 0.7637, 2.86, 0.217, 273, 249, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 2-CYCLOPROPYL-45- DIMETHYLTHIENO[54-D]PYRIMIDINE-6-CARBOXYLIC ACID
4061, 5hd7A, 0.7637, 3.37, 0.213, 347, 258, DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT MUTANT SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL) PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5- YL]PYRROLIDINE-3-CARBOXAMIDE
4062, 5dwrA, 0.7637, 2.75, 0.223, 273, 247, IDENTIFICATION OF N-(4-((1R3S5S)-3-AMINO-5-METHYLCYCLOHEXYL)PYRIDIN- 3-YL)-6-(26-DIFLUOROPHENYL)-5-FLUOROPICOLINAMIDE (PIM447) A POTENT AND SELECTIVE PROVIRAL INSERTION SITE OF MOLONEY MURINE LEUKEMIA (PIM) 12 AND 3 KINASE INHIBITOR IN CLINICAL TRIALS FOR HEMATOLOGICAL MALIGNANCIES
4063, 4medA, 0.7637, 2.83, 0.230, 272, 248, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE DERIVATIVES
4064, 4euuB, 0.7637, 3.30, 0.187, 307, 262, STRUCTURE OF BX-795 COMPLEXED WITH HUMAN TBK1 KINASE DOMAIN PHOSPHORYLATED ON SER172
4065, 3qzhA, 0.7637, 2.94, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124
4066, 3qu0A, 0.7637, 2.93, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-38
4067, 3qtwA, 0.7637, 2.90, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-13
4068, 2xj2A, 0.7637, 2.84, 0.230, 273, 248, PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INHIBITOR
4069, 2e9pA, 0.7637, 3.44, 0.258, 269, 256, STRUCTURE OF H-CHK1 COMPLEXED WITH A771129
4070, 5tobA, 0.7636, 2.23, 0.370, 245, 238, SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF FAK INHIBITORS IMPROVES PYK2 POTENCY
4071, 5n50A, 0.7636, 2.77, 0.230, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(4-CHLOROPHENYL) SULFANYLACETOHYDRAZIDE
4072, 5eymB, 0.7636, 2.84, 0.195, 292, 246, MEK1 IN COMPLEX WITH BI 847325
4073, 5aadA, 0.7636, 2.78, 0.236, 252, 246, AURORA A KINASE BOUND TO AN IMIDAZOPYRIDINE INHIBITOR (7A)
4074, 4yljA, 0.7636, 2.90, 0.228, 346, 250, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
4075, 4ll5A, 0.7636, 2.81, 0.226, 268, 248, CRYSTAL STRUCTURE OF PIM-1 IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
4076, 3pupB, 0.7636, 3.21, 0.230, 347, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OS1)
4077, 3orxF, 0.7636, 3.12, 0.238, 274, 252, PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
4078, 2ydiA, 0.7636, 3.58, 0.256, 279, 258, DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
4079, 2ghgA, 0.7636, 3.52, 0.256, 269, 258, H-CHK1 COMPLEXED WITH A431994
4080, 1y6bA, 0.7636, 2.88, 0.328, 266, 247, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
4081, 6ft7A, 0.7635, 3.24, 0.169, 356, 255, CRYSTAL STRUCTURE OF CLK3 IN COMPLEX WITH COMPOUND 8A 
4082, 6bfnB, 0.7635, 3.22, 0.228, 294, 254, CRYSTAL STRUCTURE OF HUMAN IRAK1
4083, 5kpkB, 0.7635, 3.12, 0.234, 344, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0209
4084, 4xv1B, 0.7635, 2.42, 0.266, 249, 244, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX7904
4085, 4qtbA, 0.7635, 3.43, 0.212, 351, 259, STRUCTURE OF HUMAN ERK1 IN COMPLEX WITH SCH772984 REVEALING A NOVEL INHIBITOR-INDUCED BINDING POCKET
4086, 3rk5A, 0.7635, 2.93, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-72
4087, 3pxrA, 0.7635, 2.95, 0.220, 294, 250, APO CDK2 CRYSTALLIZED FROM JEFFAMINE
4088, 3bgpA, 0.7635, 2.74, 0.227, 272, 247, HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1
4089, 2nruD, 0.7635, 3.23, 0.275, 293, 255, CRYSTAL STRUCTURE OF IRAK-4
4090, 2g01B, 0.7635, 3.31, 0.193, 356, 259, PYRAZOLOQUINOLONES AS NOVEL SELECTIVE JNK1 INHIBITORS
4091, 5lxcA, 0.7634, 3.01, 0.200, 383, 250, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 5372 (COMPOUND 1)
4092, 5f95A, 0.7634, 3.22, 0.230, 345, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 18: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-PHENYLPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4093, 4qq5A, 0.7634, 2.96, 0.368, 275, 250, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE HARBORING THE V550L GATE-KEEPER MUTATION IN COMPLEX WITH FIIN-2 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
4094, 4n6zA, 0.7634, 2.86, 0.218, 272, 248, PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
4095, 4ijpA, 0.7634, 3.00, 0.202, 330, 253, CRYSTAL STRUCTURE OF HUMAN PRPF4B KINASE DOMAIN IN COMPLEX WITH 4-{5- [(2-CHLORO-PYRIDIN-4-YLMETHYL)-CARBAMOYL]-THIOPHEN-2-YL}- BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMINE
4096, 4gt4A, 0.7634, 2.69, 0.276, 274, 246, STRUCTURE OF UNLIGANDED INACTIVE ROR2 KINASE DOMAIN
4097, 3r1yA, 0.7634, 2.97, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134
4098, 3pupA, 0.7634, 3.22, 0.230, 346, 257, STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OS1)
4099, 3l1sA, 0.7634, 3.12, 0.231, 336, 255, 3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
4100, 5xqxA, 0.7633, 2.91, 0.215, 340, 251, HUMAN CDK8-CYCC IN COMPLEX WITH COMPOUND 4: N-METHYL-4-(4-PYRIDYL)-1H- PYRROLE-2-CARBOXAMIDE
4101, 4j71B, 0.7633, 3.29, 0.241, 347, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R
4102, 3vbyA, 0.7633, 2.72, 0.228, 267, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4103, 3mygA, 0.7633, 2.76, 0.232, 252, 246, AURORA A KINASE COMPLEXED WITH SCH 1473759
4104, 3bi6A, 0.7633, 2.88, 0.205, 258, 249, WEE1 KINASE COMPLEX WITH INHIBITOR PD352396
4105, 2vgpA, 0.7633, 2.85, 0.203, 265, 251, CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
4106, 1x8bA, 0.7633, 2.81, 0.219, 259, 247, STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824
4107, 5airA, 0.7632, 3.22, 0.233, 353, 257, STRUCTURAL ANALYSIS OF MOUSE GSK3BETA FUSED WITH LRP6 PEPTIDE.
4108, 3sd0B, 0.7632, 3.22, 0.230, 349, 257, IDENTIFICATION OF A GLYCOGEN SYNTHASE KINASE-3B INHIBITOR THAT ATTENUATES HYPERACTIVITY IN CLOCK MUTANT MICE
4109, 3r28A, 0.7632, 2.93, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140
4110, 3du8B, 0.7632, 3.15, 0.230, 339, 256, CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
4111, 2no3B, 0.7632, 3.31, 0.197, 357, 259, NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
4112, 1ykrA, 0.7632, 3.12, 0.225, 298, 253, CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR
4113, 5t1tC, 0.7631, 2.96, 0.268, 286, 250, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4114, 5op7A, 0.7631, 3.12, 0.259, 261, 251, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIMIDINE LRRK2 INHIBITOR
4115, 4yu2C, 0.7631, 2.89, 0.228, 346, 250, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
4116, 3qtuA, 0.7631, 2.94, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-132
4117, 2xj1A, 0.7631, 2.76, 0.227, 273, 247, PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR
4118, 2b54A, 0.7631, 2.97, 0.211, 298, 251, HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305
4119, 5n4rA, 0.7630, 2.78, 0.226, 273, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(AZEPAN-1-YL)-1-(1H-INDOL-3-YL) PROPAN-1-ONE
4120, 4rc4A, 0.7630, 2.75, 0.231, 272, 247, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4121, 4nttA, 0.7630, 3.03, 0.231, 339, 255, STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE BOUND TO ADP AND ONE MAGNESIUM ION
4122, 4azeC, 0.7630, 2.90, 0.232, 348, 250, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
4123, 4azeB, 0.7630, 2.90, 0.232, 345, 250, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
4124, 4azeA, 0.7630, 2.90, 0.232, 348, 250, HUMAN DYRK1A IN COMPLEX WITH LEUCETTINE L41
4125, 3ulzA, 0.7630, 2.99, 0.254, 291, 248, CRYSTAL STRUCTURE OF APO BAK1
4126, 3o17A, 0.7630, 3.36, 0.204, 357, 260, CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM
4127, 3fzsA, 0.7630, 2.54, 0.340, 254, 244, CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
4128, 3f2aA, 0.7630, 2.81, 0.222, 276, 248, CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA
4129, 1q97B, 0.7630, 3.31, 0.193, 361, 259, THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE SKY1P WITH BOUND ATP
4130, 4ptgA, 0.7629, 3.17, 0.234, 333, 256, STRUCTURE OF A CARBOXAMINE COMPOUND (26) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) TO GSK3B
4131, 4mq1A, 0.7629, 2.76, 0.214, 345, 248, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4132, 4ksqA, 0.7629, 2.77, 0.271, 258, 247, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B
4133, 4ez3A, 0.7629, 2.85, 0.222, 294, 248, CDK2 IN COMPLEX WITH NSC 134199
4134, 4acdA, 0.7629, 3.23, 0.233, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4135, 3rk7A, 0.7629, 2.96, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-71
4136, 3eb0C, 0.7629, 2.85, 0.229, 310, 249, CRYSTAL STRUCTURE OF CGD4_240 FROM CRYPTOSPORIDIUM PARVUM IN COMPLEX WITH INDIRUBIN E804
4137, 3dlsB, 0.7629, 2.83, 0.241, 280, 249, CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
4138, 2z2wA, 0.7629, 2.87, 0.205, 260, 249, HUMAND WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770
4139, 2w1fA, 0.7629, 2.81, 0.244, 253, 246, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
4140, 2cguA, 0.7629, 3.38, 0.263, 263, 255, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4141, 5cs6B, 0.7628, 2.67, 0.187, 316, 246, CRYSTAL STRUCTURE OF CK2ALPHA WITH COMPOUND 3 BOUND
4142, 4yljC, 0.7628, 2.92, 0.228, 346, 250, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
4143, 4xhkB, 0.7628, 2.81, 0.226, 269, 248, PIM1 KINASE IN COMPLEX WITH COMPOUND 1S
4144, 4g9cA, 0.7628, 2.69, 0.250, 265, 248, HUMAN B-RAF KINASE DOMAIN BOUND TO A TYPE II PYRAZOLOPYRIDINE INHIBITOR
4145, 5unpB, 0.7627, 3.19, 0.213, 347, 254, STRUCTURE OF CDC2-LIKE KINASE 2 (CLK2) IN COMPLEX WITH COMPOUND T-025 [N2-METHYL-N4-(PYRIMIDIN-2-YLMETHYL)-5-(QUINOLIN-6-YL)-7H-PYRROLO[2; 3-D]PYRIMIDINE-2;4-DIAMINE] 
4146, 5unpA, 0.7627, 3.19, 0.213, 347, 254, STRUCTURE OF CDC2-LIKE KINASE 2 (CLK2) IN COMPLEX WITH COMPOUND T-025 [N2-METHYL-N4-(PYRIMIDIN-2-YLMETHYL)-5-(QUINOLIN-6-YL)-7H-PYRROLO[2; 3-D]PYRIMIDINE-2;4-DIAMINE] 
4147, 5nkiA, 0.7627, 2.57, 0.320, 268, 244, CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH COMPOUND 4B
4148, 5j1vC, 0.7627, 3.10, 0.223, 314, 251, CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH PYRIDO[34- G]QUINAZOLINE DERIVATIVE ZW29 (COMPOUND 13)
4149, 4ianB, 0.7627, 3.03, 0.202, 319, 253, CRYSTAL STRUCTURE OF APO HUMAN PRPF4B KINASE DOMAIN
4150, 4i41A, 0.7627, 2.76, 0.231, 272, 247, CRYSTAL STRUCTURE OF HUMAN SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE
4151, 4hyhA, 0.7627, 3.26, 0.265, 263, 253, X-RAY CRYSTAL STRUCTURE OF COMPOUND 39 BOUND TO HUMAN CHK1 KINASE DOMAIN
4152, 4hgsA, 0.7627, 3.50, 0.170, 302, 264, CRYSTAL STRUCTURE OF CK1GS WITH COMPOUND 13
4153, 1zysA, 0.7627, 3.59, 0.264, 271, 258, CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR
4154, 1q99A, 0.7627, 3.00, 0.190, 354, 253, CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE SKY1P COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE AMP-PNP
4155, 4y73C, 0.7626, 3.11, 0.270, 290, 252, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
4156, 4l53A, 0.7626, 2.52, 0.270, 296, 244, CRYSTAL STRUCTURE OF (1R4R)-4-{4-[7-AMINO-2-(123-BENZOTHIADIAZOL-7- YL)-3-CHLOROFURO[23-C]PYRIDIN-4-YL]-1H-PYRAZOL-1-YL}CYCLOHEXAN-1-OL BOUND TO TAK1-TAB1
4157, 4ianA, 0.7626, 3.03, 0.202, 321, 253, CRYSTAL STRUCTURE OF APO HUMAN PRPF4B KINASE DOMAIN
4158, 4agwB, 0.7626, 2.52, 0.339, 257, 242, DISCOVERY OF A SMALL MOLECULE TYPE II INHIBITOR OF WILD- TYPE AND GATEKEEPER MUTANTS OF BCR-ABL PDGFRALPHA KIT AND SRC KINASES
4159, 3vbqA, 0.7626, 2.71, 0.215, 271, 246, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4160, 3r8lA, 0.7626, 2.96, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L3-4
4161, 5v5nA, 0.7625, 2.63, 0.291, 294, 244, CRYSTAL STRUCTURE OF TAKINIB BOUND TO TAK1
4162, 5n4zA, 0.7625, 2.73, 0.231, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-4-(4-HYDROXYPHENYL)BUT-3-EN-2- ONE
4163, 4iirA, 0.7625, 2.94, 0.191, 325, 251, CRYSTAL STRUCTURE OF AMPPNP-BOUND HUMAN PRPF4B KINASE DOMAIN
4164, 4fk3A, 0.7625, 2.49, 0.258, 251, 244, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
4165, 3qxoA, 0.7625, 2.95, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84
4166, 3pxzA, 0.7625, 3.16, 0.210, 302, 252, CDK2 TERNARY COMPLEX WITH JWS648 AND ANS
4167, 3f7zB, 0.7625, 3.18, 0.235, 339, 255, X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
4168, 6b16A, 0.7624, 3.24, 0.226, 285, 257, P21-ACTIVATED KINASE 1 IN COMPLEX WITH A 4-AZAINDOLE INHIBITOR
4169, 5vd7A, 0.7624, 3.11, 0.199, 261, 251, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 098 A MK1775 ANALOGUE
4170, 5kpkA, 0.7624, 3.13, 0.234, 346, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0209
4171, 4ptcB, 0.7624, 3.23, 0.230, 347, 257, STRUCTURE OF A CARBOXAMIDE COMPOUND (3) (2-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}-4-OXO-4H-1LAMBDA~4~3-THIAZOLE-5-CARBOXAMIDE) TO GSK3B
4172, 4accA, 0.7624, 3.23, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4173, 3sd0A, 0.7624, 3.23, 0.230, 350, 257, IDENTIFICATION OF A GLYCOGEN SYNTHASE KINASE-3B INHIBITOR THAT ATTENUATES HYPERACTIVITY IN CLOCK MUTANT MICE
4174, 3r7yA, 0.7624, 3.01, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88
4175, 3amyA, 0.7624, 2.87, 0.189, 318, 249, CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN
4176, 5wg5A, 0.7623, 3.32, 0.193, 617, 259, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224061
4177, 5vd8A, 0.7623, 3.11, 0.199, 260, 251, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 099 A MK1775 ANALOGUE
4178, 5n4uA, 0.7623, 2.73, 0.227, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 5-(2-AMINO-13-THIAZOL-4- YL)-13-DIHYDROBENZIMIDAZOL-2-ONE
4179, 5hd4A, 0.7623, 3.36, 0.217, 347, 258, DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT WILD TYPE SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL) PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5- YL]PYRROLIDINE-3-CARBOXAMIDE
4180, 4g16A, 0.7623, 3.46, 0.170, 302, 264, CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2- YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
4181, 4bhnA, 0.7623, 2.52, 0.239, 256, 243, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4182, 4bcqA, 0.7623, 2.87, 0.206, 292, 252, STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4- HETEROARYL-PYRIMIDINE INHIBITOR
4183, 4as0A, 0.7623, 2.79, 0.226, 273, 248, CYCLOMETALATED PHTHALIMIDES AS PROTEIN KINASE INHIBITORS
4184, 3uokB, 0.7623, 3.12, 0.237, 265, 249, AURORA A IN COMPLEX WITH YL5-81-1
4185, 3royA, 0.7623, 2.97, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154
4186, 3r6xA, 0.7623, 2.98, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158
4187, 3n9xA, 0.7623, 3.29, 0.191, 374, 257, CRYSTAL STRUCTURE OF MAP KINASE FROM PLASMODIUM BERGHEI PB000659.00.0
4188, 3cy3A, 0.7623, 2.75, 0.227, 270, 247, CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND THE JNK INHIBITOR V
4189, 1vr2A, 0.7623, 3.15, 0.336, 275, 250, HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
4190, 5wg4A, 0.7622, 3.30, 0.181, 621, 259, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257284
4191, 5eymA, 0.7622, 2.84, 0.199, 292, 246, MEK1 IN COMPLEX WITH BI 847325
4192, 4n6yA, 0.7622, 2.80, 0.222, 273, 248, PIM1 COMPLEXED WITH A PHENYLCARBOXAMIDE
4193, 3uohB, 0.7622, 2.99, 0.243, 264, 247, AURORA A IN COMPLEX WITH RPM1722
4194, 3uohA, 0.7622, 2.99, 0.243, 264, 247, AURORA A IN COMPLEX WITH RPM1722
4195, 2vrxB, 0.7622, 3.01, 0.210, 274, 252, STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
4196, 1q97A, 0.7622, 2.94, 0.215, 351, 251, THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE SKY1P WITH BOUND ATP
4197, 6fniA, 0.7621, 2.76, 0.290, 261, 245, CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH NVP-BHG712 
4198, 5k3yA, 0.7621, 3.02, 0.193, 267, 254, CRYSTAL STRUCTURE OF AURORAB/INCENP IN COMPLEX WITH BI 811283
4199, 5jzjB, 0.7621, 2.83, 0.229, 261, 249, CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH AMPPN
4200, 4ztmD, 0.7621, 2.79, 0.276, 282, 246, IRAK4-INHIBITOR CO-STRUCTURE
4201, 4ifcA, 0.7621, 3.05, 0.202, 327, 253, CRYSTAL STRUCTURE OF ADP-BOUND HUMAN PRPF4B KINASE DOMAIN
4202, 4bieB, 0.7621, 2.54, 0.234, 257, 244, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4203, 4afjB, 0.7621, 3.04, 0.234, 346, 252, 5-ARYL-4-CARBOXAMIDE-13-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4204, 4achA, 0.7621, 3.25, 0.233, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4205, 3r1sA, 0.7621, 2.98, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127
4206, 3dkoA, 0.7621, 3.06, 0.309, 275, 249, COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
4207, 2bilB, 0.7621, 2.80, 0.230, 274, 248, THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE
4208, 5myvB, 0.7620, 3.23, 0.178, 349, 258, CRYSTAL STRUCTURE OF SRPK2 IN COMPLEX WITH COMPOUND 1
4209, 4tw9A, 0.7620, 3.33, 0.211, 290, 261, DIFLUORO-DIOXOLO-BENZOIMIDAZOL-BENZAMIDES AS POTENT INHIBITORS OF CK1DELTA AND EPSILON WITH NANOMOLAR INHIBITORY ACTIVITY ON CANCER CELL PROLIFERATION
4210, 4mq2C, 0.7620, 2.88, 0.225, 339, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4211, 3rk9A, 0.7620, 2.97, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-74
4212, 2gdoA, 0.7620, 3.37, 0.268, 269, 254, 4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
4213, 1q8yA, 0.7620, 2.94, 0.215, 351, 251, THE STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P WITH BOUND ADP
4214, 5n4oA, 0.7619, 2.67, 0.220, 271, 246, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE (E)-3-(P-TOLYL)ACRYLIC ACID
4215, 4yu2B, 0.7619, 2.91, 0.228, 347, 250, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
4216, 4qqcA, 0.7619, 2.94, 0.369, 273, 249, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE DOMAIN IN COMPLEX WITH FIIN-2 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
4217, 3uokA, 0.7619, 3.14, 0.237, 265, 249, AURORA A IN COMPLEX WITH YL5-81-1
4218, 3ti1A, 0.7619, 2.99, 0.228, 294, 250, CDK2 IN COMPLEX WITH SUNITINIB
4219, 3rjcA, 0.7619, 2.96, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4-12
4220, 3begA, 0.7619, 3.44, 0.188, 348, 260, CRYSTAL STRUCTURE OF SR PROTEIN KINASE 1 COMPLEXED TO ITS SUBSTRATE ASF/SF2
4221, 2brnA, 0.7619, 3.43, 0.259, 268, 255, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4222, 1uwjA, 0.7619, 2.92, 0.264, 264, 250, THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
4223, 4p5zA, 0.7618, 2.85, 0.300, 267, 247, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
4224, 4g17A, 0.7618, 3.47, 0.170, 302, 264, CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H- BENZIMIDAZOLE-6-CARBONITRILE
4225, 4fc0A, 0.7618, 2.70, 0.268, 254, 246, CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT INHIBITOR
4226, 2vx3C, 0.7618, 2.86, 0.225, 338, 249, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
4227, 2vwwA, 0.7618, 2.49, 0.281, 253, 242, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
4228, 2izsA, 0.7618, 3.53, 0.163, 298, 264, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4229, 2bziB, 0.7618, 2.76, 0.231, 272, 247, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2
4230, 1xwsA, 0.7618, 2.78, 0.222, 273, 248, CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
4231, 5ztnA, 0.7617, 3.11, 0.213, 395, 253, THE CRYSTAL STRUCTURE OF HUMAN DYRK2 IN COMPLEX WITH CURCUMIN 
4232, 5we8A, 0.7617, 2.97, 0.231, 270, 247, CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH N-{(3R)-1-[(4-CHLOROPHENYL) METHYL]PYRROLIDIN-3-YL}-2-(3-METHOXYPHENYL)-N-METHYLQUINOLINE-4- CARBOXAMIDE (COMPOUND 8)
4233, 5w4wC, 0.7617, 3.39, 0.217, 284, 263, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
4234, 5vd5A, 0.7617, 3.04, 0.213, 260, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 050 A MK1775 ANALOUGUE
4235, 5airB, 0.7617, 3.26, 0.233, 361, 257, STRUCTURAL ANALYSIS OF MOUSE GSK3BETA FUSED WITH LRP6 PEPTIDE.
4236, 4c2wA, 0.7617, 3.12, 0.213, 268, 254, CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH AMP-PNP
4237, 3tiyA, 0.7617, 2.93, 0.229, 293, 249, CDK2 IN COMPLEX WITH NSC 35676
4238, 3bgzA, 0.7617, 2.77, 0.219, 267, 247, HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3
4239, 2wo6B, 0.7617, 2.96, 0.224, 339, 250, HUMAN DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A IN COMPLEX WITH A CONSENSUS SUBSTRATE PEPTIDE
4240, 2no3A, 0.7617, 3.30, 0.193, 357, 259, NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
4241, 1q3wA, 0.7617, 3.24, 0.233, 344, 257, GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
4242, 5nhpA, 0.7616, 3.55, 0.210, 338, 262, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
4243, 3unkA, 0.7616, 2.98, 0.227, 295, 251, CDK2 IN COMPLEX WITH INHIBITOR YL5-083
4244, 2y6mA, 0.7616, 2.98, 0.313, 262, 249, CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN
4245, 1m7nB, 0.7616, 3.08, 0.306, 299, 252, CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
4246, 1hckA, 0.7616, 2.92, 0.221, 294, 249, HUMAN CYCLIN-DEPENDENT KINASE 2
4247, 6g97A, 0.7615, 3.41, 0.204, 344, 260, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4248, 5vd4A, 0.7615, 3.12, 0.203, 261, 251, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 016 A MK1775 ANALOUGUE
4249, 5vc4A, 0.7615, 3.05, 0.204, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB-ISOMER
4250, 5o2cA, 0.7615, 3.21, 0.253, 368, 257, CRYSTAL STRUCTURE OF WNK3 KINASE AND CCT1 DIDOMAIN IN A UNPHOSPHORYLATED STATE
4251, 5o13A, 0.7615, 2.68, 0.237, 270, 245, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL-MOLECULE INHIBITOR
4252, 5ceqA, 0.7615, 2.36, 0.307, 269, 241, DLK IN COMPLEX WITH INHIBITOR 2-((1-CYCLOPENTYL-5-(1-(OXETAN-3-YL) PIPERIDIN-4-YL)-1H-PYRAZOL-3-YL)AMINO)ISONICOTINONITRILE
4253, 4yp8C, 0.7615, 2.88, 0.273, 287, 249, IRAK4-INHIBITOR CO-STRUCTURE
4254, 4mh7A, 0.7615, 1.98, 0.326, 248, 233, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1896
4255, 2cgxA, 0.7615, 3.40, 0.263, 265, 255, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4256, 4c3rA, 0.7614, 2.79, 0.244, 252, 246, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP
4257, 2zoqA, 0.7614, 3.44, 0.203, 351, 261, STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
4258, 2x7fC, 0.7614, 2.74, 0.238, 285, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
4259, 2x7fA, 0.7614, 2.67, 0.240, 276, 246, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
4260, 2objA, 0.7614, 2.80, 0.219, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
4261, 1pxpA, 0.7614, 2.98, 0.224, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(24-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]- N N -DIMETHYL-BENZENE-14-DIAMINE
4262, 1pxiA, 0.7614, 3.01, 0.220, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(25-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE
4263, 5f95B, 0.7613, 3.26, 0.230, 338, 257, CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH COMPOUND 18: 2- [(CYCLOPROPYLCARBONYL)AMINO]-N-(4-PHENYLPYRIDIN-3-YL)PYRIDINE-4- CARBOXAMIDE
4264, 5ceiA, 0.7613, 3.21, 0.191, 345, 256, CRYSTAL STRUCTURE OF CDK8:CYCLIN C COMPLEX WITH COMPOUND 22
4265, 4u44B, 0.7613, 3.05, 0.217, 296, 254, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 16)
4266, 4qyyA, 0.7613, 3.46, 0.216, 337, 259, DISCOVERY OF NOVEL DUAL MECHANISM ERK INHIBITORS BY AFFINITY SELECTION SCREENING OF AN INACTIVE KINASE STATE
4267, 5ztnB, 0.7612, 3.11, 0.213, 395, 253, THE CRYSTAL STRUCTURE OF HUMAN DYRK2 IN COMPLEX WITH CURCUMIN 
4268, 5w5qB, 0.7612, 3.03, 0.217, 297, 254, MAP4K4 IN COMPLEX WITH INHIBITOR COMPOUND 12 (N3-METHYL-10-(3-METHYL- 3-(5-METHYLOXAZOL-2-YL)BUT-1-YN-1-YL)-6;7-DIHYDRO-5H-5;7- METHANOBENZO[C]IMIDAZO[1;2-A]AZEPINE-2;3-DICARBOXAMIDE) 
4269, 5oktA, 0.7612, 3.44, 0.216, 285, 264, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
4270, 5aneA, 0.7612, 2.92, 0.225, 294, 249, CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH 6-METHOXY-7H- PURINE PROCESSED WITH THE CRYSTALDIRECT AUTOMATED MOUNTING AND CRYO-COOLING TECHNOLOGY
4271, 4yo6A, 0.7612, 2.92, 0.273, 286, 249, IRAK4-INHIBITOR CO-STRUCTURE
4272, 4yljD, 0.7612, 2.92, 0.228, 347, 250, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
4273, 4oboA, 0.7612, 2.77, 0.239, 275, 247, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 22) 6-(3-CHLOROPHENYL) QUINAZOLIN-4-AMINE
4274, 4lgdB, 0.7612, 2.95, 0.233, 350, 253, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4275, 3rpoA, 0.7612, 3.00, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156
4276, 3r73A, 0.7612, 3.00, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164
4277, 2hxqA, 0.7612, 3.44, 0.259, 272, 255, CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
4278, 1omwA, 0.7612, 3.34, 0.180, 614, 261, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS
4279, 5w5oN, 0.7611, 2.30, 0.258, 272, 240, IDENTIFICATION OF POTENT AND SELECTIVE RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES.
4280, 5nxdA, 0.7611, 2.30, 0.283, 271, 240, LIM DOMAIN KINASE 2 (LIMK2) IN COMPLEX WITH TH-300
4281, 5nhvA, 0.7611, 3.27, 0.210, 345, 257, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
4282, 4zy5A, 0.7611, 3.03, 0.221, 283, 253, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 17
4283, 4rblA, 0.7611, 2.70, 0.236, 271, 246, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE DERIVATIVES
4284, 4k9yA, 0.7611, 3.17, 0.362, 271, 254, FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-[4-(6-AMINO- PURIN-9-YL)-PHENYL]-3-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-UREA
4285, 4ijpB, 0.7611, 3.04, 0.198, 333, 253, CRYSTAL STRUCTURE OF HUMAN PRPF4B KINASE DOMAIN IN COMPLEX WITH 4-{5- [(2-CHLORO-PYRIDIN-4-YLMETHYL)-CARBAMOYL]-THIOPHEN-2-YL}- BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMINE
4286, 4ifcB, 0.7611, 3.01, 0.194, 329, 252, CRYSTAL STRUCTURE OF ADP-BOUND HUMAN PRPF4B KINASE DOMAIN
4287, 4acdB, 0.7611, 3.25, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4288, 3unjA, 0.7611, 2.92, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31
4289, 3pxfA, 0.7611, 3.16, 0.210, 302, 252, CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
4290, 2gmxB, 0.7611, 3.30, 0.197, 357, 259, SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
4291, 1m7nA, 0.7611, 2.93, 0.312, 299, 250, CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
4292, 4mq2B, 0.7610, 2.89, 0.225, 338, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4293, 4hglA, 0.7610, 3.48, 0.170, 302, 264, CRYSTAL STRUCTURE OF CK1G3 WITH COMPOUND 1
4294, 4dglC, 0.7610, 3.31, 0.195, 334, 256, CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME
4295, 3ztxB, 0.7610, 2.95, 0.203, 272, 251, AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN.
4296, 3kk8A, 0.7610, 3.39, 0.254, 283, 260, CAMKII SUBSTRATE COMPLEX A
4297, 2xneA, 0.7610, 2.71, 0.246, 246, 244, STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
4298, 2xixA, 0.7610, 2.73, 0.232, 272, 246, PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
4299, 2clxA, 0.7610, 2.98, 0.225, 293, 249, 4-ARYLAZO-35-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY CRYSTAL STRUCTURE IN COMPLEX WITH CDK2 SELECTIVITY AND CELLULAR EFFECTS
4300, 5to8A, 0.7609, 2.41, 0.357, 250, 241, SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF FAK INHIBITORS IMPROVES PYK2 POTENCY
4301, 5n5lA, 0.7609, 2.77, 0.227, 271, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND [2-OXO-2-(1H-PYRROL-2-YL)ETHYL] 5-BROMO-1H- INDOLE-3-CARBOXYLATE
4302, 5hlpA, 0.7609, 3.25, 0.246, 337, 256, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937
4303, 4accB, 0.7609, 3.24, 0.230, 350, 257, GSK3B IN COMPLEX WITH INHIBITOR
4304, 3sv0A, 0.7609, 3.55, 0.201, 294, 264, CRYSTAL STRUCTURE OF CASEIN KINASE-1 LIKE PROTEIN IN PLANT
4305, 3qzgA, 0.7609, 2.96, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76
4306, 3cr0A, 0.7609, 2.70, 0.199, 257, 246, WEE1 KINASE COMPLEX WITH INHIBITOR PD259_809
4307, 2cgvA, 0.7609, 3.43, 0.266, 264, 256, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4308, 4yu2D, 0.7608, 2.92, 0.228, 346, 250, CRYSTAL STRUCTURE OF DYRK1A WITH HARMINE-DERIVATIZED ANNH-75 INHIBITOR
4309, 4u41A, 0.7608, 2.77, 0.239, 275, 247, MAP4K4 BOUND TO INHIBITOR COMPOUND 1
4310, 4iaaA, 0.7608, 2.77, 0.235, 272, 247, CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE
4311, 4hnfB, 0.7608, 3.37, 0.221, 290, 263, CRYSTAL STRUCTURE OF CK1D IN COMPLEX WITH PF4800567
4312, 3kk9A, 0.7608, 3.17, 0.254, 275, 256, CAMKII SUBSTRATE COMPLEX B
4313, 2qoqA, 0.7608, 3.01, 0.313, 284, 249, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BASE AMP-PNP BOUND STRUCTURE
4314, 1q8zA, 0.7608, 3.03, 0.190, 354, 253, THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P
4315, 4ztnC, 0.7607, 2.92, 0.262, 284, 248, IRAK4-INHIBITOR CO-STRUCTURE
4316, 4yljB, 0.7607, 2.94, 0.228, 347, 250, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-IODO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLINE-6-CARBOXYLIC ACID INHIBITOR 5J
4317, 4apcA, 0.7607, 2.85, 0.204, 293, 250, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1)
4318, 3r8zA, 0.7607, 2.95, 0.225, 290, 249, CDK2 IN COMPLEX WITH INHIBITOR RC-1-136
4319, 5ur1B, 0.7606, 2.97, 0.357, 265, 249, FGFR1 KINASE DOMAIN COMPLEX WITH SN37333 IN REVERSIBLE BINDING MODE
4320, 4l3pA, 0.7606, 2.38, 0.270, 295, 241, CRYSTAL STRUCTURE OF 2-(1-BENZOTHIOPHEN-7-YL)-4-[1-(PIPERIDIN-4-YL)- 1H-PYRAZOL-4-YL]FURO[23-C]PYRIDIN-7-AMINE BOUND TO TAK1-TAB1
4321, 4iq6B, 0.7606, 3.20, 0.230, 332, 256, GSK-3BETA WITH INHIBITOR 6-CHLORO-N-CYCLOHEXYL-4-(1H-PYRROLO[23- B]PYRIDIN-3-YL)PYRIDIN-2-AMINE
4322, 4bibA, 0.7606, 2.46, 0.241, 254, 241, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4323, 2x8dA, 0.7606, 3.64, 0.256, 279, 258, DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
4324, 2vwuA, 0.7606, 2.54, 0.281, 253, 242, EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
4325, 1j3hB, 0.7606, 3.15, 0.252, 327, 254, CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
4326, 1howA, 0.7606, 3.15, 0.205, 346, 254, THE X-RAY CRYSTAL STRUCTURE OF SKY1P AN SR PROTEIN KINASE IN YEAST
4327, 5n5mA, 0.7605, 2.78, 0.231, 272, 247, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND (R)-3-(2-((ISOQUINOLIN-5-YLMETHYL)(METHYL) CARBAMOYL)PHENYL)PYRROLIDIN-1-IUM
4328, 4kspA, 0.7605, 2.75, 0.268, 257, 246, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
4329, 4afjA, 0.7605, 3.10, 0.233, 342, 253, 5-ARYL-4-CARBOXAMIDE-13-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4330, 3kvwA, 0.7605, 3.00, 0.208, 403, 250, CRYSTAL STRUCTURE OF DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2 (DYRK2) IN COMPLEX WITH AN INDIRUBIN LIGAND
4331, 2jd5B, 0.7605, 3.29, 0.185, 360, 259, SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
4332, 2g01A, 0.7605, 3.32, 0.189, 355, 259, PYRAZOLOQUINOLONES AS NOVEL SELECTIVE JNK1 INHIBITORS
4333, 5vo2A, 0.7604, 2.38, 0.307, 269, 241, DLK IN COMPLEX WITH INHIBITOR 5-(1-ISOPROPYL-5-(1-(OXETAN-3-YL) PIPERIDIN-4-YL)-1H-PYRAZOL-3-YL)-3-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE (COMPOUND 7)
4334, 5vd9A, 0.7604, 3.07, 0.200, 261, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 097 A MK1775 ANALOGUE
4335, 4mq1B, 0.7604, 2.89, 0.225, 340, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4336, 4azfA, 0.7604, 3.16, 0.206, 404, 253, HUMAN DYRK2 IN COMPLEX WITH LEUCETTINE L41
4337, 1yi4A, 0.7604, 2.74, 0.232, 267, 246, STRUCTURE OF PIM-1 BOUND TO ADENOSINE
4338, 1i44A, 0.7604, 2.81, 0.319, 282, 248, CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
4339, 5t1sA, 0.7603, 2.92, 0.274, 280, 248, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4340, 5imeA, 0.7603, 2.92, 0.217, 280, 249, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 (PAK1) IN COMPLEX WITH COMPOUND 9
4341, 4ztnD, 0.7603, 3.02, 0.272, 285, 250, IRAK4-INHIBITOR CO-STRUCTURE
4342, 4yo6C, 0.7603, 2.82, 0.270, 286, 248, IRAK4-INHIBITOR CO-STRUCTURE
4343, 4r6vA, 0.7603, 2.97, 0.369, 273, 249, CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE HARBORING THE V550L GATE-KEEPER MUTATION IN COMPLEX WITH FIIN-3 AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS
4344, 4j7bD, 0.7603, 3.06, 0.260, 281, 250, CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1
4345, 4aaaA, 0.7603, 3.15, 0.224, 295, 254, CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN
4346, 2cgwA, 0.7603, 3.38, 0.260, 262, 254, IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
4347, 1h4lA, 0.7603, 2.78, 0.219, 278, 247, STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
4348, 5o21A, 0.7602, 3.19, 0.228, 272, 254, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A MONOPHOSPHORYLATED STATE WITH CHLORIDE BOUND IN THE ACTIVE SITE
4349, 5m57A, 0.7602, 2.59, 0.230, 261, 243, NEK2 BOUND TO ARYLAMINOPURINE 6
4350, 5fqdC, 0.7602, 3.47, 0.183, 294, 262, STRUCTURAL BASIS OF LENALIDOMIDE INDUCED CK1A DEGRADATION BY THE CRL4CRBN UBIQUITIN LIGASE
4351, 5c03B, 0.7602, 2.80, 0.235, 260, 247, CRYSTAL STRUCTURE OF KINASE
4352, 4usdA, 0.7602, 2.66, 0.246, 268, 244, HUMAN STK10 (LOK) WITH SB-633825
4353, 4qp3B, 0.7602, 3.25, 0.199, 331, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-2-((9H-PURIN-6-YL) AMINO)-3-PHENYLPROPAN-1-OL
4354, 2ow3B, 0.7602, 3.20, 0.230, 351, 256, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS- (INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
4355, 5m51A, 0.7601, 2.59, 0.230, 260, 243, NEK2 BOUND TO ARYLAMINOPURINE COMPOUND 8
4356, 5kx8C, 0.7601, 3.18, 0.266, 287, 252, IRAK4-INHIBITOR CO-STRUCTURE
4357, 5hlpB, 0.7601, 3.20, 0.235, 335, 255, X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937
4358, 5gjgA, 0.7601, 2.48, 0.281, 289, 242, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 4
4359, 5cepA, 0.7601, 2.40, 0.307, 269, 241, DLK IN COMPLEX WITH INHIBITOR N-(1-ISOPROPYL-5-(PIPERIDIN-4-YL)-1H- PYRAZOL-3-YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
4360, 4usdB, 0.7601, 2.67, 0.246, 267, 244, HUMAN STK10 (LOK) WITH SB-633825
4361, 4lmuA, 0.7601, 2.71, 0.229, 265, 245, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH THE INHIBITOR QUERCETIN (RESULTING FROM DISPLACEMENT OF SKF86002)
4362, 3raiA, 0.7601, 3.01, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160
4363, 5vd2A, 0.7600, 2.95, 0.205, 258, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PF- 03814735
4364, 5vc3A, 0.7600, 2.98, 0.204, 260, 250, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB
4365, 5uq0B, 0.7600, 2.57, 0.379, 256, 243, FGFR1 KINASE DOMAIN COMPLEX WITH FRAGMENT 22-DIMETHYL-23- DIHYDROBENZOFURAN-7-CARBOXAMIDE
4366, 4qp8B, 0.7600, 3.12, 0.209, 337, 253, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-7- (PYRIDIN-3-YL)-5H-PYRROLO[23-B]PYRAZINE
4367, 4mq2D, 0.7600, 2.89, 0.225, 329, 249, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4368, 4kbcA, 0.7600, 3.31, 0.212, 288, 260, CK1D IN COMPLEX WITH {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2- YL}METHANOL INHIBITOR
4369, 4ditA, 0.7600, 3.07, 0.238, 328, 252, CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A IMIDAZOPYRIDINE INHIBITOR
4370, 4b9dA, 0.7600, 2.95, 0.203, 290, 251, CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) WITH INHIBITOR.
4371, 3uolB, 0.7600, 2.86, 0.241, 263, 245, AURORA A IN COMPLEX WITH SO2-162
4372, 3uolA, 0.7600, 2.86, 0.241, 263, 245, AURORA A IN COMPLEX WITH SO2-162
4373, 3py0A, 0.7600, 2.94, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR SU9516
4374, 1yhsA, 0.7600, 2.76, 0.228, 267, 246, CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
4375, 1uwhB, 0.7600, 2.94, 0.264, 264, 250, THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
4376, 1pw2A, 0.7600, 3.04, 0.220, 294, 250, APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
4377, 1hclA, 0.7600, 3.04, 0.220, 294, 250, HUMAN CYCLIN-DEPENDENT KINASE 2
4378, 5fqdF, 0.7599, 3.51, 0.190, 294, 263, STRUCTURAL BASIS OF LENALIDOMIDE INDUCED CK1A DEGRADATION BY THE CRL4CRBN UBIQUITIN LIGASE
4379, 5cswB, 0.7599, 2.50, 0.254, 252, 244, B-RAF IN COMPLEX WITH DABRAFENIB
4380, 4ztnA, 0.7599, 2.96, 0.273, 286, 249, IRAK4-INHIBITOR CO-STRUCTURE
4381, 4twnA, 0.7599, 3.24, 0.313, 276, 252, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH BIRB796
4382, 4lgdD, 0.7599, 2.95, 0.233, 338, 253, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4383, 2gmxA, 0.7599, 3.33, 0.193, 357, 259, SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
4384, 1pxjA, 0.7599, 3.03, 0.220, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(24-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE
4385, 1jpaA, 0.7599, 2.79, 0.280, 273, 246, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
4386, 5y86A, 0.7598, 3.13, 0.198, 391, 252, CRYSTAL STRUCTURE OF KINASE 
4387, 5w4wB, 0.7598, 3.49, 0.216, 291, 264, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
4388, 5fdxA, 0.7598, 3.11, 0.364, 280, 250, STRUCTURE OF DDR1 RECEPTOR TYROSINE KINASE IN COMPLEX WITH D2164 INHIBITOR AT 2.65 ANGSTROMS RESOLUTION.
4389, 3r9hA, 0.7598, 3.01, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-142
4390, 3r71A, 0.7598, 3.04, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162
4391, 2hxlA, 0.7598, 3.48, 0.263, 272, 255, CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
4392, 3qtxA, 0.7597, 2.99, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-35
4393, 3pizA, 0.7597, 2.23, 0.326, 245, 239, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O- TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]- METHANONE
4394, 3og7A, 0.7597, 2.50, 0.263, 247, 243, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
4395, 5t31A, 0.7596, 3.16, 0.212, 334, 255, EXPLOITING AN ASP-GLU SWITCH IN GLYCOGEN SYNTHASE KINASE 3 TO DESIGN PARALOG SELECTIVE INHIBITORS FOR USE IN ACUTE MYELOID LEUKEMIA
4396, 5t1sC, 0.7596, 2.97, 0.263, 284, 247, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4397, 5jrqB, 0.7596, 2.25, 0.272, 246, 239, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-6-VEM
4398, 5hx6B, 0.7596, 2.47, 0.282, 264, 241, CRYSTAL STRUCTURE OF RIP1 KINASE WITH A BENZO[B][14]OXAZEPIN-4-ONE
4399, 5ax9B, 0.7596, 2.70, 0.220, 274, 245, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2 AND NCK- INTERACTING PROTEIN KINASE IN COMPLEX WITH COMPUND 9
4400, 4tn6A, 0.7596, 3.58, 0.230, 292, 265, CK1D IN COMPLEX WITH INHIBITOR
4401, 2broA, 0.7596, 3.53, 0.258, 272, 256, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4402, 1zltA, 0.7596, 3.47, 0.255, 272, 255, CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG
4403, 4u3yB, 0.7595, 3.19, 0.220, 300, 255, APO MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4 (MAP4K4)
4404, 4qp1B, 0.7595, 3.37, 0.202, 343, 258, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
4405, 4pteA, 0.7595, 3.20, 0.235, 341, 255, STRUCTURE OF A CARVOXAMIDE COMPOUND (15) (N-[4-(ISOQUINOLIN-7-YL) PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) TO GSK3B
4406, 4bidA, 0.7595, 2.46, 0.241, 254, 241, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4407, 2b9iA, 0.7595, 3.12, 0.194, 338, 253, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM MSG5
4408, 5x17B, 0.7594, 3.46, 0.223, 289, 264, CRYSTAL STRUCTURE OF MURINE CK1D IN COMPLEX WITH ADP
4409, 4xs2D, 0.7594, 2.86, 0.276, 277, 246, IRAK4-INHIBITOR CO-STRUCTURE
4410, 4fv7A, 0.7594, 3.40, 0.200, 342, 260, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E94
4411, 3qqgA, 0.7594, 2.96, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2-5
4412, 3k2lA, 0.7594, 3.18, 0.209, 402, 253, CRYSTAL STRUCTURE OF DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 2 (DYRK2)
4413, 2wo6A, 0.7594, 3.06, 0.227, 344, 251, HUMAN DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A IN COMPLEX WITH A CONSENSUS SUBSTRATE PEPTIDE
4414, 2vx3B, 0.7594, 2.89, 0.225, 340, 249, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
4415, 5oopA, 0.7593, 3.33, 0.265, 261, 253, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMP-PNP
4416, 5o26B, 0.7593, 3.01, 0.249, 265, 253, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A DIPHOSPHORYLATED STATE AND IN COMPLEX WITH AMP-PNP/MG2+
4417, 5icpA, 0.7593, 3.26, 0.203, 343, 256, CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-CHLORO-PHENYL)-PYRROLIDIN-1-YL]- (5-METHYL-IMIDAZO[51-B][134]THIADIAZOL-2-YL)-METHANONE
4418, 3uzpB, 0.7593, 3.16, 0.223, 284, 256, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
4419, 3tizA, 0.7593, 2.93, 0.229, 293, 249, CDK2 IN COMPLEX WITH NSC 111848
4420, 2cjmA, 0.7593, 2.94, 0.224, 285, 250, MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
4421, 1pxnA, 0.7593, 2.97, 0.224, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL
4422, 4twcB, 0.7592, 3.39, 0.214, 292, 262, 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL)THIAZOLE-4- CARBOXAMIDE DERIVATIVES AS POTENT INHIBITORS OF CK1D/E
4423, 4qp7A, 0.7592, 3.05, 0.198, 337, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 2-(1H-PYRAZOL-4-YL)-5H- PYRROLO[23-B]PYRAZINE
4424, 4iirB, 0.7592, 2.92, 0.192, 327, 250, CRYSTAL STRUCTURE OF AMPPNP-BOUND HUMAN PRPF4B KINASE DOMAIN
4425, 3qqkA, 0.7592, 3.00, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4
4426, 3cs9C, 0.7592, 2.27, 0.349, 243, 238, HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
4427, 2w1eA, 0.7592, 2.82, 0.245, 252, 245, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
4428, 1jstA, 0.7592, 3.21, 0.212, 297, 255, PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
4429, 5w4wA, 0.7591, 3.49, 0.216, 291, 264, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
4430, 5vo1A, 0.7591, 2.41, 0.307, 269, 241, DLK IN COMPLEX WITH COMPOUND 10 (5-(1-ISOPROPYL-5-(3-(OXETAN-3-YL)-3- AZABICYCLO[3.1.0]HEXAN-6-YL)-1H-PYRAZOL-3-YL)-3-(TRIFLUOROMETHYL) PYRIDIN-2-AMINE)
4431, 5ootA, 0.7591, 3.24, 0.267, 260, 251, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- BENZODIAZEPINONE LRRK2 INHIBITOR
4432, 5myvC, 0.7591, 3.42, 0.181, 348, 260, CRYSTAL STRUCTURE OF SRPK2 IN COMPLEX WITH COMPOUND 1
4433, 4kbkB, 0.7591, 3.38, 0.209, 289, 263, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
4434, 4hyiA, 0.7591, 3.42, 0.259, 269, 255, X-RAY CRYSTAL STRUCTURE OF COMPOUND 40 BOUND TO HUMAN CHK1 KINASE DOMAIN
4435, 3qtzA, 0.7591, 3.00, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-36
4436, 3qtqA, 0.7591, 2.94, 0.225, 294, 249, CDK2 IN COMPLEX WITH INHIBITOR RC-1-137
4437, 3o7lD, 0.7591, 3.11, 0.252, 333, 254, CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX
4438, 3eidC, 0.7591, 2.95, 0.216, 290, 250, CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
4439, 4mygA, 0.7590, 3.13, 0.198, 335, 252, MAPK13 ACTIVE FORM
4440, 3s00A, 0.7590, 3.01, 0.220, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L4-14
4441, 2vx3D, 0.7590, 2.89, 0.225, 342, 249, CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY TYROSINE- PHOSPHORYLATION-REGULATED KINASE 1A
4442, 5k5nA, 0.7589, 3.03, 0.239, 331, 251, CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367 A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR
4443, 5jt2A, 0.7589, 2.59, 0.265, 257, 245, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-BISAMIDE
4444, 5d9lA, 0.7589, 3.13, 0.238, 299, 252, RSK2 N-TERMINAL KINASE IN COMPLEX WITH BIS-PHENOL PYRAZOLE
4445, 3q4zA, 0.7589, 2.93, 0.216, 282, 250, STRUCTURE OF UNPHOSPHORYLATED PAK1 KINASE DOMAIN
4446, 2c3kA, 0.7589, 3.43, 0.259, 262, 255, IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
4447, 1yi3A, 0.7589, 2.80, 0.228, 267, 246, CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
4448, 1gngB, 0.7589, 3.29, 0.233, 355, 258, GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
4449, 5vc6A, 0.7588, 3.06, 0.201, 259, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PHA- 848125
4450, 2bikB, 0.7588, 2.78, 0.231, 272, 247, HUMAN PIM1 PHOSPHORYLATED ON SER261
4451, 5v5yA, 0.7587, 3.05, 0.210, 259, 248, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775
4452, 5nxdB, 0.7587, 2.33, 0.279, 271, 240, LIM DOMAIN KINASE 2 (LIMK2) IN COMPLEX WITH TH-300
4453, 5lxdA, 0.7587, 3.13, 0.210, 385, 252, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 1610 (COMPOUND 2)
4454, 5kplA, 0.7587, 3.28, 0.230, 339, 256, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0705
4455, 5drbA, 0.7587, 3.15, 0.260, 273, 254, CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH WNK463
4456, 5cswA, 0.7587, 2.57, 0.253, 254, 245, B-RAF IN COMPLEX WITH DABRAFENIB
4457, 4qp2B, 0.7587, 3.28, 0.207, 329, 256, CRYSTAL STRUCTURE OF ERKS IN COMPLEX WITH 5-CHLOROBENZO[D]OXAZOL-2- AMINE
4458, 4ic7D, 0.7587, 3.40, 0.204, 353, 260, CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT
4459, 4cqeA, 0.7587, 2.55, 0.254, 250, 244, B-RAF KINASE V600E MUTANT IN COMPLEX WITH  A DIARYLTHIAZOLE B-RAF INHIBITOR
4460, 3qxpA, 0.7587, 2.96, 0.210, 294, 248, CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
4461, 3qc4A, 0.7587, 3.11, 0.222, 276, 252, PDK1 IN COMPLEX WITH DFG-OUT INHIBITOR XXX
4462, 3nizA, 0.7587, 3.21, 0.233, 288, 253, CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH ADP BOUND.
4463, 1r0eB, 0.7587, 3.24, 0.233, 344, 257, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR
4464, 6g93A, 0.7586, 3.27, 0.199, 343, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4465, 3uo6B, 0.7586, 2.94, 0.240, 264, 246, AURORA A IN COMPLEX WITH YL5-083
4466, 3uo6A, 0.7586, 2.94, 0.240, 264, 246, AURORA A IN COMPLEX WITH YL5-083
4467, 3rpvA, 0.7586, 2.99, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-88
4468, 3r8uA, 0.7586, 3.03, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-132
4469, 5kplB, 0.7585, 3.23, 0.235, 339, 255, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD0705
4470, 3uysC, 0.7585, 3.49, 0.216, 286, 264, CRYSTAL STRUCTURE OF APO HUMAN CK1D
4471, 3py1A, 0.7585, 2.96, 0.203, 302, 251, CDK2 TERNARY COMPLEX WITH SU9516 AND ANS
4472, 3etaB, 0.7585, 3.01, 0.327, 292, 248, KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
4473, 2qg5A, 0.7585, 3.20, 0.210, 284, 257, CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840
4474, 2p0cB, 0.7585, 2.25, 0.329, 248, 237, CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
4475, 1pf8A, 0.7585, 2.87, 0.226, 298, 248, CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR
4476, 1ia8A, 0.7585, 3.47, 0.267, 272, 255, THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1
4477, 1h4lB, 0.7585, 2.79, 0.219, 278, 247, STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
4478, 6groA, 0.7584, 3.46, 0.160, 293, 263, HUMAN CSNK1G3 BOUND TO SB-223133 
4479, 5lxdB, 0.7584, 3.13, 0.210, 385, 252, CRYSTAL STRUCTURE OF DYRK2 IN COMPLEX WITH EHT 1610 (COMPOUND 2)
4480, 4crlA, 0.7584, 3.23, 0.204, 339, 255, CRYSTAL STRUCTURE OF HUMAN CDK8-CYCLIN C IN COMPLEX WITH CORTISTATIN A
4481, 2ow3A, 0.7584, 3.24, 0.230, 346, 256, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS- (INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
4482, 1r0eA, 0.7584, 3.25, 0.233, 344, 257, GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR
4483, 5o23B, 0.7583, 3.29, 0.228, 278, 254, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A MONOPHOSPHORYLATED APO STATE
4484, 5mzlA, 0.7583, 2.63, 0.221, 269, 244, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE N-QUINOLIN-5-YLPYRIDINE- 3-CARBOXAMIDE
4485, 5anjA, 0.7583, 3.00, 0.224, 291, 250, CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH N-(9H-PURIN-6-YL) THIOPHENE-2-CARBOXAMIDE  PROCESSED WITH THE CRYSTALDIRECT AUTOMATED MOUNTING AND CRYO-COOLING TECHNOLOGY
4486, 5ajqA, 0.7583, 3.04, 0.226, 280, 248, HUMAN LOK (STK10) IN COMPLEX WITH BOSUTINIB
4487, 4lm5A, 0.7583, 2.74, 0.233, 264, 245, CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH 2-{4-[(3-AMINOPROPYL) AMINO]QUINAZOLIN-2-YL}PHENOL (RESULTING FROM DISPLACEMENT OF SKF86002)
4488, 4lghB, 0.7583, 2.12, 0.346, 247, 234, CRYSTAL STRUCTURE OF 1NM-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE
4489, 4erwA, 0.7583, 3.06, 0.225, 292, 249, CDK2 IN COMPLEX WITH STAUROSPORINE
4490, 3s0oA, 0.7583, 2.98, 0.213, 293, 249, CDK2 IN COMPLEX WITH INHIBITOR RC-1-138
4491, 3en7A, 0.7583, 1.80, 0.346, 247, 231, TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH S1 A MULTITARGETED KINASE INHIBITOR
4492, 3c51B, 0.7583, 2.92, 0.246, 461, 248, CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 1 BOUND TO ADP AND MAGNESIUM CHLORIDE AT 3.55A
4493, 4dbnA, 0.7582, 2.88, 0.271, 257, 247, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1 3]THIAZOLO[54-B]PYRIDINE DERIVATIVE
4494, 1jpaB, 0.7582, 2.69, 0.284, 269, 243, CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
4495, 6bu6A, 0.7581, 3.52, 0.162, 322, 265, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A BIS- DIFLUOROPHENOL-AMINOPYRIDINE INHIBITOR
4496, 5vt1A, 0.7581, 3.28, 0.231, 265, 255, CRYSTAL STRUCTURE OF THE HUMAN CAMKK2B BOUND TO A BENZAMIDE INHIBITOR
4497, 4qpaA, 0.7581, 3.22, 0.204, 331, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-BENZYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
4498, 4qp6B, 0.7581, 3.21, 0.200, 334, 255, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 5H-PYRROLO[23-B]PYRAZINE
4499, 1ckjB, 0.7581, 3.41, 0.221, 293, 263, CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
4500, 6dkwB, 0.7580, 2.76, 0.363, 269, 248, CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE INHIBITOR; COMPOUND 3. 
4501, 5gjdA, 0.7580, 2.62, 0.282, 292, 245, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 2
4502, 2ojgA, 0.7580, 3.42, 0.217, 337, 258, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH NN-DIMETHYL-4-(4- PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4503, 2chlA, 0.7580, 3.58, 0.174, 298, 264, STRUCTURE OF CASEIN KINASE 1 GAMMA 3
4504, 5kpmA, 0.7579, 3.23, 0.235, 344, 255, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD3731
4505, 4qp4A, 0.7579, 3.06, 0.198, 337, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
4506, 4ntsB, 0.7579, 3.17, 0.227, 341, 255, APO STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
4507, 2oibC, 0.7579, 2.83, 0.278, 278, 245, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4508, 5idpA, 0.7578, 3.27, 0.200, 342, 255, CDK8-CYCC IN COMPLEX WITH (3-AMINO-1H-INDAZOL-5-YL)-[(S)-2-(4-FLUORO- PHENYL)-PIPERIDIN-1-YL]-METHANONE
4509, 4xhgA, 0.7578, 3.57, 0.186, 357, 264, STRUCTURE OF C. GLABRATA HRR25 BOUND TO ADP (FORMATE CONDITION)
4510, 4h3pA, 0.7578, 3.28, 0.220, 342, 254, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
4511, 3qqhA, 0.7578, 2.98, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2-2
4512, 3p1aA, 0.7578, 3.00, 0.232, 281, 250, STRUCTURE OF HUMAN MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE- SPECIFIC CDC2-INHIBITORY KINASE MYT1 (PKMYT1)
4513, 2x8eA, 0.7578, 3.21, 0.259, 259, 251, DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
4514, 2c3jA, 0.7578, 3.16, 0.252, 257, 250, IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
4515, 1irkA, 0.7578, 3.19, 0.317, 303, 252, CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR
4516, 5c03A, 0.7577, 2.78, 0.236, 260, 246, CRYSTAL STRUCTURE OF KINASE
4517, 4xs2A, 0.7577, 2.91, 0.275, 283, 247, IRAK4-INHIBITOR CO-STRUCTURE
4518, 3qqjA, 0.7577, 3.00, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR L2
4519, 5uitB, 0.7576, 2.91, 0.271, 283, 247, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 14
4520, 4ztsA, 0.7576, 2.70, 0.230, 249, 243, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO FK1142
4521, 4ux9D, 0.7576, 3.16, 0.186, 344, 253, CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF
4522, 4l44A, 0.7576, 3.28, 0.221, 321, 253, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM II)
4523, 3r9dA, 0.7576, 3.03, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-135
4524, 3naxA, 0.7576, 3.13, 0.221, 278, 253, PDK1 IN COMPLEX WITH INHIBITOR MP7
4525, 2izrA, 0.7576, 3.54, 0.160, 298, 263, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4526, 2brbA, 0.7576, 3.52, 0.263, 272, 255, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4527, 6gdqA, 0.7575, 3.29, 0.203, 339, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4528, 5t1tD, 0.7575, 2.99, 0.266, 283, 248, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4529, 4zk5B, 0.7575, 2.97, 0.219, 294, 251, MAP4K4 IN COMPLEX WITH INHIBITOR GNE-495
4530, 4u43B, 0.7575, 3.06, 0.230, 302, 252, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 6)
4531, 4btjB, 0.7575, 3.33, 0.212, 293, 259, TTBK1 IN COMPLEX WITH ATP
4532, 3r8vA, 0.7575, 3.04, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-1-135
4533, 3c4cB, 0.7575, 2.65, 0.256, 257, 246, B-RAF KINASE IN COMPLEX WITH PLX4720
4534, 2xnbA, 0.7575, 3.08, 0.227, 296, 251, DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
4535, 2henA, 0.7575, 2.97, 0.294, 259, 248, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
4536, 4zy6A, 0.7574, 3.18, 0.227, 284, 255, CRYSTAL STRUCTURE OF P21-ACTIVATED KINASE 1 IN COMPLEX WITH AN INHIBITOR COMPOUND 29
4537, 4yp8A, 0.7574, 3.03, 0.265, 284, 249, IRAK4-INHIBITOR CO-STRUCTURE
4538, 3uojB, 0.7574, 2.88, 0.241, 263, 245, AURORA A IN COMPLEX WITH RPM1715
4539, 3uojA, 0.7574, 2.88, 0.241, 263, 245, AURORA A IN COMPLEX WITH RPM1715
4540, 2br1A, 0.7574, 3.52, 0.259, 272, 255, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4541, 1unhA, 0.7574, 2.73, 0.216, 276, 245, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
4542, 5kx7B, 0.7573, 3.12, 0.268, 286, 250, IRAK4-INHIBITOR CO-STRUCTURE
4543, 5buiA, 0.7573, 3.22, 0.217, 338, 254, ERK2 COMPLEXED WITH 2-PYRIDIYL TETRAHYDROAZAINDAZOLE
4544, 4mwiA, 0.7573, 2.78, 0.212, 266, 250, CRYSTAL STRUCTURE OF THE HUMAN MLKL PSEUDOKINASE DOMAIN
4545, 4ae6A, 0.7573, 3.22, 0.263, 319, 255, STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2
4546, 3vw6A, 0.7573, 2.57, 0.240, 255, 242, CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR
4547, 3od6X, 0.7573, 3.39, 0.194, 344, 258, CRYSTAL STRUCTURE OF P38ALPHA Y323T ACTIVE MUTANT
4548, 1p14A, 0.7573, 2.77, 0.321, 287, 246, CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
4549, 6f3dB, 0.7572, 2.96, 0.275, 283, 247, IRAK4 IN COMPLEX WITH INHIBITOR 
4550, 5t31B, 0.7572, 3.19, 0.240, 333, 254, EXPLOITING AN ASP-GLU SWITCH IN GLYCOGEN SYNTHASE KINASE 3 TO DESIGN PARALOG SELECTIVE INHIBITORS FOR USE IN ACUTE MYELOID LEUKEMIA
4551, 5opuA, 0.7572, 3.19, 0.267, 261, 251, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIDINE LRRK2 INHIBITOR
4552, 4mq1C, 0.7572, 2.88, 0.226, 328, 248, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4553, 4ix4A, 0.7572, 3.73, 0.143, 346, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH ADP
4554, 4d4rB, 0.7572, 3.44, 0.368, 270, 258, FOCAL ADHESION KINASE CATALYTIC DOMAIN
4555, 3anqB, 0.7572, 3.00, 0.228, 343, 250, HUMAN DYRK1A/INHIBITOR COMPLEX
4556, 5vc5A, 0.7571, 3.12, 0.195, 261, 251, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH PD- 166285
4557, 3ekkA, 0.7571, 2.76, 0.317, 285, 246, INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
4558, 2ydkA, 0.7571, 3.32, 0.257, 263, 253, DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
4559, 1ungA, 0.7571, 3.10, 0.198, 288, 252, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
4560, 1q3dB, 0.7571, 3.31, 0.233, 339, 257, GSK-3 BETA COMPLEXED WITH STAUROSPORINE
4561, 1pxoA, 0.7571, 3.02, 0.224, 294, 250, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2- YL]-(3-NITRO-PHENYL)-AMINE
4562, 3pj8A, 0.7570, 2.97, 0.225, 288, 249, STRUCTURE OF CDK2 IN COMPLEX WITH A PYRAZOLO[43-D]PYRIMIDINE BIOISOSTERE OF ROSCOVITINE.
4563, 3pj1A, 0.7570, 2.18, 0.329, 241, 237, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(26-DICHLORO- PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-34- DIHYDRO-1H-PYRIMIDO[45-D]PYRIMIDIN-2-ONE
4564, 2oicD, 0.7570, 2.73, 0.279, 284, 244, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
4565, 2in6A, 0.7570, 2.85, 0.220, 256, 245, WEE1 KINASE COMPLEX WITH INHIBITOR PD311839
4566, 1q8yB, 0.7570, 3.26, 0.195, 357, 257, THE STRUCTURE OF THE YEAST SR PROTEIN KINASE SKY1P WITH BOUND ADP
4567, 5o21B, 0.7569, 3.24, 0.228, 273, 254, CRYSTAL STRUCTURE OF WNK3 KINASE DOMAIN IN A MONOPHOSPHORYLATED STATE WITH CHLORIDE BOUND IN THE ACTIVE SITE
4568, 4yzmA, 0.7569, 2.93, 0.259, 260, 247, HUMANIZED ROCO4 BOUND TO LRRK2-IN1
4569, 2w5aA, 0.7569, 3.21, 0.232, 267, 250, HUMAN NEK2 KINASE ADP-BOUND
4570, 2i6lA, 0.7569, 2.94, 0.235, 292, 247, CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6)
4571, 6bu6D, 0.7568, 3.47, 0.163, 318, 263, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A BIS- DIFLUOROPHENOL-AMINOPYRIDINE INHIBITOR
4572, 6b2qB, 0.7568, 2.87, 0.250, 266, 248, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
4573, 5vdaA, 0.7568, 3.07, 0.201, 259, 249, CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV- 101 A MK1775 ANALOGUE
4574, 4zp5B, 0.7568, 3.07, 0.218, 300, 252, MAP4K4 IN COMPLEX WITH INHIBITOR
4575, 4qp9A, 0.7568, 3.12, 0.210, 335, 252, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-PROPYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
4576, 4mq1D, 0.7568, 2.89, 0.226, 336, 248, THE CRYSTAL STRUCTURE OF DYRK1A WITH A BOUND PYRIDO[23-D]PYRIMIDINE INHIBITOR
4577, 3uixA, 0.7568, 2.71, 0.234, 266, 244, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
4578, 3h0yA, 0.7568, 2.77, 0.238, 250, 244, AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
4579, 2oibA, 0.7568, 2.87, 0.273, 280, 245, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4580, 2henC, 0.7568, 2.98, 0.294, 259, 248, CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
4581, 6g9aA, 0.7567, 3.35, 0.211, 341, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4582, 5uiqC, 0.7567, 2.96, 0.267, 280, 247, CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 9
4583, 5oprA, 0.7567, 3.14, 0.269, 258, 249, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMINOPYRIDINE LRRK2 INHIBITOR
4584, 4usfB, 0.7567, 3.19, 0.252, 285, 250, HUMAN SLK WITH SB-440719
4585, 2w5bA, 0.7567, 2.94, 0.234, 271, 248, HUMAN NEK2 KINASE ATPGAMMAS-BOUND
4586, 5op5A, 0.7566, 3.15, 0.264, 259, 250, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIMIDINE LRRK2 INHIBITOR
4587, 5j95B, 0.7566, 3.11, 0.218, 300, 252, MAP4K4 IN COMPLEX WITH INHIBITOR
4588, 4xj0B, 0.7566, 3.55, 0.216, 338, 259, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR 14K
4589, 4wnpB, 0.7566, 3.34, 0.267, 272, 258, STRUCTURE OF ULK1 BOUND TO A POTENT INHIBITOR
4590, 2x7gA, 0.7566, 3.41, 0.170, 344, 259, STRUCTURE OF HUMAN SERINE-ARGININE-RICH PROTEIN-SPECIFIC KINASE 2 (SRPK2) BOUND TO PURVALANOL B
4591, 2w1dA, 0.7566, 2.82, 0.246, 251, 244, STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
4592, 2oibB, 0.7566, 2.70, 0.275, 278, 244, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
4593, 1y6aA, 0.7566, 2.69, 0.322, 261, 242, CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
4594, 5kx8A, 0.7565, 2.96, 0.270, 285, 248, IRAK4-INHIBITOR CO-STRUCTURE
4595, 5flfE, 0.7565, 2.89, 0.382, 258, 246, DISEASE LINKED MUTATION IN FGFR
4596, 4lgdA, 0.7565, 3.01, 0.233, 350, 253, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4597, 3zu7A, 0.7565, 3.47, 0.205, 344, 259, CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE MAP KINASE ERK2
4598, 3unzB, 0.7565, 2.81, 0.242, 263, 244, AURORA A IN COMPLEX WITH RPM1679
4599, 3k54A, 0.7565, 2.27, 0.343, 243, 239, STRUCTURES OF HUMAN BRUTON S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES.
4600, 3unzA, 0.7564, 2.81, 0.242, 263, 244, AURORA A IN COMPLEX WITH RPM1679
4601, 3rkbA, 0.7564, 3.13, 0.224, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR RC-2-73
4602, 2a1aB, 0.7564, 2.72, 0.244, 269, 246, PKR KINASE DOMAIN-EIF2ALPHA COMPLEX
4603, 1buhA, 0.7564, 2.70, 0.218, 287, 243, CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1
4604, 5mqvC, 0.7563, 3.33, 0.211, 288, 261, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
4605, 5c01B, 0.7563, 2.79, 0.228, 260, 246, CRYSTAL STRUCTURE OF KINASE
4606, 3pxyA, 0.7563, 3.00, 0.228, 294, 250, CDK2 IN COMPLEX WITH INHIBITOR JWS648
4607, 3j4rE, 0.7563, 3.18, 0.239, 325, 255, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A LINEAR CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4608, 3j4rD, 0.7563, 3.18, 0.239, 325, 255, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A LINEAR CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4609, 3j4qE, 0.7563, 3.18, 0.239, 325, 255, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A BENT CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4610, 3j4qD, 0.7563, 3.18, 0.239, 325, 255, PSEUDO-ATOMIC MODEL OF THE AKAP18-PKA COMPLEX IN A BENT CONFORMATION DERIVED FROM ELECTRON MICROSCOPY
4611, 3ii5B, 0.7563, 2.91, 0.270, 257, 248, THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
4612, 3anrB, 0.7563, 3.00, 0.224, 342, 250, HUMAN DYRK1A/HARMINE COMPLEX
4613, 2qo2A, 0.7563, 3.14, 0.313, 282, 249, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION DEPHOSPHORYLATED APO STRUCTURE
4614, 5vuaB, 0.7562, 2.81, 0.224, 270, 245, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4615, 5op2A, 0.7562, 3.33, 0.267, 263, 255, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4616, 5di1B, 0.7562, 3.07, 0.218, 300, 252, MAP4K4 IN COMPLEX WITH AN INHIBITOR
4617, 4ztrA, 0.7562, 2.71, 0.230, 249, 243, HUMAN AURORA A CATALYTIC DOMAIN BOUND TO FK1141
4618, 3nlbA, 0.7562, 3.38, 0.258, 261, 252, NOVEL KINASE PROFILE HIGHLIGHTS THE TEMPORAL BASIS OF CONTEXT DEPENDENT CHECKPOINT PATHWAYS TO CELL DEATH
4619, 1unhB, 0.7562, 2.74, 0.212, 276, 245, STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE ALOISINE AND INDIRUBIN.
4620, 5tf9A, 0.7561, 2.87, 0.251, 262, 243, CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH MN2+AMPPNP AND WNK476
4621, 5n51A, 0.7561, 2.63, 0.222, 268, 243, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 34-DIBROMOTHIOPHENE-2-CARBOXYLIC ACID
4622, 3vbwA, 0.7561, 2.60, 0.223, 264, 242, EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4623, 1uwjB, 0.7561, 3.16, 0.267, 263, 251, THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
4624, 5x18A, 0.7560, 3.75, 0.161, 294, 267, CRYSTAL STRUCTURE OF CASEIN KINASE I HOMOLOG 1
4625, 5l6pA, 0.7560, 3.06, 0.282, 274, 248, EPHB3 KINASE DOMAIN COVALENTLY BOUND TO AN IRREVERSIBLE INHIBITOR (COMPOUND 6)
4626, 4l52A, 0.7560, 2.58, 0.272, 295, 243, CRYSTAL STRUCTURE OF 1-(4-{4-[7-AMINO-2-(123-BENZOTHIADIAZOL-7-YL) FURO[23-C]PYRIDIN-4-YL]-1H-PYRAZOL-1-YL}PIPERIDIN-1-YL)ETHAN-1-ONE BOUND TO TAK1-TAB1
4627, 4ix5A, 0.7560, 3.72, 0.143, 346, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH AMP-PNP
4628, 4f9cA, 0.7560, 3.36, 0.187, 306, 256, HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND XL413
4629, 2b9jA, 0.7560, 3.13, 0.194, 337, 252, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM FAR1
4630, 1jqhA, 0.7560, 3.37, 0.315, 291, 257, IGF-1 RECEPTOR KINASE DOMAIN
4631, 5t1tA, 0.7559, 2.96, 0.267, 283, 247, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4632, 5hbeA, 0.7559, 3.20, 0.201, 344, 254, CDK8-CYCC IN COMPLEX WITH 8-[3-CHLORO-5-(1-METHYL-22-DIOXO-2 3- DIHYDRO-1H-2L6-BENZO[C]ISOTHIAZOL-5-YL)-PYRIDIN- 4-YL]-1-OXA-38- DIAZA-SPIRO[4.5]DECAN-2-ONE
4633, 5ar7A, 0.7559, 2.70, 0.246, 278, 244, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH BIARYL UREA
4634, 4ae9A, 0.7559, 3.34, 0.258, 321, 256, STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT C ALPHA 2
4635, 3uytB, 0.7559, 3.31, 0.212, 286, 259, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
4636, 5wg3A, 0.7558, 3.21, 0.204, 618, 255, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG258748
4637, 4q2aA, 0.7558, 3.18, 0.258, 271, 252, WNK1: A CHLORIDE SENSOR VIA AUTOPHOSPHORYLATION
4638, 3oriB, 0.7558, 2.88, 0.232, 267, 246, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 1)
4639, 2qo7A, 0.7558, 3.06, 0.315, 278, 248, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION DEPHOSPHORYLATED AMP-PNP BOUND
4640, 5osmA, 0.7557, 3.12, 0.225, 292, 249, CDK2(F80C C177A) WITH COVALENT ADDUCT AT C80
4641, 5n52A, 0.7557, 2.64, 0.222, 268, 243, CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-3-(23-DIMETHOXYPHENYL)ACRYLIC ACID
4642, 4p4cA, 0.7557, 2.95, 0.304, 266, 247, HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVATIVES
4643, 4mhaB, 0.7557, 1.88, 0.330, 246, 230, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1817
4644, 4ix6A, 0.7557, 3.72, 0.143, 346, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE SOAKED WITH ATP
4645, 2qlqB, 0.7557, 2.09, 0.352, 248, 233, CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
4646, 2iztA, 0.7557, 3.49, 0.172, 296, 262, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4647, 2b9hA, 0.7557, 3.14, 0.194, 337, 252, CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM STE7
4648, 5w4wD, 0.7556, 3.36, 0.212, 287, 260, IDENTIFICATION AND PROFILING OF A SELECTIVE AND BRAIN PENETRANT RADIOLIGAND FOR IN VIVO TARGET OCCUPANCY MEASUREMENT OF CASEIN KINASE 1 (CK1) INHIBITORS
4649, 5t1sD, 0.7556, 2.94, 0.268, 281, 246, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4650, 5o11A, 0.7556, 2.64, 0.218, 268, 243, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL-MOLECULE INHIBITOR
4651, 5nxcL, 0.7556, 2.46, 0.273, 274, 242, LIM DOMAIN KINASE 1 (LIMK1) IN COMPLEX WITH PF-00477736
4652, 5hnbA, 0.7556, 3.22, 0.205, 342, 254, CDK8-CYCC IN COMPLEX WITH [6-HYDROXY-3-(3-METHYL-BENZYL)-1H-INDAZOL-5- YL]-((S)-3-HYDROXY-PYRROLIDIN-1-YL)-METHANONE
4653, 4rvtB, 0.7556, 3.25, 0.220, 297, 254, MAP4K4 IN COMPLEX WITH A PYRIDIN-2(1H)-ONE DERIVATIVE
4654, 4l3lA, 0.7556, 3.24, 0.214, 291, 252, CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN (ZINC ANOMALOUS)
4655, 4bf2A, 0.7556, 2.49, 0.237, 253, 240, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4656, 2ojjA, 0.7556, 3.49, 0.217, 344, 258, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3- CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3- CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4657, 2brmA, 0.7556, 3.33, 0.266, 263, 252, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4658, 1y8yA, 0.7556, 2.91, 0.227, 292, 247, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1 5-A]PYRIMIDINE INHIBITOR
4659, 4z7hA, 0.7555, 3.00, 0.206, 385, 248, CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC KINASE-RNASE REGION - COMPLEX WITH IMIDAZOPYRIDINE COMPOUND 3
4660, 4onaA, 0.7555, 3.25, 0.256, 465, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1517
4661, 3zhpC, 0.7555, 3.17, 0.275, 272, 251, HUMAN MST3 (STK24) IN COMPLEX WITH MO25BETA
4662, 3etaA, 0.7555, 2.95, 0.328, 293, 247, KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
4663, 3anrA, 0.7555, 3.01, 0.228, 342, 250, HUMAN DYRK1A/HARMINE COMPLEX
4664, 5kpmB, 0.7554, 3.25, 0.239, 345, 255, GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH BRD3731
4665, 4l46A, 0.7554, 3.25, 0.230, 317, 252, CRYSTAL STRUCTURES OF HUMAN P70S6K1-WT
4666, 4ix5B, 0.7554, 3.70, 0.147, 350, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH AMP-PNP
4667, 1h0vA, 0.7554, 2.88, 0.224, 288, 246, HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5 -YL]METHOXYPURINE
4668, 5tx5B, 0.7553, 2.50, 0.287, 263, 240, RIP1 KINASE ( FLAG 1-294 C34A C127A C233A C240A) WITH GSK772
4669, 5nguA, 0.7553, 3.36, 0.210, 339, 257, HUMAN ERK2 WITH AN ERK1/2 INHIBITOR
4670, 5ar4A, 0.7553, 2.41, 0.245, 274, 241, RIP2 KINASE CATALYTIC DOMAIN (1 - 310) COMPLEX WITH SB-203580
4671, 3uytC, 0.7553, 3.44, 0.213, 286, 263, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
4672, 3mvjB, 0.7553, 3.23, 0.224, 320, 255, HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
4673, 2bzkB, 0.7553, 2.66, 0.222, 268, 243, CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE
4674, 2a19B, 0.7553, 2.83, 0.240, 263, 246, PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX.
4675, 1jqhC, 0.7553, 3.38, 0.315, 291, 257, IGF-1 RECEPTOR KINASE DOMAIN
4676, 5ukfA, 0.7552, 3.56, 0.166, 322, 265, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE 1 BOUND TO AN OXINDOLE INHIBITOR
4677, 5hieC, 0.7552, 2.53, 0.256, 253, 242, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
4678, 5fdpA, 0.7552, 3.45, 0.354, 285, 254, STRUCTURE OF DDR1 RECEPTOR TYROSINE KINASE IN COMPLEX WITH D2099 INHIBITOR AT 2.25 ANGSTROMS RESOLUTION.
4679, 4xj0A, 0.7552, 3.59, 0.216, 345, 259, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR 14K
4680, 2nryD, 0.7552, 3.13, 0.259, 282, 247, CRYSTAL STRUCTURE OF IRAK-4
4681, 5we8B, 0.7551, 3.04, 0.235, 272, 247, CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH N-{(3R)-1-[(4-CHLOROPHENYL) METHYL]PYRROLIDIN-3-YL}-2-(3-METHOXYPHENYL)-N-METHYLQUINOLINE-4- CARBOXAMIDE (COMPOUND 8)
4682, 4enxA, 0.7551, 2.72, 0.221, 266, 244, CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH INHIBITOR (2E5Z)-2- (2-CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-NITROBENZYLIDENE)THIAZOLIDIN-4- ONE
4683, 3h0zA, 0.7551, 2.64, 0.236, 248, 242, AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
4684, 4yo6D, 0.7550, 3.11, 0.268, 285, 250, IRAK4-INHIBITOR CO-STRUCTURE
4685, 4y73A, 0.7550, 3.13, 0.268, 289, 250, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN WITH INHIBITOR
4686, 4rj3A, 0.7550, 2.94, 0.224, 287, 246, CDK2 WITH EGFR INHIBITOR COMPOUND 8
4687, 4kikB, 0.7550, 3.16, 0.212, 648, 255, HUMAN IKB KINASE BETA
4688, 4enyA, 0.7550, 2.65, 0.226, 261, 243, CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH (2E5Z)-2-(2- CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-METHOXYBENZYLIDENE)THIAZOLIDIN-4- ONE
4689, 4aotA, 0.7550, 2.92, 0.249, 278, 245, CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 (LOK) BOUND TO GW830263A
4690, 3oriA, 0.7550, 2.78, 0.229, 267, 245, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 1)
4691, 2pk9A, 0.7550, 2.93, 0.222, 287, 248, STRUCTURE OF THE PHO85-PHO80 CDK-CYCLIN COMPLEX OF THE PHOSPHATE-RESPONSIVE SIGNAL TRANSDUCTION PATHWAY
4692, 4lynA, 0.7549, 2.91, 0.223, 287, 247, CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2-WT) COMPLEX WITH (2S)-N-(5-(((5-TERT-BUTYL-13-OXAZOL-2-YL)METHYL)SULFANYL)-13- THIAZOL-2-YL)-2-PHENYLPROPANAMIDE
4693, 3anqA, 0.7549, 3.03, 0.228, 342, 250, HUMAN DYRK1A/INHIBITOR COMPLEX
4694, 1i09A, 0.7549, 3.27, 0.231, 338, 255, STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
4695, 1gngA, 0.7549, 3.30, 0.242, 348, 256, GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
4696, 1ckiA, 0.7549, 3.22, 0.218, 292, 257, RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317
4697, 5opbA, 0.7548, 3.29, 0.268, 262, 254, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH INDAZOLE LRRK2 INHIBITOR
4698, 4qyhB, 0.7548, 3.36, 0.259, 264, 251, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE GNE-783
4699, 4ix6B, 0.7548, 3.71, 0.147, 350, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE SOAKED WITH ATP
4700, 5k75C, 0.7547, 2.99, 0.267, 282, 247, IRAK4 IN COMPLEX WITH COMPOUND 1
4701, 4ztmC, 0.7547, 2.81, 0.278, 282, 245, IRAK4-INHIBITOR CO-STRUCTURE
4702, 4f7sA, 0.7547, 3.32, 0.196, 339, 255, CRYSTAL STRUCTURE OF HUMAN CDK8/CYCC IN THE DMG-IN CONFORMATION
4703, 4btjA, 0.7547, 3.45, 0.219, 292, 260, TTBK1 IN COMPLEX WITH ATP
4704, 2x6eA, 0.7547, 2.82, 0.247, 249, 243, AURORA-A BOUND TO AN INHIBITOR
4705, 2oicB, 0.7547, 2.73, 0.278, 276, 241, CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
4706, 5m5aA, 0.7546, 2.75, 0.276, 315, 243, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4707, 5k5nB, 0.7546, 3.24, 0.240, 334, 254, CRYSTAL STRUCTURE OF GSK-3BETA COMPLEXED WITH PF-04802367 A HIGHLY SELECTIVE BRAIN-PENETRANT KINASE INHIBITOR
4708, 5gjfA, 0.7546, 2.65, 0.281, 298, 242, CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH LIGAND 3
4709, 4qygA, 0.7546, 3.27, 0.256, 264, 250, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE COMPOUND 14
4710, 4ix4B, 0.7546, 3.60, 0.140, 350, 264, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE IN COMPLEX WITH ADP
4711, 4ix3A, 0.7546, 3.73, 0.143, 346, 265, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE
4712, 3ormA, 0.7546, 2.81, 0.229, 266, 245, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN D76A MUTANT
4713, 2c5yA, 0.7546, 2.97, 0.227, 290, 247, DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
4714, 4qygB, 0.7545, 3.36, 0.259, 264, 251, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE COMPOUND 14
4715, 3nw6A, 0.7545, 3.18, 0.310, 301, 252, CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11A)
4716, 3anrC, 0.7545, 3.03, 0.224, 337, 250, HUMAN DYRK1A/HARMINE COMPLEX
4717, 1v0bA, 0.7545, 2.92, 0.222, 286, 248, CRYSTAL STRUCTURE OF THE T198A MUTANT OF PFPK5
4718, 5op4A, 0.7544, 3.12, 0.262, 259, 248, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMINOPYRIMIDINE LRRK2 INHIBITOR
4719, 6b8uA, 0.7543, 2.89, 0.271, 253, 247, CRYSTALS STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINYL BENZAMIDE INHIBITOR
4720, 5t1sB, 0.7543, 2.82, 0.272, 282, 243, IRAK4 KINASE - COMPOUND 1 CO-STRUCTURE
4721, 5oorA, 0.7543, 3.36, 0.278, 273, 252, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH STAUROSPORINE
4722, 5acbD, 0.7543, 3.42, 0.243, 319, 259, CRYSTAL STRUCTURE OF THE HUMAN CDK12-CYCLINK COMPLEX
4723, 4xv2A, 0.7543, 2.36, 0.262, 247, 240, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH DABRAFENIB
4724, 1ywnA, 0.7543, 3.26, 0.331, 279, 248, VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[23-D]PYRIMIDINE
4725, 6bruA, 0.7542, 3.59, 0.151, 322, 265, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE BOUND TO A (S)- 2-PHENYLAMINOPTERIDINONE INHIBITOR
4726, 6b2qC, 0.7542, 2.87, 0.243, 264, 247, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
4727, 5oktB, 0.7542, 3.29, 0.212, 281, 259, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH IWP-2 
4728, 5d10A, 0.7542, 2.09, 0.329, 248, 234, KINASE DOMAIN OF CSRC IN COMPLEX WITH RL236
4729, 4rmzA, 0.7542, 3.14, 0.260, 284, 250, CRYSTAL STRUCTURE OF IRAK-4
4730, 3f69A, 0.7542, 2.81, 0.228, 270, 246, CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
4731, 5o12A, 0.7541, 2.57, 0.228, 264, 241, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL-MOLECULE INHIBITOR
4732, 4knbD, 0.7541, 2.58, 0.359, 247, 237, C-MET IN COMPLEX WITH OSI LIGAND
4733, 4iq6A, 0.7541, 3.22, 0.232, 324, 254, GSK-3BETA WITH INHIBITOR 6-CHLORO-N-CYCLOHEXYL-4-(1H-PYRROLO[23- B]PYRIDIN-3-YL)PYRIDIN-2-AMINE
4734, 4cqeB, 0.7541, 2.49, 0.260, 248, 242, B-RAF KINASE V600E MUTANT IN COMPLEX WITH  A DIARYLTHIAZOLE B-RAF INHIBITOR
4735, 2hz0B, 0.7540, 2.17, 0.346, 243, 234, ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
4736, 6cnxA, 0.7539, 3.66, 0.165, 322, 266, CRYSTAL STRUCTURE OF THE HUMAN VACCINIA-RELATED KINASE 1 (VRK1) BOUND TO AN N-PROPYNYL-N-ISOPENTYL-DIHYDROPTERIDIN INHIBITOR
4737, 5osjA, 0.7539, 3.11, 0.224, 292, 250, CDK2(WT) WITH COVALENT ADDUCT AT C177
4738, 4lg4C, 0.7539, 3.19, 0.230, 288, 252, STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4739, 4fv1A, 0.7539, 3.47, 0.218, 342, 257, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK4
4740, 4btmB, 0.7539, 3.37, 0.201, 293, 259, TTBK1 IN COMPLEX WITH INHIBITOR
4741, 3qc4B, 0.7539, 2.86, 0.227, 278, 247, PDK1 IN COMPLEX WITH DFG-OUT INHIBITOR XXX
4742, 2c3iB, 0.7539, 2.75, 0.238, 266, 244, CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I
4743, 2c30A, 0.7539, 3.56, 0.190, 289, 258, CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6
4744, 5ct7B, 0.7538, 2.67, 0.253, 254, 245, BRAF IN COMPLEX WITH RAF265
4745, 4btmA, 0.7538, 3.40, 0.208, 292, 259, TTBK1 IN COMPLEX WITH INHIBITOR
4746, 3vugA, 0.7538, 3.37, 0.198, 356, 257, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M2 IN MAP KINASE JNK1
4747, 3dtcA, 0.7538, 2.14, 0.355, 245, 234, CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16
4748, 3c7qA, 0.7538, 3.19, 0.331, 286, 248, STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120
4749, 5k75D, 0.7537, 2.96, 0.272, 280, 246, IRAK4 IN COMPLEX WITH COMPOUND 1
4750, 5hieB, 0.7537, 2.91, 0.270, 259, 248, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
4751, 5c01A, 0.7537, 2.77, 0.229, 258, 245, CRYSTAL STRUCTURE OF KINASE
4752, 4nt4A, 0.7537, 3.43, 0.168, 300, 262, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF GILGAMESH ISOFORM I FROM DROSOPHILA MELANOGASTER
4753, 4ifgA, 0.7537, 3.26, 0.252, 452, 254, CRYSTAL STRUCTURE OF TGCDPK1 WITH INHIBITOR BOUND
4754, 3teiA, 0.7537, 3.12, 0.211, 339, 251, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE
4755, 5vubB, 0.7536, 2.82, 0.230, 269, 244, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4756, 5oq6A, 0.7536, 3.26, 0.273, 257, 249, STRUCTURE OF CHK1 12-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- BENZODIAZEPINONE LRRK2 INHIBITOR
4757, 5opvA, 0.7536, 3.19, 0.261, 261, 249, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIDINE LRRK2 INHIBITOR
4758, 5hidB, 0.7536, 2.84, 0.267, 269, 247, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH AZ628
4759, 4xv2B, 0.7536, 2.57, 0.259, 249, 243, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH DABRAFENIB
4760, 4umqA, 0.7536, 2.98, 0.286, 314, 245, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4761, 4u41B, 0.7536, 3.13, 0.218, 297, 252, MAP4K4 BOUND TO INHIBITOR COMPOUND 1
4762, 4oboB, 0.7536, 3.07, 0.219, 297, 251, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 22) 6-(3-CHLOROPHENYL) QUINAZOLIN-4-AMINE
4763, 2qodA, 0.7536, 3.13, 0.315, 274, 248, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y602F MUTANT
4764, 2jiiB, 0.7536, 3.42, 0.161, 326, 261, STRUCTURE OF VACCINIA RELATED KINASE 3
4765, 4l3jA, 0.7535, 3.31, 0.218, 291, 252, CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN
4766, 4ix3B, 0.7535, 3.78, 0.139, 350, 266, CRYSTAL STRUCTURE OF A STT7 HOMOLOG FROM MICROMONAS ALGAE
4767, 3w55A, 0.7535, 3.07, 0.217, 335, 249, THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083
4768, 2v0dA, 0.7535, 2.98, 0.223, 292, 247, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
4769, 2ojiA, 0.7535, 3.51, 0.217, 344, 258, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3- CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
4770, 2j4zB, 0.7535, 3.09, 0.242, 269, 248, STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
4771, 5i5zA, 0.7534, 3.23, 0.206, 345, 253, CDK8-CYCC IN COMPLEX WITH 8-(1-METHYL-22-DIOXO-23-DIHYDRO-1H-2L6- BENZO[C]ISOTHIAZOL-5-YL)-[16]NAPHTHYRIDINE-2-CARBOXYLIC ACID METHYLAMIDE
4772, 3o71A, 0.7534, 3.35, 0.215, 340, 256, CRYSTAL STRUCTURE OF ERK2/DCC PEPTIDE COMPLEX
4773, 2uzoA, 0.7534, 2.90, 0.227, 290, 247, CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
4774, 2qvsE, 0.7534, 3.17, 0.228, 323, 254, CRYSTAL STRUCTURE OF TYPE IIA HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
4775, 5nzzE, 0.7533, 3.12, 0.208, 343, 250, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4776, 4umrA, 0.7533, 3.00, 0.286, 313, 245, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4777, 4qyeA, 0.7533, 3.37, 0.267, 271, 251, CHK1 KINASE DOMAIN IN COMPLEX WITH DIARYLPYRAZINE COMPOUND 1
4778, 4fv3A, 0.7533, 3.49, 0.218, 346, 257, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6
4779, 5oq8A, 0.7532, 3.28, 0.261, 261, 253, STRUCTURE OF CHK1 12-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4780, 4wg5A, 0.7532, 3.28, 0.256, 464, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1647
4781, 4umpD, 0.7532, 3.27, 0.278, 321, 252, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4782, 4rvmA, 0.7532, 3.38, 0.267, 264, 251, CHK1 KINASE DOMAIN WITH DIAZACARBAZOLE COMPOUND 19
4783, 2qoiA, 0.7532, 3.14, 0.315, 274, 248, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F DOUBLE MUTANT
4784, 1pxlA, 0.7532, 2.94, 0.228, 290, 246, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(24-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]- (4-TRIFLUOROMETHYL-PHENYL)-AMINE
4785, 1jqhB, 0.7532, 3.42, 0.315, 287, 257, IGF-1 RECEPTOR KINASE DOMAIN
4786, 4qpaB, 0.7531, 3.43, 0.210, 345, 257, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH 7-(1-BENZYL-1H-PYRAZOL-4- YL)-2-(PYRIDIN-4-YL)-5H-PYRROLO[23-B]PYRAZINE
4787, 4g9rB, 0.7531, 3.06, 0.269, 261, 249, B-RAF V600E KINASE DOMAIN BOUND TO A TYPE II DIHYDROQUINAZOLINE INHIBITOR
4788, 2brgA, 0.7531, 3.25, 0.261, 257, 249, STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
4789, 5tvtA, 0.7530, 2.99, 0.283, 321, 247, STRUCTURE OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE
4790, 5kx8D, 0.7530, 3.14, 0.258, 283, 248, IRAK4-INHIBITOR CO-STRUCTURE
4791, 5a4lB, 0.7530, 3.05, 0.225, 339, 249, DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT
4792, 4xhlA, 0.7530, 3.31, 0.175, 330, 257, STRUCTURE OF S. CEREVISIAE HRR25 1-394 (K38R MUTANT)
4793, 4wuaA, 0.7530, 3.48, 0.193, 344, 259, CRYSTAL STRUCTURE OF HUMAN SRPK1 COMPLEXED TO AN INHIBITOR SRPIN340
4794, 4qyhA, 0.7530, 3.29, 0.260, 264, 250, CHK1 KINASE DOMAIN IN COMPLEX WITH DIAZACARBAZOLE GNE-783
4795, 4ficB, 0.7530, 2.04, 0.351, 245, 231, KINASE DOMAIN OF CSRC IN COMPLEX WITH A HINGE REGION-BINDING FRAGMENT
4796, 3vukA, 0.7530, 3.38, 0.198, 355, 257, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M5 IN MAP KINASE JNK1
4797, 3h0zC, 0.7530, 2.58, 0.237, 246, 240, AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
4798, 4ftiA, 0.7529, 3.41, 0.263, 270, 251, CRYSTAL STRUCTURE OF THE CHK1
4799, 3vudA, 0.7529, 3.31, 0.195, 355, 256, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M1 IN MAP KINASE JNK1
4800, 5xyzB, 0.7528, 1.86, 0.320, 234, 231, THE STRUCTURE OF HUMAN BTK KINASE DOMAIN IN COMPLEX WITH A COVALENT INHIBITOR 
4801, 5wngB, 0.7528, 3.01, 0.222, 365, 248, X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 
4802, 5mahA, 0.7528, 2.89, 0.275, 316, 244, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4803, 5hieA, 0.7528, 2.93, 0.263, 258, 247, BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH DABRAFENIB
4804, 5a54B, 0.7528, 3.10, 0.224, 339, 250, DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
4805, 4ihpA, 0.7528, 3.26, 0.248, 454, 254, CRYSTAL STRUCTURE OF TGCDPK1 WITH INHIBITOR BOUND
4806, 4fg8B, 0.7528, 2.58, 0.242, 268, 240, CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-315 IN COMPLEX WITH ATP
4807, 4aotB, 0.7528, 3.01, 0.251, 279, 247, CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 (LOK) BOUND TO GW830263A
4808, 1cm8B, 0.7528, 3.09, 0.188, 327, 250, PHOSPHORYLATED MAP KINASE P38-GAMMA
4809, 1cm8A, 0.7528, 3.09, 0.188, 327, 250, PHOSPHORYLATED MAP KINASE P38-GAMMA
4810, 6g9hA, 0.7527, 3.40, 0.219, 343, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4811, 5vdkA, 0.7527, 2.96, 0.207, 260, 246, CRYSTAL STRUCTURE OF HUMAN WEE2 KINASE DOMAIN IN COMPLEX WITH MK1775
4812, 5hbjA, 0.7527, 3.18, 0.209, 342, 253, CDK8-CYCC IN COMPLEX WITH 8-[2-AMINO-3-CHLORO-5-(1-METHYL-1H-INDAZOL- 5-YL)-PYRIDIN-4-YL]-28-DIAZA-SPIRO[4.5]DECAN-1-ONE
4813, 3oz6B, 0.7527, 2.92, 0.230, 341, 248, CRYSTAL STRUCTURE OF MAPK FROM CRYPTOSPORIDIUM PARVUM CGD2_1960
4814, 3lfnA, 0.7527, 2.84, 0.229, 285, 245, CRYSTAL STRUCTURE OF CDK2 WITH SAR57 AN AMINOINDAZOLE TYPE INHIBITOR
4815, 2qq7B, 0.7527, 1.86, 0.348, 244, 230, CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
4816, 2qg5D, 0.7527, 3.26, 0.215, 283, 256, CRYPTOSPORIDIUM PARVUM CALCIUM DEPENDENT PROTEIN KINASE CGD7_1840
4817, 2c69A, 0.7527, 2.99, 0.223, 292, 247, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
4818, 5w8rA, 0.7526, 3.28, 0.256, 456, 254, TOXOPLASMA GONDII CDPK1 IN COMPLEX WITH INHIBITOR 3CIB-PPI
4819, 5oq7B, 0.7526, 3.13, 0.277, 256, 249, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4820, 5d9kB, 0.7526, 3.07, 0.200, 280, 250, RSK2 N-TERMINAL KINASE IN COMPLEX WITH BI-D1870
4821, 4ztnB, 0.7526, 2.81, 0.272, 282, 243, IRAK4-INHIBITOR CO-STRUCTURE
4822, 4usfA, 0.7526, 3.07, 0.258, 277, 248, HUMAN SLK WITH SB-440719
4823, 4qp1A, 0.7526, 3.36, 0.207, 342, 256, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-CYCLOHEXYL-9H-PURIN-6- AMINE
4824, 4obqB, 0.7526, 2.98, 0.220, 293, 250, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 31) N-[3-(4- AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PYRROLIDIN-1-YL)ACETAMIDE
4825, 3vuhA, 0.7526, 3.31, 0.195, 355, 256, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M3 IN MAP KINASE JNK1
4826, 3uytA, 0.7526, 3.33, 0.219, 287, 260, CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
4827, 2ofvB, 0.7526, 2.10, 0.353, 244, 232, CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
4828, 2c6oA, 0.7526, 2.94, 0.227, 290, 247, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
4829, 2c3lA, 0.7526, 3.38, 0.267, 265, 251, IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
4830, 1wzyA, 0.7526, 3.49, 0.213, 350, 258, CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
4831, 5vucB, 0.7525, 2.84, 0.221, 269, 244, PIM1 KINASE IN COMPLEX WITH A BENZOFURANONE INHIBITOR
4832, 5l4qB, 0.7525, 3.02, 0.212, 287, 245, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE 1 (AAK1) IN COMPLEX WITH LKB1 (AAK1 DUAL INHIBITOR)
4833, 4yc6E, 0.7525, 2.98, 0.211, 285, 247, CDK1/CKS1
4834, 4mx9A, 0.7525, 3.31, 0.256, 459, 254, CDPK1 FROM NEOSPORA CANINUM IN COMPLEX WITH INHIBITOR UW1294
4835, 3hkoA, 0.7525, 3.35, 0.199, 319, 256, CRYSTAL STRUCTURE OF A CDPK KINASE DOMAIN FROM CRYPTOSPORIDIUM PARVUM CGD7_40
4836, 5ih5A, 0.7524, 3.33, 0.224, 286, 259, HUMAN CASEIN KINASE 1 ISOFORM DELTA (KINASE DOMAIN) IN COMPLEX WITH EPIBLASTIN A
4837, 5ebzJ, 0.7524, 3.27, 0.239, 655, 259, CRYSTAL STRUCTURE OF HUMAN IKK1
4838, 4m84A, 0.7524, 3.30, 0.256, 464, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1455
4839, 4m3qA, 0.7524, 1.90, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1917
4840, 3zhpD, 0.7524, 3.06, 0.277, 264, 249, HUMAN MST3 (STK24) IN COMPLEX WITH MO25BETA
4841, 3ot3A, 0.7524, 3.28, 0.260, 259, 250, X-RAY CRYSTAL STRUCTURE OF COMPOUND 22K BOUND TO HUMAN CHK1 KINASE DOMAIN
4842, 2qooA, 0.7524, 3.14, 0.310, 273, 248, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F:Y602F:Y742F TRIPLE MUTANT
4843, 2qofA, 0.7524, 3.15, 0.315, 280, 248, HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION Y596F MUTANT
4844, 6g91A, 0.7523, 3.32, 0.199, 344, 256, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4845, 5w80A, 0.7523, 3.28, 0.256, 453, 254, TOXOPLASMA GONDII CDPK1 IN COMPLEX WITH INHIBITOR GXJ-237
4846, 4joaA, 0.7523, 2.37, 0.309, 250, 236, CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 7-AZAINDOLE BASED INHIBITOR
4847, 2oj9A, 0.7523, 3.22, 0.317, 295, 252, STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR
4848, 1ob3A, 0.7523, 2.94, 0.223, 277, 247, STRUCTURE OF P. FALCIPARUM PFPK5
4849, 5uq1A, 0.7522, 2.98, 0.214, 288, 248, CRYSTAL STRUCTURE OF HUMAN CDK2-SPY1 COMPLEX
4850, 5k00A, 0.7522, 2.75, 0.279, 311, 244, MELK IN COMPLEX WITH NVS-MELK5
4851, 4i5mA, 0.7522, 3.07, 0.226, 273, 248, SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4852, 3q5zA, 0.7522, 3.23, 0.156, 336, 257, CRYSTAL STRUCTURE OF VIRULENT ALLELE ROP5B PSEUDOKINASE DOMAIN
4853, 5w84A, 0.7521, 2.98, 0.269, 279, 245, CRYSTAL STRUCTURE OF IRAK-4 WITH A 46-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)
4854, 4rvkA, 0.7521, 3.49, 0.269, 264, 253, CHK1 KINASE DOMAIN WITH DIAZACARBAZOLE COMPOUND 8: N-[3-(6-CYANO-9H- PYRROLO[23-B:54-C ]DIPYRIDIN-3-YL)PHENYL]ACETAMIDE
4855, 4fv2A, 0.7521, 3.51, 0.218, 344, 257, CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5
4856, 3u9nA, 0.7521, 3.21, 0.269, 257, 249, X-RAY CRYSTAL STRUCTURE OF COMPOUND 1 BOUND TO HUMAN CHK1 KINASE DOMAIN
4857, 3op5A, 0.7521, 3.57, 0.163, 320, 264, HUMAN VACCINIA-RELATED KINASE 1
4858, 2r3oA, 0.7521, 2.88, 0.229, 289, 245, CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
4859, 2io6A, 0.7521, 2.69, 0.212, 252, 241, WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961
4860, 2bdwA, 0.7521, 3.66, 0.245, 309, 261, CRYSTAL STRUCTURE OF THE AUTO-INHIBITED KINASE DOMAIN OF CALCIUM/CALMODULIN ACTIVATED KINASE II
4861, 1j3hA, 0.7521, 3.24, 0.228, 329, 254, CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
4862, 5w9eA, 0.7520, 3.30, 0.256, 451, 254, TOXOPLASMA GONDII CDPK1 IN COMPLEX WITH INHIBITOR GXJ-186
4863, 4fsrA, 0.7520, 3.27, 0.261, 269, 249, CRYSTAL STRUCTURE OF THE CHK1
4864, 1pxkA, 0.7520, 2.99, 0.228, 290, 246, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(24-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]- N -HYDROXYIMINOFORMAMIDE
4865, 4ylkA, 0.7519, 3.14, 0.223, 341, 251, CRYSTAL STRUCTURE OF DYRK1A IN COMPLEX WITH 10-CHLORO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5S
4866, 4fkuA, 0.7519, 3.10, 0.225, 293, 249, CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4867, 3zzwA, 0.7519, 3.10, 0.270, 269, 248, CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF ROR2
4868, 3qbnA, 0.7519, 2.78, 0.238, 250, 244, STRUCTURE OF HUMAN AURORA A IN COMPLEX WITH A DIAMINOPYRIMIDINE
4869, 6b2pA, 0.7518, 2.65, 0.223, 255, 242, DUAL INHIBITION OF THE ESSENTIAL PROTEIN KINASES A AND B IN MYCOBACTERIUM TUBERCULOSIS
4870, 4kbkC, 0.7518, 3.29, 0.209, 280, 258, CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H- PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
4871, 4h58C, 0.7518, 3.03, 0.253, 272, 249, BRAF IN COMPLEX WITH COMPOUND 3
4872, 2c68A, 0.7518, 2.96, 0.223, 290, 247, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
4873, 4yllA, 0.7517, 3.14, 0.223, 340, 251, CRYSTAL STRUCTURE OF DYRK1AA IN COMPLEX WITH 10-BROMO-SUBSTITUTED 11H- INDOLO[32-C]QUINOLONE-6-CARBOXYLIC ACID INHIBITOR 5T
4874, 4ft9A, 0.7517, 3.38, 0.260, 270, 250, CRYSTAL STRUCTURE OF THE CHK1
4875, 3is5F, 0.7517, 3.14, 0.236, 266, 250, CRYSTAL STRUCTURE OF CDPK KINASE DOMAIN FROM TOXOPLASMA GONDII TGME49_018720
4876, 3e3pA, 0.7517, 3.01, 0.180, 337, 250, GLYCOGEN SYNTHASE KINASE FROM LEISHMANIA MAJOR
4877, 1tvoA, 0.7517, 3.44, 0.218, 350, 257, THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
4878, 6bfaA, 0.7516, 3.30, 0.248, 464, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1553
4879, 5xzwB, 0.7516, 2.77, 0.251, 379, 243, CRYSTAL STRUCTURE OF RAD53 1-466
4880, 5w91A, 0.7516, 3.31, 0.252, 451, 254, TOXOPLASMA GONDII CDPK1 IN COMPLEX WITH INHIBITOR LZH118
4881, 5lcjA, 0.7516, 3.33, 0.199, 345, 256, IN-GEL ACTIVITY-BASED PROTEIN PROFILING OF A CLICKABLE COVALENT ERK 1/2 INHIBITOR
4882, 5ih6A, 0.7516, 3.35, 0.224, 286, 259, HUMAN CASEIN KINASE 1 ISOFORM DELTA (KINASE DOMAIN) IN COMPLEX WITH EPIBLASTIN A DERIVATIVE
4883, 4xh0A, 0.7516, 3.39, 0.167, 350, 258, STRUCTURE OF C. GLABRATA HRR25 BOUND TO ADP (SO4 CONDITION)
4884, 4m97A, 0.7516, 3.24, 0.261, 465, 253, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM NEOSPORA CANINUM
4885, 3v5tA, 0.7516, 3.29, 0.252, 460, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1299
4886, 3umwA, 0.7516, 2.85, 0.221, 264, 244, CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR (Z)-2-[(1H- INDAZOL-3-YL)METHYLENE]-6-METHOXY-7-(PIPERAZIN-1-YLMETHYL)BENZOFURAN- 3(2H)-ONE
4887, 3lfsA, 0.7516, 2.97, 0.228, 290, 246, CRYSTAL STRUCTURE OF CDK2 WITH SAR37 AN AMINOINDAZOLE TYPE INHIBITOR
4888, 3lfqA, 0.7516, 2.95, 0.229, 289, 245, CRYSTAL STRUCTURE OF CDK2 WITH SAR60 AN AMINOINDAZOLE TYPE INHIBITOR
4889, 3e3pB, 0.7516, 3.02, 0.180, 337, 250, GLYCOGEN SYNTHASE KINASE FROM LEISHMANIA MAJOR
4890, 2nryC, 0.7516, 3.08, 0.261, 280, 245, CRYSTAL STRUCTURE OF IRAK-4
4891, 1gz8A, 0.7516, 2.93, 0.224, 290, 246, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3 -METHYL-2 -OXO)BUTOXYPURINE
4892, 1e1xA, 0.7516, 2.89, 0.224, 290, 245, HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
4893, 5hvjB, 0.7515, 3.14, 0.273, 284, 249, CRYSTAL STRUCTURE OF LIMK1 D460N MUTANT IN COMPLEX WITH AMP-PNP
4894, 5a4eB, 0.7515, 3.06, 0.225, 322, 249, DYRK1A IN COMPLEX WITH METHOXY BENZOTHIAZOLE FRAGMENT
4895, 4xv3A, 0.7515, 2.34, 0.276, 244, 239, B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX7922
4896, 4s33A, 0.7515, 3.44, 0.206, 347, 257, ERK2 R65S MUTANT COMPLEXED WITH AMP-PNP
4897, 4l43A, 0.7515, 3.38, 0.231, 316, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM I)
4898, 4ibmB, 0.7515, 3.04, 0.317, 294, 249, CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH AN INHIBITOR IRFIN-1
4899, 4ft3A, 0.7515, 3.12, 0.263, 269, 247, CRYSTAL STRUCTURE OF THE CHK1
4900, 4erkA, 0.7515, 3.52, 0.217, 350, 258, THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE
4901, 3vuiA, 0.7515, 3.34, 0.195, 355, 256, CRYSTAL STRUCTURE OF A CYSTEINE-DEFICIENT MUTANT M2 IN MAP KINASE JNK1
4902, 3uysD, 0.7515, 3.31, 0.209, 284, 258, CRYSTAL STRUCTURE OF APO HUMAN CK1D
4903, 5oneA, 0.7514, 3.00, 0.241, 257, 245, CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH FMF-03-145-1 (COMPOUND 2)
4904, 4wg3A, 0.7514, 3.31, 0.248, 460, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1610
4905, 3vw6B, 0.7514, 2.54, 0.237, 253, 240, CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR
4906, 3oroA, 0.7514, 2.97, 0.228, 272, 246, MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 4)
4907, 3nw7A, 0.7514, 3.14, 0.312, 297, 250, CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (34)
4908, 1wccA, 0.7514, 2.78, 0.225, 283, 244, SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
4909, 1wakA, 0.7514, 3.44, 0.190, 353, 258, X-RAY STRUCTURE OF SRPK1
4910, 1b38A, 0.7514, 2.90, 0.224, 290, 245, HUMAN CYCLIN-DEPENDENT KINASE 2
4911, 5xv7A, 0.7513, 3.49, 0.189, 350, 259, SRPK1 IN COMPLEX WITH ALECTINIB
4912, 4yjnA, 0.7513, 3.30, 0.252, 460, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1639
4913, 4l45A, 0.7513, 3.35, 0.227, 317, 251, CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389E
4914, 5w9rA, 0.7512, 3.29, 0.252, 445, 254, TOXOPLASMA GONDII CDPK1 IN COMPLEX WITH INHIBITOR LJQ138
4915, 5mafA, 0.7512, 2.85, 0.292, 315, 243, CRYSTAL STRUCTURE OF MELK IN COMPLEX WITH AN INHIBITOR
4916, 5a4eA, 0.7512, 3.05, 0.225, 341, 249, DYRK1A IN COMPLEX WITH METHOXY BENZOTHIAZOLE FRAGMENT
4917, 4ztlC, 0.7512, 3.17, 0.259, 282, 247, IRAK4-INHIBITOR CO-STRUCTURE
4918, 4mxaA, 0.7512, 3.32, 0.256, 459, 254, CDPK1 FROM NEOSPORA CANINUM IN COMPLEX WITH INHIBITOR RM-1-132
4919, 4jbvA, 0.7512, 3.31, 0.252, 458, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1268
4920, 4bf2B, 0.7512, 2.46, 0.238, 252, 239, CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4921, 3zonA, 0.7512, 2.85, 0.237, 261, 245, HUMAN TYK2 PSEUDOKINASE DOMAIN BOUND TO A KINASE INHIBITOR
4922, 3pa4A, 0.7512, 3.28, 0.257, 257, 249, X-RAY CRYSTAL STRUCTURE OF COMPOUND 2A BOUND TO HUMAN CHK1 KINASE DOMAIN
4923, 2hy0A, 0.7512, 3.42, 0.271, 272, 251, CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22
4924, 2c6kA, 0.7512, 2.96, 0.223, 292, 247, CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
4925, 6g9mA, 0.7511, 3.52, 0.214, 341, 257, FRAGMENT-BASED DISCOVERY OF A HIGHLY POTENT; ORALLY BIOAVAILABLE INHIBITOR WHICH MODULATES THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 
4926, 4fsnA, 0.7511, 3.46, 0.262, 270, 252, CRYSTAL STRUCTURE OF THE CHK1
4927, 3v3vA, 0.7511, 3.29, 0.196, 351, 255, STRUCTURAL AND FUNCTIONAL ANALYSIS OF QUERCETAGETIN A NATURAL JNK1 INHIBITOR
4928, 3p9jA, 0.7511, 2.80, 0.243, 249, 243, AURORA A KINASE DOMAIN WITH PHTHALAZINONE PYRAZOLE INHIBITOR
4929, 3erkA, 0.7511, 3.47, 0.210, 350, 257, THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025
4930, 2izuA, 0.7511, 3.54, 0.160, 297, 262, STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
4931, 1q3dA, 0.7511, 3.36, 0.230, 339, 256, GSK-3 BETA COMPLEXED WITH STAUROSPORINE
4932, 5nzzG, 0.7510, 3.25, 0.207, 342, 251, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4933, 3rp9A, 0.7510, 3.35, 0.209, 350, 253, CRYSTAL STRUCTURE OF THE APO MAPK FROM TOXOPLASMA GONDII 25.M01780 OR TGME49_007820
4934, 5uoxB, 0.7509, 2.60, 0.237, 252, 241, STRUCTURE-BASED DESIGN OF ASK1 INHIBITORS AS POTENTIAL FIRST-IN-CLASS AGENTS FOR HEART FAILURE
4935, 3dxnA, 0.7509, 3.11, 0.275, 258, 247, CRYSTAL STRUCTURE OF THE CALCIUM-DEPENDENT KINASE FROM TOXOPLASMA GONDII 541.M00134 KINASE DOMAIN.
4936, 6f3eB, 0.7508, 3.08, 0.259, 282, 247, IRAK4 IN COMPLEX WITH INHIBITOR 
4937, 4hokM, 0.7508, 3.63, 0.220, 291, 264, CRYSTAL STRUCTURE OF APO CK1E
4938, 4ft7A, 0.7508, 3.38, 0.264, 270, 250, CRYSTAL STRUCTURE OF THE CHK1
4939, 3pa3A, 0.7508, 3.35, 0.272, 259, 250, X-RAY CRYSTAL STRUCTURE OF COMPOUND 70 BOUND TO HUMAN CHK1 KINASE DOMAIN
4940, 3oz6A, 0.7508, 3.17, 0.206, 343, 252, CRYSTAL STRUCTURE OF MAPK FROM CRYPTOSPORIDIUM PARVUM CGD2_1960
4941, 2b9fA, 0.7508, 3.34, 0.217, 337, 253, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FUS3
4942, 5oq7A, 0.7507, 3.25, 0.279, 259, 251, STRUCTURE OF CHK1 8-PT. MUTANT COMPLEX WITH ARYLBENZAMIDE LRRK2 INHIBITOR
4943, 5nzzF, 0.7507, 3.12, 0.201, 341, 249, CRYSTAL STRUCTURE OF PHOSPHORYLATED P38AMAPK IN COMPLEX WITH TAB1 
4944, 4e7wA, 0.7507, 3.28, 0.213, 359, 254, STRUCTURE OF GSK3 FROM USTILAGO MAYDIS
4945, 1nvsA, 0.7507, 3.41, 0.267, 264, 251, THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078
4946, 5a4qB, 0.7506, 3.08, 0.225, 335, 249, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
4947, 4yc6C, 0.7506, 3.01, 0.211, 285, 247, CDK1/CKS1
4948, 4qyfA, 0.7506, 3.34, 0.260, 269, 250, CHK1 KINASE DOMAIN IN COMPLEX WITH AMINOPYRAZINE COMPOUND 13
4949, 4d2tD, 0.7506, 3.34, 0.279, 319, 251, STRUCTURE OF MELK IN COMPLEX WITH INHIBITORS
4950, 1w8cA, 0.7506, 2.94, 0.224, 290, 246, CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H- PURIN-2-YLAMINE AND MONOMERIC CDK2
4951, 1v0pA, 0.7506, 2.93, 0.220, 277, 246, STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX
4952, 1ol6A, 0.7506, 2.58, 0.233, 245, 240, STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A
4953, 6dcgA, 0.7505, 3.38, 0.220, 326, 254, DISCOVERY OF MK-8353: AN ORALLY BIOAVAILABLE DUAL MECHANISM ERK INHIBITOR FOR ONCOLOGY 
4954, 5mqvA, 0.7505, 3.33, 0.216, 286, 259, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
4955, 5hbhA, 0.7505, 3.23, 0.206, 336, 252, CDK8-CYCC IN COMPLEX WITH 5-{5-CHLORO-4-[1-(2-METHOXY-ETHYL)-18- DIAZA-SPIRO[4.5]DEC-8-YL]-PYRIDIN-3-YL}-1-METHYL-13-DIHYDRO- BENZO[C]ISOTHIAZOLE 22-DIOXIDE
4956, 4yc6A, 0.7505, 3.01, 0.211, 285, 247, CDK1/CKS1
4957, 3tkiA, 0.7505, 3.44, 0.270, 272, 252, CRYSTAL STRUCTURE OF CHK1 IN COMPLEX WITH INHIBITOR S25
4958, 3q96A, 0.7505, 2.88, 0.268, 253, 246, B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR
4959, 3comB, 0.7505, 3.16, 0.236, 279, 254, CRYSTAL STRUCTURE OF MST1 KINASE
4960, 5opsA, 0.7504, 3.16, 0.266, 258, 248, STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH PYRROLOPYRIDINE LRRK2 INHIBITOR
4961, 4xs2C, 0.7504, 3.03, 0.264, 281, 246, IRAK4-INHIBITOR CO-STRUCTURE
4962, 4ksqB, 0.7504, 2.80, 0.253, 255, 245, CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR 5B
4963, 3t3vA, 0.7504, 3.32, 0.248, 453, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH BUMPED KINASE INHIBITOR RM-1-87
4964, 3pj3A, 0.7504, 2.13, 0.316, 240, 234, CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)- (3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[45-B]PYRIDIN-6-YL)- BENZAMIDE
4965, 5oatB, 0.7503, 3.39, 0.190, 359, 258, PINK1 STRUCTURE
4966, 5jn2A, 0.7503, 3.33, 0.248, 450, 254, CRYSTAL STRUCTURE OF TGCDPK1 BOUND TO NVPACU106
4967, 5jh6A, 0.7503, 2.31, 0.262, 288, 237, CRYSTAL STRUCTURE OF TL10-92 BOUND TO TAK1-TAB1
4968, 5a4qA, 0.7503, 3.04, 0.225, 341, 249, DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
4969, 4yp8D, 0.7503, 3.17, 0.272, 285, 250, IRAK4-INHIBITOR CO-STRUCTURE
4970, 4tw9B, 0.7503, 3.44, 0.212, 289, 260, DIFLUORO-DIOXOLO-BENZOIMIDAZOL-BENZAMIDES AS POTENT INHIBITORS OF CK1DELTA AND EPSILON WITH NANOMOLAR INHIBITORY ACTIVITY ON CANCER CELL PROLIFERATION
4971, 4fsuA, 0.7503, 3.38, 0.264, 260, 250, CRYSTAL STRUCTURE OF THE CHK1
4972, 4ek5A, 0.7503, 2.97, 0.229, 289, 245, CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4973, 3i79A, 0.7503, 3.30, 0.240, 455, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1)
4974, 4m3qB, 0.7502, 1.69, 0.344, 236, 227, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1917
4975, 3v51A, 0.7502, 3.33, 0.252, 459, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR RM-1-176
4976, 2r3rA, 0.7502, 2.90, 0.229, 290, 245, CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
4977, 1b39A, 0.7502, 2.91, 0.224, 290, 245, HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
4978, 5mqvF, 0.7501, 3.39, 0.215, 286, 260, CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE I DELTA IN COMPLEX WITH 4-(2 5-DIMETHOXYPHENYL)-N-(4-(5-(4-FLUORPHENYL)-2-(METHYLTHIO)-1H- IMIDAZOL-4-YL)-PYRIDIN-2-YL)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDE
4979, 5k76B, 0.7501, 2.86, 0.275, 281, 244, IRAK4 IN COMPLEX WITH COMPOUND 28
4980, 5ih4A, 0.7501, 3.37, 0.224, 286, 259, HUMAN CASEIN KINASE 1 ISOFORM DELTA APO (KINASE DOMAIN)
4981, 4uyaA, 0.7501, 2.35, 0.335, 274, 236, STRUCTURE OF MLK4 KINASE DOMAIN WITH ATPGAMMAS
4982, 4s32A, 0.7501, 3.46, 0.206, 346, 257, CRYSTAL STRUCTURE OF ERK2 AMP-PNP COMPLEX
4983, 3w16A, 0.7501, 2.79, 0.239, 249, 243, STRUCTURE OF AURORA KINASE A COMPLEXED TO PYRAZOLE-AMINOQUINOLINE INHIBITOR III
4984, 3uliA, 0.7501, 2.96, 0.232, 286, 246, HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) BOUND TO AZABENZIMIDAZOLE DERIVATIVE
4985, 3pxqA, 0.7501, 3.01, 0.222, 298, 248, CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
4986, 5valB, 0.7500, 2.78, 0.261, 254, 245, BRAF IN COMPLEX WITH N-(3-(TERT-BUTYL)PHENYL)-4-METHYL-3-(6- MORPHOLINOPYRIMIDIN-4-YL)BENZAMIDE
4987, 4wg4A, 0.7500, 3.34, 0.248, 454, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1613
4988, 4s34A, 0.7500, 3.35, 0.191, 343, 256, ERK2 (I84A) IN COMPLEX WITH AMP-PNP
4989, 4ek4A, 0.7500, 2.97, 0.224, 287, 245, CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4990, 3vapA, 0.7500, 2.85, 0.247, 249, 243, SYNTHESIS AND SAR STUDIES OF IMIDAZO-[12-A]-PYRAZINE AURORA KINASE INHIBITORS WITH IMPROVED OFF TARGET KINASE SELECTIVITY
4991, 3d2kA, 0.7500, 2.65, 0.243, 245, 239, CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY LYS240- >ARG MET302->LEU) IN COMPLEX WITH [7-(2-{2-[3-(3-CHLORO- PHENYL)-UREIDO]-THIAZOL-5-YL}-ETHYLAMINO)-PYRAZOLO[43- D]PYRIMIDIN-1-YL]-ACETIC ACID
4992, 1fotA, 0.7500, 3.17, 0.234, 299, 252, STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE
4993, 5l4qA, 0.7499, 2.71, 0.211, 293, 242, CRYSTAL STRUCTURE OF ADAPTOR PROTEIN 2 ASSOCIATED KINASE 1 (AAK1) IN COMPLEX WITH LKB1 (AAK1 DUAL INHIBITOR)
4994, 4xp2A, 0.7499, 3.47, 0.206, 337, 257, CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
4995, 4u45B, 0.7499, 3.04, 0.220, 295, 250, MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 25)
4996, 4tzrA, 0.7499, 3.33, 0.256, 461, 254, CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN COMPLEX WITH INHIBITOR UW1561
4997, 4eqmE, 0.7499, 2.94, 0.232, 268, 246, STRUCTURAL ANALYSIS OF STAPHYLOCOCCUS AUREUS SERINE/THREONINE KINASE PKNB
4998, 5mhqA, 0.7498, 3.02, 0.220, 291, 246, CCT068127 IN COMPLEX WITH CDK2
4999, 5jt2C, 0.7498, 2.42, 0.280, 251, 239, BRAFV600E KINASE DOMAIN IN COMPLEX WITH CHEMICALLY LINKED VEMURAFENIB INHIBITOR VEM-BISAMIDE
5000, 5jmsA, 0.7498, 3.36, 0.252, 447, 254, CRYSTAL STRUCTURE OF TGCDPK1 BOUND TO CGP060476
